Human Phenotype Ontology 
Grandparent Node:
expand
Abnormality of skin morphology (HP:0011121)help
Parent Node:
expand
Abnormality of the vasculature (HP:0002597)help
Parent Node:
expand
Generalized abnormality of skin (HP:0011354)help
..Starting node
..expand
Vascular skin abnormality (HP:0011276)help
Term ID: 11276
Name: Vascular skin abnormality
Synonym: Skin vascular malformation; Vascular abnormalities restricted to skin
Definition:
Comments:
Reference: HP:0011276
Genes and Diseases:
 
       Child Nodes:
........expandCutis marmorata (HP:0000965) help
........expandTelangiectasia (HP:0001009) help
................... HP:0001232 Nail bed telangiectasia
................... HP:0007489 Diffuse telangiectasia
................... HP:0007583 Telangiectasia macularis eruptiva perstans
................... HP:0007763 Retinal telangiectasia
................... HP:0100579 Mucosal telangiectasiae
................... HP:0100585 Telangiectasia of the skin
........expandAngiokeratoma (HP:0001014) help
................... HP:0001071 Angiokeratoma corporis diffusum
........expandUrticaria (HP:0001025) help
................... HP:0011971 Dermatographic urticaria
................... HP:0025081 Darier's sign
................... HP:0410133 Chronic idiopathic urticaria
................... HP:0410134 Physical urticaria
........expandSubcutaneous hemorrhage (HP:0001933) help
................... HP:0000978 Bruising susceptibility
................... HP:0000979 Purpura
................... HP:0007420 Spontaneous hematomas
........expandProminent superficial blood vessels (HP:0007394) help
................... HP:0001015 Prominent superficial veins
........expandErythema (HP:0010783) help
................... HP:0001041 Facial erythema
................... HP:0025493 Palmoplantar erythema
................... HP:0025535 Shawl sign
................... HP:0025536 V-sign
................... HP:0031180 Erythema migrans
................... HP:0031181 Necrolytic migratory erythema
................... HP:0040323 Erythema of the eyelids
........expandNon-pruritic urticaria (HP:0011137) help
........expandAngioedema (HP:0100665) help
........expandVasculitis in the skin (HP:0200029) help
................... HP:0200030 Punctate vasculitis skin lesions

 Sister Nodes: 
..expandAbnormality of subcutaneous fat tissue (HP:0001001) help
..expandCutaneous photosensitivity (HP:0000992) help
..expandDermatological manifestations of systemic disorders (HP:0001005) help
..expandDesquamation of skin soon after birth (HP:0007549) help
..expandEctodermal dysplasia (HP:0000968) help
..expandFlushing (HP:0031284) help
..expandFragile skin (HP:0001030) help
..expandGeneralized papillary lesions (HP:0007482) help
..expandPoor wound healing (HP:0001058) help
..expandPrematurely aged appearance (HP:0007495) help
..expandSubcutaneous calcification (HP:0007618) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0011276HP:0011276Vascular skin abnormality0ABCC6 CL E G H36857ORPHA:758Pseudoxanthoma elasticum415
HP:0011276HP:0011276Vascular skin abnormality0ABCC9 CL E G H1006060OMIM:619719INTELLECTUAL DISABILITY AND MYOPATHY SYNDROME; IDMYS254
HP:0011276HP:0011276Vascular skin abnormality0ABL1 CL E G H2576OMIM:617602Congenital heart defects and skeletal malformations syndrome51
HP:0011276HP:0011276Vascular skin abnormality0ACP5 CL E G H54124OMIM:607944Spondyloenchondrodysplasia with immune dysregulation16
HP:0011276HP:0011276Vascular skin abnormality0ACTA2 CL E G H59130OMIM:611788AORTIC ANEURYSM, FAMILIAL THORACIC 6; AAT694
HP:0011276HP:0011276Vascular skin abnormality0ACTA2 CL E G H59130ORPHA:91387Familial thoracic aortic aneurysm and aortic dissection94
HP:0011276HP:0011276Vascular skin abnormality0ACTA2 CL E G H59130ORPHA:2573Moyamoya disease94
HP:0011276HP:0011276Vascular skin abnormality0ACVRL1 CL E G H94175ORPHA:774Hereditary hemorrhagic telangiectasia178
HP:0011276HP:0011276Vascular skin abnormality0ACVRL1 CL E G H94175OMIM:600376Telangiectasia, hereditary hemorrhagic, type 2178
HP:0011276HP:0011276Vascular skin abnormality0ADA2 CL E G H518161839OMIM:182410Sneddon syndrome22
HP:0011276HP:0011276Vascular skin abnormality0ADA2 CL E G H518161839ORPHA:820Sneddon syndromeHP:0040281 - Very frequent22
HP:0011276HP:0011276Vascular skin abnormality0ADA2 CL E G H518161839OMIM:615688Vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome22
HP:0011276HP:0011276Vascular skin abnormality0ADAM17 CL E G H6868195OMIM:614328INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 1; NISBD12
HP:0011276HP:0011276Vascular skin abnormality0ADAM17 CL E G H6868195ORPHA:294023Neonatal inflammatory skin and bowel disease2
HP:0011276HP:0011276Vascular skin abnormality0ADAMTS2 CL E G H9509218OMIM:225410Ehlers-Danlos syndrome, type VII, autosomal recessive165
HP:0011276HP:0011276Vascular skin abnormality0ADAR CL E G H103225ORPHA:51Aicardi-Goutières syndrome116
HP:0011276HP:0011276Vascular skin abnormality0ADGRE2 CL E G H308173337OMIM:125630Dermodistortive urticaria2
HP:0011276HP:0011276Vascular skin abnormality0AEBP1 CL E G H165303ORPHA:536532Classical-like Ehlers-Danlos syndrome type 2
HP:0011276HP:0011276Vascular skin abnormality0AEBP1 CL E G H165303OMIM:618000Ehlers-Danlos syndrome, classic-like, 2
HP:0011276HP:0011276Vascular skin abnormality0AGA CL E G H175318OMIM:208400ASPARTYLGLUCOSAMINURIA76
HP:0011276HP:0011276Vascular skin abnormality0AGA CL E G H175318ORPHA:93AspartylglucosaminuriaHP:0040283 - Occasional76
HP:0011276HP:0011276Vascular skin abnormality0AGPAT2 CL E G H10555325ORPHA:528Congenital generalized lipodystrophy85
HP:0011276HP:0011276Vascular skin abnormality0AGXT CL E G H189341OMIM:259900Hyperoxaluria, primary, type I260
HP:0011276HP:0011276Vascular skin abnormality0AIP CL E G H9049358OMIM:219090Pituitary adenoma 4, ACTH-secreting, somatic95
HP:0011276HP:0011276Vascular skin abnormality0AKT1 CL E G H207391ORPHA:201Cowden syndrome54
HP:0011276HP:0011276Vascular skin abnormality0AKT1 CL E G H207391ORPHA:744Proteus syndromeHP:0040281 - Very frequent54
HP:0011276HP:0011276Vascular skin abnormality0AKT3 CL E G H10000393OMIM:615937Megalencephaly-Polymicrogyria-Polydactyly-Hydrocephalus syndrome 219
HP:0011276HP:0011276Vascular skin abnormality0ALDH18A1 CL E G H58329722OMIM:219150Cutis laxa, autosomal recessive, type IIIA89
HP:0011276HP:0011276Vascular skin abnormality0ALDH3A2 CL E G H224403ORPHA:816Sjögren-Larsson syndrome87
HP:0011276HP:0011276Vascular skin abnormality0ALOX12B CL E G H242430OMIM:242100Ichthyosis, congenital, autosomal recessive 275
HP:0011276HP:0011276Vascular skin abnormality0ALOXE3 CL E G H5934413743OMIM:242100Ichthyosis, congenital, autosomal recessive 263
HP:0011276HP:0011276Vascular skin abnormality0ALOXE3 CL E G H5934413743OMIM:606545Ichthyosis, congenital, autosomal recessive 363
HP:0011276HP:0011276Vascular skin abnormality0ALPK1 CL E G H8021620917OMIM:614979Splenomegaly, cytopenia, and vision loss
HP:0011276HP:0011276Vascular skin abnormality0ANAPC1 CL E G H6468219988ORPHA:221008Rothmund-Thomson syndrome type 12
HP:0011276HP:0011276Vascular skin abnormality0ANGPT1 CL E G H284484OMIM:619361ANGIOEDEMA, HEREDITARY, 5; HAE55
HP:0011276HP:0011276Vascular skin abnormality0ANKRD26 CL E G H2285229186OMIM:188000THROMBOCYTOPENIA 2; THC2106
HP:0011276HP:0011276Vascular skin abnormality0ANTXR1 CL E G H8416821014OMIM:230740Gapo syndrome8
HP:0011276HP:0011276Vascular skin abnormality0ANTXR2 CL E G H11842921732ORPHA:2176Infantile systemic hyalinosis49
HP:0011276HP:0011276Vascular skin abnormality0AP1S1 CL E G H1174559OMIM:609313Mental retardation, enteropathy, deafness, peripheral neuropathy, ichthyosis, and keratoderma1
HP:0011276HP:0011276Vascular skin abnormality0APOE CL E G H348613ORPHA:158029Sea-blue histiocytosis39
HP:0011276HP:0011276Vascular skin abnormality0AQP5 CL E G H362638ORPHA:2337Non-epidermolytic palmoplantar keratoderma5
HP:0011276HP:0011276Vascular skin abnormality0ARHGAP31 CL E G H5751429216ORPHA:974Adams-Oliver syndrome147
HP:0011276HP:0011276Vascular skin abnormality0ARHGAP31 CL E G H5751429216OMIM:100300Adams-Oliver syndrome 1147
HP:0011276HP:0011276Vascular skin abnormality0ARID1B CL E G H5749218040OMIM:135900Coffin-Siris syndrome 1219
HP:0011276HP:0011276Vascular skin abnormality0ARL6IP6 CL E G H15118824048ORPHA:1556Cutis marmorata telangiectatica congenita1
HP:0011276HP:0011276Vascular skin abnormality0ARMC5 CL E G H7979825781ORPHA:189427Cushing syndrome due to macronodular adrenal hyperplasia7
HP:0011276HP:0011276Vascular skin abnormality0ARPC1B CL E G H10095704OMIM:617718Platelet abnormalities with eosinophilia and immune-mediated inflammatory disease
HP:0011276HP:0011276Vascular skin abnormality0ARPC4 CL E G H10093707OMIM:620141
HP:0011276HP:0011276Vascular skin abnormality0ARVCF CL E G H421728ORPHA:56722q11.2 deletion syndrome1
HP:0011276HP:0011276Vascular skin abnormality0ARX CL E G H17030218060ORPHA:94083Partington syndrome166
HP:0011276HP:0011276Vascular skin abnormality0ASXL1 CL E G H17102318318ORPHA:98850Aggressive systemic mastocytosis145
HP:0011276HP:0011276Vascular skin abnormality0ASXL1 CL E G H17102318318ORPHA:98849Systemic mastocytosis with associated hematologic neoplasm145
HP:0011276HP:0011276Vascular skin abnormality0ATM CL E G H472795ORPHA:100Ataxia-telangiectasia3267
HP:0011276HP:0011276Vascular skin abnormality0ATM CL E G H472795OMIM:208900ATAXIA-TELANGIECTASIA3267
HP:0011276HP:0011276Vascular skin abnormality0ATP2C1 CL E G H2703213211OMIM:169600Benign chronic pemphigus56
HP:0011276HP:0011276Vascular skin abnormality0ATP2C1 CL E G H2703213211ORPHA:2841Familial benign chronic pemphigus56
HP:0011276HP:0011276Vascular skin abnormality0ATP6 CL E G H45087414ORPHA:104Leber hereditary optic neuropathy
HP:0011276HP:0011276Vascular skin abnormality0ATP6V0A2 CL E G H2354518481ORPHA:357074Autosomal recessive cutis laxa type 2, classic type140
HP:0011276HP:0011276Vascular skin abnormality0ATP6V0A2 CL E G H2354518481ORPHA:2834Wrinkly skin syndrome140
HP:0011276HP:0011276Vascular skin abnormality0ATP6V1A CL E G H523851ORPHA:357074Autosomal recessive cutis laxa type 2, classic type3
HP:0011276HP:0011276Vascular skin abnormality0ATP6V1E1 CL E G H529857ORPHA:357074Autosomal recessive cutis laxa type 2, classic type2
HP:0011276HP:0011276Vascular skin abnormality0ATP7A CL E G H538869ORPHA:565Menkes disease192
HP:0011276HP:0011276Vascular skin abnormality0ATP7A CL E G H538869ORPHA:198Occipital horn syndrome192
HP:0011276HP:0011276Vascular skin abnormality0ATP7A CL E G H538869OMIM:304150Occipital horn syndrome192
HP:0011276HP:0011276Vascular skin abnormality0ATP7B CL E G H540870ORPHA:905Wilson disease315
HP:0011276HP:0011276Vascular skin abnormality0ATR CL E G H545882OMIM:614564Cutaneous telangiectasia and cancer syndrome, familial168
HP:0011276HP:0011276Vascular skin abnormality0ATRX CL E G H546886ORPHA:231401Alpha-thalassemia-myelodysplastic syndrome169
HP:0011276HP:0011276Vascular skin abnormality0ATRX CL E G H546886ORPHA:96253Cushing disease169
HP:0011276HP:0011276Vascular skin abnormality0ATRX CL E G H546886ORPHA:100075Neuroendocrine tumor of stomach169
HP:0011276HP:0011276Vascular skin abnormality0B3GALT6 CL E G H12679217978ORPHA:536467B3GALT6-related spondylodysplastic Ehlers-Danlos syndrome38
HP:0011276HP:0011276Vascular skin abnormality0BANF1 CL E G H881517397OMIM:614008Nestor-Guillermo progeria syndrome22
HP:0011276HP:0011276Vascular skin abnormality0BCOR CL E G H5488020893ORPHA:520Acute promyelocytic leukemia101
HP:0011276HP:0011276Vascular skin abnormality0BLM CL E G H6411058ORPHA:125Bloom syndrome314
HP:0011276HP:0011276Vascular skin abnormality0BLM CL E G H6411058OMIM:210900Bloom syndrome314
HP:0011276HP:0011276Vascular skin abnormality0BLOC1S3 CL E G H38855220914OMIM:614077Hermansky-Pudlak syndrome 842
HP:0011276HP:0011276Vascular skin abnormality0BLOC1S5 CL E G H6391518561OMIM:619172HERMANSKY-PUDLAK SYNDROME 11; HPS11
HP:0011276HP:0011276Vascular skin abnormality0BMP2 CL E G H6501069OMIM:235200Hemochromatosis, type 113
HP:0011276HP:0011276Vascular skin abnormality0BMPR2 CL E G H6591078OMIM:178600Pulmonary hypertension, primary, 1525
HP:0011276HP:0011276Vascular skin abnormality0BRAF CL E G H6731097ORPHA:96253Cushing disease276
HP:0011276HP:0011276Vascular skin abnormality0BRAF CL E G H6731097OMIM:163950Noonan syndrome 1276
HP:0011276HP:0011276Vascular skin abnormality0BRD4 CL E G H2347613575ORPHA:199Cornelia de Lange syndrome
HP:0011276HP:0011276Vascular skin abnormality0BSCL2 CL E G H2658015832ORPHA:528Congenital generalized lipodystrophy105
HP:0011276HP:0011276Vascular skin abnormality0C1R CL E G H7151246OMIM:130080Ehlers-Danlos syndrome, periodontal type, 115
HP:0011276HP:0011276Vascular skin abnormality0C1S CL E G H7161247OMIM:617174Ehlers-Danlos syndrome, periodontal type, 27
HP:0011276HP:0011276Vascular skin abnormality0C2 CL E G H7171248OMIM:217000Complement component 2 deficiency23
HP:0011276HP:0011276Vascular skin abnormality0C4A CL E G H7201323OMIM:614380Complement component 4A deficiency1
HP:0011276HP:0011276Vascular skin abnormality0CALR CL E G H8111455OMIM:254450Myelofibrosismyelofibrosis with myeloid metaplasia, included1
HP:0011276HP:0011276Vascular skin abnormality0CALR CL E G H8111455ORPHA:824Primary myelofibrosis1
HP:0011276HP:0011276Vascular skin abnormality0CARMIL2 CL E G H14620627089OMIM:618131IMMUNODEFICIENCY 58; IMD583
HP:0011276HP:0011276Vascular skin abnormality0CASP10 CL E G H8431500ORPHA:3261Autoimmune lymphoproliferative syndrome87
HP:0011276HP:0011276Vascular skin abnormality0CASP10 CL E G H8431500OMIM:603909Autoimmune lymphoproliferative syndrome, type IIA87
HP:0011276HP:0011276Vascular skin abnormality0CASZ1 CL E G H5489726002ORPHA:16061p36 deletion syndrome3
HP:0011276HP:0011276Vascular skin abnormality0CAV1 CL E G H8571527ORPHA:528Congenital generalized lipodystrophy11
HP:0011276HP:0011276Vascular skin abnormality0CAV1 CL E G H8571527ORPHA:220393Diffuse cutaneous systemic sclerosis11
HP:0011276HP:0011276Vascular skin abnormality0CAV1 CL E G H8571527ORPHA:220402Limited cutaneous systemic sclerosis11
HP:0011276HP:0011276Vascular skin abnormality0CAV1 CL E G H8571527OMIM:606721Lipodystrophy, familial partial, type 711
HP:0011276HP:0011276Vascular skin abnormality0CAVIN1 CL E G H2841199688ORPHA:528Congenital generalized lipodystrophy48
HP:0011276HP:0011276Vascular skin abnormality0CBL CL E G H8671541ORPHA:98850Aggressive systemic mastocytosis317
HP:0011276HP:0011276Vascular skin abnormality0CBS CL E G H8751550ORPHA:394Classic homocystinuria242
HP:0011276HP:0011276Vascular skin abnormality0CBS CL E G H8751550OMIM:236200Homocystinuria due to cystathionine beta-synthase deficiency242
HP:0011276HP:0011276Vascular skin abnormality0CCM2 CL E G H8360521708OMIM:603284Cerebral cavernous malformations-237
HP:0011276HP:0011276Vascular skin abnormality0CCM2 CL E G H8360521708ORPHA:221061Familial cerebral cavernous malformationHP:0040283 - Occasional37
HP:0011276HP:0011276Vascular skin abnormality0CCN2 CL E G H14902500ORPHA:220393Diffuse cutaneous systemic sclerosis
HP:0011276HP:0011276Vascular skin abnormality0CCN2 CL E G H14902500ORPHA:220402Limited cutaneous systemic sclerosis
HP:0011276HP:0011276Vascular skin abnormality0CCR6 CL E G H12351607ORPHA:220393Diffuse cutaneous systemic sclerosis
HP:0011276HP:0011276Vascular skin abnormality0CCR6 CL E G H12351607ORPHA:220402Limited cutaneous systemic sclerosis
HP:0011276HP:0011276Vascular skin abnormality0CD109 CL E G H13522821685ORPHA:853Fetal and neonatal alloimmune thrombocytopenia
HP:0011276HP:0011276Vascular skin abnormality0CD19 CL E G H9301633ORPHA:1572Common variable immunodeficiency38
HP:0011276HP:0011276Vascular skin abnormality0CD28 CL E G H9401653ORPHA:2584Classic mycosis fungoides
HP:0011276HP:0011276Vascular skin abnormality0CD81 CL E G H9751701ORPHA:1572Common variable immunodeficiency1
HP:0011276HP:0011276Vascular skin abnormality0CD81 CL E G H9751701OMIM:613496Immunodeficiency, common variable, 61
HP:0011276HP:0011276Vascular skin abnormality0CDH23 CL E G H6407213733ORPHA:96253Cushing disease636
HP:0011276HP:0011276Vascular skin abnormality0CDKN1B CL E G H10271785ORPHA:276152Multiple endocrine neoplasia type 4102
HP:0011276HP:0011276Vascular skin abnormality0CFH CL E G H30754883OMIM:235400Hemolytic uremic syndrome, atypical, susceptibility to, 186
HP:0011276HP:0011276Vascular skin abnormality0CFHR1 CL E G H30784888OMIM:235400Hemolytic uremic syndrome, atypical, susceptibility to, 1
HP:0011276HP:0011276Vascular skin abnormality0CFHR3 CL E G H1087816980OMIM:235400Hemolytic uremic syndrome, atypical, susceptibility to, 1
HP:0011276HP:0011276Vascular skin abnormality0CHST14 CL E G H11318924464OMIM:601776Ehlers-Danlos syndrome, musculocontractural type 127
HP:0011276HP:0011276Vascular skin abnormality0CHST14 CL E G H11318924464ORPHA:2953Musculocontractural Ehlers-Danlos syndrome27
HP:0011276HP:0011276Vascular skin abnormality0CIB1 CL E G H1051916920ORPHA:302Epidermodysplasia verruciformis
HP:0011276HP:0011276Vascular skin abnormality0CLCN7 CL E G H11862025ORPHA:667Autosomal recessive malignant osteopetrosis102
HP:0011276HP:0011276Vascular skin abnormality0CLCN7 CL E G H11862025OMIM:611490Osteopetrosis, autosomal recessive 4102
HP:0011276HP:0011276Vascular skin abnormality0CLEC7A CL E G H6458114558ORPHA:1334Chronic mucocutaneous candidiasis3
HP:0011276HP:0011276Vascular skin abnormality0COG4 CL E G H2583918620OMIM:618150Saul-Wilson syndrome67
HP:0011276HP:0011276Vascular skin abnormality0COG8 CL E G H8434218623ORPHA:95428COG8-CDG39
HP:0011276HP:0011276Vascular skin abnormality0COL1A1 CL E G H12772197ORPHA:287Classical Ehlers-Danlos syndrome373
HP:0011276HP:0011276Vascular skin abnormality0COL1A1 CL E G H12772197OMIM:619115COMBINED OSTEOGENESIS IMPERFECTA AND EHLERS-DANLOS SYNDROME 1; OIEDS1373
HP:0011276HP:0011276Vascular skin abnormality0COL1A1 CL E G H12772197ORPHA:31112Dermatofibrosarcoma protuberans373
HP:0011276HP:0011276Vascular skin abnormality0COL1A1 CL E G H12772197OMIM:130060Ehlers-Danlos syndrome, arthrochalasia type, 1373
HP:0011276HP:0011276Vascular skin abnormality0COL1A1 CL E G H12772197OMIM:166200Osteogenesis imperfecta, type I373
HP:0011276HP:0011276Vascular skin abnormality0COL1A2 CL E G H12782198ORPHA:230851Cardiac-valvular Ehlers-Danlos syndrome243
HP:0011276HP:0011276Vascular skin abnormality0COL1A2 CL E G H12782198OMIM:619120COMBINED OSTEOGENESIS IMPERFECTA AND EHLERS-DANLOS SYNDROME 2; OIEDS2243
HP:0011276HP:0011276Vascular skin abnormality0COL1A2 CL E G H12782198OMIM:617821Ehlers-Danlos syndrome, arthrochalasia type, 2243
HP:0011276HP:0011276Vascular skin abnormality0COL1A2 CL E G H12782198OMIM:225320Ehlers-Danlos syndrome, autosomal recessive, cardiac valvular form243
HP:0011276HP:0011276Vascular skin abnormality0COL3A1 CL E G H12812201ORPHA:2500Acrogeria749
HP:0011276HP:0011276Vascular skin abnormality0COL3A1 CL E G H12812201OMIM:130050Ehlers-Danlos syndrome, Vascular type749
HP:0011276HP:0011276Vascular skin abnormality0COL3A1 CL E G H12812201OMIM:618343Polymicrogyria with or without vascular-type ehlers-danlos syndrome749
HP:0011276HP:0011276Vascular skin abnormality0COL3A1 CL E G H12812201ORPHA:286Vascular Ehlers-Danlos syndrome749
HP:0011276HP:0011276Vascular skin abnormality0COL5A1 CL E G H12892209ORPHA:287Classical Ehlers-Danlos syndrome660
HP:0011276HP:0011276Vascular skin abnormality0COL5A1 CL E G H12892209OMIM:130000Ehlers-danlos syndrome, type I660
HP:0011276HP:0011276Vascular skin abnormality0COL5A2 CL E G H12902210ORPHA:287Classical Ehlers-Danlos syndrome325
HP:0011276HP:0011276Vascular skin abnormality0COL5A2 CL E G H12902210OMIM:130010Ehlers-Danlos syndrome, classic type, 2325
HP:0011276HP:0011276Vascular skin abnormality0COL7A1 CL E G H12942214ORPHA:158673Localized dystrophic epidermolysis bullosa, acral form263
HP:0011276HP:0011276Vascular skin abnormality0COMT CL E G H13122228ORPHA:56722q11.2 deletion syndrome6
HP:0011276HP:0011276Vascular skin abnormality0COX1 CL E G H45127419ORPHA:104Leber hereditary optic neuropathy
HP:0011276HP:0011276Vascular skin abnormality0COX1 CL E G H45127419ORPHA:550MELAS
HP:0011276HP:0011276Vascular skin abnormality0COX2 CL E G H45137421ORPHA:550MELAS
HP:0011276HP:0011276Vascular skin abnormality0COX3 CL E G H45147422ORPHA:104Leber hereditary optic neuropathy
HP:0011276HP:0011276Vascular skin abnormality0COX3 CL E G H45147422ORPHA:550MELAS
HP:0011276HP:0011276Vascular skin abnormality0COX7B CL E G H13492291ORPHA:2556Microphthalmia with linear skin defects syndrome6
HP:0011276HP:0011276Vascular skin abnormality0CPN1 CL E G H13692312OMIM:212070Carboxypeptidase N deficiency2
HP:0011276HP:0011276Vascular skin abnormality0CR2 CL E G H13802336ORPHA:1572Common variable immunodeficiency10
HP:0011276HP:0011276Vascular skin abnormality0CREB3L1 CL E G H9099318856OMIM:616229Osteogenesis imperfecta, type XVI4
HP:0011276HP:0011276Vascular skin abnormality0CSTA CL E G H14752481ORPHA:263534Acral peeling skin syndrome4
HP:0011276HP:0011276Vascular skin abnormality0CTC1 CL E G H8016926169OMIM:612199Cerebroretinal microangiopathy with calcifications and cysts160
HP:0011276HP:0011276Vascular skin abnormality0CTC1 CL E G H8016926169ORPHA:1775Dyskeratosis congenita160
HP:0011276HP:0011276Vascular skin abnormality0CTLA4 CL E G H14932505ORPHA:2584Classic mycosis fungoides10
HP:0011276HP:0011276Vascular skin abnormality0CTLA4 CL E G H14932505ORPHA:900Granulomatosis with polyangiitis10
HP:0011276HP:0011276Vascular skin abnormality0CTNNB1 CL E G H14992514ORPHA:891Familial exudative vitreoretinopathy88
HP:0011276HP:0011276Vascular skin abnormality0CTSA CL E G H54769251OMIM:256540Galactosialidosis51
HP:0011276HP:0011276Vascular skin abnormality0CTSB CL E G H15082527ORPHA:50943Keratolytic winter erythema1
HP:0011276HP:0011276Vascular skin abnormality0CTSB CL E G H15082527OMIM:148370Keratolytic winter erythema1
HP:0011276HP:0011276Vascular skin abnormality0CYLD CL E G H15402584ORPHA:211Familial cylindromatosis126
HP:0011276HP:0011276Vascular skin abnormality0CYLD CL E G H15402584ORPHA:867Familial multiple trichoepithelioma126
HP:0011276HP:0011276Vascular skin abnormality0CYTB CL E G H45197427ORPHA:104Leber hereditary optic neuropathy
HP:0011276HP:0011276Vascular skin abnormality0DAXX CL E G H16162681ORPHA:100075Neuroendocrine tumor of stomach
HP:0011276HP:0011276Vascular skin abnormality0DDB2 CL E G H16432718ORPHA:910Xeroderma pigmentosum30
HP:0011276HP:0011276Vascular skin abnormality0DDB2 CL E G H16432718OMIM:278740Xeroderma pigmentosum, complementation group E30
HP:0011276HP:0011276Vascular skin abnormality0DDR2 CL E G H49212731OMIM:618175WARBURG-CINOTTI SYNDROME; WRCN45
HP:0011276HP:0011276Vascular skin abnormality0DDX11 CL E G H16632736OMIM:613398Warsaw breakage syndrome13
HP:0011276HP:0011276Vascular skin abnormality0DHCR7 CL E G H17172860ORPHA:818Smith-Lemli-Opitz syndrome159
HP:0011276HP:0011276Vascular skin abnormality0DIAPH1 CL E G H17292876ORPHA:2573Moyamoya disease118
HP:0011276HP:0011276Vascular skin abnormality0DKC1 CL E G H17362890ORPHA:1775Dyskeratosis congenita65
HP:0011276HP:0011276Vascular skin abnormality0DLL4 CL E G H545672910ORPHA:974Adams-Oliver syndrome9
HP:0011276HP:0011276Vascular skin abnormality0DLL4 CL E G H545672910OMIM:616589Adams-Oliver syndrome 69
HP:0011276HP:0011276Vascular skin abnormality0DNAJC30 CL E G H8427716410ORPHA:104Leber hereditary optic neuropathy
HP:0011276HP:0011276Vascular skin abnormality0DNAJC30 CL E G H8427716410OMIM:619382LEBER HEREDITARY OPTIC NEUROPATHY, AUTOSOMAL RECESSIVE; LHONAR
HP:0011276HP:0011276Vascular skin abnormality0DNASE1L3 CL E G H17762959ORPHA:36412Hypocomplementemic urticarial vasculitis3
HP:0011276HP:0011276Vascular skin abnormality0DOCK6 CL E G H5757219189ORPHA:974Adams-Oliver syndrome18
HP:0011276HP:0011276Vascular skin abnormality0DOCK6 CL E G H5757219189OMIM:614219Adams-Oliver syndrome 218
HP:0011276HP:0011276Vascular skin abnormality0DPM1 CL E G H88133005OMIM:608799Congenital disorder of glycosylation, type IE27
HP:0011276HP:0011276Vascular skin abnormality0DSE CL E G H2994021144ORPHA:2953Musculocontractural Ehlers-Danlos syndrome13
HP:0011276HP:0011276Vascular skin abnormality0DSG4 CL E G H14740921307OMIM:607903Hypotrichosis 663
HP:0011276HP:0011276Vascular skin abnormality0DSP CL E G H18323052OMIM:615821Cardiomyopathy, dilated, with woolly hair, keratoderma, and tooth agenesis747
HP:0011276HP:0011276Vascular skin abnormality0DSP CL E G H18323052OMIM:607655Skin fragility-woolly hair syndrome747
HP:0011276HP:0011276Vascular skin abnormality0DST CL E G H6671090OMIM:614653Neuropathy, hereditary sensory and autonomic, type VI108
HP:0011276HP:0011276Vascular skin abnormality0DTNBP1 CL E G H8406217328OMIM:614076Hermansky-Pudlak syndrome 746
HP:0011276HP:0011276Vascular skin abnormality0EGFR CL E G H19563236ORPHA:294023Neonatal inflammatory skin and bowel disease257
HP:0011276HP:0011276Vascular skin abnormality0ELMO2 CL E G H6391617233ORPHA:3019Ramon syndrome3
HP:0011276HP:0011276Vascular skin abnormality0ELN CL E G H20063327ORPHA:91387Familial thoracic aortic aneurysm and aortic dissection172
HP:0011276HP:0011276Vascular skin abnormality0ELOVL4 CL E G H678514415OMIM:614457Ichthyosis, spastic quadriplegia, and mental retardation62
HP:0011276HP:0011276Vascular skin abnormality0ELOVL4 CL E G H678514415ORPHA:1955Spinocerebellar ataxia type 3462
HP:0011276HP:0011276Vascular skin abnormality0EMILIN1 CL E G H1111719880OMIM:6200802
HP:0011276HP:0011276Vascular skin abnormality0ENG CL E G H20223349ORPHA:774Hereditary hemorrhagic telangiectasia186
HP:0011276HP:0011276Vascular skin abnormality0ENG CL E G H20223349OMIM:187300Telangiectasia, hereditary hemorrhagic, type 1186
HP:0011276HP:0011276Vascular skin abnormality0ENPP1 CL E G H51673356ORPHA:758Pseudoxanthoma elasticum151
HP:0011276HP:0011276Vascular skin abnormality0EOGT CL E G H28520328526ORPHA:974Adams-Oliver syndrome4
HP:0011276HP:0011276Vascular skin abnormality0EOGT CL E G H28520328526OMIM:615297Adams-Oliver syndrome 44
HP:0011276HP:0011276Vascular skin abnormality0EPHB2 CL E G H20483393OMIM:618462Bleeding disorder, platelet-type, 227
HP:0011276HP:0011276Vascular skin abnormality0EPHB4 CL E G H20503395ORPHA:137667Capillary malformation-arteriovenous malformationHP:0040282 - Frequent3
HP:0011276HP:0011276Vascular skin abnormality0EPHB4 CL E G H20503395OMIM:618196Capillary malformation-arteriovenous malformation 23
HP:0011276HP:0011276Vascular skin abnormality0ERCC2 CL E G H20683434OMIM:601675Trichothiodystrophy 1, photosensitive106
HP:0011276HP:0011276Vascular skin abnormality0ERCC2 CL E G H20683434ORPHA:910Xeroderma pigmentosum106
HP:0011276HP:0011276Vascular skin abnormality0ERCC2 CL E G H20683434OMIM:278730Xeroderma pigmentosum, complementation group D106
HP:0011276HP:0011276Vascular skin abnormality0ERCC2 CL E G H20683434ORPHA:220295Xeroderma pigmentosum-Cockayne syndrome complex106
HP:0011276HP:0011276Vascular skin abnormality0ERCC3 CL E G H20713435ORPHA:910Xeroderma pigmentosum54
HP:0011276HP:0011276Vascular skin abnormality0ERCC3 CL E G H20713435ORPHA:220295Xeroderma pigmentosum-Cockayne syndrome complex54
HP:0011276HP:0011276Vascular skin abnormality0ERCC4 CL E G H20723436ORPHA:910Xeroderma pigmentosum158
HP:0011276HP:0011276Vascular skin abnormality0ERCC4 CL E G H20723436OMIM:278760Xeroderma pigmentosum, complementation group F158
HP:0011276HP:0011276Vascular skin abnormality0ERCC4 CL E G H20723436ORPHA:220295Xeroderma pigmentosum-Cockayne syndrome complex158
HP:0011276HP:0011276Vascular skin abnormality0ERCC5 CL E G H20733437ORPHA:910Xeroderma pigmentosum83
HP:0011276HP:0011276Vascular skin abnormality0ERCC5 CL E G H20733437ORPHA:220295Xeroderma pigmentosum-Cockayne syndrome complex83
HP:0011276HP:0011276Vascular skin abnormality0ERCC6 CL E G H20743438OMIM:278800De Sanctis-Cacchione syndrome199
HP:0011276HP:0011276Vascular skin abnormality0ERCC6 CL E G H20743438OMIM:600630Uv-Sensitive syndrome 1199
HP:0011276HP:0011276Vascular skin abnormality0ETHE1 CL E G H2347423287OMIM:602473Encephalopathy, ethylmalonic42
HP:0011276HP:0011276Vascular skin abnormality0ETHE1 CL E G H2347423287ORPHA:51188Ethylmalonic encephalopathy42
HP:0011276HP:0011276Vascular skin abnormality0ETV6 CL E G H21203495OMIM:616216Thrombocytopenia 513
HP:0011276HP:0011276Vascular skin abnormality0F10 CL E G H21593528ORPHA:328Congenital factor X deficiency33
HP:0011276HP:0011276Vascular skin abnormality0F12 CL E G H21613530OMIM:610618ANGIOEDEMA, HEREDITARY, TYPE III; HAE328
HP:0011276HP:0011276Vascular skin abnormality0F13A1 CL E G H21623531ORPHA:331Congenital factor XIII deficiency60
HP:0011276HP:0011276Vascular skin abnormality0F13A1 CL E G H21623531OMIM:613225Factor XIII, A subunit, deficiency of60
HP:0011276HP:0011276Vascular skin abnormality0F13B CL E G H21653534ORPHA:331Congenital factor XIII deficiency32
HP:0011276HP:0011276Vascular skin abnormality0F13B CL E G H21653534OMIM:613235Factor XIIIB deficiency32
HP:0011276HP:0011276Vascular skin abnormality0F2 CL E G H21473535OMIM:613679Congenital prothrombin deficiency44
HP:0011276HP:0011276Vascular skin abnormality0F5 CL E G H21533542ORPHA:326Congenital factor V deficiency159
HP:0011276HP:0011276Vascular skin abnormality0F5 CL E G H21533542OMIM:227400Factor V deficiency159
HP:0011276HP:0011276Vascular skin abnormality0F7 CL E G H21553544ORPHA:327Congenital factor VII deficiency70
HP:0011276HP:0011276Vascular skin abnormality0F8 CL E G H21573546ORPHA:177926Bleeding disorder in hemophilia A carriers without FVIII deficiency303
HP:0011276HP:0011276Vascular skin abnormality0F8 CL E G H21573546OMIM:306700Hemophilia A303
HP:0011276HP:0011276Vascular skin abnormality0F8 CL E G H21573546ORPHA:169805Moderate hemophilia A303
HP:0011276HP:0011276Vascular skin abnormality0F8 CL E G H21573546ORPHA:169802Severe hemophilia A303
HP:0011276HP:0011276Vascular skin abnormality0FANCA CL E G H21753582OMIM:227650Fanconi anemia340
HP:0011276HP:0011276Vascular skin abnormality0FANCC CL E G H21763584OMIM:227645Fanconi anemia, complementation group C410
HP:0011276HP:0011276Vascular skin abnormality0FANCD2 CL E G H21773585OMIM:227646Fanconi anemia, complementation group D2147
HP:0011276HP:0011276Vascular skin abnormality0FANCE CL E G H21783586OMIM:600901Fanconi anemia, complementation group E73
HP:0011276HP:0011276Vascular skin abnormality0FAS CL E G H35511920ORPHA:3261Autoimmune lymphoproliferative syndrome59
HP:0011276HP:0011276Vascular skin abnormality0FAS CL E G H35511920OMIM:601859Autoimmune lymphoproliferative syndrome59
HP:0011276HP:0011276Vascular skin abnormality0FASLG CL E G H35611936OMIM:601859Autoimmune lymphoproliferative syndrome37
HP:0011276HP:0011276Vascular skin abnormality0FASLG CL E G H35611936ORPHA:3261Autoimmune lymphoproliferative syndrome37
HP:0011276HP:0011276Vascular skin abnormality0FBN1 CL E G H22003603ORPHA:91387Familial thoracic aortic aneurysm and aortic dissection1361
HP:0011276HP:0011276Vascular skin abnormality0FBN1 CL E G H22003603OMIM:616914Marfan lipodystrophy syndrome1361
HP:0011276HP:0011276Vascular skin abnormality0FCGR2C CL E G H910315626ORPHA:3002Immune thrombocytopenia
HP:0011276HP:0011276Vascular skin abnormality0FECH CL E G H22353647ORPHA:79278Autosomal erythropoietic protoporphyria145
HP:0011276HP:0011276Vascular skin abnormality0FECH CL E G H22353647OMIM:177000Protoporphyria, erythropoietic, 1145
HP:0011276HP:0011276Vascular skin abnormality0FERMT1 CL E G H5561215889ORPHA:2908Kindler epidermolysis bullosa136
HP:0011276HP:0011276Vascular skin abnormality0FERMT1 CL E G H5561215889OMIM:173650Kindler syndrome136
HP:0011276HP:0011276Vascular skin abnormality0FERMT3 CL E G H8370623151OMIM:612840Leukocyte adhesion deficiency, type III23
HP:0011276HP:0011276Vascular skin abnormality0FGA CL E G H22433661OMIM:202400Afibrinogenemia, congenitalhypofibrinogenemia, congenital, included47
HP:0011276HP:0011276Vascular skin abnormality0FGB CL E G H22443662OMIM:202400Afibrinogenemia, congenitalhypofibrinogenemia, congenital, included62
HP:0011276HP:0011276Vascular skin abnormality0FGG CL E G H22663694OMIM:202400Afibrinogenemia, congenitalhypofibrinogenemia, congenital, included34
HP:0011276HP:0011276Vascular skin abnormality0FIP1L1 CL E G H8160819124ORPHA:520Acute promyelocytic leukemia4
HP:0011276HP:0011276Vascular skin abnormality0FKBP14 CL E G H5503318625OMIM:614557Ehlers-Danlos syndrome, kyphoscoliotic type, 213
HP:0011276HP:0011276Vascular skin abnormality0FKBP14 CL E G H5503318625ORPHA:300179Kyphoscoliotic Ehlers-Danlos syndrome due to FKBP22 deficiency13
HP:0011276HP:0011276Vascular skin abnormality0FLNA CL E G H23163754ORPHA:75497X-linked Ehlers-Danlos syndrome493
HP:0011276HP:0011276Vascular skin abnormality0FLT4 CL E G H23243767OMIM:153100Lymphatic malformation 190
HP:0011276HP:0011276Vascular skin abnormality0FOS CL E G H23533796ORPHA:528Congenital generalized lipodystrophy
HP:0011276HP:0011276Vascular skin abnormality0FOXE3 CL E G H23013808ORPHA:91387Familial thoracic aortic aneurysm and aortic dissection23
HP:0011276HP:0011276Vascular skin abnormality0FOXP3 CL E G H509436106ORPHA:37042Immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome32
HP:0011276HP:0011276Vascular skin abnormality0FRG1 CL E G H24833954OMIM:158900Facioscapulohumeral muscular dystrophy 11
HP:0011276HP:0011276Vascular skin abnormality0FTO CL E G H7906824678OMIM:612938Growth retardation, developmental delay, coarse facies, and earlydeath70
HP:0011276HP:0011276Vascular skin abnormality0FUCA1 CL E G H25174006OMIM:230000FUCOSIDOSIS43
HP:0011276HP:0011276Vascular skin abnormality0FUCA1 CL E G H25174006ORPHA:349FucosidosisHP:0040282 - Frequent43
HP:0011276HP:0011276Vascular skin abnormality0FYB1 CL E G H25334036OMIM:273900THROMBOCYTOPENIA 3; THC34
HP:0011276HP:0011276Vascular skin abnormality0FZD4 CL E G H83224042ORPHA:891Familial exudative vitreoretinopathy109
HP:0011276HP:0011276Vascular skin abnormality0G6PC3 CL E G H9257924861OMIM:612541Neutropenia, severe congenital, 4, autosomal recessive37
HP:0011276HP:0011276Vascular skin abnormality0GABRD CL E G H25634084ORPHA:16061p36 deletion syndrome10
HP:0011276HP:0011276Vascular skin abnormality0GATA1 CL E G H26234170OMIM:314050Thrombocytopenia with beta-thalassemia, X-linked29
HP:0011276HP:0011276Vascular skin abnormality0GATA1 CL E G H26234170OMIM:300367Thrombocytopenia, X-linked, with or without dyserythropoietic anemia29
HP:0011276HP:0011276Vascular skin abnormality0GATA2 CL E G H26244171ORPHA:3226Deafness-lymphedema-leukemia syndrome137
HP:0011276HP:0011276Vascular skin abnormality0GBA1 CL E G H26294177ORPHA:77259Gaucher disease type 1
HP:0011276HP:0011276Vascular skin abnormality0GBA1 CL E G H26294177OMIM:608013Gaucher disease, perinatal lethal
HP:0011276HP:0011276Vascular skin abnormality0GBA1 CL E G H26294177ORPHA:2072Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome
HP:0011276HP:0011276Vascular skin abnormality0GDF2 CL E G H26584217ORPHA:774Hereditary hemorrhagic telangiectasia8
HP:0011276HP:0011276Vascular skin abnormality0GDF2 CL E G H26584217OMIM:615506TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 5; HHT58
HP:0011276HP:0011276Vascular skin abnormality0GFI1B CL E G H83284238OMIM:187900Bleeding disorder, platelet-type, 173
HP:0011276HP:0011276Vascular skin abnormality0GGCX CL E G H26774247OMIM:277450VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 1129
HP:0011276HP:0011276Vascular skin abnormality0GIMAP5 CL E G H5534018005OMIM:619463PORTAL HYPERTENSION, NONCIRRHOTIC, 2; NCPH2
HP:0011276HP:0011276Vascular skin abnormality0GJA1 CL E G H26974274ORPHA:1010Autosomal dominant palmoplantar keratoderma and congenital alopecia68
HP:0011276HP:0011276Vascular skin abnormality0GJA1 CL E G H26974274ORPHA:317Erythrokeratodermia variabilis68
HP:0011276HP:0011276Vascular skin abnormality0GJA1 CL E G H26974274OMIM:617525Erythrokeratodermia variabilis et progressiva 368
HP:0011276HP:0011276Vascular skin abnormality0GJA1 CL E G H26974274OMIM:104100Palmoplantar keratoderma with congenital alopecia68
HP:0011276HP:0011276Vascular skin abnormality0GJA5 CL E G H27024279OMIM:612474Chromosome 1q21.1 deletion syndrome, 1.35-mb39
HP:0011276HP:0011276Vascular skin abnormality0GJA8 CL E G H27034281OMIM:612474Chromosome 1q21.1 deletion syndrome, 1.35-mb34
HP:0011276HP:0011276Vascular skin abnormality0GJB3 CL E G H27074285ORPHA:317Erythrokeratodermia variabilis74
HP:0011276HP:0011276Vascular skin abnormality0GJB4 CL E G H1275344286ORPHA:317Erythrokeratodermia variabilis12
HP:0011276HP:0011276Vascular skin abnormality0GJB4 CL E G H1275344286OMIM:617524Erythrokeratodermia variabilis et progressiva 212
HP:0011276HP:0011276Vascular skin abnormality0GLA CL E G H27174296ORPHA:324Fabry disease291
HP:0011276HP:0011276Vascular skin abnormality0GLA CL E G H27174296OMIM:301500Fabry disease291
HP:0011276HP:0011276Vascular skin abnormality0GLB1 CL E G H27204298OMIM:230500GM1-gangliosidosis, type I120
HP:0011276HP:0011276Vascular skin abnormality0GLUL CL E G H27524341OMIM:610015GLUTAMINE DEFICIENCY, CONGENITAL98
HP:0011276HP:0011276Vascular skin abnormality0GNA11 CL E G H27674379ORPHA:1556Cutis marmorata telangiectatica congenita16
HP:0011276HP:0011276Vascular skin abnormality0GNA14 CL E G H96304382ORPHA:1063Tufted angioma
HP:0011276HP:0011276Vascular skin abnormality0GNAQ CL E G H27764390ORPHA:3205Sturge-Weber syndrome7
HP:0011276HP:0011276Vascular skin abnormality0GNAS CL E G H27784392OMIM:219080ACTH-independent macronodular adrenal hyperplasia101
HP:0011276HP:0011276Vascular skin abnormality0GNAS CL E G H27784392ORPHA:189427Cushing syndrome due to macronodular adrenal hyperplasia101
HP:0011276HP:0011276Vascular skin abnormality0GNB2 CL E G H27834398OMIM:619503NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND DYSMORPHIC FACIES; NEDHYDF
HP:0011276HP:0011276Vascular skin abnormality0GNPTAB CL E G H7915829670ORPHA:576Mucolipidosis type II240
HP:0011276HP:0011276Vascular skin abnormality0GP1BA CL E G H28114439ORPHA:274Bernard-Soulier syndrome23
HP:0011276HP:0011276Vascular skin abnormality0GP1BA CL E G H28114439OMIM:153670Bernard-Soulier syndrome, type A2, autosomal dominant23
HP:0011276HP:0011276Vascular skin abnormality0GP1BA CL E G H28114439OMIM:231200BERNARD-SOULIER SYNDROME; BSS23
HP:0011276HP:0011276Vascular skin abnormality0GP1BA CL E G H28114439ORPHA:853Fetal and neonatal alloimmune thrombocytopenia23
HP:0011276HP:0011276Vascular skin abnormality0GP1BB CL E G H28124440ORPHA:56722q11.2 deletion syndrome8
HP:0011276HP:0011276Vascular skin abnormality0GP1BB CL E G H28124440ORPHA:274Bernard-Soulier syndrome8
HP:0011276HP:0011276Vascular skin abnormality0GP1BB CL E G H28124440OMIM:231200BERNARD-SOULIER SYNDROME; BSS8
HP:0011276HP:0011276Vascular skin abnormality0GP1BB CL E G H28124440ORPHA:853Fetal and neonatal alloimmune thrombocytopenia8
HP:0011276HP:0011276Vascular skin abnormality0GP6 CL E G H5120614388OMIM:614201Bleeding disorder, platelet-type, 1124
HP:0011276HP:0011276Vascular skin abnormality0GP9 CL E G H28154444ORPHA:274Bernard-Soulier syndrome21
HP:0011276HP:0011276Vascular skin abnormality0GP9 CL E G H28154444OMIM:231200BERNARD-SOULIER SYNDROME; BSS21
HP:0011276HP:0011276Vascular skin abnormality0GPR35 CL E G H28594492ORPHA:171Primary sclerosing cholangitis2
HP:0011276HP:0011276Vascular skin abnormality0GSN CL E G H29344620ORPHA:85448AGel amyloidosis53
HP:0011276HP:0011276Vascular skin abnormality0GUCY1A1 CL E G H29824685OMIM:615750Moyamoya disease 6 with achalasia
HP:0011276HP:0011276Vascular skin abnormality0GUCY1A1 CL E G H29824685ORPHA:401945Moyamoya disease with early-onset achalasia
HP:0011276HP:0011276Vascular skin abnormality0H4C3 CL E G H83644787OMIM:619758TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 1; TEVANED1
HP:0011276HP:0011276Vascular skin abnormality0HBA1 CL E G H30394823ORPHA:98791Alpha-thalassemia-intellectual disability syndrome linked to chromosome 16200
HP:0011276HP:0011276Vascular skin abnormality0HBA2 CL E G H30404824ORPHA:98791Alpha-thalassemia-intellectual disability syndrome linked to chromosome 1688
HP:0011276HP:0011276Vascular skin abnormality0HCCS CL E G H30524837ORPHA:2556Microphthalmia with linear skin defects syndrome11
HP:0011276HP:0011276Vascular skin abnormality0HDAC8 CL E G H5586913315ORPHA:199Cornelia de Lange syndrome37
HP:0011276HP:0011276Vascular skin abnormality0HDAC8 CL E G H5586913315OMIM:300882Cornelia de Lange syndrome 537
HP:0011276HP:0011276Vascular skin abnormality0HEATR3 CL E G H5502726087OMIM:620072
HP:0011276HP:0011276Vascular skin abnormality0HEY2 CL E G H234934881ORPHA:91387Familial thoracic aortic aneurysm and aortic dissection
HP:0011276HP:0011276Vascular skin abnormality0HFE CL E G H30774886OMIM:235200Hemochromatosis, type 138
HP:0011276HP:0011276Vascular skin abnormality0HIRA CL E G H72904916ORPHA:56722q11.2 deletion syndrome3
HP:0011276HP:0011276Vascular skin abnormality0HLA-B CL E G H31064932ORPHA:36426Stevens-Johnson syndrome4
HP:0011276HP:0011276Vascular skin abnormality0HLA-DPA1 CL E G H31134938ORPHA:900Granulomatosis with polyangiitis
HP:0011276HP:0011276Vascular skin abnormality0HLA-DPB1 CL E G H31154940ORPHA:900Granulomatosis with polyangiitis1
HP:0011276HP:0011276Vascular skin abnormality0HLA-DQB1 CL E G H31194944ORPHA:703Bullous pemphigoid
HP:0011276HP:0011276Vascular skin abnormality0HLA-DRB1 CL E G H31234948ORPHA:703Bullous pemphigoid2
HP:0011276HP:0011276Vascular skin abnormality0HLA-DRB1 CL E G H31234948ORPHA:220393Diffuse cutaneous systemic sclerosis2
HP:0011276HP:0011276Vascular skin abnormality0HLA-DRB1 CL E G H31234948ORPHA:220402Limited cutaneous systemic sclerosis2
HP:0011276HP:0011276Vascular skin abnormality0HOXA11 CL E G H32075101OMIM:605432Radioulnar synostosis with amegakaryocytic thrombocytopenia3
HP:0011276HP:0011276Vascular skin abnormality0HPGD CL E G H32485154OMIM:259100Hypertrophic osteoarthropathy, primary, autosomal recessive 155
HP:0011276HP:0011276Vascular skin abnormality0HPS1 CL E G H32575163OMIM:203300Hermansky-Pudlak syndrome 1121
HP:0011276HP:0011276Vascular skin abnormality0HPS3 CL E G H8434315597OMIM:614072Hermansky-Pudlak syndrome 367
HP:0011276HP:0011276Vascular skin abnormality0HPS4 CL E G H8978115844OMIM:614073Hermansky-Pudlak syndrome 4123
HP:0011276HP:0011276Vascular skin abnormality0HPS5 CL E G H1123417022OMIM:614074Hermansky-Pudlak syndrome 5105
HP:0011276HP:0011276Vascular skin abnormality0HPS6 CL E G H7980318817OMIM:614075Hermansky-Pudlak syndrome 645
HP:0011276HP:0011276Vascular skin abnormality0HS3ST6 CL E G H6471114178OMIM:619367ANGIOEDEMA, HEREDITARY, 8; HAE8
HP:0011276HP:0011276Vascular skin abnormality0HSPG2 CL E G H33395273ORPHA:16061p36 deletion syndrome345
HP:0011276HP:0011276Vascular skin abnormality0IARS2 CL E G H5569929685OMIM:616007Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia25
HP:0011276HP:0011276Vascular skin abnormality0ICOS CL E G H298515351ORPHA:1572Common variable immunodeficiency32
HP:0011276HP:0011276Vascular skin abnormality0IFIH1 CL E G H6413518873ORPHA:51Aicardi-Goutières syndrome28
HP:0011276HP:0011276Vascular skin abnormality0IFIH1 CL E G H6413518873OMIM:615846Aicardi-Goutieres syndrome 728
HP:0011276HP:0011276Vascular skin abnormality0IFNG CL E G H34585438ORPHA:88Idiopathic aplastic anemia23
HP:0011276HP:0011276Vascular skin abnormality0IKBKG CL E G H85175961OMIM:308300Incontinentia pigmenti52
HP:0011276HP:0011276Vascular skin abnormality0IKBKG CL E G H85175961ORPHA:464Incontinentia pigmenti52
HP:0011276HP:0011276Vascular skin abnormality0IKZF1 CL E G H1032013176ORPHA:36426Stevens-Johnson syndrome8
HP:0011276HP:0011276Vascular skin abnormality0IL12A CL E G H35925969ORPHA:186Primary biliary cholangitis
HP:0011276HP:0011276Vascular skin abnormality0IL12RB1 CL E G H35945971ORPHA:319552Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency46
HP:0011276HP:0011276Vascular skin abnormality0IL12RB1 CL E G H35945971ORPHA:186Primary biliary cholangitis46
HP:0011276HP:0011276Vascular skin abnormality0IL17F CL E G H11274416404ORPHA:1334Chronic mucocutaneous candidiasis14
HP:0011276HP:0011276Vascular skin abnormality0IL17RA CL E G H237655985ORPHA:1334Chronic mucocutaneous candidiasis196
HP:0011276HP:0011276Vascular skin abnormality0IL17RC CL E G H8481818358ORPHA:1334Chronic mucocutaneous candidiasis4
HP:0011276HP:0011276Vascular skin abnormality0IL36RN CL E G H2652515561OMIM:614204PSORIASIS 14, PUSTULAR; PSORS1451
HP:0011276HP:0011276Vascular skin abnormality0IL7 CL E G H35746023ORPHA:302Epidermodysplasia verruciformis
HP:0011276HP:0011276Vascular skin abnormality0IPO8 CL E G H105269853ORPHA:60030Loeys-Dietz syndrome
HP:0011276HP:0011276Vascular skin abnormality0IPO8 CL E G H105269853OMIM:619472VISS syndrome
HP:0011276HP:0011276Vascular skin abnormality0IRF2BP2 CL E G H35994821729ORPHA:520Acute promyelocytic leukemia4
HP:0011276HP:0011276Vascular skin abnormality0IRF2BP2 CL E G H35994821729ORPHA:1572Common variable immunodeficiency4
HP:0011276HP:0011276Vascular skin abnormality0IRF5 CL E G H36636120ORPHA:220393Diffuse cutaneous systemic sclerosis4
HP:0011276HP:0011276Vascular skin abnormality0IRF5 CL E G H36636120ORPHA:220402Limited cutaneous systemic sclerosis4
HP:0011276HP:0011276Vascular skin abnormality0IRF5 CL E G H36636120ORPHA:186Primary biliary cholangitis4
HP:0011276HP:0011276Vascular skin abnormality0ITGA2 CL E G H36736137ORPHA:853Fetal and neonatal alloimmune thrombocytopenia119
HP:0011276HP:0011276Vascular skin abnormality0ITGA2B CL E G H36746138OMIM:187800Bleeding disorder, platelet-type, 1669
HP:0011276HP:0011276Vascular skin abnormality0ITGA2B CL E G H36746138ORPHA:853Fetal and neonatal alloimmune thrombocytopenia69
HP:0011276HP:0011276Vascular skin abnormality0ITGA2B CL E G H36746138OMIM:273800Glanzmann thrombasthenia69
HP:0011276HP:0011276Vascular skin abnormality0ITGA2B CL E G H36746138ORPHA:849Glanzmann thrombasthenia69
HP:0011276HP:0011276Vascular skin abnormality0ITGA3 CL E G H36756139OMIM:614748Interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa, congenital6
HP:0011276HP:0011276Vascular skin abnormality0ITGB3 CL E G H36906156ORPHA:853Fetal and neonatal alloimmune thrombocytopenia80
HP:0011276HP:0011276Vascular skin abnormality0ITGB3 CL E G H36906156ORPHA:849Glanzmann thrombasthenia80
HP:0011276HP:0011276Vascular skin abnormality0ITGB3 CL E G H36906156OMIM:619267GLANZMANN THROMBASTHENIA 2; GT280
HP:0011276HP:0011276Vascular skin abnormality0JAK2 CL E G H37176192OMIM:254450Myelofibrosismyelofibrosis with myeloid metaplasia, included57
HP:0011276HP:0011276Vascular skin abnormality0JAK2 CL E G H37176192ORPHA:729Polycythemia vera57
HP:0011276HP:0011276Vascular skin abnormality0JAK2 CL E G H37176192ORPHA:824Primary myelofibrosis57
HP:0011276HP:0011276Vascular skin abnormality0JAM2 CL E G H5849414686ORPHA:1980Bilateral striopallidodentate calcinosis
HP:0011276HP:0011276Vascular skin abnormality0JMJD1C CL E G H22103712313ORPHA:56722q11.2 deletion syndrome2
HP:0011276HP:0011276Vascular skin abnormality0KCNAB2 CL E G H85146229ORPHA:16061p36 deletion syndrome1
HP:0011276HP:0011276Vascular skin abnormality0KCNQ2 CL E G H37856296ORPHA:439218KCNQ2-related epileptic encephalopathy528
HP:0011276HP:0011276Vascular skin abnormality0KDSR CL E G H25314021ORPHA:317Erythrokeratodermia variabilis4
HP:0011276HP:0011276Vascular skin abnormality0KDSR CL E G H25314021OMIM:617526Erythrokeratodermia variabilis et progressiva 44
HP:0011276HP:0011276Vascular skin abnormality0KDSR CL E G H25314021ORPHA:316Progressive symmetric erythrokeratodermia4
HP:0011276HP:0011276Vascular skin abnormality0KIAA0319L CL E G H7993230071ORPHA:220402Limited cutaneous systemic sclerosis
HP:0011276HP:0011276Vascular skin abnormality0KIT CL E G H38156342ORPHA:280785Bullous diffuse cutaneous mastocytosis327
HP:0011276HP:0011276Vascular skin abnormality0KIT CL E G H38156342ORPHA:79455Cutaneous mastocytoma327
HP:0011276HP:0011276Vascular skin abnormality0KIT CL E G H38156342OMIM:606764Gastrointestinal stromal tumor327
HP:0011276HP:0011276Vascular skin abnormality0KIT CL E G H38156342OMIM:154800Mastocytosis, cutaneous327
HP:0011276HP:0011276Vascular skin abnormality0KIT CL E G H38156342ORPHA:98849Systemic mastocytosis with associated hematologic neoplasm327
HP:0011276HP:0011276Vascular skin abnormality0KLLN CL E G H10014474837212ORPHA:201Cowden syndrome1
HP:0011276HP:0011276Vascular skin abnormality0KNG1 CL E G H38276383OMIM:619363ANGIOEDEMA, HEREDITARY, 6; HAE67
HP:0011276HP:0011276Vascular skin abnormality0KRAS CL E G H38456407OMIM:609942Noonan syndrome 3196
HP:0011276HP:0011276Vascular skin abnormality0KRIT1 CL E G H8891573ORPHA:221061Familial cerebral cavernous malformationHP:0040283 - Occasional92
HP:0011276HP:0011276Vascular skin abnormality0KRT1 CL E G H38486412ORPHA:530838KRT1-related diffuse nonepidermolytic keratoderma100
HP:0011276HP:0011276Vascular skin abnormality0KRT10 CL E G H38586413OMIM:607602Ichthyosis, cyclic, with epidermolytic hyperkeratosis45
HP:0011276HP:0011276Vascular skin abnormality0KRT14 CL E G H38616416ORPHA:79396Autosomal dominant generalized epidermolysis bullosa simplex, severe form110
HP:0011276HP:0011276Vascular skin abnormality0KRT2 CL E G H38496439ORPHA:455Superficial epidermolytic ichthyosis67
HP:0011276HP:0011276Vascular skin abnormality0KRT5 CL E G H38526442ORPHA:79396Autosomal dominant generalized epidermolysis bullosa simplex, severe form173
HP:0011276HP:0011276Vascular skin abnormality0KRT5 CL E G H38526442ORPHA:158681Epidermolysis bullosa simplex with circinate migratory erythema173
HP:0011276HP:0011276Vascular skin abnormality0KRT5 CL E G H38526442OMIM:609352EPIDERMOLYSIS BULLOSA SIMPLEX WITH MIGRATORY CIRCINATE ERYTHEMA173
HP:0011276HP:0011276Vascular skin abnormality0KRT83 CL E G H38896460ORPHA:316Progressive symmetric erythrokeratodermia65
HP:0011276HP:0011276Vascular skin abnormality0LARP7 CL E G H5157424912ORPHA:319671Alazami syndrome16
HP:0011276HP:0011276Vascular skin abnormality0LBR CL E G H39306518OMIM:613471Reynolds syndrome70
HP:0011276HP:0011276Vascular skin abnormality0LBR CL E G H39306518ORPHA:779Reynolds syndrome70
HP:0011276HP:0011276Vascular skin abnormality0LCP2 CL E G H39376529OMIM:619374IMMUNODEFICIENCY 81; IMD81
HP:0011276HP:0011276Vascular skin abnormality0LEMD2 CL E G H22149621244OMIM:619322MARBACH-RUSTAD PROGEROID SYNDROME; MARUPS1
HP:0011276HP:0011276Vascular skin abnormality0LIG1 CL E G H39786598OMIM:619774IMMUNODEFICIENCY 96; IMD969
HP:0011276HP:0011276Vascular skin abnormality0LIG4 CL E G H39816601ORPHA:235Dubowitz syndrome88
HP:0011276HP:0011276Vascular skin abnormality0LIG4 CL E G H39816601ORPHA:99812LIG4 syndrome88
HP:0011276HP:0011276Vascular skin abnormality0LIG4 CL E G H39816601OMIM:606593Lig4 syndrome88
HP:0011276HP:0011276Vascular skin abnormality0LIPN CL E G H64341823452OMIM:613943Ichthyosis, congenital, autosomal recessive 81
HP:0011276HP:0011276Vascular skin abnormality0LMAN1 CL E G H39986631ORPHA:35909Combined deficiency of factor V and factor VIII56
HP:0011276HP:0011276Vascular skin abnormality0LMNA CL E G H40006636ORPHA:79474Atypical Werner syndrome645
HP:0011276HP:0011276Vascular skin abnormality0LMNA CL E G H40006636ORPHA:740Hutchinson-Gilford progeria syndrome645
HP:0011276HP:0011276Vascular skin abnormality0LMNA CL E G H40006636OMIM:151660Lipodystrophy, familial partial, type 2645
HP:0011276HP:0011276Vascular skin abnormality0LMX1B CL E G H40106654ORPHA:4958189q33.3q34.11 microdeletion syndrome165
HP:0011276HP:0011276Vascular skin abnormality0LORICRIN CL E G H40146663ORPHA:316Progressive symmetric erythrokeratodermia
HP:0011276HP:0011276Vascular skin abnormality0LOX CL E G H40156664ORPHA:91387Familial thoracic aortic aneurysm and aortic dissection6
HP:0011276HP:0011276Vascular skin abnormality0LRP1 CL E G H40356692ORPHA:79100Atrophoderma vermiculata4
HP:0011276HP:0011276Vascular skin abnormality0LRP1 CL E G H40356692OMIM:604093Keratosis pilaris atrophicans4
HP:0011276HP:0011276Vascular skin abnormality0LRP5 CL E G H40416697ORPHA:891Familial exudative vitreoretinopathy125
HP:0011276HP:0011276Vascular skin abnormality0LSM11 CL E G H13435330860ORPHA:51Aicardi-Goutières syndrome
HP:0011276HP:0011276Vascular skin abnormality0LUZP1 CL E G H779814985ORPHA:16061p36 deletion syndrome
HP:0011276HP:0011276Vascular skin abnormality0LYST CL E G H11301968ORPHA:352723Attenuated Chédiak-Higashi syndrome239
HP:0011276HP:0011276Vascular skin abnormality0LYST CL E G H11301968ORPHA:167Chédiak-Higashi syndrome239
HP:0011276HP:0011276Vascular skin abnormality0LYST CL E G H11301968OMIM:214500Chediak-Higashi syndrome239
HP:0011276HP:0011276Vascular skin abnormality0MANBA CL E G H41266831OMIM:248510MANNOSIDOSIS, BETA A, LYSOSOMAL55
HP:0011276HP:0011276Vascular skin abnormality0MAP2K1 CL E G H56046840OMIM:163950Noonan syndrome 1134
HP:0011276HP:0011276Vascular skin abnormality0MAPK1 CL E G H55946871OMIM:619087NOONAN SYNDROME 13; NS132
HP:0011276HP:0011276Vascular skin abnormality0MASP1 CL E G H56486901OMIM:2579203mc syndrome 121
HP:0011276HP:0011276Vascular skin abnormality0MAT2A CL E G H41446904ORPHA:91387Familial thoracic aortic aneurysm and aortic dissection13
HP:0011276HP:0011276Vascular skin abnormality0MBTPS2 CL E G H5136015455ORPHA:2273Ichthyosis follicularis-alopecia-photophobia syndrome22
HP:0011276HP:0011276Vascular skin abnormality0MBTPS2 CL E G H5136015455OMIM:308800Keratosis follicularis spinulosa decalvans, X-linked22
HP:0011276HP:0011276Vascular skin abnormality0MBTPS2 CL E G H5136015455ORPHA:659Mutilating palmoplantar keratoderma with periorificial keratotic plaques22
HP:0011276HP:0011276Vascular skin abnormality0MCFD2 CL E G H9041118451ORPHA:35909Combined deficiency of factor V and factor VIII77
HP:0011276HP:0011276Vascular skin abnormality0MEFV CL E G H42106998ORPHA:342Familial Mediterranean fever281
HP:0011276HP:0011276Vascular skin abnormality0MEFV CL E G H42106998OMIM:608068NEUTROPHILIC DERMATOSIS, ACUTE FEBRILE281
HP:0011276HP:0011276Vascular skin abnormality0MFAP5 CL E G H807629673ORPHA:91387Familial thoracic aortic aneurysm and aortic dissection11
HP:0011276HP:0011276Vascular skin abnormality0MMEL1 CL E G H7925814668ORPHA:186Primary biliary cholangitis
HP:0011276HP:0011276Vascular skin abnormality0MMP23B CL E G H85107171ORPHA:16061p36 deletion syndrome
HP:0011276HP:0011276Vascular skin abnormality0MPL CL E G H43527217OMIM:254450Myelofibrosismyelofibrosis with myeloid metaplasia, included97
HP:0011276HP:0011276Vascular skin abnormality0MPL CL E G H43527217ORPHA:729Polycythemia vera97
HP:0011276HP:0011276Vascular skin abnormality0MPL CL E G H43527217ORPHA:824Primary myelofibrosis97
HP:0011276HP:0011276Vascular skin abnormality0MRE11 CL E G H43617230OMIM:604391Ataxia-Telangiectasia-Like disorder 1532
HP:0011276HP:0011276Vascular skin abnormality0MS4A1 CL E G H9317315ORPHA:1572Common variable immunodeficiency1
HP:0011276HP:0011276Vascular skin abnormality0MST1 CL E G H44857380ORPHA:171Primary sclerosing cholangitis1
HP:0011276HP:0011276Vascular skin abnormality0MTAP CL E G H45077413OMIM:112250Diaphyseal medullary stenosis with malignant fibrous histiocytoma85
HP:0011276HP:0011276Vascular skin abnormality0MVK CL E G H45987530ORPHA:343Hyperimmunoglobulinemia D with periodic fever150
HP:0011276HP:0011276Vascular skin abnormality0MYD88 CL E G H46157562ORPHA:33226Waldenström macroglobulinemia9
HP:0011276HP:0011276Vascular skin abnormality0MYH11 CL E G H46297569OMIM:132900Aortic aneurysm, familial thoracic 4418
HP:0011276HP:0011276Vascular skin abnormality0MYH11 CL E G H46297569ORPHA:229Familial aortic dissection418
HP:0011276HP:0011276Vascular skin abnormality0MYH11 CL E G H46297569ORPHA:91387Familial thoracic aortic aneurysm and aortic dissection418
HP:0011276HP:0011276Vascular skin abnormality0MYH9 CL E G H46277579OMIM:155100Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss297
HP:0011276HP:0011276Vascular skin abnormality0MYH9 CL E G H46277579ORPHA:182050MYH9-related disease297
HP:0011276HP:0011276Vascular skin abnormality0MYLK CL E G H46387590ORPHA:91387Familial thoracic aortic aneurysm and aortic dissection326
HP:0011276HP:0011276Vascular skin abnormality0MYOF CL E G H265093656OMIM:619366ANGIOEDEMA, HEREDITARY, 7; HAE7
HP:0011276HP:0011276Vascular skin abnormality0MYORG CL E G H5746219918ORPHA:1980Bilateral striopallidodentate calcinosis
HP:0011276HP:0011276Vascular skin abnormality0NABP1 CL E G H6485926232ORPHA:520Acute promyelocytic leukemia
HP:0011276HP:0011276Vascular skin abnormality0NAGA CL E G H46687631ORPHA:79279Alpha-N-acetylgalactosaminidase deficiency type 147
HP:0011276HP:0011276Vascular skin abnormality0NAGA CL E G H46687631ORPHA:79280Alpha-N-acetylgalactosaminidase deficiency type 247
HP:0011276HP:0011276Vascular skin abnormality0NAGA CL E G H46687631OMIM:609242Kanzaki disease47
HP:0011276HP:0011276Vascular skin abnormality0NAXD CL E G H5573925576OMIM:618321Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 2
HP:0011276HP:0011276Vascular skin abnormality0NBEAL2 CL E G H2321831928OMIM:139090Gray platelet syndrome127
HP:0011276HP:0011276Vascular skin abnormality0NBEAL2 CL E G H2321831928ORPHA:721Gray platelet syndrome127
HP:0011276HP:0011276Vascular skin abnormality0ND1 CL E G H45357455ORPHA:104Leber hereditary optic neuropathy
HP:0011276HP:0011276Vascular skin abnormality0ND1 CL E G H45357455ORPHA:550MELAS
HP:0011276HP:0011276Vascular skin abnormality0ND2 CL E G H45367456ORPHA:104Leber hereditary optic neuropathy
HP:0011276HP:0011276Vascular skin abnormality0ND4 CL E G H45387459ORPHA:104Leber hereditary optic neuropathy
HP:0011276HP:0011276Vascular skin abnormality0ND4 CL E G H45387459ORPHA:550MELAS
HP:0011276HP:0011276Vascular skin abnormality0ND4L CL E G H45397460ORPHA:104Leber hereditary optic neuropathy
HP:0011276HP:0011276Vascular skin abnormality0ND5 CL E G H45407461ORPHA:104Leber hereditary optic neuropathy
HP:0011276HP:0011276Vascular skin abnormality0ND5 CL E G H45407461ORPHA:550MELAS
HP:0011276HP:0011276Vascular skin abnormality0ND6 CL E G H45417462ORPHA:104Leber hereditary optic neuropathy
HP:0011276HP:0011276Vascular skin abnormality0ND6 CL E G H45417462ORPHA:550MELAS
HP:0011276HP:0011276Vascular skin abnormality0NDP CL E G H46937678ORPHA:891Familial exudative vitreoretinopathy39
HP:0011276HP:0011276Vascular skin abnormality0NDUFB11 CL E G H5453920372ORPHA:2556Microphthalmia with linear skin defects syndrome3
HP:0011276HP:0011276Vascular skin abnormality0NDUFS2 CL E G H47207708ORPHA:104Leber hereditary optic neuropathy65
HP:0011276HP:0011276Vascular skin abnormality0NEU1 CL E G H47587758ORPHA:93400Congenital sialidosis type 243
HP:0011276HP:0011276Vascular skin abnormality0NEU1 CL E G H47587758ORPHA:812Sialidosis type 1HP:0040281 - Very frequent43
HP:0011276HP:0011276Vascular skin abnormality0NF1 CL E G H47637765ORPHA:9768517q11 microdeletion syndrome1952
HP:0011276HP:0011276Vascular skin abnormality0NFIA CL E G H47747784ORPHA:4019861p31p32 microdeletion syndrome12
HP:0011276HP:0011276Vascular skin abnormality0NFIA CL E G H47747784OMIM:613735Brain malformations with or without urinary tract defects12
HP:0011276HP:0011276Vascular skin abnormality0NFIX CL E G H47847788ORPHA:561Marshall-Smith syndrome40
HP:0011276HP:0011276Vascular skin abnormality0NFIX CL E G H47847788OMIM:614753Sotos syndrome 240
HP:0011276HP:0011276Vascular skin abnormality0NFKB1 CL E G H47907794ORPHA:1572Common variable immunodeficiency7
HP:0011276HP:0011276Vascular skin abnormality0NFKB2 CL E G H47917795ORPHA:1572Common variable immunodeficiency11
HP:0011276HP:0011276Vascular skin abnormality0NHP2 CL E G H5565114377ORPHA:1775Dyskeratosis congenita27
HP:0011276HP:0011276Vascular skin abnormality0NIPBL CL E G H2583628862ORPHA:199Cornelia de Lange syndrome494
HP:0011276HP:0011276Vascular skin abnormality0NIPBL CL E G H2583628862OMIM:122470Cornelia de Lange syndrome 1494
HP:0011276HP:0011276Vascular skin abnormality0NLRC4 CL E G H5848416412OMIM:616050AUTOINFLAMMATION WITH INFANTILE ENTEROCOLITIS; AIFEC30
HP:0011276HP:0011276Vascular skin abnormality0NLRC4 CL E G H5848416412OMIM:616115FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 4; FCAS430
HP:0011276HP:0011276Vascular skin abnormality0NLRP12 CL E G H9166222938OMIM:611762Familial cold autoinflammatory syndrome 299
HP:0011276HP:0011276Vascular skin abnormality0NLRP3 CL E G H11454816400ORPHA:1451CINCA syndrome217
HP:0011276HP:0011276Vascular skin abnormality0NLRP3 CL E G H11454816400OMIM:617772Deafness, autosomal dominant 34, with or without inflammation217
HP:0011276HP:0011276Vascular skin abnormality0NLRP3 CL E G H11454816400OMIM:120100FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1; FCAS1217
HP:0011276HP:0011276Vascular skin abnormality0NLRP3 CL E G H11454816400ORPHA:47045Familial cold urticaria217
HP:0011276HP:0011276Vascular skin abnormality0NLRP3 CL E G H11454816400ORPHA:575Muckle-Wells syndrome217
HP:0011276HP:0011276Vascular skin abnormality0NOD2 CL E G H641275331ORPHA:90340Blau syndrome187
HP:0011276HP:0011276Vascular skin abnormality0NOP10 CL E G H5550514378ORPHA:1775Dyskeratosis congenita17
HP:0011276HP:0011276Vascular skin abnormality0NOTCH1 CL E G H48517881ORPHA:974Adams-Oliver syndrome452
HP:0011276HP:0011276Vascular skin abnormality0NPM1 CL E G H48697910ORPHA:520Acute promyelocytic leukemia12
HP:0011276HP:0011276Vascular skin abnormality0NPM1 CL E G H48697910ORPHA:1775Dyskeratosis congenita12
HP:0011276HP:0011276Vascular skin abnormality0NR3C1 CL E G H29087978ORPHA:96253Cushing disease79
HP:0011276HP:0011276Vascular skin abnormality0NSDHL CL E G H5081413398OMIM:308050Congenital hemidysplasia with ichthyosiform erythroderma and limb defects34
HP:0011276HP:0011276Vascular skin abnormality0NSUN2 CL E G H5488825994ORPHA:235Dubowitz syndrome84
HP:0011276HP:0011276Vascular skin abnormality0NTRK1 CL E G H49148031ORPHA:642Hereditary sensory and autonomic neuropathy type 497
HP:0011276HP:0011276Vascular skin abnormality0NUMA1 CL E G H49268059ORPHA:520Acute promyelocytic leukemia
HP:0011276HP:0011276Vascular skin abnormality0OCLN CL E G H1005066588104OMIM:251290Band-Like calcification with simplified gyration and polymicrogyria23
HP:0011276HP:0011276Vascular skin abnormality0ODC1 CL E G H49538109ORPHA:544488Global developmental delay-alopecia-macrocephaly-facial dysmorphism-structural brain anomalies syndromeHP:0040283 - Occasional1
HP:0011276HP:0011276Vascular skin abnormality0ORAI1 CL E G H8487625896ORPHA:3204Stormorken-Sjaastad-Langslet syndrome19
HP:0011276HP:0011276Vascular skin abnormality0P2RY12 CL E G H6480518124OMIM:609821Bleeding disorder, platelet-type, 85
HP:0011276HP:0011276Vascular skin abnormality0PARN CL E G H50738609ORPHA:1775Dyskeratosis congenita26
HP:0011276HP:0011276Vascular skin abnormality0PCNA CL E G H51118729OMIM:615919Ataxia-Telangiectasia-Like disorder 21
HP:0011276HP:0011276Vascular skin abnormality0PCNA CL E G H51118729ORPHA:438134PCNA-related progressive neurodegenerative photosensitivity syndrome1
HP:0011276HP:0011276Vascular skin abnormality0PDCD10 CL E G H112358761ORPHA:221061Familial cerebral cavernous malformationHP:0040283 - Occasional21
HP:0011276HP:0011276Vascular skin abnormality0PDE11A CL E G H509408773ORPHA:1359Carney complex13
HP:0011276HP:0011276Vascular skin abnormality0PDE11A CL E G H509408773OMIM:610475Pigmented nodular adrenocortical disease, primary, 213
HP:0011276HP:0011276Vascular skin abnormality0PDE11A CL E G H509408773ORPHA:189439Primary pigmented nodular adrenocortical disease13
HP:0011276HP:0011276Vascular skin abnormality0PDE8B CL E G H86228794ORPHA:189439Primary pigmented nodular adrenocortical disease75
HP:0011276HP:0011276Vascular skin abnormality0PDGFB CL E G H51558800ORPHA:1980Bilateral striopallidodentate calcinosis9
HP:0011276HP:0011276Vascular skin abnormality0PDGFB CL E G H51558800ORPHA:31112Dermatofibrosarcoma protuberans9
HP:0011276HP:0011276Vascular skin abnormality0PDGFRB CL E G H51598804ORPHA:1980Bilateral striopallidodentate calcinosis28
HP:0011276HP:0011276Vascular skin abnormality0PDPN CL E G H1063029602ORPHA:16061p36 deletion syndrome
HP:0011276HP:0011276Vascular skin abnormality0PDSS1 CL E G H2359017759OMIM:614651Coenzyme Q10 deficiency, primary, 240
HP:0011276HP:0011276Vascular skin abnormality0PEPD CL E G H51848840ORPHA:742Prolidase deficiency66
HP:0011276HP:0011276Vascular skin abnormality0PEPD CL E G H51848840OMIM:170100Prolidase deficiency66
HP:0011276HP:0011276Vascular skin abnormality0PERP CL E G H6406517637ORPHA:659Mutilating palmoplantar keratoderma with periorificial keratotic plaques
HP:0011276HP:0011276Vascular skin abnormality0PEX6 CL E G H51908859ORPHA:95433Autosomal recessive spinocerebellar ataxia-blindness-deafness syndrome98
HP:0011276HP:0011276Vascular skin abnormality0PGAP2 CL E G H2731517893ORPHA:247262Hyperphosphatasia-intellectual disability syndrome8
HP:0011276HP:0011276Vascular skin abnormality0PGAP3 CL E G H9321023719ORPHA:247262Hyperphosphatasia-intellectual disability syndrome20
HP:0011276HP:0011276Vascular skin abnormality0PGM3 CL E G H52388907OMIM:615816Immunodeficiency 2315
HP:0011276HP:0011276Vascular skin abnormality0PGM3 CL E G H52388907ORPHA:443811PGM3-CDG15
HP:0011276HP:0011276Vascular skin abnormality0PIGL CL E G H94878966ORPHA:3474CHIME syndrome36
HP:0011276HP:0011276Vascular skin abnormality0PIGL CL E G H94878966ORPHA:247262Hyperphosphatasia-intellectual disability syndrome36
HP:0011276HP:0011276Vascular skin abnormality0PIGO CL E G H8472023215ORPHA:247262Hyperphosphatasia-intellectual disability syndrome84
HP:0011276HP:0011276Vascular skin abnormality0PIGT CL E G H5160414938OMIM:615399Paroxysmal nocturnal hemoglobinuria 212
HP:0011276HP:0011276Vascular skin abnormality0PIGV CL E G H5565026031ORPHA:247262Hyperphosphatasia-intellectual disability syndrome57
HP:0011276HP:0011276Vascular skin abnormality0PIGW CL E G H28409823213ORPHA:247262Hyperphosphatasia-intellectual disability syndrome6
HP:0011276HP:0011276Vascular skin abnormality0PIGY CL E G H8499228213ORPHA:247262Hyperphosphatasia-intellectual disability syndrome2
HP:0011276HP:0011276Vascular skin abnormality0PIK3CA CL E G H52908975ORPHA:201Cowden syndrome162
HP:0011276HP:0011276Vascular skin abnormality0PIK3CA CL E G H52908975ORPHA:276280Hemihyperplasia-multiple lipomatosis syndrome162
HP:0011276HP:0011276Vascular skin abnormality0PIK3CA CL E G H52908975OMIM:602501Megalencephaly-Capillary malformation-polymicrogyria syndrome162
HP:0011276HP:0011276Vascular skin abnormality0PIK3CA CL E G H52908975ORPHA:60040Megalencephaly-capillary malformation-polymicrogyria syndrome162
HP:0011276HP:0011276Vascular skin abnormality0PLAU CL E G H53289052OMIM:601709Quebec platelet disorder50
HP:0011276HP:0011276Vascular skin abnormality0PLCG2 CL E G H53369066OMIM:614878Autoinflammation, antibody deficiency, and immune dysregulation, plcg2-associated21
HP:0011276HP:0011276Vascular skin abnormality0PLCG2 CL E G H53369066OMIM:614468FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 3; FCAS321
HP:0011276HP:0011276Vascular skin abnormality0PLEC CL E G H53399069OMIM:131950Epidermolysis bullosa simplex, Ogna type759
HP:0011276HP:0011276Vascular skin abnormality0PLG CL E G H53409071OMIM:619360ANGIOEDEMA, HEREDITARY, 4; HAE411
HP:0011276HP:0011276Vascular skin abnormality0PLOD1 CL E G H53519081OMIM:225400Ehlers-Danlos syndrome, kyphoscoliotic type, 1105
HP:0011276HP:0011276Vascular skin abnormality0PLOD1 CL E G H53519081ORPHA:1900Kyphoscoliotic Ehlers-Danlos syndrome due to lysyl hydroxylase 1 deficiency105
HP:0011276HP:0011276Vascular skin abnormality0PLOD3 CL E G H89859083OMIM:612394Bone fragility with contractures, arterial rupture, and deafness5
HP:0011276HP:0011276Vascular skin abnormality0PML CL E G H53719113ORPHA:520Acute promyelocytic leukemia3
HP:0011276HP:0011276Vascular skin abnormality0POLA1 CL E G H54229173OMIM:301220PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED; PDR2
HP:0011276HP:0011276Vascular skin abnormality0POLD1 CL E G H54249175OMIM:615381Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome731
HP:0011276HP:0011276Vascular skin abnormality0POLE CL E G H54269177OMIM:615139Facial dysmorphism, immunodeficiency, livedo, and short stature1129
HP:0011276HP:0011276Vascular skin abnormality0POLH CL E G H54299181ORPHA:90342Xeroderma pigmentosum variant155
HP:0011276HP:0011276Vascular skin abnormality0POLH CL E G H54299181OMIM:278750Xeroderma pigmentosum, Variant type155
HP:0011276HP:0011276Vascular skin abnormality0POLR3A CL E G H1112830074ORPHA:3455Wiedemann-Rautenstrauch syndrome138
HP:0011276HP:0011276Vascular skin abnormality0POLR3A CL E G H1112830074OMIM:264090Wiedemann-Rautenstrauch syndrome138
HP:0011276HP:0011276Vascular skin abnormality0PORCN CL E G H6484017652ORPHA:2092Focal dermal hypoplasia20
HP:0011276HP:0011276Vascular skin abnormality0PORCN CL E G H6484017652OMIM:305600Focal dermal hypoplasia20
HP:0011276HP:0011276Vascular skin abnormality0POU2AF1 CL E G H54509211ORPHA:186Primary biliary cholangitis
HP:0011276HP:0011276Vascular skin abnormality0PPARG CL E G H54689236ORPHA:528Congenital generalized lipodystrophy42
HP:0011276HP:0011276Vascular skin abnormality0PPARG CL E G H54689236OMIM:604367Lipodystrophy, familial partial, type 342
HP:0011276HP:0011276Vascular skin abnormality0PPARG CL E G H54689236ORPHA:79083PPARG-related familial partial lipodystrophy42
HP:0011276HP:0011276Vascular skin abnormality0PPP1R15B CL E G H8491914951OMIM:616817Microcephaly, short stature, and impaired glucose metabolism 22
HP:0011276HP:0011276Vascular skin abnormality0PRDM16 CL E G H6397614000ORPHA:16061p36 deletion syndrome148
HP:0011276HP:0011276Vascular skin abnormality0PRDM5 CL E G H111079349ORPHA:90354Brittle cornea syndrome58
HP:0011276HP:0011276Vascular skin abnormality0PRF1 CL E G H55519360ORPHA:540Familial hemophagocytic lymphohistiocytosis58
HP:0011276HP:0011276Vascular skin abnormality0PRF1 CL E G H55519360ORPHA:88Idiopathic aplastic anemia58
HP:0011276HP:0011276Vascular skin abnormality0PRKACA CL E G H55669380OMIM:615830Pigmented nodular adrenocortical disease, primary, 42
HP:0011276HP:0011276Vascular skin abnormality0PRKACA CL E G H55669380ORPHA:189439Primary pigmented nodular adrenocortical disease2
HP:0011276HP:0011276Vascular skin abnormality0PRKACG CL E G H55689382OMIM:616176Bleeding disorder, platelet-type, 192
HP:0011276HP:0011276Vascular skin abnormality0PRKAR1A CL E G H55739388ORPHA:520Acute promyelocytic leukemia134
HP:0011276HP:0011276Vascular skin abnormality0PRKAR1A CL E G H55739388ORPHA:1359Carney complex134
HP:0011276HP:0011276Vascular skin abnormality0PRKAR1A CL E G H55739388OMIM:610489Pigmented nodular adrenocortical disease, primary, 1134
HP:0011276HP:0011276Vascular skin abnormality0PRKAR1A CL E G H55739388ORPHA:189439Primary pigmented nodular adrenocortical disease134
HP:0011276HP:0011276Vascular skin abnormality0PRKCD CL E G H55809399ORPHA:3261Autoimmune lymphoproliferative syndrome10
HP:0011276HP:0011276Vascular skin abnormality0PRKCD CL E G H55809399ORPHA:1572Common variable immunodeficiency10
HP:0011276HP:0011276Vascular skin abnormality0PRKCZ CL E G H55909412ORPHA:16061p36 deletion syndrome
HP:0011276HP:0011276Vascular skin abnormality0PRKG1 CL E G H55929414ORPHA:91387Familial thoracic aortic aneurysm and aortic dissection41
HP:0011276HP:0011276Vascular skin abnormality0PROC CL E G H56249451ORPHA:745Severe hereditary thrombophilia due to congenital protein C deficiency65
HP:0011276HP:0011276Vascular skin abnormality0PROC CL E G H56249451OMIM:612304Thrombophilia due to protein C deficiency, autosomal recessive65
HP:0011276HP:0011276Vascular skin abnormality0PROS1 CL E G H56279456ORPHA:743Severe hereditary thrombophilia due to congenital protein S deficiency75
HP:0011276HP:0011276Vascular skin abnormality0PROS1 CL E G H56279456OMIM:614514Thrombophilia due to protein S deficiency, autosomal recessive75
HP:0011276HP:0011276Vascular skin abnormality0PROS1 CL E G H56279456OMIM:612336Thrombophilia, hereditary, due to protein S deficiency, autosomal75
HP:0011276HP:0011276Vascular skin abnormality0PRTN3 CL E G H56579495ORPHA:900Granulomatosis with polyangiitis
HP:0011276HP:0011276Vascular skin abnormality0PSMB8 CL E G H56969545OMIM:256040Proteasome-associated autoinflammatory syndrome 1 and digenic forms20
HP:0011276HP:0011276Vascular skin abnormality0PSMG2 CL E G H5698424929OMIM:619183PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 4; PRAAS4
HP:0011276HP:0011276Vascular skin abnormality0PTDSS1 CL E G H97919587OMIM:151050Lenz-Majewski hyperostotic dwarfism6
HP:0011276HP:0011276Vascular skin abnormality0PTEN CL E G H57289588ORPHA:109Bannayan-Riley-Ruvalcaba syndrome948
HP:0011276HP:0011276Vascular skin abnormality0PTEN CL E G H57289588ORPHA:201Cowden syndrome948
HP:0011276HP:0011276Vascular skin abnormality0PTEN CL E G H57289588ORPHA:744Proteus syndromeHP:0040281 - Very frequent948
HP:0011276HP:0011276Vascular skin abnormality0PTPN11 CL E G H57819644OMIM:163950Noonan syndrome 1291
HP:0011276HP:0011276Vascular skin abnormality0PTPN22 CL E G H261919652ORPHA:900Granulomatosis with polyangiitis3
HP:0011276HP:0011276Vascular skin abnormality0PYCR1 CL E G H58319721OMIM:612940Cutis laxa, autosomal recessive, type IIB53
HP:0011276HP:0011276Vascular skin abnormality0PYCR1 CL E G H58319721OMIM:614438Cutis laxa, autosomal recessive, type IIIB53
HP:0011276HP:0011276Vascular skin abnormality0RAB27A CL E G H58739766ORPHA:79477Griscelli syndrome type 267
HP:0011276HP:0011276Vascular skin abnormality0RAC2 CL E G H58809802OMIM:618987IMMUNODEFICIENCY 73C WITH DEFECTIVE NEUTROPHIL CHEMOTAXIS AND HYPOGAMMAGLOBULINEMIA; IMD73C9
HP:0011276HP:0011276Vascular skin abnormality0RAD21 CL E G H58859811ORPHA:199Cornelia de Lange syndrome25
HP:0011276HP:0011276Vascular skin abnormality0RAD21 CL E G H58859811OMIM:614701Cornelia de Lange syndrome 425
HP:0011276HP:0011276Vascular skin abnormality0RARA CL E G H59149864ORPHA:520Acute promyelocytic leukemia2
HP:0011276HP:0011276Vascular skin abnormality0RASA1 CL E G H59219871ORPHA:137667Capillary malformation-arteriovenous malformationHP:0040282 - Frequent88
HP:0011276HP:0011276Vascular skin abnormality0RASA1 CL E G H59219871ORPHA:90307Parkes Weber syndrome88
HP:0011276HP:0011276Vascular skin abnormality0RASGRP1 CL E G H101259878ORPHA:3261Autoimmune lymphoproliferative syndrome
HP:0011276HP:0011276Vascular skin abnormality0RBPJ CL E G H35165724ORPHA:974Adams-Oliver syndrome3
HP:0011276HP:0011276Vascular skin abnormality0RECQL4 CL E G H94019949ORPHA:221016Rothmund-Thomson syndrome type 2445
HP:0011276HP:0011276Vascular skin abnormality0RECQL4 CL E G H94019949OMIM:268400ROTHMUND-THOMSON SYNDROME; RTS445
HP:0011276HP:0011276Vascular skin abnormality0RERE CL E G H4739965ORPHA:16061p36 deletion syndrome16
HP:0011276HP:0011276Vascular skin abnormality0RHOH CL E G H399686OMIM:618307Epidermodysplasia verruciformis, susceptibility to, 4
HP:0011276HP:0011276Vascular skin abnormality0RIN2 CL E G H5445318750OMIM:613075Macs syndrome43
HP:0011276HP:0011276Vascular skin abnormality0RIN2 CL E G H5445318750ORPHA:217335RIN2 syndrome43
HP:0011276HP:0011276Vascular skin abnormality0RNASEH2A CL E G H1053518518ORPHA:51Aicardi-Goutières syndrome33
HP:0011276HP:0011276Vascular skin abnormality0RNASEH2B CL E G H7962125671ORPHA:51Aicardi-Goutières syndrome34
HP:0011276HP:0011276Vascular skin abnormality0RNASEH2C CL E G H8415324116ORPHA:51Aicardi-Goutières syndrome60
HP:0011276HP:0011276Vascular skin abnormality0RNF113A CL E G H773712974OMIM:300953Trichothiodystrophy 5, nonphotosensitive3
HP:0011276HP:0011276Vascular skin abnormality0RNF168 CL E G H16591826661ORPHA:420741RIDDLE syndrome7
HP:0011276HP:0011276Vascular skin abnormality0RNF213 CL E G H5767414539ORPHA:2573Moyamoya disease14
HP:0011276HP:0011276Vascular skin abnormality0RNU7-1 CL E G H10014774434033ORPHA:51Aicardi-Goutières syndrome
HP:0011276HP:0011276Vascular skin abnormality0RPS6KA3 CL E G H619710432OMIM:303600Coffin-Lowry syndrome65
HP:0011276HP:0011276Vascular skin abnormality0RREB1 CL E G H623910449ORPHA:56722q11.2 deletion syndrome
HP:0011276HP:0011276Vascular skin abnormality0RTEL1 CL E G H5175015888ORPHA:1775Dyskeratosis congenita77
HP:0011276HP:0011276Vascular skin abnormality0RUNX1 CL E G H86110471ORPHA:98850Aggressive systemic mastocytosis181
HP:0011276HP:0011276Vascular skin abnormality0RUNX1 CL E G H86110471OMIM:601399Platelet disorder, familial, with associated myeloid malignancy181
HP:0011276HP:0011276Vascular skin abnormality0SAMD9 CL E G H548091348OMIM:617053Mirage syndrome8
HP:0011276HP:0011276Vascular skin abnormality0SAMHD1 CL E G H2593915925ORPHA:51Aicardi-Goutières syndrome55
HP:0011276HP:0011276Vascular skin abnormality0SBDS CL E G H5111919440ORPHA:88Idiopathic aplastic anemia26
HP:0011276HP:0011276Vascular skin abnormality0SCARB2 CL E G H9501665ORPHA:77259Gaucher disease type 177
HP:0011276HP:0011276Vascular skin abnormality0SCN10A CL E G H633610582ORPHA:90026Primary erythromelalgia146
HP:0011276HP:0011276Vascular skin abnormality0SCN11A CL E G H1128010583ORPHA:90026Primary erythromelalgia19
HP:0011276HP:0011276Vascular skin abnormality0SCN9A CL E G H633510597ORPHA:90026Primary erythromelalgia318
HP:0011276HP:0011276Vascular skin abnormality0SDHB CL E G H639010681ORPHA:201Cowden syndrome237
HP:0011276HP:0011276Vascular skin abnormality0SDHB CL E G H639010681OMIM:606764Gastrointestinal stromal tumor237
HP:0011276HP:0011276Vascular skin abnormality0SDHC CL E G H639110682ORPHA:201Cowden syndrome147
HP:0011276HP:0011276Vascular skin abnormality0SDHC CL E G H639110682OMIM:606764Gastrointestinal stromal tumor147
HP:0011276HP:0011276Vascular skin abnormality0SDHD CL E G H639210683ORPHA:100093Carcinoid syndrome129
HP:0011276HP:0011276Vascular skin abnormality0SDHD CL E G H639210683ORPHA:201Cowden syndrome129
HP:0011276HP:0011276Vascular skin abnormality0SEC23B CL E G H1048310702ORPHA:201Cowden syndrome60
HP:0011276HP:0011276Vascular skin abnormality0SEC24C CL E G H963210705ORPHA:56722q11.2 deletion syndrome
HP:0011276HP:0011276Vascular skin abnormality0SEMA4D CL E G H1050710732ORPHA:171Primary sclerosing cholangitis
HP:0011276HP:0011276Vascular skin abnormality0SERPINE1 CL E G H50548583ORPHA:465Congenital plasminogen activator inhibitor type 1 deficiency39
HP:0011276HP:0011276Vascular skin abnormality0SERPINF2 CL E G H53459075ORPHA:79Congenital alpha2-antiplasmin deficiency8
HP:0011276HP:0011276Vascular skin abnormality0SERPINF2 CL E G H53459075OMIM:262850Plasmin inhibitor deficiency8
HP:0011276HP:0011276Vascular skin abnormality0SERPING1 CL E G H7101228OMIM:106100Angioedema, hereditary, 164
HP:0011276HP:0011276Vascular skin abnormality0SERPING1 CL E G H7101228ORPHA:100050Hereditary angioedema type 164
HP:0011276HP:0011276Vascular skin abnormality0SETX CL E G H23064445OMIM:606002Spinocerebellar ataxia, autosomal recessive 1162
HP:0011276HP:0011276Vascular skin abnormality0SF3B4 CL E G H1026210771OMIM:154400Acrofacial dysostosis 1, Nager type49
HP:0011276HP:0011276Vascular skin abnormality0SH2B3 CL E G H1001929605OMIM:254450Myelofibrosismyelofibrosis with myeloid metaplasia, included4
HP:0011276HP:0011276Vascular skin abnormality0SIK3 CL E G H2338729165OMIM:618162Spondyloepimetaphyseal dysplasia, Krakow type
HP:0011276HP:0011276Vascular skin abnormality0SKI CL E G H649710896ORPHA:16061p36 deletion syndrome150
HP:0011276HP:0011276Vascular skin abnormality0SLC20A2 CL E G H657510947ORPHA:1980Bilateral striopallidodentate calcinosis70
HP:0011276HP:0011276Vascular skin abnormality0SLC25A24 CL E G H2995720662OMIM:612289Fontaine progeroid syndrome
HP:0011276HP:0011276Vascular skin abnormality0SLC27A4 CL E G H1099910998OMIM:608649ICHTHYOSIS PREMATURITY SYNDROME; IPS26
HP:0011276HP:0011276Vascular skin abnormality0SLC29A3 CL E G H5531523096ORPHA:168569H syndrome68
HP:0011276HP:0011276Vascular skin abnormality0SLC29A3 CL E G H5531523096OMIM:602782Histiocytosis-lymphadenopathy plus syndrome68
HP:0011276HP:0011276Vascular skin abnormality0SLC2A10 CL E G H8103113444OMIM:208050Arterial tortuosity syndrome178
HP:0011276HP:0011276Vascular skin abnormality0SLC2A10 CL E G H8103113444ORPHA:3342Arterial tortuosity syndrome178
HP:0011276HP:0011276Vascular skin abnormality0SLC35A1 CL E G H1055911021OMIM:603585Congenital disorder of glycosylation, type IIf24
HP:0011276HP:0011276Vascular skin abnormality0SLC35A1 CL E G H1055911021ORPHA:238459SLC35A1-CDG24
HP:0011276HP:0011276Vascular skin abnormality0SLC37A4 CL E G H25424061ORPHA:79259Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib110
HP:0011276HP:0011276Vascular skin abnormality0SLC37A4 CL E G H25424061OMIM:232240GLYCOGEN STORAGE DISEASE Ic110
HP:0011276HP:0011276Vascular skin abnormality0SLC39A13 CL E G H9125220859OMIM:612350Ehlers-Danlos syndrome, spondylodysplastic type, 324
HP:0011276HP:0011276Vascular skin abnormality0SLC39A13 CL E G H9125220859ORPHA:157965SLC39A13-related spondylodysplastic Ehlers-Danlos syndrome24
HP:0011276HP:0011276Vascular skin abnormality0SLC39A4 CL E G H5563017129ORPHA:37Acrodermatitis enteropathica55
HP:0011276HP:0011276Vascular skin abnormality0SLC39A4 CL E G H5563017129OMIM:201100Acrodermatitis enteropathica, Zinc-Deficiency type55
HP:0011276HP:0011276Vascular skin abnormality0SLC51A CL E G H20093129955OMIM:619484CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 6; PFIC6
HP:0011276HP:0011276Vascular skin abnormality0SLFN14 CL E G H34261832689OMIM:616913Bleeding disorder, platelet-type, 206
HP:0011276HP:0011276Vascular skin abnormality0SLURP1 CL E G H5715218746ORPHA:87503Mal de Meleda15
HP:0011276HP:0011276Vascular skin abnormality0SLURP1 CL E G H5715218746OMIM:248300Meleda disease15
HP:0011276HP:0011276Vascular skin abnormality0SMAD2 CL E G H40876768ORPHA:91387Familial thoracic aortic aneurysm and aortic dissection7
HP:0011276HP:0011276Vascular skin abnormality0SMAD3 CL E G H40886769ORPHA:284984Aneurysm-osteoarthritis syndrome260
HP:0011276HP:0011276Vascular skin abnormality0SMAD3 CL E G H40886769ORPHA:91387Familial thoracic aortic aneurysm and aortic dissection260
HP:0011276HP:0011276Vascular skin abnormality0SMAD3 CL E G H40886769OMIM:613795LOEYS-DIETZ SYNDROME 3; LDS3260
HP:0011276HP:0011276Vascular skin abnormality0SMAD4 CL E G H40896770ORPHA:91387Familial thoracic aortic aneurysm and aortic dissection504
HP:0011276HP:0011276Vascular skin abnormality0SMAD4 CL E G H40896770ORPHA:774Hereditary hemorrhagic telangiectasia504
HP:0011276HP:0011276Vascular skin abnormality0SMAD4 CL E G H40896770OMIM:175050Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome504
HP:0011276HP:0011276Vascular skin abnormality0SMC1A CL E G H824311111ORPHA:199Cornelia de Lange syndrome135
HP:0011276HP:0011276Vascular skin abnormality0SMC1A CL E G H824311111OMIM:300590Cornelia de Lange syndrome 2135
HP:0011276HP:0011276Vascular skin abnormality0SMC3 CL E G H91262468ORPHA:199Cornelia de Lange syndrome91
HP:0011276HP:0011276Vascular skin abnormality0SMC3 CL E G H91262468OMIM:610759Cornelia de Lange syndrome 391
HP:0011276HP:0011276Vascular skin abnormality0SNX10 CL E G H2988714974ORPHA:667Autosomal recessive malignant osteopetrosis2
HP:0011276HP:0011276Vascular skin abnormality0SOS1 CL E G H665411187OMIM:610733Noonan syndrome 4315
HP:0011276HP:0011276Vascular skin abnormality0SOX18 CL E G H5434511194OMIM:607823Hypotrichosis-Lymphedema-Telangiectasia syndrome7
HP:0011276HP:0011276Vascular skin abnormality0SOX18 CL E G H5434511194ORPHA:69735Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome7
HP:0011276HP:0011276Vascular skin abnormality0SOX18 CL E G H5434511194OMIM:137940Hypotrichosis-Lymphedema-Telangiectasia-Renal defect syndrome7
HP:0011276HP:0011276Vascular skin abnormality0SPEN CL E G H2301317575ORPHA:16061p36 deletion syndrome4
HP:0011276HP:0011276Vascular skin abnormality0SPIB CL E G H668911242ORPHA:186Primary biliary cholangitis
HP:0011276HP:0011276Vascular skin abnormality0SPINK5 CL E G H1100515464OMIM:256500Netherton syndrome100
HP:0011276HP:0011276Vascular skin abnormality0SPINK5 CL E G H1100515464ORPHA:634Netherton syndrome100
HP:0011276HP:0011276Vascular skin abnormality0SPRED2 CL E G H20073417722OMIM:619745NOONAN SYNDROME 14; NS14
HP:0011276HP:0011276Vascular skin abnormality0SREBF1 CL E G H672011289OMIM:619016IFAP SYNDROME 2; IFAP21
HP:0011276HP:0011276Vascular skin abnormality0SRSF2 CL E G H642710783ORPHA:98850Aggressive systemic mastocytosis1
HP:0011276HP:0011276Vascular skin abnormality0SRSF2 CL E G H642710783ORPHA:98849Systemic mastocytosis with associated hematologic neoplasm1
HP:0011276HP:0011276Vascular skin abnormality0STAG1 CL E G H1027411354ORPHA:502434STAG1-related intellectual disability-facial dysmorphism-gastroesophageal reflux syndrome9
HP:0011276HP:0011276Vascular skin abnormality0STAT3 CL E G H677411364ORPHA:520Acute promyelocytic leukemia110
HP:0011276HP:0011276Vascular skin abnormality0STAT3 CL E G H677411364OMIM:147060Hyper-IgE recurrent infection syndrome110
HP:0011276HP:0011276Vascular skin abnormality0STAT5B CL E G H677711367ORPHA:520Acute promyelocytic leukemia12
HP:0011276HP:0011276Vascular skin abnormality0STIM1 CL E G H678611386ORPHA:3204Stormorken-Sjaastad-Langslet syndrome31
HP:0011276HP:0011276Vascular skin abnormality0STING1 CL E G H34006127962OMIM:615934STING-associated vasculopathy, infantile-onset
HP:0011276HP:0011276Vascular skin abnormality0STN1 CL E G H7999126200OMIM:617341Cerebroretinal microangiopathy with calcifications and cysts 22
HP:0011276HP:0011276Vascular skin abnormality0STX11 CL E G H867611429ORPHA:540Familial hemophagocytic lymphohistiocytosis85
HP:0011276HP:0011276Vascular skin abnormality0STXBP1 CL E G H681211444ORPHA:4958189q33.3q34.11 microdeletion syndrome237
HP:0011276HP:0011276Vascular skin abnormality0STXBP2 CL E G H681311445ORPHA:540Familial hemophagocytic lymphohistiocytosis70
HP:0011276HP:0011276Vascular skin abnormality0SULT2B1 CL E G H682011459OMIM:617571Ichthyosis, congenital, autosomal recessive 144
HP:0011276HP:0011276Vascular skin abnormality0SUPT16H CL E G H1119811465OMIM:619480NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND THIN CORPUS CALLOSUM; NEDDFAC
HP:0011276HP:0011276Vascular skin abnormality0SYK CL E G H685011491OMIM:619381IMMUNODEFICIENCY 82 WITH SYSTEMIC INFLAMMATION; IMD821
HP:0011276HP:0011276Vascular skin abnormality0TALDO1 CL E G H688811559ORPHA:101028Transaldolase deficiency34
HP:0011276HP:0011276Vascular skin abnormality0TALDO1 CL E G H688811559OMIM:606003Transaldolase deficiency34
HP:0011276HP:0011276Vascular skin abnormality0TBL1XR1 CL E G H7971829529ORPHA:520Acute promyelocytic leukemia22
HP:0011276HP:0011276Vascular skin abnormality0TBX1 CL E G H689911592ORPHA:56722q11.2 deletion syndrome32
HP:0011276HP:0011276Vascular skin abnormality0TBXA2R CL E G H691511608OMIM:614009BLEEDING DISORDER, PLATELET-TYPE, 13, SUSCEPTIBILITY TO; BDPLT1310
HP:0011276HP:0011276Vascular skin abnormality0TCF4 CL E G H692511634ORPHA:171Primary sclerosing cholangitis241
HP:0011276HP:0011276Vascular skin abnormality0TCIRG1 CL E G H1031211647ORPHA:667Autosomal recessive malignant osteopetrosis82
HP:0011276HP:0011276Vascular skin abnormality0TERC CL E G H701211727ORPHA:1775Dyskeratosis congenita48
HP:0011276HP:0011276Vascular skin abnormality0TERC CL E G H701211727ORPHA:88Idiopathic aplastic anemia48
HP:0011276HP:0011276Vascular skin abnormality0TERT CL E G H701511730ORPHA:1775Dyskeratosis congenita238
HP:0011276HP:0011276Vascular skin abnormality0TERT CL E G H701511730ORPHA:88Idiopathic aplastic anemia238
HP:0011276HP:0011276Vascular skin abnormality0TET2 CL E G H5479025941ORPHA:98850Aggressive systemic mastocytosis3
HP:0011276HP:0011276Vascular skin abnormality0TET2 CL E G H5479025941ORPHA:729Polycythemia vera3
HP:0011276HP:0011276Vascular skin abnormality0TET2 CL E G H5479025941ORPHA:824Primary myelofibrosis3
HP:0011276HP:0011276Vascular skin abnormality0TET2 CL E G H5479025941ORPHA:98849Systemic mastocytosis with associated hematologic neoplasm3
HP:0011276HP:0011276Vascular skin abnormality0TFR2 CL E G H703611762OMIM:604250Hemochromatosis, type 367
HP:0011276HP:0011276Vascular skin abnormality0TGFB2 CL E G H704211768ORPHA:91387Familial thoracic aortic aneurysm and aortic dissection162
HP:0011276HP:0011276Vascular skin abnormality0TGFB2 CL E G H704211768OMIM:614816LOEYS-DIETZ SYNDROME 4; LDS4162
HP:0011276HP:0011276Vascular skin abnormality0TGFB3 CL E G H704311769ORPHA:91387Familial thoracic aortic aneurysm and aortic dissection85
HP:0011276HP:0011276Vascular skin abnormality0TGFB3 CL E G H704311769OMIM:615582LOEYS-DIETZ SYNDROME 5; LDS585
HP:0011276HP:0011276Vascular skin abnormality0TGFBR1 CL E G H704611772ORPHA:91387Familial thoracic aortic aneurysm and aortic dissection239
HP:0011276HP:0011276Vascular skin abnormality0TGFBR1 CL E G H704611772ORPHA:60030Loeys-Dietz syndrome239
HP:0011276HP:0011276Vascular skin abnormality0TGFBR2 CL E G H704811773ORPHA:91387Familial thoracic aortic aneurysm and aortic dissection253
HP:0011276HP:0011276Vascular skin abnormality0TGFBR2 CL E G H704811773ORPHA:60030Loeys-Dietz syndrome253
HP:0011276HP:0011276Vascular skin abnormality0TGM1 CL E G H705111777ORPHA:281127Acral self-healing collodion baby98
HP:0011276HP:0011276Vascular skin abnormality0TGM5 CL E G H933311781ORPHA:263534Acral peeling skin syndrome44
HP:0011276HP:0011276Vascular skin abnormality0TGM5 CL E G H933311781OMIM:609796Peeling skin syndrome, Acral type44
HP:0011276HP:0011276Vascular skin abnormality0TINF2 CL E G H2627711824ORPHA:1775Dyskeratosis congenita60
HP:0011276HP:0011276Vascular skin abnormality0TMC6 CL E G H1132218021ORPHA:302Epidermodysplasia verruciformis10
HP:0011276HP:0011276Vascular skin abnormality0TMC8 CL E G H14713820474ORPHA:302Epidermodysplasia verruciformis4
HP:0011276HP:0011276Vascular skin abnormality0TNFRSF13B CL E G H2349518153ORPHA:1572Common variable immunodeficiency32
HP:0011276HP:0011276Vascular skin abnormality0TNFRSF13C CL E G H11565017755ORPHA:1572Common variable immunodeficiency12
HP:0011276HP:0011276Vascular skin abnormality0TNFRSF1A CL E G H713211916ORPHA:32960Tumor necrosis factor receptor 1 associated periodic syndrome131
HP:0011276HP:0011276Vascular skin abnormality0TNFRSF1B CL E G H713311917ORPHA:2584Classic mycosis fungoides
HP:0011276HP:0011276Vascular skin abnormality0TNFSF11 CL E G H860011926ORPHA:667Autosomal recessive malignant osteopetrosis44
HP:0011276HP:0011276Vascular skin abnormality0TNFSF12 CL E G H874211927ORPHA:1572Common variable immunodeficiency1
HP:0011276HP:0011276Vascular skin abnormality0TNFSF15 CL E G H996611931ORPHA:186Primary biliary cholangitis
HP:0011276HP:0011276Vascular skin abnormality0TNPO3 CL E G H2353417103ORPHA:186Primary biliary cholangitis71
HP:0011276HP:0011276Vascular skin abnormality0TNXB CL E G H714811976ORPHA:230839Classical-like Ehlers-Danlos syndrome type 1134
HP:0011276HP:0011276Vascular skin abnormality0TNXB CL E G H714811976OMIM:606408Ehlers-Danlos syndrome, classic-like134
HP:0011276HP:0011276Vascular skin abnormality0TP53 CL E G H715711998ORPHA:96253Cushing disease911
HP:0011276HP:0011276Vascular skin abnormality0TRAF3IP2 CL E G H107581343ORPHA:1334Chronic mucocutaneous candidiasis4
HP:0011276HP:0011276Vascular skin abnormality0TREX1 CL E G H1127712269ORPHA:51Aicardi-Goutières syndrome56
HP:0011276HP:0011276Vascular skin abnormality0TREX1 CL E G H1127712269OMIM:225750Aicardi-Goutieres syndrome 156
HP:0011276HP:0011276Vascular skin abnormality0TREX1 CL E G H1127712269ORPHA:247691Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations56
HP:0011276HP:0011276Vascular skin abnormality0TREX1 CL E G H1127712269OMIM:192315Vasculopathy, retinal, with cerebral leukodystrophy56
HP:0011276HP:0011276Vascular skin abnormality0TRNF CL E G H45587481ORPHA:550MELAS
HP:0011276HP:0011276Vascular skin abnormality0TRNH CL E G H45647487ORPHA:550MELAS
HP:0011276HP:0011276Vascular skin abnormality0TRNL1 CL E G H45677490ORPHA:550MELAS
HP:0011276HP:0011276Vascular skin abnormality0TRNQ CL E G H45727495ORPHA:550MELAS
HP:0011276HP:0011276Vascular skin abnormality0TRNS1 CL E G H45747497ORPHA:550MELAS
HP:0011276HP:0011276Vascular skin abnormality0TRNS2 CL E G H45757498ORPHA:550MELAS
HP:0011276HP:0011276Vascular skin abnormality0TRNW CL E G H45787501ORPHA:550MELAS
HP:0011276HP:0011276Vascular skin abnormality0TRPM4 CL E G H5479517993ORPHA:316Progressive symmetric erythrokeratodermia124
HP:0011276HP:0011276Vascular skin abnormality0TRPV3 CL E G H16251418084ORPHA:659Mutilating palmoplantar keratoderma with periorificial keratotic plaques151
HP:0011276HP:0011276Vascular skin abnormality0TSPAN12 CL E G H2355421641ORPHA:891Familial exudative vitreoretinopathy39
HP:0011276HP:0011276Vascular skin abnormality0TYMS CL E G H729812441ORPHA:1775Dyskeratosis congenita1
HP:0011276HP:0011276Vascular skin abnormality0UBE4B CL E G H1027712500ORPHA:16061p36 deletion syndrome
HP:0011276HP:0011276Vascular skin abnormality0UFD1 CL E G H735312520ORPHA:56722q11.2 deletion syndrome
HP:0011276HP:0011276Vascular skin abnormality0UNC13D CL E G H20129423147ORPHA:540Familial hemophagocytic lymphohistiocytosis116
HP:0011276HP:0011276Vascular skin abnormality0USB1 CL E G H7965025792ORPHA:1775Dyskeratosis congenita8
HP:0011276HP:0011276Vascular skin abnormality0USB1 CL E G H7965025792OMIM:604173Poikiloderma with neutropenia8
HP:0011276HP:0011276Vascular skin abnormality0USF3 CL E G H20571730494ORPHA:201Cowden syndrome1
HP:0011276HP:0011276Vascular skin abnormality0USP18 CL E G H1127412616OMIM:617397Pseudo-Torch syndrome 22
HP:0011276HP:0011276Vascular skin abnormality0USP48 CL E G H8419618533ORPHA:96253Cushing disease1
HP:0011276HP:0011276Vascular skin abnormality0USP8 CL E G H910112631ORPHA:96253Cushing disease7
HP:0011276HP:0011276Vascular skin abnormality0USP8 CL E G H910112631OMIM:219090Pituitary adenoma 4, ACTH-secreting, somatic7
HP:0011276HP:0011276Vascular skin abnormality0UVSSA CL E G H5765429304OMIM:614640Uv-Sensitive syndrome 33
HP:0011276HP:0011276Vascular skin abnormality0VPS53 CL E G H5527525608OMIM:615851Pontocerebellar hypoplasia, type 2E26
HP:0011276HP:0011276Vascular skin abnormality0VWF CL E G H745012726OMIM:193400Von willebrand disease, type 1533
HP:0011276HP:0011276Vascular skin abnormality0VWF CL E G H745012726OMIM:613554Von willebrand disease, type 2533
HP:0011276HP:0011276Vascular skin abnormality0VWF CL E G H745012726OMIM:277480Von willebrand disease, type 3533
HP:0011276HP:0011276Vascular skin abnormality0WAS CL E G H745412731OMIM:313900Thrombocytopenia 165
HP:0011276HP:0011276Vascular skin abnormality0WAS CL E G H745412731ORPHA:906Wiskott-Aldrich syndrome65
HP:0011276HP:0011276Vascular skin abnormality0WAS CL E G H745412731OMIM:301000Wiskott-Aldrich syndrome65
HP:0011276HP:0011276Vascular skin abnormality0WIPF1 CL E G H745612736ORPHA:906Wiskott-Aldrich syndrome6
HP:0011276HP:0011276Vascular skin abnormality0WNT10A CL E G H8032613829OMIM:257980Odontoonychodermal dysplasia71
HP:0011276HP:0011276Vascular skin abnormality0WNT10A CL E G H8032613829ORPHA:50944Schöpf-Schulz-Passarge syndrome71
HP:0011276HP:0011276Vascular skin abnormality0WRAP53 CL E G H5513525522ORPHA:1775Dyskeratosis congenita40
HP:0011276HP:0011276Vascular skin abnormality0WRN CL E G H748612791ORPHA:902Werner syndrome310
HP:0011276HP:0011276Vascular skin abnormality0XPA CL E G H750712814ORPHA:910Xeroderma pigmentosum34
HP:0011276HP:0011276Vascular skin abnormality0XPA CL E G H750712814OMIM:278700Xeroderma pigmentosum, complementation group A34
HP:0011276HP:0011276Vascular skin abnormality0XPC CL E G H750812816ORPHA:910Xeroderma pigmentosum86
HP:0011276HP:0011276Vascular skin abnormality0XPC CL E G H750812816OMIM:278720Xeroderma pigmentosum, complementation group C86
HP:0011276HP:0011276Vascular skin abnormality0XPNPEP2 CL E G H751212823OMIM:300909Acquired angioedema4
HP:0011276HP:0011276Vascular skin abnormality0XPNPEP2 CL E G H751212823ORPHA:100057Renin-angiotensin-aldosterone system-blocker-induced angioedema4
HP:0011276HP:0011276Vascular skin abnormality0XPR1 CL E G H921312827ORPHA:1980Bilateral striopallidodentate calcinosis4
HP:0011276HP:0011276Vascular skin abnormality0XRCC4 CL E G H751812831ORPHA:99812LIG4 syndrome9
HP:0011276HP:0011276Vascular skin abnormality0ZBTB16 CL E G H770412930ORPHA:520Acute promyelocytic leukemia1
HP:0011276HP:0011276Vascular skin abnormality0ZMPSTE24 CL E G H1026912877ORPHA:740Hutchinson-Gilford progeria syndrome83
HP:0011276HP:0011276Vascular skin abnormality0ZMPSTE24 CL E G H1026912877OMIM:608612Mandibuloacral dysplasia with type B lipodystrophy83
HP:0011276HP:0011276Vascular skin abnormality0ZMPSTE24 CL E G H1026912877OMIM:275210Restrictive dermopathy, lethal83
HP:0011276HP:0011276Vascular skin abnormality0ZNF408 CL E G H7979720041ORPHA:891Familial exudative vitreoretinopathy14
HP:0011276HP:0011276Vascular skin abnormality0ZNF469 CL E G H8462723216ORPHA:90354Brittle cornea syndrome397
HP:0011276HP:0011137Non-pruritic urticaria1 CL E G H
HP:0011276HP:0001933Subcutaneous hemorrhage1ABCC6 CL E G H36857ORPHA:758Pseudoxanthoma elasticum415
HP:0011276HP:0001009Telangiectasia1ABCC6 CL E G H36857ORPHA:758Pseudoxanthoma elasticum415
HP:0011276HP:0000965Cutis marmorata1ABCC9 CL E G H1006060OMIM:619719INTELLECTUAL DISABILITY AND MYOPATHY SYNDROME; IDMYS254
HP:0011276HP:0000965Cutis marmorata1ABL1 CL E G H2576OMIM:617602Congenital heart defects and skeletal malformations syndrome.51
HP:0011276HP:0001933Subcutaneous hemorrhage1ACP5 CL E G H54124OMIM:607944Spondyloenchondrodysplasia with immune dysregulation16
HP:0011276HP:0033832Livedo1ACTA2 CL E G H59130OMIM:611788AORTIC ANEURYSM, FAMILIAL THORACIC 6; AAT694
HP:0011276HP:0000965Cutis marmorata1ACTA2 CL E G H59130ORPHA:91387Familial thoracic aortic aneurysm and aortic dissectionHP:0040281 - Very frequent94
HP:0011276HP:0001933Subcutaneous hemorrhage1ACTA2 CL E G H59130ORPHA:91387Familial thoracic aortic aneurysm and aortic dissection94
HP:0011276HP:0001009Telangiectasia1ACTA2 CL E G H59130ORPHA:2573Moyamoya diseaseHP:0040281 - Very frequent94
HP:0011276HP:0001933Subcutaneous hemorrhage1ACVRL1 CL E G H94175ORPHA:774Hereditary hemorrhagic telangiectasia178
HP:0011276HP:0001009Telangiectasia1ACVRL1 CL E G H94175ORPHA:774Hereditary hemorrhagic telangiectasia178
HP:0011276HP:0001009Telangiectasia1ACVRL1 CL E G H94175OMIM:600376Telangiectasia, hereditary hemorrhagic, type 2178
HP:0011276HP:0000965Cutis marmorata1ADA2 CL E G H518161839OMIM:182410Sneddon syndrome.22
HP:0011276HP:0033832Livedo1ADA2 CL E G H518161839OMIM:182410Sneddon syndrome22
HP:0011276HP:0000965Cutis marmorata1ADA2 CL E G H518161839ORPHA:820Sneddon syndromeHP:0040281 - Very frequent22
HP:0011276HP:0001933Subcutaneous hemorrhage1ADA2 CL E G H518161839OMIM:615688Vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome22
HP:0011276HP:0000965Cutis marmorata1ADA2 CL E G H518161839OMIM:615688Vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome22
HP:0011276HP:0033832Livedo1ADA2 CL E G H518161839OMIM:615688Vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome22
HP:0011276HP:0010783Erythema1ADAM17 CL E G H6868195OMIM:614328INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 1; NISBD12
HP:0011276HP:0010783Erythema1ADAM17 CL E G H6868195ORPHA:294023Neonatal inflammatory skin and bowel diseaseHP:0040282 - Frequent2
HP:0011276HP:0001933Subcutaneous hemorrhage1ADAMTS2 CL E G H9509218OMIM:225410Ehlers-Danlos syndrome, type VII, autosomal recessive165
HP:0011276HP:0000965Cutis marmorata1ADAR CL E G H103225ORPHA:51Aicardi-Goutières syndromeHP:0040283 - Occasional116
HP:0011276HP:0001025Urticaria1ADGRE2 CL E G H308173337OMIM:125630Dermodistortive urticaria.2
HP:0011276HP:0010783Erythema1ADGRE2 CL E G H308173337OMIM:125630Dermodistortive urticaria2
HP:0011276HP:0007394Prominent superficial blood vessels1AEBP1 CL E G H165303ORPHA:536532Classical-like Ehlers-Danlos syndrome type 2
HP:0011276HP:0001933Subcutaneous hemorrhage1AEBP1 CL E G H165303ORPHA:536532Classical-like Ehlers-Danlos syndrome type 2
HP:0011276HP:0001933Subcutaneous hemorrhage1AEBP1 CL E G H165303OMIM:618000Ehlers-Danlos syndrome, classic-like, 2
HP:0011276HP:0007394Prominent superficial blood vessels1AEBP1 CL E G H165303OMIM:618000Ehlers-Danlos syndrome, classic-like, 2
HP:0011276HP:0001014Angiokeratoma1AGA CL E G H175318OMIM:208400ASPARTYLGLUCOSAMINURIA76
HP:0011276HP:0007394Prominent superficial blood vessels1AGPAT2 CL E G H10555325ORPHA:528Congenital generalized lipodystrophy85
HP:0011276HP:0000965Cutis marmorata1AGXT CL E G H189341OMIM:259900Hyperoxaluria, primary, type I.260
HP:0011276HP:0001933Subcutaneous hemorrhage1AIP CL E G H9049358OMIM:219090Pituitary adenoma 4, ACTH-secreting, somatic95
HP:0011276HP:0010783Erythema1AIP CL E G H9049358OMIM:219090Pituitary adenoma 4, ACTH-secreting, somatic95
HP:0011276HP:0001009Telangiectasia1AKT1 CL E G H207391ORPHA:201Cowden syndrome54
HP:0011276HP:0000965Cutis marmorata1AKT3 CL E G H10000393OMIM:615937Megalencephaly-Polymicrogyria-Polydactyly-Hydrocephalus syndrome 2.19
HP:0011276HP:0007394Prominent superficial blood vessels1ALDH18A1 CL E G H58329722OMIM:219150Cutis laxa, autosomal recessive, type IIIA.89
HP:0011276HP:0001025Urticaria1ALDH3A2 CL E G H224403ORPHA:816Sjögren-Larsson syndromeHP:0040283 - Occasional87
HP:0011276HP:0010783Erythema1ALDH3A2 CL E G H224403ORPHA:816Sjögren-Larsson syndromeHP:0040281 - Very frequent87
HP:0011276HP:0010783Erythema1ALOX12B CL E G H242430OMIM:242100Ichthyosis, congenital, autosomal recessive 2HP:0040283 - Occasional75
HP:0011276HP:0010783Erythema1ALOXE3 CL E G H5934413743OMIM:242100Ichthyosis, congenital, autosomal recessive 2HP:0040283 - Occasional63
HP:0011276HP:0010783Erythema1ALOXE3 CL E G H5934413743OMIM:606545Ichthyosis, congenital, autosomal recessive 3HP:0040283 - Occasional63
HP:0011276HP:0001025Urticaria1ALPK1 CL E G H8021620917OMIM:614979Splenomegaly, cytopenia, and vision loss.
HP:0011276HP:0001009Telangiectasia1ANAPC1 CL E G H6468219988ORPHA:221008Rothmund-Thomson syndrome type 1HP:0040282 - Frequent2
HP:0011276HP:0010783Erythema1ANAPC1 CL E G H6468219988ORPHA:221008Rothmund-Thomson syndrome type 12
HP:0011276HP:0100665Angioedema1ANGPT1 CL E G H284484OMIM:619361ANGIOEDEMA, HEREDITARY, 5; HAE55
HP:0011276HP:0001933Subcutaneous hemorrhage1ANKRD26 CL E G H2285229186OMIM:188000THROMBOCYTOPENIA 2; THC2106
HP:0011276HP:0007394Prominent superficial blood vessels1ANTXR1 CL E G H8416821014OMIM:230740Gapo syndrome8
HP:0011276HP:0001009Telangiectasia1ANTXR2 CL E G H11842921732ORPHA:2176Infantile systemic hyalinosis49
HP:0011276HP:0001025Urticaria1ANTXR2 CL E G H11842921732ORPHA:2176Infantile systemic hyalinosisHP:0040281 - Very frequent49
HP:0011276HP:0010783Erythema1AP1S1 CL E G H1174559OMIM:609313Mental retardation, enteropathy, deafness, peripheral neuropathy, ichthyosis, and keratoderma.1
HP:0011276HP:0001933Subcutaneous hemorrhage1APOE CL E G H348613ORPHA:158029Sea-blue histiocytosis39
HP:0011276HP:0010783Erythema1AQP5 CL E G H362638ORPHA:2337Non-epidermolytic palmoplantar keratodermaHP:0040282 - Frequent5
HP:0011276HP:0000965Cutis marmorata1ARHGAP31 CL E G H5751429216ORPHA:974Adams-Oliver syndromeHP:0040281 - Very frequent147
HP:0011276HP:0000965Cutis marmorata1ARHGAP31 CL E G H5751429216OMIM:100300Adams-Oliver syndrome 1.147
HP:0011276HP:0000965Cutis marmorata1ARID1B CL E G H5749218040OMIM:135900Coffin-Siris syndrome 1.219
HP:0011276HP:0001933Subcutaneous hemorrhage1ARL6IP6 CL E G H15118824048ORPHA:1556Cutis marmorata telangiectatica congenitaHP:0040281 - Very frequent1
HP:0011276HP:0001009Telangiectasia1ARL6IP6 CL E G H15118824048ORPHA:1556Cutis marmorata telangiectatica congenita1
HP:0011276HP:0000965Cutis marmorata1ARL6IP6 CL E G H15118824048ORPHA:1556Cutis marmorata telangiectatica congenitaHP:0040281 - Very frequent1
HP:0011276HP:0001933Subcutaneous hemorrhage1ARMC5 CL E G H7979825781ORPHA:189427Cushing syndrome due to macronodular adrenal hyperplasia7
HP:0011276HP:0200029Vasculitis in the skin1ARPC1B CL E G H10095704OMIM:617718Platelet abnormalities with eosinophilia and immune-mediated inflammatory disease
HP:0011276HP:0001009Telangiectasia1ARPC4 CL E G H10093707OMIM:620141
HP:0011276HP:0001933Subcutaneous hemorrhage1ARVCF CL E G H421728ORPHA:56722q11.2 deletion syndrome1
HP:0011276HP:0001009Telangiectasia1ARX CL E G H17030218060ORPHA:94083Partington syndrome166
HP:0011276HP:0001025Urticaria1ASXL1 CL E G H17102318318ORPHA:98850Aggressive systemic mastocytosisHP:0040283 - Occasional145
HP:0011276HP:0001025Urticaria1ASXL1 CL E G H17102318318ORPHA:98849Systemic mastocytosis with associated hematologic neoplasmHP:0040283 - Occasional145
HP:0011276HP:0001009Telangiectasia1ATM CL E G H472795ORPHA:100Ataxia-telangiectasia3267
HP:0011276HP:0001009Telangiectasia1ATM CL E G H472795OMIM:208900ATAXIA-TELANGIECTASIA3267
HP:0011276HP:0010783Erythema1ATP2C1 CL E G H2703213211OMIM:169600Benign chronic pemphigus.56
HP:0011276HP:0010783Erythema1ATP2C1 CL E G H2703213211ORPHA:2841Familial benign chronic pemphigusHP:0040281 - Very frequent56
HP:0011276HP:0001009Telangiectasia1ATP6 CL E G H45087414ORPHA:104Leber hereditary optic neuropathy
HP:0011276HP:0007394Prominent superficial blood vessels1ATP6V0A2 CL E G H2354518481ORPHA:357074Autosomal recessive cutis laxa type 2, classic type140
HP:0011276HP:0007394Prominent superficial blood vessels1ATP6V0A2 CL E G H2354518481ORPHA:2834Wrinkly skin syndrome140
HP:0011276HP:0007394Prominent superficial blood vessels1ATP6V1A CL E G H523851ORPHA:357074Autosomal recessive cutis laxa type 2, classic type3
HP:0011276HP:0007394Prominent superficial blood vessels1ATP6V1E1 CL E G H529857ORPHA:357074Autosomal recessive cutis laxa type 2, classic type2
HP:0011276HP:0001933Subcutaneous hemorrhage1ATP7A CL E G H538869ORPHA:565Menkes disease192
HP:0011276HP:0001933Subcutaneous hemorrhage1ATP7A CL E G H538869OMIM:304150Occipital horn syndrome192
HP:0011276HP:0001933Subcutaneous hemorrhage1ATP7A CL E G H538869ORPHA:198Occipital horn syndrome192
HP:0011276HP:0001933Subcutaneous hemorrhage1ATP7B CL E G H540870ORPHA:905Wilson disease315
HP:0011276HP:0033832Livedo1ATR CL E G H545882OMIM:614564Cutaneous telangiectasia and cancer syndrome, familial168
HP:0011276HP:0001009Telangiectasia1ATR CL E G H545882OMIM:614564Cutaneous telangiectasia and cancer syndrome, familial.168
HP:0011276HP:0001933Subcutaneous hemorrhage1ATRX CL E G H546886ORPHA:231401Alpha-thalassemia-myelodysplastic syndrome169
HP:0011276HP:0001933Subcutaneous hemorrhage1ATRX CL E G H546886ORPHA:96253Cushing disease169
HP:0011276HP:0001009Telangiectasia1ATRX CL E G H546886ORPHA:100075Neuroendocrine tumor of stomach169
HP:0011276HP:0001933Subcutaneous hemorrhage1B3GALT6 CL E G H12679217978ORPHA:536467B3GALT6-related spondylodysplastic Ehlers-Danlos syndrome38
HP:0011276HP:0007394Prominent superficial blood vessels1BANF1 CL E G H881517397OMIM:614008Nestor-Guillermo progeria syndrome22
HP:0011276HP:0001933Subcutaneous hemorrhage1BCOR CL E G H5488020893ORPHA:520Acute promyelocytic leukemia101
HP:0011276HP:0001009Telangiectasia1BLM CL E G H6411058ORPHA:125Bloom syndromeHP:0040283 - Occasional314
HP:0011276HP:0001009Telangiectasia1BLM CL E G H6411058OMIM:210900Bloom syndrome314
HP:0011276HP:0010783Erythema1BLM CL E G H6411058OMIM:210900Bloom syndrome314
HP:0011276HP:0001933Subcutaneous hemorrhage1BLOC1S3 CL E G H38855220914OMIM:614077Hermansky-Pudlak syndrome 842
HP:0011276HP:0001933Subcutaneous hemorrhage1BLOC1S5 CL E G H6391518561OMIM:619172HERMANSKY-PUDLAK SYNDROME 11; HPS11
HP:0011276HP:0001009Telangiectasia1BMP2 CL E G H6501069OMIM:235200Hemochromatosis, type 1.13
HP:0011276HP:0001009Telangiectasia1BMPR2 CL E G H6591078OMIM:178600Pulmonary hypertension, primary, 1.525
HP:0011276HP:0001933Subcutaneous hemorrhage1BRAF CL E G H6731097ORPHA:96253Cushing disease276
HP:0011276HP:0001933Subcutaneous hemorrhage1BRAF CL E G H6731097OMIM:163950Noonan syndrome 1276
HP:0011276HP:0000965Cutis marmorata1BRD4 CL E G H2347613575ORPHA:199Cornelia de Lange syndromeHP:0040282 - Frequent
HP:0011276HP:0007394Prominent superficial blood vessels1BSCL2 CL E G H2658015832ORPHA:528Congenital generalized lipodystrophy105
HP:0011276HP:0001933Subcutaneous hemorrhage1C1R CL E G H7151246OMIM:130080Ehlers-Danlos syndrome, periodontal type, 115
HP:0011276HP:0007394Prominent superficial blood vessels1C1R CL E G H7151246OMIM:130080Ehlers-Danlos syndrome, periodontal type, 115
HP:0011276HP:0001933Subcutaneous hemorrhage1C1S CL E G H7161247OMIM:617174Ehlers-Danlos syndrome, periodontal type, 27
HP:0011276HP:0001933Subcutaneous hemorrhage1C2 CL E G H7171248OMIM:217000Complement component 2 deficiency23
HP:0011276HP:0001933Subcutaneous hemorrhage1C4A CL E G H7201323OMIM:614380Complement component 4A deficiency1
HP:0011276HP:0001933Subcutaneous hemorrhage1CALR CL E G H8111455OMIM:254450Myelofibrosismyelofibrosis with myeloid metaplasia, included1
HP:0011276HP:0001933Subcutaneous hemorrhage1CALR CL E G H8111455ORPHA:824Primary myelofibrosis1
HP:0011276HP:0001025Urticaria1CARMIL2 CL E G H14620627089OMIM:618131IMMUNODEFICIENCY 58; IMD583
HP:0011276HP:0001933Subcutaneous hemorrhage1CASP10 CL E G H8431500ORPHA:3261Autoimmune lymphoproliferative syndrome87
HP:0011276HP:0001025Urticaria1CASP10 CL E G H8431500ORPHA:3261Autoimmune lymphoproliferative syndromeHP:0040283 - Occasional87
HP:0011276HP:0001025Urticaria1CASP10 CL E G H8431500OMIM:603909Autoimmune lymphoproliferative syndrome, type IIA.87
HP:0011276HP:0001933Subcutaneous hemorrhage1CASP10 CL E G H8431500OMIM:603909Autoimmune lymphoproliferative syndrome, type IIA87
HP:0011276HP:0001009Telangiectasia1CASZ1 CL E G H5489726002ORPHA:16061p36 deletion syndromeHP:0040283 - Occasional3
HP:0011276HP:0007394Prominent superficial blood vessels1CAV1 CL E G H8571527ORPHA:528Congenital generalized lipodystrophy11
HP:0011276HP:0001009Telangiectasia1CAV1 CL E G H8571527ORPHA:220393Diffuse cutaneous systemic sclerosis11
HP:0011276HP:0001009Telangiectasia1CAV1 CL E G H8571527ORPHA:220402Limited cutaneous systemic sclerosis11
HP:0011276HP:0000965Cutis marmorata1CAV1 CL E G H8571527OMIM:606721Lipodystrophy, familial partial, type 711
HP:0011276HP:0007394Prominent superficial blood vessels1CAVIN1 CL E G H2841199688ORPHA:528Congenital generalized lipodystrophy48
HP:0011276HP:0001025Urticaria1CBL CL E G H8671541ORPHA:98850Aggressive systemic mastocytosisHP:0040283 - Occasional317
HP:0011276HP:0001025Urticaria1CBS CL E G H8751550ORPHA:394Classic homocystinuriaHP:0040283 - Occasional242
HP:0011276HP:0001933Subcutaneous hemorrhage1CBS CL E G H8751550ORPHA:394Classic homocystinuriaHP:0040283 - Occasional242
HP:0011276HP:0000965Cutis marmorata1CBS CL E G H8751550OMIM:236200Homocystinuria due to cystathionine beta-synthase deficiency.242
HP:0011276HP:0001009Telangiectasia1CCM2 CL E G H8360521708OMIM:603284Cerebral cavernous malformations-2.37
HP:0011276HP:0001009Telangiectasia1CCN2 CL E G H14902500ORPHA:220393Diffuse cutaneous systemic sclerosis
HP:0011276HP:0001009Telangiectasia1CCN2 CL E G H14902500ORPHA:220402Limited cutaneous systemic sclerosis
HP:0011276HP:0001009Telangiectasia1CCR6 CL E G H12351607ORPHA:220393Diffuse cutaneous systemic sclerosis
HP:0011276HP:0001009Telangiectasia1CCR6 CL E G H12351607ORPHA:220402Limited cutaneous systemic sclerosis
HP:0011276HP:0001933Subcutaneous hemorrhage1CD109 CL E G H13522821685ORPHA:853Fetal and neonatal alloimmune thrombocytopenia
HP:0011276HP:0001933Subcutaneous hemorrhage1CD19 CL E G H9301633ORPHA:1572Common variable immunodeficiency38
HP:0011276HP:0010783Erythema1CD28 CL E G H9401653ORPHA:2584Classic mycosis fungoidesHP:0040281 - Very frequent
HP:0011276HP:0001933Subcutaneous hemorrhage1CD81 CL E G H9751701ORPHA:1572Common variable immunodeficiency1
HP:0011276HP:0001933Subcutaneous hemorrhage1CD81 CL E G H9751701OMIM:613496Immunodeficiency, common variable, 61
HP:0011276HP:0001933Subcutaneous hemorrhage1CDH23 CL E G H6407213733ORPHA:96253Cushing disease636
HP:0011276HP:0010783Erythema1CDKN1B CL E G H10271785ORPHA:276152Multiple endocrine neoplasia type 4HP:0040283 - Occasional102
HP:0011276HP:0001933Subcutaneous hemorrhage1CFH CL E G H30754883OMIM:235400Hemolytic uremic syndrome, atypical, susceptibility to, 186
HP:0011276HP:0001933Subcutaneous hemorrhage1CFHR1 CL E G H30784888OMIM:235400Hemolytic uremic syndrome, atypical, susceptibility to, 1
HP:0011276HP:0001933Subcutaneous hemorrhage1CFHR3 CL E G H1087816980OMIM:235400Hemolytic uremic syndrome, atypical, susceptibility to, 1
HP:0011276HP:0001933Subcutaneous hemorrhage1CHST14 CL E G H11318924464OMIM:601776Ehlers-Danlos syndrome, musculocontractural type 127
HP:0011276HP:0001933Subcutaneous hemorrhage1CHST14 CL E G H11318924464ORPHA:2953Musculocontractural Ehlers-Danlos syndromeHP:0040281 - Very frequent27
HP:0011276HP:0001009Telangiectasia1CIB1 CL E G H1051916920ORPHA:302Epidermodysplasia verruciformis
HP:0011276HP:0001933Subcutaneous hemorrhage1CLCN7 CL E G H11862025ORPHA:667Autosomal recessive malignant osteopetrosis102
HP:0011276HP:0001933Subcutaneous hemorrhage1CLCN7 CL E G H11862025OMIM:611490Osteopetrosis, autosomal recessive 4102
HP:0011276HP:0010783Erythema1CLEC7A CL E G H6458114558ORPHA:1334Chronic mucocutaneous candidiasisHP:0040281 - Very frequent3
HP:0011276HP:0007394Prominent superficial blood vessels1COG4 CL E G H2583918620OMIM:618150Saul-Wilson syndrome67
HP:0011276HP:0001933Subcutaneous hemorrhage1COG8 CL E G H8434218623ORPHA:95428COG8-CDG39
HP:0011276HP:0001933Subcutaneous hemorrhage1COL1A1 CL E G H12772197ORPHA:287Classical Ehlers-Danlos syndrome373
HP:0011276HP:0001933Subcutaneous hemorrhage1COL1A1 CL E G H12772197OMIM:619115COMBINED OSTEOGENESIS IMPERFECTA AND EHLERS-DANLOS SYNDROME 1; OIEDS1373
HP:0011276HP:0010783Erythema1COL1A1 CL E G H12772197ORPHA:31112Dermatofibrosarcoma protuberansHP:0040281 - Very frequent373
HP:0011276HP:0001933Subcutaneous hemorrhage1COL1A1 CL E G H12772197OMIM:130060Ehlers-Danlos syndrome, arthrochalasia type, 1373
HP:0011276HP:0001933Subcutaneous hemorrhage1COL1A1 CL E G H12772197OMIM:166200Osteogenesis imperfecta, type I373
HP:0011276HP:0001933Subcutaneous hemorrhage1COL1A2 CL E G H12782198ORPHA:230851Cardiac-valvular Ehlers-Danlos syndrome243
HP:0011276HP:0001933Subcutaneous hemorrhage1COL1A2 CL E G H12782198OMIM:619120COMBINED OSTEOGENESIS IMPERFECTA AND EHLERS-DANLOS SYNDROME 2; OIEDS2243
HP:0011276HP:0001933Subcutaneous hemorrhage1COL1A2 CL E G H12782198OMIM:617821Ehlers-Danlos syndrome, arthrochalasia type, 2243
HP:0011276HP:0001933Subcutaneous hemorrhage1COL1A2 CL E G H12782198OMIM:225320Ehlers-Danlos syndrome, autosomal recessive, cardiac valvular form243
HP:0011276HP:0001009Telangiectasia1COL3A1 CL E G H12812201ORPHA:2500Acrogeria749
HP:0011276HP:0001933Subcutaneous hemorrhage1COL3A1 CL E G H12812201OMIM:130050Ehlers-Danlos syndrome, Vascular type749
HP:0011276HP:0001933Subcutaneous hemorrhage1COL3A1 CL E G H12812201OMIM:618343Polymicrogyria with or without vascular-type ehlers-danlos syndrome749
HP:0011276HP:0001009Telangiectasia1COL3A1 CL E G H12812201ORPHA:286Vascular Ehlers-Danlos syndrome749
HP:0011276HP:0001933Subcutaneous hemorrhage1COL3A1 CL E G H12812201ORPHA:286Vascular Ehlers-Danlos syndrome749
HP:0011276HP:0001933Subcutaneous hemorrhage1COL5A1 CL E G H12892209ORPHA:287Classical Ehlers-Danlos syndrome660
HP:0011276HP:0001933Subcutaneous hemorrhage1COL5A1 CL E G H12892209OMIM:130000Ehlers-danlos syndrome, type I660
HP:0011276HP:0001933Subcutaneous hemorrhage1COL5A2 CL E G H12902210ORPHA:287Classical Ehlers-Danlos syndrome325
HP:0011276HP:0001933Subcutaneous hemorrhage1COL5A2 CL E G H12902210OMIM:130010Ehlers-Danlos syndrome, classic type, 2325
HP:0011276HP:0001009Telangiectasia1COL7A1 CL E G H12942214ORPHA:158673Localized dystrophic epidermolysis bullosa, acral formHP:0040282 - Frequent263
HP:0011276HP:0010783Erythema1COL7A1 CL E G H12942214ORPHA:158673Localized dystrophic epidermolysis bullosa, acral formHP:0040282 - Frequent263
HP:0011276HP:0001933Subcutaneous hemorrhage1COMT CL E G H13122228ORPHA:56722q11.2 deletion syndrome6
HP:0011276HP:0001009Telangiectasia1COX1 CL E G H45127419ORPHA:104Leber hereditary optic neuropathy
HP:0011276HP:0010783Erythema1COX1 CL E G H45127419ORPHA:550MELASHP:0040283 - Occasional
HP:0011276HP:0010783Erythema1COX2 CL E G H45137421ORPHA:550MELASHP:0040283 - Occasional
HP:0011276HP:0001009Telangiectasia1COX3 CL E G H45147422ORPHA:104Leber hereditary optic neuropathy
HP:0011276HP:0010783Erythema1COX3 CL E G H45147422ORPHA:550MELASHP:0040283 - Occasional
HP:0011276HP:0010783Erythema1COX7B CL E G H13492291ORPHA:2556Microphthalmia with linear skin defects syndromeHP:0040281 - Very frequent6
HP:0011276HP:0100665Angioedema1CPN1 CL E G H13692312OMIM:212070Carboxypeptidase N deficiency.2
HP:0011276HP:0001933Subcutaneous hemorrhage1CR2 CL E G H13802336ORPHA:1572Common variable immunodeficiency10
HP:0011276HP:0001933Subcutaneous hemorrhage1CREB3L1 CL E G H9099318856OMIM:616229Osteogenesis imperfecta, type XVI4
HP:0011276HP:0010783Erythema1CSTA CL E G H14752481ORPHA:263534Acral peeling skin syndromeHP:0040282 - Frequent4
HP:0011276HP:0001009Telangiectasia1CTC1 CL E G H8016926169OMIM:612199Cerebroretinal microangiopathy with calcifications and cysts160
HP:0011276HP:0001009Telangiectasia1CTC1 CL E G H8016926169ORPHA:1775Dyskeratosis congenita160
HP:0011276HP:0010783Erythema1CTLA4 CL E G H14932505ORPHA:2584Classic mycosis fungoidesHP:0040281 - Very frequent10
HP:0011276HP:0001933Subcutaneous hemorrhage1CTLA4 CL E G H14932505ORPHA:900Granulomatosis with polyangiitis10
HP:0011276HP:0001009Telangiectasia1CTNNB1 CL E G H14992514ORPHA:891Familial exudative vitreoretinopathy88
HP:0011276HP:0001009Telangiectasia1CTSA CL E G H54769251OMIM:256540Galactosialidosis51
HP:0011276HP:0010783Erythema1CTSB CL E G H15082527ORPHA:50943Keratolytic winter erythemaHP:0040281 - Very frequent1
HP:0011276HP:0010783Erythema1CTSB CL E G H15082527OMIM:148370Keratolytic winter erythema.1
HP:0011276HP:0001009Telangiectasia1CYLD CL E G H15402584ORPHA:211Familial cylindromatosis126
HP:0011276HP:0001009Telangiectasia1CYLD CL E G H15402584ORPHA:867Familial multiple trichoepithelioma126
HP:0011276HP:0001009Telangiectasia1CYTB CL E G H45197427ORPHA:104Leber hereditary optic neuropathy
HP:0011276HP:0001009Telangiectasia1DAXX CL E G H16162681ORPHA:100075Neuroendocrine tumor of stomach
HP:0011276HP:0010783Erythema1DDB2 CL E G H16432718ORPHA:910Xeroderma pigmentosumHP:0040282 - Frequent30
HP:0011276HP:0001009Telangiectasia1DDB2 CL E G H16432718ORPHA:910Xeroderma pigmentosumHP:0040281 - Very frequent30
HP:0011276HP:0001009Telangiectasia1DDB2 CL E G H16432718OMIM:278740Xeroderma pigmentosum, complementation group E.30
HP:0011276HP:0010783Erythema1DDR2 CL E G H49212731OMIM:618175WARBURG-CINOTTI SYNDROME; WRCN45
HP:0011276HP:0000965Cutis marmorata1DDX11 CL E G H16632736OMIM:613398Warsaw breakage syndrome.13
HP:0011276HP:0000965Cutis marmorata1DHCR7 CL E G H17172860ORPHA:818Smith-Lemli-Opitz syndromeHP:0040282 - Frequent159
HP:0011276HP:0001009Telangiectasia1DIAPH1 CL E G H17292876ORPHA:2573Moyamoya diseaseHP:0040281 - Very frequent118
HP:0011276HP:0001009Telangiectasia1DKC1 CL E G H17362890ORPHA:1775Dyskeratosis congenita65
HP:0011276HP:0000965Cutis marmorata1DLL4 CL E G H545672910ORPHA:974Adams-Oliver syndromeHP:0040281 - Very frequent9
HP:0011276HP:0000965Cutis marmorata1DLL4 CL E G H545672910OMIM:616589Adams-Oliver syndrome 6HP:0040283 - Occasional9
HP:0011276HP:0001009Telangiectasia1DNAJC30 CL E G H8427716410ORPHA:104Leber hereditary optic neuropathy
HP:0011276HP:0001009Telangiectasia1DNAJC30 CL E G H8427716410OMIM:619382LEBER HEREDITARY OPTIC NEUROPATHY, AUTOSOMAL RECESSIVE; LHONAR
HP:0011276HP:0100665Angioedema1DNASE1L3 CL E G H17762959ORPHA:36412Hypocomplementemic urticarial vasculitisHP:0040282 - Frequent3
HP:0011276HP:0000965Cutis marmorata1DOCK6 CL E G H5757219189ORPHA:974Adams-Oliver syndromeHP:0040281 - Very frequent18
HP:0011276HP:0000965Cutis marmorata1DOCK6 CL E G H5757219189OMIM:614219Adams-Oliver syndrome 2.18
HP:0011276HP:0001009Telangiectasia1DPM1 CL E G H88133005OMIM:608799Congenital disorder of glycosylation, type IE.27
HP:0011276HP:0001933Subcutaneous hemorrhage1DSE CL E G H2994021144ORPHA:2953Musculocontractural Ehlers-Danlos syndromeHP:0040281 - Very frequent13
HP:0011276HP:0010783Erythema1DSG4 CL E G H14740921307OMIM:607903Hypotrichosis 6.63
HP:0011276HP:0010783Erythema1DSP CL E G H18323052OMIM:615821Cardiomyopathy, dilated, with woolly hair, keratoderma, and tooth agenesis.747
HP:0011276HP:0010783Erythema1DSP CL E G H18323052OMIM:607655Skin fragility-woolly hair syndrome747
HP:0011276HP:0010783Erythema1DST CL E G H6671090OMIM:614653Neuropathy, hereditary sensory and autonomic, type VI108
HP:0011276HP:0001933Subcutaneous hemorrhage1DTNBP1 CL E G H8406217328OMIM:614076Hermansky-Pudlak syndrome 746
HP:0011276HP:0010783Erythema1EGFR CL E G H19563236ORPHA:294023Neonatal inflammatory skin and bowel diseaseHP:0040282 - Frequent257
HP:0011276HP:0001009Telangiectasia1ELMO2 CL E G H6391617233ORPHA:3019Ramon syndrome3
HP:0011276HP:0000965Cutis marmorata1ELN CL E G H20063327ORPHA:91387Familial thoracic aortic aneurysm and aortic dissectionHP:0040281 - Very frequent172
HP:0011276HP:0001933Subcutaneous hemorrhage1ELN CL E G H20063327ORPHA:91387Familial thoracic aortic aneurysm and aortic dissection172
HP:0011276HP:0010783Erythema1ELOVL4 CL E G H678514415OMIM:614457Ichthyosis, spastic quadriplegia, and mental retardation.62
HP:0011276HP:0001025Urticaria1ELOVL4 CL E G H678514415ORPHA:1955Spinocerebellar ataxia type 34HP:0040281 - Very frequent62
HP:0011276HP:0001933Subcutaneous hemorrhage1EMILIN1 CL E G H1111719880OMIM:6200802
HP:0011276HP:0001933Subcutaneous hemorrhage1ENG CL E G H20223349ORPHA:774Hereditary hemorrhagic telangiectasia186
HP:0011276HP:0001009Telangiectasia1ENG CL E G H20223349ORPHA:774Hereditary hemorrhagic telangiectasia186
HP:0011276HP:0001009Telangiectasia1ENG CL E G H20223349OMIM:187300Telangiectasia, hereditary hemorrhagic, type 1186
HP:0011276HP:0001009Telangiectasia1ENPP1 CL E G H51673356ORPHA:758Pseudoxanthoma elasticum151
HP:0011276HP:0001933Subcutaneous hemorrhage1ENPP1 CL E G H51673356ORPHA:758Pseudoxanthoma elasticum151
HP:0011276HP:0000965Cutis marmorata1EOGT CL E G H28520328526ORPHA:974Adams-Oliver syndromeHP:0040281 - Very frequent4
HP:0011276HP:0000965Cutis marmorata1EOGT CL E G H28520328526OMIM:615297Adams-Oliver syndrome 4HP:0040283 - Occasional4
HP:0011276HP:0001933Subcutaneous hemorrhage1EPHB2 CL E G H20483393OMIM:618462Bleeding disorder, platelet-type, 227
HP:0011276HP:0001009Telangiectasia1EPHB4 CL E G H20503395ORPHA:137667Capillary malformation-arteriovenous malformationHP:0040283 - Occasional3
HP:0011276HP:0001009Telangiectasia1EPHB4 CL E G H20503395OMIM:618196Capillary malformation-arteriovenous malformation 2.3
HP:0011276HP:0001009Telangiectasia1ERCC2 CL E G H20683434OMIM:601675Trichothiodystrophy 1, photosensitive.106
HP:0011276HP:0001009Telangiectasia1ERCC2 CL E G H20683434ORPHA:910Xeroderma pigmentosumHP:0040281 - Very frequent106
HP:0011276HP:0010783Erythema1ERCC2 CL E G H20683434ORPHA:910Xeroderma pigmentosumHP:0040282 - Frequent106
HP:0011276HP:0001009Telangiectasia1ERCC2 CL E G H20683434OMIM:278730Xeroderma pigmentosum, complementation group D.106
HP:0011276HP:0001025Urticaria1ERCC2 CL E G H20683434ORPHA:220295Xeroderma pigmentosum-Cockayne syndrome complexHP:0040281 - Very frequent106
HP:0011276HP:0010783Erythema1ERCC3 CL E G H20713435ORPHA:910Xeroderma pigmentosumHP:0040282 - Frequent54
HP:0011276HP:0001009Telangiectasia1ERCC3 CL E G H20713435ORPHA:910Xeroderma pigmentosumHP:0040281 - Very frequent54
HP:0011276HP:0001025Urticaria1ERCC3 CL E G H20713435ORPHA:220295Xeroderma pigmentosum-Cockayne syndrome complexHP:0040281 - Very frequent54
HP:0011276HP:0001009Telangiectasia1ERCC4 CL E G H20723436ORPHA:910Xeroderma pigmentosumHP:0040281 - Very frequent158
HP:0011276HP:0010783Erythema1ERCC4 CL E G H20723436ORPHA:910Xeroderma pigmentosumHP:0040282 - Frequent158
HP:0011276HP:0010783Erythema1ERCC4 CL E G H20723436OMIM:278760Xeroderma pigmentosum, complementation group F158
HP:0011276HP:0001025Urticaria1ERCC4 CL E G H20723436ORPHA:220295Xeroderma pigmentosum-Cockayne syndrome complexHP:0040281 - Very frequent158
HP:0011276HP:0001009Telangiectasia1ERCC5 CL E G H20733437ORPHA:910Xeroderma pigmentosumHP:0040281 - Very frequent83
HP:0011276HP:0010783Erythema1ERCC5 CL E G H20733437ORPHA:910Xeroderma pigmentosumHP:0040282 - Frequent83
HP:0011276HP:0001025Urticaria1ERCC5 CL E G H20733437ORPHA:220295Xeroderma pigmentosum-Cockayne syndrome complexHP:0040281 - Very frequent83
HP:0011276HP:0001009Telangiectasia1ERCC6 CL E G H20743438OMIM:278800De Sanctis-Cacchione syndrome.199
HP:0011276HP:0001009Telangiectasia1ERCC6 CL E G H20743438OMIM:600630Uv-Sensitive syndrome 1.199
HP:0011276HP:0001933Subcutaneous hemorrhage1ETHE1 CL E G H2347423287OMIM:602473Encephalopathy, ethylmalonic42
HP:0011276HP:0001933Subcutaneous hemorrhage1ETHE1 CL E G H2347423287ORPHA:51188Ethylmalonic encephalopathy42
HP:0011276HP:0001933Subcutaneous hemorrhage1ETV6 CL E G H21203495OMIM:616216Thrombocytopenia 513
HP:0011276HP:0001933Subcutaneous hemorrhage1F10 CL E G H21593528ORPHA:328Congenital factor X deficiency33
HP:0011276HP:0100665Angioedema1F12 CL E G H21613530OMIM:610618ANGIOEDEMA, HEREDITARY, TYPE III; HAE328
HP:0011276HP:0001933Subcutaneous hemorrhage1F13A1 CL E G H21623531ORPHA:331Congenital factor XIII deficiencyHP:0040282 - Frequent60
HP:0011276HP:0001933Subcutaneous hemorrhage1F13A1 CL E G H21623531OMIM:613225Factor XIII, A subunit, deficiency of60
HP:0011276HP:0001933Subcutaneous hemorrhage1F13B CL E G H21653534ORPHA:331Congenital factor XIII deficiencyHP:0040282 - Frequent32
HP:0011276HP:0001933Subcutaneous hemorrhage1F13B CL E G H21653534OMIM:613235Factor XIIIB deficiency32
HP:0011276HP:0001933Subcutaneous hemorrhage1F2 CL E G H21473535OMIM:613679Congenital prothrombin deficiency44
HP:0011276HP:0001933Subcutaneous hemorrhage1F5 CL E G H21533542ORPHA:326Congenital factor V deficiency159
HP:0011276HP:0001933Subcutaneous hemorrhage1F5 CL E G H21533542OMIM:227400Factor V deficiency159
HP:0011276HP:0001933Subcutaneous hemorrhage1F7 CL E G H21553544ORPHA:327Congenital factor VII deficiency70
HP:0011276HP:0001933Subcutaneous hemorrhage1F8 CL E G H21573546ORPHA:177926Bleeding disorder in hemophilia A carriers without FVIII deficiency303
HP:0011276HP:0001933Subcutaneous hemorrhage1F8 CL E G H21573546OMIM:306700Hemophilia A303
HP:0011276HP:0001933Subcutaneous hemorrhage1F8 CL E G H21573546ORPHA:169805Moderate hemophilia AHP:0040282 - Frequent303
HP:0011276HP:0001933Subcutaneous hemorrhage1F8 CL E G H21573546ORPHA:169802Severe hemophilia A303
HP:0011276HP:0001933Subcutaneous hemorrhage1FANCA CL E G H21753582OMIM:227650Fanconi anemia340
HP:0011276HP:0001933Subcutaneous hemorrhage1FANCC CL E G H21763584OMIM:227645Fanconi anemia, complementation group C410
HP:0011276HP:0001933Subcutaneous hemorrhage1FANCD2 CL E G H21773585OMIM:227646Fanconi anemia, complementation group D2147
HP:0011276HP:0001933Subcutaneous hemorrhage1FANCE CL E G H21783586OMIM:600901Fanconi anemia, complementation group E73
HP:0011276HP:0001025Urticaria1FAS CL E G H35511920OMIM:601859Autoimmune lymphoproliferative syndrome.59
HP:0011276HP:0001025Urticaria1FAS CL E G H35511920ORPHA:3261Autoimmune lymphoproliferative syndromeHP:0040283 - Occasional59
HP:0011276HP:0001933Subcutaneous hemorrhage1FAS CL E G H35511920ORPHA:3261Autoimmune lymphoproliferative syndrome59
HP:0011276HP:0001025Urticaria1FASLG CL E G H35611936ORPHA:3261Autoimmune lymphoproliferative syndromeHP:0040283 - Occasional37
HP:0011276HP:0001933Subcutaneous hemorrhage1FASLG CL E G H35611936ORPHA:3261Autoimmune lymphoproliferative syndrome37
HP:0011276HP:0001025Urticaria1FASLG CL E G H35611936OMIM:601859Autoimmune lymphoproliferative syndrome.37
HP:0011276HP:0000965Cutis marmorata1FBN1 CL E G H22003603ORPHA:91387Familial thoracic aortic aneurysm and aortic dissectionHP:0040281 - Very frequent1361
HP:0011276HP:0001933Subcutaneous hemorrhage1FBN1 CL E G H22003603ORPHA:91387Familial thoracic aortic aneurysm and aortic dissection1361
HP:0011276HP:0001933Subcutaneous hemorrhage1FBN1 CL E G H22003603OMIM:616914Marfan lipodystrophy syndrome1361
HP:0011276HP:0001933Subcutaneous hemorrhage1FCGR2C CL E G H910315626ORPHA:3002Immune thrombocytopenia
HP:0011276HP:0010783Erythema1FECH CL E G H22353647ORPHA:79278Autosomal erythropoietic protoporphyriaHP:0040281 - Very frequent145
HP:0011276HP:0010783Erythema1FECH CL E G H22353647OMIM:177000Protoporphyria, erythropoietic, 1.145
HP:0011276HP:0010783Erythema1FERMT1 CL E G H5561215889ORPHA:2908Kindler epidermolysis bullosaHP:0040281 - Very frequent136
HP:0011276HP:0001009Telangiectasia1FERMT1 CL E G H5561215889OMIM:173650Kindler syndrome136
HP:0011276HP:0001933Subcutaneous hemorrhage1FERMT3 CL E G H8370623151OMIM:612840Leukocyte adhesion deficiency, type III23
HP:0011276HP:0001933Subcutaneous hemorrhage1FGA CL E G H22433661OMIM:202400Afibrinogenemia, congenitalhypofibrinogenemia, congenital, included47
HP:0011276HP:0001933Subcutaneous hemorrhage1FGB CL E G H22443662OMIM:202400Afibrinogenemia, congenitalhypofibrinogenemia, congenital, included62
HP:0011276HP:0001933Subcutaneous hemorrhage1FGG CL E G H22663694OMIM:202400Afibrinogenemia, congenitalhypofibrinogenemia, congenital, included34
HP:0011276HP:0001933Subcutaneous hemorrhage1FIP1L1 CL E G H8160819124ORPHA:520Acute promyelocytic leukemia4
HP:0011276HP:0001933Subcutaneous hemorrhage1FKBP14 CL E G H5503318625OMIM:614557Ehlers-Danlos syndrome, kyphoscoliotic type, 213
HP:0011276HP:0001933Subcutaneous hemorrhage1FKBP14 CL E G H5503318625ORPHA:300179Kyphoscoliotic Ehlers-Danlos syndrome due to FKBP22 deficiency13
HP:0011276HP:0001933Subcutaneous hemorrhage1FLNA CL E G H23163754ORPHA:75497X-linked Ehlers-Danlos syndrome493
HP:0011276HP:0007394Prominent superficial blood vessels1FLT4 CL E G H23243767OMIM:153100Lymphatic malformation 190
HP:0011276HP:0007394Prominent superficial blood vessels1FOS CL E G H23533796ORPHA:528Congenital generalized lipodystrophy
HP:0011276HP:0001933Subcutaneous hemorrhage1FOXE3 CL E G H23013808ORPHA:91387Familial thoracic aortic aneurysm and aortic dissection23
HP:0011276HP:0000965Cutis marmorata1FOXE3 CL E G H23013808ORPHA:91387Familial thoracic aortic aneurysm and aortic dissectionHP:0040281 - Very frequent23
HP:0011276HP:0001025Urticaria1FOXP3 CL E G H509436106ORPHA:37042Immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndromeHP:0040283 - Occasional32
HP:0011276HP:0001009Telangiectasia1FRG1 CL E G H24833954OMIM:158900Facioscapulohumeral muscular dystrophy 11
HP:0011276HP:0000965Cutis marmorata1FTO CL E G H7906824678OMIM:612938Growth retardation, developmental delay, coarse facies, and earlydeath.70
HP:0011276HP:0001014Angiokeratoma1FUCA1 CL E G H25174006OMIM:230000FUCOSIDOSIS.43
HP:0011276HP:0001933Subcutaneous hemorrhage1FYB1 CL E G H25334036OMIM:273900THROMBOCYTOPENIA 3; THC34
HP:0011276HP:0001009Telangiectasia1FZD4 CL E G H83224042ORPHA:891Familial exudative vitreoretinopathy109
HP:0011276HP:0007394Prominent superficial blood vessels1G6PC3 CL E G H9257924861OMIM:612541Neutropenia, severe congenital, 4, autosomal recessive37
HP:0011276HP:0001009Telangiectasia1GABRD CL E G H25634084ORPHA:16061p36 deletion syndromeHP:0040283 - Occasional10
HP:0011276HP:0001933Subcutaneous hemorrhage1GATA1 CL E G H26234170OMIM:314050Thrombocytopenia with beta-thalassemia, X-linked29
HP:0011276HP:0001933Subcutaneous hemorrhage1GATA1 CL E G H26234170OMIM:300367Thrombocytopenia, X-linked, with or without dyserythropoietic anemia29
HP:0011276HP:0001933Subcutaneous hemorrhage1GATA2 CL E G H26244171ORPHA:3226Deafness-lymphedema-leukemia syndrome137
HP:0011276HP:0001933Subcutaneous hemorrhage1GBA1 CL E G H26294177ORPHA:77259Gaucher disease type 1
HP:0011276HP:0001933Subcutaneous hemorrhage1GBA1 CL E G H26294177OMIM:608013Gaucher disease, perinatal lethal
HP:0011276HP:0001933Subcutaneous hemorrhage1GBA1 CL E G H26294177ORPHA:2072Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome
HP:0011276HP:0001933Subcutaneous hemorrhage1GDF2 CL E G H26584217ORPHA:774Hereditary hemorrhagic telangiectasia8
HP:0011276HP:0001009Telangiectasia1GDF2 CL E G H26584217ORPHA:774Hereditary hemorrhagic telangiectasia8
HP:0011276HP:0001009Telangiectasia1GDF2 CL E G H26584217OMIM:615506TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 5; HHT58
HP:0011276HP:0001933Subcutaneous hemorrhage1GFI1B CL E G H83284238OMIM:187900Bleeding disorder, platelet-type, 173
HP:0011276HP:0001933Subcutaneous hemorrhage1GGCX CL E G H26774247OMIM:277450VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 1129
HP:0011276HP:0001933Subcutaneous hemorrhage1GIMAP5 CL E G H5534018005OMIM:619463PORTAL HYPERTENSION, NONCIRRHOTIC, 2; NCPH2
HP:0011276HP:0010783Erythema1GJA1 CL E G H26974274ORPHA:1010Autosomal dominant palmoplantar keratoderma and congenital alopecia68
HP:0011276HP:0010783Erythema1GJA1 CL E G H26974274ORPHA:317Erythrokeratodermia variabilisHP:0040281 - Very frequent68
HP:0011276HP:0010783Erythema1GJA1 CL E G H26974274OMIM:617525Erythrokeratodermia variabilis et progressiva 3.68
HP:0011276HP:0010783Erythema1GJA1 CL E G H26974274OMIM:104100Palmoplantar keratoderma with congenital alopecia68
HP:0011276HP:0010783Erythema1GJA5 CL E G H27024279OMIM:612474Chromosome 1q21.1 deletion syndrome, 1.35-mb39
HP:0011276HP:0010783Erythema1GJA8 CL E G H27034281OMIM:612474Chromosome 1q21.1 deletion syndrome, 1.35-mb34
HP:0011276HP:0010783Erythema1GJB3 CL E G H27074285ORPHA:317Erythrokeratodermia variabilisHP:0040281 - Very frequent74
HP:0011276HP:0010783Erythema1GJB4 CL E G H1275344286ORPHA:317Erythrokeratodermia variabilisHP:0040281 - Very frequent12
HP:0011276HP:0010783Erythema1GJB4 CL E G H1275344286OMIM:617524Erythrokeratodermia variabilis et progressiva 2.12
HP:0011276HP:0001014Angiokeratoma1GLA CL E G H27174296OMIM:301500Fabry disease.291
HP:0011276HP:0001009Telangiectasia1GLA CL E G H27174296ORPHA:324Fabry disease291
HP:0011276HP:0001014Angiokeratoma1GLA CL E G H27174296ORPHA:324Fabry diseaseHP:0040281 - Very frequent291
HP:0011276HP:0001014Angiokeratoma1GLB1 CL E G H27204298OMIM:230500GM1-gangliosidosis, type I120
HP:0011276HP:0010783Erythema1GLUL CL E G H27524341OMIM:610015GLUTAMINE DEFICIENCY, CONGENITAL98
HP:0011276HP:0000965Cutis marmorata1GNA11 CL E G H27674379ORPHA:1556Cutis marmorata telangiectatica congenitaHP:0040281 - Very frequent16
HP:0011276HP:0001933Subcutaneous hemorrhage1GNA11 CL E G H27674379ORPHA:1556Cutis marmorata telangiectatica congenitaHP:0040281 - Very frequent16
HP:0011276HP:0001009Telangiectasia1GNA11 CL E G H27674379ORPHA:1556Cutis marmorata telangiectatica congenita16
HP:0011276HP:0001933Subcutaneous hemorrhage1GNA14 CL E G H96304382ORPHA:1063Tufted angioma
HP:0011276HP:0001009Telangiectasia1GNAQ CL E G H27764390ORPHA:3205Sturge-Weber syndrome7
HP:0011276HP:0001933Subcutaneous hemorrhage1GNAS CL E G H27784392OMIM:219080ACTH-independent macronodular adrenal hyperplasia101
HP:0011276HP:0001933Subcutaneous hemorrhage1GNAS CL E G H27784392ORPHA:189427Cushing syndrome due to macronodular adrenal hyperplasia101
HP:0011276HP:0001025Urticaria1GNB2 CL E G H27834398OMIM:619503NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND DYSMORPHIC FACIES; NEDHYDF
HP:0011276HP:0010783Erythema1GNB2 CL E G H27834398OMIM:619503NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND DYSMORPHIC FACIES; NEDHYDF
HP:0011276HP:0001009Telangiectasia1GNPTAB CL E G H7915829670ORPHA:576Mucolipidosis type II240
HP:0011276HP:0001933Subcutaneous hemorrhage1GP1BA CL E G H28114439ORPHA:274Bernard-Soulier syndrome23
HP:0011276HP:0001933Subcutaneous hemorrhage1GP1BA CL E G H28114439OMIM:153670Bernard-Soulier syndrome, type A2, autosomal dominant23
HP:0011276HP:0001933Subcutaneous hemorrhage1GP1BA CL E G H28114439OMIM:231200BERNARD-SOULIER SYNDROME; BSS23
HP:0011276HP:0001933Subcutaneous hemorrhage1GP1BA CL E G H28114439ORPHA:853Fetal and neonatal alloimmune thrombocytopenia23
HP:0011276HP:0001933Subcutaneous hemorrhage1GP1BB CL E G H28124440ORPHA:56722q11.2 deletion syndrome8
HP:0011276HP:0001933Subcutaneous hemorrhage1GP1BB CL E G H28124440ORPHA:274Bernard-Soulier syndrome8
HP:0011276HP:0001933Subcutaneous hemorrhage1GP1BB CL E G H28124440OMIM:231200BERNARD-SOULIER SYNDROME; BSS8
HP:0011276HP:0001933Subcutaneous hemorrhage1GP1BB CL E G H28124440ORPHA:853Fetal and neonatal alloimmune thrombocytopenia8
HP:0011276HP:0001933Subcutaneous hemorrhage1GP6 CL E G H5120614388OMIM:614201Bleeding disorder, platelet-type, 1124
HP:0011276HP:0001933Subcutaneous hemorrhage1GP9 CL E G H28154444ORPHA:274Bernard-Soulier syndrome21
HP:0011276HP:0001933Subcutaneous hemorrhage1GP9 CL E G H28154444OMIM:231200BERNARD-SOULIER SYNDROME; BSS21
HP:0011276HP:0001009Telangiectasia1GPR35 CL E G H28594492ORPHA:171Primary sclerosing cholangitis2
HP:0011276HP:0007394Prominent superficial blood vessels1GPR35 CL E G H28594492ORPHA:171Primary sclerosing cholangitis2
HP:0011276HP:0001933Subcutaneous hemorrhage1GSN CL E G H29344620ORPHA:85448AGel amyloidosis53
HP:0011276HP:0000965Cutis marmorata1GUCY1A1 CL E G H29824685OMIM:615750Moyamoya disease 6 with achalasiaHP:0040283 - Occasional
HP:0011276HP:0000965Cutis marmorata1GUCY1A1 CL E G H29824685ORPHA:401945Moyamoya disease with early-onset achalasiaHP:0040283 - Occasional
HP:0011276HP:0000965Cutis marmorata1H4C3 CL E G H83644787OMIM:619758TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 1; TEVANED1
HP:0011276HP:0001933Subcutaneous hemorrhage1HBA1 CL E G H30394823ORPHA:98791Alpha-thalassemia-intellectual disability syndrome linked to chromosome 16200
HP:0011276HP:0001933Subcutaneous hemorrhage1HBA2 CL E G H30404824ORPHA:98791Alpha-thalassemia-intellectual disability syndrome linked to chromosome 1688
HP:0011276HP:0010783Erythema1HCCS CL E G H30524837ORPHA:2556Microphthalmia with linear skin defects syndromeHP:0040281 - Very frequent11
HP:0011276HP:0000965Cutis marmorata1HDAC8 CL E G H5586913315ORPHA:199Cornelia de Lange syndromeHP:0040282 - Frequent37
HP:0011276HP:0000965Cutis marmorata1HDAC8 CL E G H5586913315OMIM:300882Cornelia de Lange syndrome 537
HP:0011276HP:0000965Cutis marmorata1HEATR3 CL E G H5502726087OMIM:620072
HP:0011276HP:0000965Cutis marmorata1HEY2 CL E G H234934881ORPHA:91387Familial thoracic aortic aneurysm and aortic dissectionHP:0040281 - Very frequent
HP:0011276HP:0001933Subcutaneous hemorrhage1HEY2 CL E G H234934881ORPHA:91387Familial thoracic aortic aneurysm and aortic dissection
HP:0011276HP:0001009Telangiectasia1HFE CL E G H30774886OMIM:235200Hemochromatosis, type 1.38
HP:0011276HP:0001933Subcutaneous hemorrhage1HIRA CL E G H72904916ORPHA:56722q11.2 deletion syndrome3
HP:0011276HP:0010783Erythema1HLA-B CL E G H31064932ORPHA:36426Stevens-Johnson syndromeHP:0040281 - Very frequent4
HP:0011276HP:0001933Subcutaneous hemorrhage1HLA-DPA1 CL E G H31134938ORPHA:900Granulomatosis with polyangiitis
HP:0011276HP:0001933Subcutaneous hemorrhage1HLA-DPB1 CL E G H31154940ORPHA:900Granulomatosis with polyangiitis1
HP:0011276HP:0010783Erythema1HLA-DQB1 CL E G H31194944ORPHA:703Bullous pemphigoidHP:0040281 - Very frequent
HP:0011276HP:0001025Urticaria1HLA-DQB1 CL E G H31194944ORPHA:703Bullous pemphigoidHP:0040281 - Very frequent
HP:0011276HP:0001025Urticaria1HLA-DRB1 CL E G H31234948ORPHA:703Bullous pemphigoidHP:0040281 - Very frequent2
HP:0011276HP:0010783Erythema1HLA-DRB1 CL E G H31234948ORPHA:703Bullous pemphigoidHP:0040281 - Very frequent2
HP:0011276HP:0001009Telangiectasia1HLA-DRB1 CL E G H31234948ORPHA:220393Diffuse cutaneous systemic sclerosis2
HP:0011276HP:0001009Telangiectasia1HLA-DRB1 CL E G H31234948ORPHA:220402Limited cutaneous systemic sclerosis2
HP:0011276HP:0001933Subcutaneous hemorrhage1HOXA11 CL E G H32075101OMIM:605432Radioulnar synostosis with amegakaryocytic thrombocytopenia3
HP:0011276HP:0010783Erythema1HPGD CL E G H32485154OMIM:259100Hypertrophic osteoarthropathy, primary, autosomal recessive 1.55
HP:0011276HP:0001933Subcutaneous hemorrhage1HPS1 CL E G H32575163OMIM:203300Hermansky-Pudlak syndrome 1121
HP:0011276HP:0001933Subcutaneous hemorrhage1HPS3 CL E G H8434315597OMIM:614072Hermansky-Pudlak syndrome 367
HP:0011276HP:0001933Subcutaneous hemorrhage1HPS4 CL E G H8978115844OMIM:614073Hermansky-Pudlak syndrome 4123
HP:0011276HP:0001933Subcutaneous hemorrhage1HPS5 CL E G H1123417022OMIM:614074Hermansky-Pudlak syndrome 5105
HP:0011276HP:0001933Subcutaneous hemorrhage1HPS6 CL E G H7980318817OMIM:614075Hermansky-Pudlak syndrome 645
HP:0011276HP:0100665Angioedema1HS3ST6 CL E G H6471114178OMIM:619367ANGIOEDEMA, HEREDITARY, 8; HAE8
HP:0011276HP:0001009Telangiectasia1HSPG2 CL E G H33395273ORPHA:16061p36 deletion syndromeHP:0040283 - Occasional345
HP:0011276HP:0001009Telangiectasia1IARS2 CL E G H5569929685OMIM:616007Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia25
HP:0011276HP:0001933Subcutaneous hemorrhage1ICOS CL E G H298515351ORPHA:1572Common variable immunodeficiency32
HP:0011276HP:0000965Cutis marmorata1IFIH1 CL E G H6413518873ORPHA:51Aicardi-Goutières syndromeHP:0040283 - Occasional28
HP:0011276HP:0001025Urticaria1IFIH1 CL E G H6413518873OMIM:615846Aicardi-Goutieres syndrome 728
HP:0011276HP:0001933Subcutaneous hemorrhage1IFNG CL E G H34585438ORPHA:88Idiopathic aplastic anemia23
HP:0011276HP:0010783Erythema1IKBKG CL E G H85175961ORPHA:464Incontinentia pigmentiHP:0040281 - Very frequent52
HP:0011276HP:0010783Erythema1IKBKG CL E G H85175961OMIM:308300Incontinentia pigmenti.52
HP:0011276HP:0001009Telangiectasia1IKBKG CL E G H85175961ORPHA:464Incontinentia pigmenti52
HP:0011276HP:0010783Erythema1IKZF1 CL E G H1032013176ORPHA:36426Stevens-Johnson syndromeHP:0040281 - Very frequent8
HP:0011276HP:0001025Urticaria1IL12A CL E G H35925969ORPHA:186Primary biliary cholangitis
HP:0011276HP:0200029Vasculitis in the skin1IL12RB1 CL E G H35945971ORPHA:319552Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiencyHP:0040284 - Very rare46
HP:0011276HP:0001025Urticaria1IL12RB1 CL E G H35945971ORPHA:186Primary biliary cholangitis46
HP:0011276HP:0010783Erythema1IL17F CL E G H11274416404ORPHA:1334Chronic mucocutaneous candidiasisHP:0040281 - Very frequent14
HP:0011276HP:0010783Erythema1IL17RA CL E G H237655985ORPHA:1334Chronic mucocutaneous candidiasisHP:0040281 - Very frequent196
HP:0011276HP:0010783Erythema1IL17RC CL E G H8481818358ORPHA:1334Chronic mucocutaneous candidiasisHP:0040281 - Very frequent4
HP:0011276HP:0010783Erythema1IL36RN CL E G H2652515561OMIM:614204PSORIASIS 14, PUSTULAR; PSORS1451
HP:0011276HP:0001009Telangiectasia1IL7 CL E G H35746023ORPHA:302Epidermodysplasia verruciformis
HP:0011276HP:0001933Subcutaneous hemorrhage1IPO8 CL E G H105269853ORPHA:60030Loeys-Dietz syndrome
HP:0011276HP:0001933Subcutaneous hemorrhage1IPO8 CL E G H105269853OMIM:619472VISS syndrome
HP:0011276HP:0007394Prominent superficial blood vessels1IPO8 CL E G H105269853OMIM:619472VISS syndrome
HP:0011276HP:0001933Subcutaneous hemorrhage1IRF2BP2 CL E G H35994821729ORPHA:520Acute promyelocytic leukemia4
HP:0011276HP:0001933Subcutaneous hemorrhage1IRF2BP2 CL E G H35994821729ORPHA:1572Common variable immunodeficiency4
HP:0011276HP:0001009Telangiectasia1IRF5 CL E G H36636120ORPHA:220393Diffuse cutaneous systemic sclerosis4
HP:0011276HP:0001009Telangiectasia1IRF5 CL E G H36636120ORPHA:220402Limited cutaneous systemic sclerosis4
HP:0011276HP:0001025Urticaria1IRF5 CL E G H36636120ORPHA:186Primary biliary cholangitis4
HP:0011276HP:0001933Subcutaneous hemorrhage1ITGA2 CL E G H36736137ORPHA:853Fetal and neonatal alloimmune thrombocytopenia119
HP:0011276HP:0001933Subcutaneous hemorrhage1ITGA2B CL E G H36746138OMIM:187800Bleeding disorder, platelet-type, 1669
HP:0011276HP:0001933Subcutaneous hemorrhage1ITGA2B CL E G H36746138ORPHA:853Fetal and neonatal alloimmune thrombocytopenia69
HP:0011276HP:0001933Subcutaneous hemorrhage1ITGA2B CL E G H36746138ORPHA:849Glanzmann thrombasthenia69
HP:0011276HP:0001933Subcutaneous hemorrhage1ITGA2B CL E G H36746138OMIM:273800Glanzmann thrombasthenia69
HP:0011276HP:0010783Erythema1ITGA3 CL E G H36756139OMIM:614748Interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa, congenital.6
HP:0011276HP:0001933Subcutaneous hemorrhage1ITGB3 CL E G H36906156ORPHA:853Fetal and neonatal alloimmune thrombocytopenia80
HP:0011276HP:0001933Subcutaneous hemorrhage1ITGB3 CL E G H36906156ORPHA:849Glanzmann thrombasthenia80
HP:0011276HP:0001933Subcutaneous hemorrhage1ITGB3 CL E G H36906156OMIM:619267GLANZMANN THROMBASTHENIA 2; GT280
HP:0011276HP:0001933Subcutaneous hemorrhage1JAK2 CL E G H37176192OMIM:254450Myelofibrosismyelofibrosis with myeloid metaplasia, included57
HP:0011276HP:0001933Subcutaneous hemorrhage1JAK2 CL E G H37176192ORPHA:729Polycythemia vera57
HP:0011276HP:0001933Subcutaneous hemorrhage1JAK2 CL E G H37176192ORPHA:824Primary myelofibrosis57
HP:0011276HP:0001933Subcutaneous hemorrhage1JAM2 CL E G H5849414686ORPHA:1980Bilateral striopallidodentate calcinosisHP:0040281 - Very frequent
HP:0011276HP:0001933Subcutaneous hemorrhage1JMJD1C CL E G H22103712313ORPHA:56722q11.2 deletion syndrome2
HP:0011276HP:0001009Telangiectasia1KCNAB2 CL E G H85146229ORPHA:16061p36 deletion syndromeHP:0040283 - Occasional1
HP:0011276HP:0010783Erythema1KCNQ2 CL E G H37856296ORPHA:439218KCNQ2-related epileptic encephalopathy528
HP:0011276HP:0010783Erythema1KDSR CL E G H25314021ORPHA:317Erythrokeratodermia variabilisHP:0040281 - Very frequent4
HP:0011276HP:0010783Erythema1KDSR CL E G H25314021OMIM:617526Erythrokeratodermia variabilis et progressiva 4.4
HP:0011276HP:0010783Erythema1KDSR CL E G H25314021ORPHA:316Progressive symmetric erythrokeratodermiaHP:0040281 - Very frequent4
HP:0011276HP:0001009Telangiectasia1KIAA0319L CL E G H7993230071ORPHA:220402Limited cutaneous systemic sclerosis
HP:0011276HP:0001025Urticaria1KIT CL E G H38156342ORPHA:280785Bullous diffuse cutaneous mastocytosisHP:0040281 - Very frequent327
HP:0011276HP:0001025Urticaria1KIT CL E G H38156342ORPHA:79455Cutaneous mastocytomaHP:0040281 - Very frequent327
HP:0011276HP:0100665Angioedema1KIT CL E G H38156342ORPHA:79455Cutaneous mastocytoma327
HP:0011276HP:0010783Erythema1KIT CL E G H38156342ORPHA:79455Cutaneous mastocytoma327
HP:0011276HP:0001009Telangiectasia1KIT CL E G H38156342ORPHA:79455Cutaneous mastocytoma327
HP:0011276HP:0001025Urticaria1KIT CL E G H38156342OMIM:606764Gastrointestinal stromal tumor.327
HP:0011276HP:0001025Urticaria1KIT CL E G H38156342OMIM:154800Mastocytosis, cutaneous.327
HP:0011276HP:0010783Erythema1KIT CL E G H38156342OMIM:154800Mastocytosis, cutaneous.327
HP:0011276HP:0001009Telangiectasia1KIT CL E G H38156342OMIM:154800Mastocytosis, cutaneous327
HP:0011276HP:0001025Urticaria1KIT CL E G H38156342ORPHA:98849Systemic mastocytosis with associated hematologic neoplasmHP:0040283 - Occasional327
HP:0011276HP:0001009Telangiectasia1KLLN CL E G H10014474837212ORPHA:201Cowden syndrome1
HP:0011276HP:0100665Angioedema1KNG1 CL E G H38276383OMIM:619363ANGIOEDEMA, HEREDITARY, 6; HAE67
HP:0011276HP:0001933Subcutaneous hemorrhage1KRAS CL E G H38456407OMIM:609942Noonan syndrome 3196
HP:0011276HP:0010783Erythema1KRT1 CL E G H38486412ORPHA:530838KRT1-related diffuse nonepidermolytic keratodermaHP:0040282 - Frequent100
HP:0011276HP:0010783Erythema1KRT10 CL E G H38586413OMIM:607602Ichthyosis, cyclic, with epidermolytic hyperkeratosis.45
HP:0011276HP:0010783Erythema1KRT14 CL E G H38616416ORPHA:79396Autosomal dominant generalized epidermolysis bullosa simplex, severe formHP:0040281 - Very frequent110
HP:0011276HP:0010783Erythema1KRT2 CL E G H38496439ORPHA:455Superficial epidermolytic ichthyosisHP:0040283 - Occasional67
HP:0011276HP:0010783Erythema1KRT5 CL E G H38526442ORPHA:79396Autosomal dominant generalized epidermolysis bullosa simplex, severe formHP:0040281 - Very frequent173
HP:0011276HP:0010783Erythema1KRT5 CL E G H38526442ORPHA:158681Epidermolysis bullosa simplex with circinate migratory erythema173
HP:0011276HP:0010783Erythema1KRT5 CL E G H38526442OMIM:609352EPIDERMOLYSIS BULLOSA SIMPLEX WITH MIGRATORY CIRCINATE ERYTHEMA173
HP:0011276HP:0010783Erythema1KRT83 CL E G H38896460ORPHA:316Progressive symmetric erythrokeratodermiaHP:0040281 - Very frequent65
HP:0011276HP:0000965Cutis marmorata1LARP7 CL E G H5157424912ORPHA:319671Alazami syndromeHP:0040282 - Frequent16
HP:0011276HP:0001009Telangiectasia1LBR CL E G H39306518OMIM:613471Reynolds syndrome70
HP:0011276HP:0001009Telangiectasia1LBR CL E G H39306518ORPHA:779Reynolds syndrome70
HP:0011276HP:0001933Subcutaneous hemorrhage1LCP2 CL E G H39376529OMIM:619374IMMUNODEFICIENCY 81; IMD81
HP:0011276HP:0007394Prominent superficial blood vessels1LEMD2 CL E G H22149621244OMIM:619322MARBACH-RUSTAD PROGEROID SYNDROME; MARUPS1
HP:0011276HP:0001009Telangiectasia1LIG1 CL E G H39786598OMIM:619774IMMUNODEFICIENCY 96; IMD969
HP:0011276HP:0000965Cutis marmorata1LIG4 CL E G H39816601ORPHA:235Dubowitz syndromeHP:0040283 - Occasional88
HP:0011276HP:0001009Telangiectasia1LIG4 CL E G H39816601OMIM:606593Lig4 syndromeHP:0040284 - Very rare88
HP:0011276HP:0001009Telangiectasia1LIG4 CL E G H39816601ORPHA:99812LIG4 syndrome88
HP:0011276HP:0010783Erythema1LIG4 CL E G H39816601ORPHA:99812LIG4 syndromeHP:0040282 - Frequent88
HP:0011276HP:0010783Erythema1LIPN CL E G H64341823452OMIM:613943Ichthyosis, congenital, autosomal recessive 8.1
HP:0011276HP:0001933Subcutaneous hemorrhage1LMAN1 CL E G H39986631ORPHA:35909Combined deficiency of factor V and factor VIII56
HP:0011276HP:0007394Prominent superficial blood vessels1LMNA CL E G H40006636ORPHA:79474Atypical Werner syndrome645
HP:0011276HP:0001009Telangiectasia1LMNA CL E G H40006636ORPHA:79474Atypical Werner syndrome645
HP:0011276HP:0007394Prominent superficial blood vessels1LMNA CL E G H40006636ORPHA:740Hutchinson-Gilford progeria syndromeHP:0040281 - Very frequent645
HP:0011276HP:0007394Prominent superficial blood vessels1LMNA CL E G H40006636OMIM:151660Lipodystrophy, familial partial, type 2645
HP:0011276HP:0001009Telangiectasia1LMX1B CL E G H40106654ORPHA:4958189q33.3q34.11 microdeletion syndromeHP:0040283 - Occasional165
HP:0011276HP:0010783Erythema1LORICRIN CL E G H40146663ORPHA:316Progressive symmetric erythrokeratodermiaHP:0040281 - Very frequent
HP:0011276HP:0000965Cutis marmorata1LOX CL E G H40156664ORPHA:91387Familial thoracic aortic aneurysm and aortic dissectionHP:0040281 - Very frequent6
HP:0011276HP:0001933Subcutaneous hemorrhage1LOX CL E G H40156664ORPHA:91387Familial thoracic aortic aneurysm and aortic dissection6
HP:0011276HP:0010783Erythema1LRP1 CL E G H40356692ORPHA:79100Atrophoderma vermiculataHP:0040283 - Occasional4
HP:0011276HP:0010783Erythema1LRP1 CL E G H40356692OMIM:604093Keratosis pilaris atrophicans4
HP:0011276HP:0001009Telangiectasia1LRP5 CL E G H40416697ORPHA:891Familial exudative vitreoretinopathy125
HP:0011276HP:0000965Cutis marmorata1LSM11 CL E G H13435330860ORPHA:51Aicardi-Goutières syndromeHP:0040283 - Occasional
HP:0011276HP:0001009Telangiectasia1LUZP1 CL E G H779814985ORPHA:16061p36 deletion syndromeHP:0040283 - Occasional
HP:0011276HP:0001933Subcutaneous hemorrhage1LYST CL E G H11301968ORPHA:352723Attenuated Chédiak-Higashi syndrome239
HP:0011276HP:0001933Subcutaneous hemorrhage1LYST CL E G H11301968ORPHA:167Chédiak-Higashi syndrome239
HP:0011276HP:0001933Subcutaneous hemorrhage1LYST CL E G H11301968OMIM:214500Chediak-Higashi syndrome239
HP:0011276HP:0001014Angiokeratoma1MANBA CL E G H41266831OMIM:248510MANNOSIDOSIS, BETA A, LYSOSOMAL.55
HP:0011276HP:0001933Subcutaneous hemorrhage1MAP2K1 CL E G H56046840OMIM:163950Noonan syndrome 1134
HP:0011276HP:0001933Subcutaneous hemorrhage1MAPK1 CL E G H55946871OMIM:619087NOONAN SYNDROME 13; NS132
HP:0011276HP:0001009Telangiectasia1MASP1 CL E G H56486901OMIM:2579203mc syndrome 121
HP:0011276HP:0001933Subcutaneous hemorrhage1MAT2A CL E G H41446904ORPHA:91387Familial thoracic aortic aneurysm and aortic dissection13
HP:0011276HP:0000965Cutis marmorata1MAT2A CL E G H41446904ORPHA:91387Familial thoracic aortic aneurysm and aortic dissectionHP:0040281 - Very frequent13
HP:0011276HP:0010783Erythema1MBTPS2 CL E G H5136015455ORPHA:2273Ichthyosis follicularis-alopecia-photophobia syndromeHP:0040282 - Frequent22
HP:0011276HP:0001025Urticaria1MBTPS2 CL E G H5136015455ORPHA:2273Ichthyosis follicularis-alopecia-photophobia syndromeHP:0040283 - Occasional22
HP:0011276HP:0010783Erythema1MBTPS2 CL E G H5136015455OMIM:308800Keratosis follicularis spinulosa decalvans, X-linked22
HP:0011276HP:0010783Erythema1MBTPS2 CL E G H5136015455ORPHA:659Mutilating palmoplantar keratoderma with periorificial keratotic plaquesHP:0040281 - Very frequent22
HP:0011276HP:0001933Subcutaneous hemorrhage1MCFD2 CL E G H9041118451ORPHA:35909Combined deficiency of factor V and factor VIII77
HP:0011276HP:0010783Erythema1MEFV CL E G H42106998ORPHA:342Familial Mediterranean feverHP:0040282 - Frequent281
HP:0011276HP:0010783Erythema1MEFV CL E G H42106998OMIM:608068NEUTROPHILIC DERMATOSIS, ACUTE FEBRILE281
HP:0011276HP:0001933Subcutaneous hemorrhage1MFAP5 CL E G H807629673ORPHA:91387Familial thoracic aortic aneurysm and aortic dissection11
HP:0011276HP:0000965Cutis marmorata1MFAP5 CL E G H807629673ORPHA:91387Familial thoracic aortic aneurysm and aortic dissectionHP:0040281 - Very frequent11
HP:0011276HP:0001025Urticaria1MMEL1 CL E G H7925814668ORPHA:186Primary biliary cholangitis
HP:0011276HP:0001009Telangiectasia1MMP23B CL E G H85107171ORPHA:16061p36 deletion syndromeHP:0040283 - Occasional
HP:0011276HP:0001933Subcutaneous hemorrhage1MPL CL E G H43527217OMIM:254450Myelofibrosismyelofibrosis with myeloid metaplasia, included97
HP:0011276HP:0001933Subcutaneous hemorrhage1MPL CL E G H43527217ORPHA:729Polycythemia vera97
HP:0011276HP:0001933Subcutaneous hemorrhage1MPL CL E G H43527217ORPHA:824Primary myelofibrosis97
HP:0011276HP:0001009Telangiectasia1MRE11 CL E G H43617230OMIM:604391Ataxia-Telangiectasia-Like disorder 1.532
HP:0011276HP:0001933Subcutaneous hemorrhage1MS4A1 CL E G H9317315ORPHA:1572Common variable immunodeficiency1
HP:0011276HP:0001009Telangiectasia1MST1 CL E G H44857380ORPHA:171Primary sclerosing cholangitis1
HP:0011276HP:0007394Prominent superficial blood vessels1MST1 CL E G H44857380ORPHA:171Primary sclerosing cholangitis1
HP:0011276HP:0001933Subcutaneous hemorrhage1MTAP CL E G H45077413OMIM:112250Diaphyseal medullary stenosis with malignant fibrous histiocytoma85
HP:0011276HP:0001933Subcutaneous hemorrhage1MVK CL E G H45987530ORPHA:343Hyperimmunoglobulinemia D with periodic fever150
HP:0011276HP:0001025Urticaria1MVK CL E G H45987530ORPHA:343Hyperimmunoglobulinemia D with periodic feverHP:0040282 - Frequent150
HP:0011276HP:0010783Erythema1MVK CL E G H45987530ORPHA:343Hyperimmunoglobulinemia D with periodic feverHP:0040283 - Occasional150
HP:0011276HP:0001933Subcutaneous hemorrhage1MYD88 CL E G H46157562ORPHA:33226Waldenström macroglobulinemia9
HP:0011276HP:0001025Urticaria1MYD88 CL E G H46157562ORPHA:33226Waldenström macroglobulinemiaHP:0040283 - Occasional9
HP:0011276HP:0000965Cutis marmorata1MYD88 CL E G H46157562ORPHA:33226Waldenström macroglobulinemiaHP:0040283 - Occasional9
HP:0011276HP:0033832Livedo1MYH11 CL E G H46297569OMIM:132900Aortic aneurysm, familial thoracic 4418
HP:0011276HP:0000965Cutis marmorata1MYH11 CL E G H46297569ORPHA:229Familial aortic dissectionHP:0040283 - Occasional418
HP:0011276HP:0001933Subcutaneous hemorrhage1MYH11 CL E G H46297569ORPHA:91387Familial thoracic aortic aneurysm and aortic dissection418
HP:0011276HP:0000965Cutis marmorata1MYH11 CL E G H46297569ORPHA:91387Familial thoracic aortic aneurysm and aortic dissectionHP:0040281 - Very frequent418
HP:0011276HP:0001933Subcutaneous hemorrhage1MYH9 CL E G H46277579OMIM:155100Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss297
HP:0011276HP:0001933Subcutaneous hemorrhage1MYH9 CL E G H46277579ORPHA:182050MYH9-related disease297
HP:0011276HP:0001933Subcutaneous hemorrhage1MYLK CL E G H46387590ORPHA:91387Familial thoracic aortic aneurysm and aortic dissection326
HP:0011276HP:0000965Cutis marmorata1MYLK CL E G H46387590ORPHA:91387Familial thoracic aortic aneurysm and aortic dissectionHP:0040281 - Very frequent326
HP:0011276HP:0100665Angioedema1MYOF CL E G H265093656OMIM:619366ANGIOEDEMA, HEREDITARY, 7; HAE7
HP:0011276HP:0001933Subcutaneous hemorrhage1MYORG CL E G H5746219918ORPHA:1980Bilateral striopallidodentate calcinosisHP:0040281 - Very frequent
HP:0011276HP:0001933Subcutaneous hemorrhage1NABP1 CL E G H6485926232ORPHA:520Acute promyelocytic leukemia
HP:0011276HP:0001009Telangiectasia1NAGA CL E G H46687631ORPHA:79279Alpha-N-acetylgalactosaminidase deficiency type 1HP:0040282 - Frequent47
HP:0011276HP:0001014Angiokeratoma1NAGA CL E G H46687631ORPHA:79280Alpha-N-acetylgalactosaminidase deficiency type 247
HP:0011276HP:0001009Telangiectasia1NAGA CL E G H46687631ORPHA:79280Alpha-N-acetylgalactosaminidase deficiency type 247
HP:0011276HP:0001014Angiokeratoma1NAGA CL E G H46687631OMIM:609242Kanzaki disease47
HP:0011276HP:0001009Telangiectasia1NAGA CL E G H46687631OMIM:609242Kanzaki disease47
HP:0011276HP:0010783Erythema1NAXD CL E G H5573925576OMIM:618321Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 2
HP:0011276HP:0001933Subcutaneous hemorrhage1NBEAL2 CL E G H2321831928OMIM:139090Gray platelet syndrome127
HP:0011276HP:0001933Subcutaneous hemorrhage1NBEAL2 CL E G H2321831928ORPHA:721Gray platelet syndrome127
HP:0011276HP:0001009Telangiectasia1ND1 CL E G H45357455ORPHA:104Leber hereditary optic neuropathy
HP:0011276HP:0010783Erythema1ND1 CL E G H45357455ORPHA:550MELASHP:0040283 - Occasional
HP:0011276HP:0001009Telangiectasia1ND2 CL E G H45367456ORPHA:104Leber hereditary optic neuropathy
HP:0011276HP:0001009Telangiectasia1ND4 CL E G H45387459ORPHA:104Leber hereditary optic neuropathy
HP:0011276HP:0010783Erythema1ND4 CL E G H45387459ORPHA:550MELASHP:0040283 - Occasional
HP:0011276HP:0001009Telangiectasia1ND4L CL E G H45397460ORPHA:104Leber hereditary optic neuropathy
HP:0011276HP:0001009Telangiectasia1ND5 CL E G H45407461ORPHA:104Leber hereditary optic neuropathy
HP:0011276HP:0010783Erythema1ND5 CL E G H45407461ORPHA:550MELASHP:0040283 - Occasional
HP:0011276HP:0001009Telangiectasia1ND6 CL E G H45417462ORPHA:104Leber hereditary optic neuropathy
HP:0011276HP:0010783Erythema1ND6 CL E G H45417462ORPHA:550MELASHP:0040283 - Occasional
HP:0011276HP:0001009Telangiectasia1NDP CL E G H46937678ORPHA:891Familial exudative vitreoretinopathy39
HP:0011276HP:0010783Erythema1NDUFB11 CL E G H5453920372ORPHA:2556Microphthalmia with linear skin defects syndromeHP:0040281 - Very frequent3
HP:0011276HP:0001009Telangiectasia1NDUFS2 CL E G H47207708ORPHA:104Leber hereditary optic neuropathy65
HP:0011276HP:0001009Telangiectasia1NEU1 CL E G H47587758ORPHA:93400Congenital sialidosis type 2HP:0040283 - Occasional43
HP:0011276HP:0001933Subcutaneous hemorrhage1NEU1 CL E G H47587758ORPHA:93400Congenital sialidosis type 243
HP:0011276HP:0001009Telangiectasia1NF1 CL E G H47637765ORPHA:9768517q11 microdeletion syndrome1952
HP:0011276HP:0000965Cutis marmorata1NFIA CL E G H47747784ORPHA:4019861p31p32 microdeletion syndrome12
HP:0011276HP:0000965Cutis marmorata1NFIA CL E G H47747784OMIM:613735Brain malformations with or without urinary tract defects.12
HP:0011276HP:0001933Subcutaneous hemorrhage1NFIX CL E G H47847788ORPHA:561Marshall-Smith syndrome40
HP:0011276HP:0000965Cutis marmorata1NFIX CL E G H47847788OMIM:614753Sotos syndrome 2.40
HP:0011276HP:0001933Subcutaneous hemorrhage1NFKB1 CL E G H47907794ORPHA:1572Common variable immunodeficiency7
HP:0011276HP:0001933Subcutaneous hemorrhage1NFKB2 CL E G H47917795ORPHA:1572Common variable immunodeficiency11
HP:0011276HP:0001009Telangiectasia1NHP2 CL E G H5565114377ORPHA:1775Dyskeratosis congenita27
HP:0011276HP:0000965Cutis marmorata1NIPBL CL E G H2583628862ORPHA:199Cornelia de Lange syndromeHP:0040282 - Frequent494
HP:0011276HP:0000965Cutis marmorata1NIPBL CL E G H2583628862OMIM:122470Cornelia de Lange syndrome 1.494
HP:0011276HP:0001025Urticaria1NLRC4 CL E G H5848416412OMIM:616050AUTOINFLAMMATION WITH INFANTILE ENTEROCOLITIS; AIFEC30
HP:0011276HP:0001025Urticaria1NLRC4 CL E G H5848416412OMIM:616115FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 4; FCAS430
HP:0011276HP:0001025Urticaria1NLRP12 CL E G H9166222938OMIM:611762Familial cold autoinflammatory syndrome 299
HP:0011276HP:0001025Urticaria1NLRP3 CL E G H11454816400ORPHA:1451CINCA syndromeHP:0040281 - Very frequent217
HP:0011276HP:0001933Subcutaneous hemorrhage1NLRP3 CL E G H11454816400ORPHA:1451CINCA syndrome217
HP:0011276HP:0001025Urticaria1NLRP3 CL E G H11454816400OMIM:617772Deafness, autosomal dominant 34, with or without inflammation.217
HP:0011276HP:0001025Urticaria1NLRP3 CL E G H11454816400OMIM:120100FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1; FCAS1217
HP:0011276HP:0001025Urticaria1NLRP3 CL E G H11454816400ORPHA:47045Familial cold urticariaHP:0040281 - Very frequent217
HP:0011276HP:0010783Erythema1NLRP3 CL E G H11454816400ORPHA:47045Familial cold urticariaHP:0040281 - Very frequent217
HP:0011276HP:0001025Urticaria1NLRP3 CL E G H11454816400ORPHA:575Muckle-Wells syndromeHP:0040282 - Frequent217
HP:0011276HP:0010783Erythema1NOD2 CL E G H641275331ORPHA:90340Blau syndromeHP:0040281 - Very frequent187
HP:0011276HP:0001009Telangiectasia1NOP10 CL E G H5550514378ORPHA:1775Dyskeratosis congenita17
HP:0011276HP:0000965Cutis marmorata1NOTCH1 CL E G H48517881ORPHA:974Adams-Oliver syndromeHP:0040281 - Very frequent452
HP:0011276HP:0001933Subcutaneous hemorrhage1NPM1 CL E G H48697910ORPHA:520Acute promyelocytic leukemia12
HP:0011276HP:0001009Telangiectasia1NPM1 CL E G H48697910ORPHA:1775Dyskeratosis congenita12
HP:0011276HP:0001933Subcutaneous hemorrhage1NR3C1 CL E G H29087978ORPHA:96253Cushing disease79
HP:0011276HP:0010783Erythema1NSDHL CL E G H5081413398OMIM:308050Congenital hemidysplasia with ichthyosiform erythroderma and limb defects.34
HP:0011276HP:0000965Cutis marmorata1NSUN2 CL E G H5488825994ORPHA:235Dubowitz syndromeHP:0040283 - Occasional84
HP:0011276HP:0001933Subcutaneous hemorrhage1NTRK1 CL E G H49148031ORPHA:642Hereditary sensory and autonomic neuropathy type 497
HP:0011276HP:0001933Subcutaneous hemorrhage1NUMA1 CL E G H49268059ORPHA:520Acute promyelocytic leukemia
HP:0011276HP:0001933Subcutaneous hemorrhage1OCLN CL E G H1005066588104OMIM:251290Band-Like calcification with simplified gyration and polymicrogyria23
HP:0011276HP:0001933Subcutaneous hemorrhage1ORAI1 CL E G H8487625896ORPHA:3204Stormorken-Sjaastad-Langslet syndrome19
HP:0011276HP:0001933Subcutaneous hemorrhage1P2RY12 CL E G H6480518124OMIM:609821Bleeding disorder, platelet-type, 85
HP:0011276HP:0001009Telangiectasia1PARN CL E G H50738609ORPHA:1775Dyskeratosis congenita26
HP:0011276HP:0001009Telangiectasia1PCNA CL E G H51118729OMIM:615919Ataxia-Telangiectasia-Like disorder 2.1
HP:0011276HP:0001009Telangiectasia1PCNA CL E G H51118729ORPHA:438134PCNA-related progressive neurodegenerative photosensitivity syndrome1
HP:0011276HP:0001933Subcutaneous hemorrhage1PDE11A CL E G H509408773ORPHA:1359Carney complex13
HP:0011276HP:0001933Subcutaneous hemorrhage1PDE11A CL E G H509408773OMIM:610475Pigmented nodular adrenocortical disease, primary, 213
HP:0011276HP:0001933Subcutaneous hemorrhage1PDE11A CL E G H509408773ORPHA:189439Primary pigmented nodular adrenocortical disease13
HP:0011276HP:0001933Subcutaneous hemorrhage1PDE8B CL E G H86228794ORPHA:189439Primary pigmented nodular adrenocortical disease75
HP:0011276HP:0001933Subcutaneous hemorrhage1PDGFB CL E G H51558800ORPHA:1980Bilateral striopallidodentate calcinosisHP:0040281 - Very frequent9
HP:0011276HP:0010783Erythema1PDGFB CL E G H51558800ORPHA:31112Dermatofibrosarcoma protuberansHP:0040281 - Very frequent9
HP:0011276HP:0001933Subcutaneous hemorrhage1PDGFRB CL E G H51598804ORPHA:1980Bilateral striopallidodentate calcinosisHP:0040281 - Very frequent28
HP:0011276HP:0001009Telangiectasia1PDPN CL E G H1063029602ORPHA:16061p36 deletion syndromeHP:0040283 - Occasional
HP:0011276HP:0000965Cutis marmorata1PDSS1 CL E G H2359017759OMIM:614651Coenzyme Q10 deficiency, primary, 2.40
HP:0011276HP:0001009Telangiectasia1PEPD CL E G H51848840OMIM:170100Prolidase deficiency66
HP:0011276HP:0010783Erythema1PEPD CL E G H51848840ORPHA:742Prolidase deficiencyHP:0040281 - Very frequent66
HP:0011276HP:0001933Subcutaneous hemorrhage1PEPD CL E G H51848840OMIM:170100Prolidase deficiency66
HP:0011276HP:0010783Erythema1PERP CL E G H6406517637ORPHA:659Mutilating palmoplantar keratoderma with periorificial keratotic plaquesHP:0040281 - Very frequent
HP:0011276HP:0001009Telangiectasia1PEX6 CL E G H51908859ORPHA:95433Autosomal recessive spinocerebellar ataxia-blindness-deafness syndrome98
HP:0011276HP:0001009Telangiectasia1PGAP2 CL E G H2731517893ORPHA:247262Hyperphosphatasia-intellectual disability syndromeHP:0040283 - Occasional8
HP:0011276HP:0001009Telangiectasia1PGAP3 CL E G H9321023719ORPHA:247262Hyperphosphatasia-intellectual disability syndromeHP:0040283 - Occasional20
HP:0011276HP:0010783Erythema1PGM3 CL E G H52388907OMIM:615816Immunodeficiency 2315
HP:0011276HP:0200029Vasculitis in the skin1PGM3 CL E G H52388907OMIM:615816Immunodeficiency 23.15
HP:0011276HP:0200029Vasculitis in the skin1PGM3 CL E G H52388907ORPHA:443811PGM3-CDGHP:0040282 - Frequent15
HP:0011276HP:0010783Erythema1PIGL CL E G H94878966ORPHA:3474CHIME syndromeHP:0040281 - Very frequent36
HP:0011276HP:0001009Telangiectasia1PIGL CL E G H94878966ORPHA:247262Hyperphosphatasia-intellectual disability syndromeHP:0040283 - Occasional36
HP:0011276HP:0001009Telangiectasia1PIGO CL E G H8472023215ORPHA:247262Hyperphosphatasia-intellectual disability syndromeHP:0040283 - Occasional84
HP:0011276HP:0001025Urticaria1PIGT CL E G H5160414938OMIM:615399Paroxysmal nocturnal hemoglobinuria 2.12
HP:0011276HP:0001009Telangiectasia1PIGV CL E G H5565026031ORPHA:247262Hyperphosphatasia-intellectual disability syndromeHP:0040283 - Occasional57
HP:0011276HP:0001009Telangiectasia1PIGW CL E G H28409823213ORPHA:247262Hyperphosphatasia-intellectual disability syndromeHP:0040283 - Occasional6
HP:0011276HP:0001009Telangiectasia1PIGY CL E G H8499228213ORPHA:247262Hyperphosphatasia-intellectual disability syndromeHP:0040283 - Occasional2
HP:0011276HP:0001009Telangiectasia1PIK3CA CL E G H52908975ORPHA:201Cowden syndrome162
HP:0011276HP:0001009Telangiectasia1PIK3CA CL E G H52908975ORPHA:276280Hemihyperplasia-multiple lipomatosis syndrome162
HP:0011276HP:0000965Cutis marmorata1PIK3CA CL E G H52908975ORPHA:60040Megalencephaly-capillary malformation-polymicrogyria syndromeHP:0040282 - Frequent162
HP:0011276HP:0001009Telangiectasia1PIK3CA CL E G H52908975ORPHA:60040Megalencephaly-capillary malformation-polymicrogyria syndrome162
HP:0011276HP:0000965Cutis marmorata1PIK3CA CL E G H52908975OMIM:602501Megalencephaly-Capillary malformation-polymicrogyria syndrome.162
HP:0011276HP:0001933Subcutaneous hemorrhage1PLAU CL E G H53289052OMIM:601709Quebec platelet disorder50
HP:0011276HP:0010783Erythema1PLCG2 CL E G H53369066OMIM:614878Autoinflammation, antibody deficiency, and immune dysregulation, plcg2-associated.21
HP:0011276HP:0001025Urticaria1PLCG2 CL E G H53369066OMIM:614468FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 3; FCAS321
HP:0011276HP:0100665Angioedema1PLCG2 CL E G H53369066OMIM:614468FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 3; FCAS321
HP:0011276HP:0010783Erythema1PLCG2 CL E G H53369066OMIM:614468FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 3; FCAS321
HP:0011276HP:0001933Subcutaneous hemorrhage1PLEC CL E G H53399069OMIM:131950Epidermolysis bullosa simplex, Ogna type759
HP:0011276HP:0100665Angioedema1PLG CL E G H53409071OMIM:619360ANGIOEDEMA, HEREDITARY, 4; HAE411
HP:0011276HP:0001933Subcutaneous hemorrhage1PLOD1 CL E G H53519081OMIM:225400Ehlers-Danlos syndrome, kyphoscoliotic type, 1105
HP:0011276HP:0001933Subcutaneous hemorrhage1PLOD1 CL E G H53519081ORPHA:1900Kyphoscoliotic Ehlers-Danlos syndrome due to lysyl hydroxylase 1 deficiency105
HP:0011276HP:0001933Subcutaneous hemorrhage1PLOD3 CL E G H89859083OMIM:612394Bone fragility with contractures, arterial rupture, and deafness5
HP:0011276HP:0001933Subcutaneous hemorrhage1PML CL E G H53719113ORPHA:520Acute promyelocytic leukemia3
HP:0011276HP:0000965Cutis marmorata1POLA1 CL E G H54229173OMIM:301220PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED; PDR2
HP:0011276HP:0001009Telangiectasia1POLD1 CL E G H54249175OMIM:615381Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome.731
HP:0011276HP:0001009Telangiectasia1POLE CL E G H54269177OMIM:615139Facial dysmorphism, immunodeficiency, livedo, and short stature1129
HP:0011276HP:0033832Livedo1POLE CL E G H54269177OMIM:615139Facial dysmorphism, immunodeficiency, livedo, and short stature1129
HP:0011276HP:0001009Telangiectasia1POLH CL E G H54299181ORPHA:90342Xeroderma pigmentosum variantHP:0040282 - Frequent155
HP:0011276HP:0001009Telangiectasia1POLH CL E G H54299181OMIM:278750Xeroderma pigmentosum, Variant type.155
HP:0011276HP:0007394Prominent superficial blood vessels1POLR3A CL E G H1112830074ORPHA:3455Wiedemann-Rautenstrauch syndrome138
HP:0011276HP:0007394Prominent superficial blood vessels1POLR3A CL E G H1112830074OMIM:264090Wiedemann-Rautenstrauch syndrome138
HP:0011276HP:0001009Telangiectasia1PORCN CL E G H6484017652OMIM:305600Focal dermal hypoplasia.20
HP:0011276HP:0001009Telangiectasia1PORCN CL E G H6484017652ORPHA:2092Focal dermal hypoplasia20
HP:0011276HP:0010783Erythema1PORCN CL E G H6484017652ORPHA:2092Focal dermal hypoplasiaHP:0040282 - Frequent20
HP:0011276HP:0001025Urticaria1POU2AF1 CL E G H54509211ORPHA:186Primary biliary cholangitis
HP:0011276HP:0007394Prominent superficial blood vessels1PPARG CL E G H54689236ORPHA:528Congenital generalized lipodystrophy42
HP:0011276HP:0007394Prominent superficial blood vessels1PPARG CL E G H54689236OMIM:604367Lipodystrophy, familial partial, type 342
HP:0011276HP:0007394Prominent superficial blood vessels1PPARG CL E G H54689236ORPHA:79083PPARG-related familial partial lipodystrophy42
HP:0011276HP:0007394Prominent superficial blood vessels1PPP1R15B CL E G H8491914951OMIM:616817Microcephaly, short stature, and impaired glucose metabolism 22
HP:0011276HP:0001009Telangiectasia1PRDM16 CL E G H6397614000ORPHA:16061p36 deletion syndromeHP:0040283 - Occasional148
HP:0011276HP:0001933Subcutaneous hemorrhage1PRDM5 CL E G H111079349ORPHA:90354Brittle cornea syndrome58
HP:0011276HP:0001933Subcutaneous hemorrhage1PRF1 CL E G H55519360ORPHA:540Familial hemophagocytic lymphohistiocytosis58
HP:0011276HP:0001933Subcutaneous hemorrhage1PRF1 CL E G H55519360ORPHA:88Idiopathic aplastic anemia58
HP:0011276HP:0001933Subcutaneous hemorrhage1PRKACA CL E G H55669380OMIM:615830Pigmented nodular adrenocortical disease, primary, 42
HP:0011276HP:0001933Subcutaneous hemorrhage1PRKACA CL E G H55669380ORPHA:189439Primary pigmented nodular adrenocortical disease2
HP:0011276HP:0001933Subcutaneous hemorrhage1PRKACG CL E G H55689382OMIM:616176Bleeding disorder, platelet-type, 192
HP:0011276HP:0001933Subcutaneous hemorrhage1PRKAR1A CL E G H55739388ORPHA:520Acute promyelocytic leukemia134
HP:0011276HP:0001933Subcutaneous hemorrhage1PRKAR1A CL E G H55739388ORPHA:1359Carney complex134
HP:0011276HP:0001933Subcutaneous hemorrhage1PRKAR1A CL E G H55739388OMIM:610489Pigmented nodular adrenocortical disease, primary, 1134
HP:0011276HP:0001933Subcutaneous hemorrhage1PRKAR1A CL E G H55739388ORPHA:189439Primary pigmented nodular adrenocortical disease134
HP:0011276HP:0001025Urticaria1PRKCD CL E G H55809399ORPHA:3261Autoimmune lymphoproliferative syndromeHP:0040283 - Occasional10
HP:0011276HP:0001933Subcutaneous hemorrhage1PRKCD CL E G H55809399ORPHA:3261Autoimmune lymphoproliferative syndrome10
HP:0011276HP:0001933Subcutaneous hemorrhage1PRKCD CL E G H55809399ORPHA:1572Common variable immunodeficiency10
HP:0011276HP:0001009Telangiectasia1PRKCZ CL E G H55909412ORPHA:16061p36 deletion syndromeHP:0040283 - Occasional
HP:0011276HP:0000965Cutis marmorata1PRKG1 CL E G H55929414ORPHA:91387Familial thoracic aortic aneurysm and aortic dissectionHP:0040281 - Very frequent41
HP:0011276HP:0001933Subcutaneous hemorrhage1PRKG1 CL E G H55929414ORPHA:91387Familial thoracic aortic aneurysm and aortic dissection41
HP:0011276HP:0001933Subcutaneous hemorrhage1PROC CL E G H56249451ORPHA:745Severe hereditary thrombophilia due to congenital protein C deficiency65
HP:0011276HP:0001933Subcutaneous hemorrhage1PROC CL E G H56249451OMIM:612304Thrombophilia due to protein C deficiency, autosomal recessive65
HP:0011276HP:0001933Subcutaneous hemorrhage1PROS1 CL E G H56279456ORPHA:743Severe hereditary thrombophilia due to congenital protein S deficiencyHP:0040282 - Frequent75
HP:0011276HP:0001933Subcutaneous hemorrhage1PROS1 CL E G H56279456OMIM:614514Thrombophilia due to protein S deficiency, autosomal recessive75
HP:0011276HP:0001933Subcutaneous hemorrhage1PROS1 CL E G H56279456OMIM:612336Thrombophilia, hereditary, due to protein S deficiency, autosomal75
HP:0011276HP:0001933Subcutaneous hemorrhage1PRTN3 CL E G H56579495ORPHA:900Granulomatosis with polyangiitis
HP:0011276HP:0010783Erythema1PSMB8 CL E G H56969545OMIM:256040Proteasome-associated autoinflammatory syndrome 1 and digenic forms.20
HP:0011276HP:0010783Erythema1PSMG2 CL E G H5698424929OMIM:619183PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 4; PRAAS4
HP:0011276HP:0000965Cutis marmorata1PTDSS1 CL E G H97919587OMIM:151050Lenz-Majewski hyperostotic dwarfism.6
HP:0011276HP:0007394Prominent superficial blood vessels1PTDSS1 CL E G H97919587OMIM:151050Lenz-Majewski hyperostotic dwarfism6
HP:0011276HP:0000965Cutis marmorata1PTEN CL E G H57289588ORPHA:109Bannayan-Riley-Ruvalcaba syndromeHP:0040283 - Occasional948
HP:0011276HP:0001933Subcutaneous hemorrhage1PTEN CL E G H57289588ORPHA:109Bannayan-Riley-Ruvalcaba syndromeHP:0040282 - Frequent948
HP:0011276HP:0001009Telangiectasia1PTEN CL E G H57289588ORPHA:109Bannayan-Riley-Ruvalcaba syndromeHP:0040283 - Occasional948
HP:0011276HP:0001009Telangiectasia1PTEN CL E G H57289588ORPHA:201Cowden syndrome948
HP:0011276HP:0001933Subcutaneous hemorrhage1PTPN11 CL E G H57819644OMIM:163950Noonan syndrome 1291
HP:0011276HP:0001933Subcutaneous hemorrhage1PTPN22 CL E G H261919652ORPHA:900Granulomatosis with polyangiitis3
HP:0011276HP:0007394Prominent superficial blood vessels1PYCR1 CL E G H58319721OMIM:612940Cutis laxa, autosomal recessive, type IIB53
HP:0011276HP:0001933Subcutaneous hemorrhage1PYCR1 CL E G H58319721OMIM:612940Cutis laxa, autosomal recessive, type IIB53
HP:0011276HP:0007394Prominent superficial blood vessels1PYCR1 CL E G H58319721OMIM:614438Cutis laxa, autosomal recessive, type IIIB53
HP:0011276HP:0001933Subcutaneous hemorrhage1RAB27A CL E G H58739766ORPHA:79477Griscelli syndrome type 267
HP:0011276HP:0001025Urticaria1RAC2 CL E G H58809802OMIM:618987IMMUNODEFICIENCY 73C WITH DEFECTIVE NEUTROPHIL CHEMOTAXIS AND HYPOGAMMAGLOBULINEMIA; IMD73C9
HP:0011276HP:0000965Cutis marmorata1RAD21 CL E G H58859811ORPHA:199Cornelia de Lange syndromeHP:0040282 - Frequent25
HP:0011276HP:0000965Cutis marmorata1RAD21 CL E G H58859811OMIM:614701Cornelia de Lange syndrome 4HP:0040283 - Occasional25
HP:0011276HP:0001933Subcutaneous hemorrhage1RARA CL E G H59149864ORPHA:520Acute promyelocytic leukemia2
HP:0011276HP:0001009Telangiectasia1RASA1 CL E G H59219871ORPHA:137667Capillary malformation-arteriovenous malformationHP:0040283 - Occasional88
HP:0011276HP:0007394Prominent superficial blood vessels1RASA1 CL E G H59219871ORPHA:90307Parkes Weber syndromeHP:0040282 - Frequent88
HP:0011276HP:0001933Subcutaneous hemorrhage1RASGRP1 CL E G H101259878ORPHA:3261Autoimmune lymphoproliferative syndrome
HP:0011276HP:0001025Urticaria1RASGRP1 CL E G H101259878ORPHA:3261Autoimmune lymphoproliferative syndromeHP:0040283 - Occasional
HP:0011276HP:0000965Cutis marmorata1RBPJ CL E G H35165724ORPHA:974Adams-Oliver syndromeHP:0040281 - Very frequent3
HP:0011276HP:0010783Erythema1RECQL4 CL E G H94019949ORPHA:221016Rothmund-Thomson syndrome type 2HP:0040281 - Very frequent445
HP:0011276HP:0001009Telangiectasia1RECQL4 CL E G H94019949OMIM:268400ROTHMUND-THOMSON SYNDROME; RTS445
HP:0011276HP:0001009Telangiectasia1RERE CL E G H4739965ORPHA:16061p36 deletion syndromeHP:0040283 - Occasional16
HP:0011276HP:0010783Erythema1RHOH CL E G H399686OMIM:618307Epidermodysplasia verruciformis, susceptibility to, 4
HP:0011276HP:0001933Subcutaneous hemorrhage1RIN2 CL E G H5445318750OMIM:613075Macs syndrome43
HP:0011276HP:0001933Subcutaneous hemorrhage1RIN2 CL E G H5445318750ORPHA:217335RIN2 syndrome43
HP:0011276HP:0000965Cutis marmorata1RNASEH2A CL E G H1053518518ORPHA:51Aicardi-Goutières syndromeHP:0040283 - Occasional33
HP:0011276HP:0000965Cutis marmorata1RNASEH2B CL E G H7962125671ORPHA:51Aicardi-Goutières syndromeHP:0040283 - Occasional34
HP:0011276HP:0000965Cutis marmorata1RNASEH2C CL E G H8415324116ORPHA:51Aicardi-Goutières syndromeHP:0040283 - Occasional60
HP:0011276HP:0000965Cutis marmorata1RNF113A CL E G H773712974OMIM:300953Trichothiodystrophy 5, nonphotosensitive.3
HP:0011276HP:0010783Erythema1RNF168 CL E G H16591826661ORPHA:420741RIDDLE syndromeHP:0040283 - Occasional7
HP:0011276HP:0001009Telangiectasia1RNF168 CL E G H16591826661ORPHA:420741RIDDLE syndromeHP:0040283 - Occasional7
HP:0011276HP:0001009Telangiectasia1RNF213 CL E G H5767414539ORPHA:2573Moyamoya diseaseHP:0040281 - Very frequent14
HP:0011276HP:0000965Cutis marmorata1RNU7-1 CL E G H10014774434033ORPHA:51Aicardi-Goutières syndromeHP:0040283 - Occasional
HP:0011276HP:0000965Cutis marmorata1RPS6KA3 CL E G H619710432OMIM:303600Coffin-Lowry syndrome.65
HP:0011276HP:0001933Subcutaneous hemorrhage1RREB1 CL E G H623910449ORPHA:56722q11.2 deletion syndrome
HP:0011276HP:0001009Telangiectasia1RTEL1 CL E G H5175015888ORPHA:1775Dyskeratosis congenita77
HP:0011276HP:0001025Urticaria1RUNX1 CL E G H86110471ORPHA:98850Aggressive systemic mastocytosisHP:0040283 - Occasional181
HP:0011276HP:0001933Subcutaneous hemorrhage1RUNX1 CL E G H86110471OMIM:601399Platelet disorder, familial, with associated myeloid malignancy181
HP:0011276HP:0001933Subcutaneous hemorrhage1SAMD9 CL E G H548091348OMIM:617053Mirage syndrome8
HP:0011276HP:0000965Cutis marmorata1SAMHD1 CL E G H2593915925ORPHA:51Aicardi-Goutières syndromeHP:0040283 - Occasional55
HP:0011276HP:0001933Subcutaneous hemorrhage1SBDS CL E G H5111919440ORPHA:88Idiopathic aplastic anemia26
HP:0011276HP:0001933Subcutaneous hemorrhage1SCARB2 CL E G H9501665ORPHA:77259Gaucher disease type 177
HP:0011276HP:0010783Erythema1SCN10A CL E G H633610582ORPHA:90026Primary erythromelalgiaHP:0040281 - Very frequent146
HP:0011276HP:0010783Erythema1SCN11A CL E G H1128010583ORPHA:90026Primary erythromelalgiaHP:0040281 - Very frequent19
HP:0011276HP:0010783Erythema1SCN9A CL E G H633510597ORPHA:90026Primary erythromelalgiaHP:0040281 - Very frequent318
HP:0011276HP:0001009Telangiectasia1SDHB CL E G H639010681ORPHA:201Cowden syndrome237
HP:0011276HP:0001025Urticaria1SDHB CL E G H639010681OMIM:606764Gastrointestinal stromal tumor.237
HP:0011276HP:0001009Telangiectasia1SDHC CL E G H639110682ORPHA:201Cowden syndrome147
HP:0011276HP:0001025Urticaria1SDHC CL E G H639110682OMIM:606764Gastrointestinal stromal tumor.147
HP:0011276HP:0001009Telangiectasia1SDHD CL E G H639210683ORPHA:100093Carcinoid syndrome129
HP:0011276HP:0001009Telangiectasia1SDHD CL E G H639210683ORPHA:201Cowden syndrome129
HP:0011276HP:0001009Telangiectasia1SEC23B CL E G H1048310702ORPHA:201Cowden syndrome60
HP:0011276HP:0001933Subcutaneous hemorrhage1SEC24C CL E G H963210705ORPHA:56722q11.2 deletion syndrome
HP:0011276HP:0007394Prominent superficial blood vessels1SEMA4D CL E G H1050710732ORPHA:171Primary sclerosing cholangitis
HP:0011276HP:0001009Telangiectasia1SEMA4D CL E G H1050710732ORPHA:171Primary sclerosing cholangitis
HP:0011276HP:0001933Subcutaneous hemorrhage1SERPINE1 CL E G H50548583ORPHA:465Congenital plasminogen activator inhibitor type 1 deficiencyHP:0040282 - Frequent39
HP:0011276HP:0001933Subcutaneous hemorrhage1SERPINF2 CL E G H53459075ORPHA:79Congenital alpha2-antiplasmin deficiency8
HP:0011276HP:0001933Subcutaneous hemorrhage1SERPINF2 CL E G H53459075OMIM:262850Plasmin inhibitor deficiency8
HP:0011276HP:0010783Erythema1SERPING1 CL E G H7101228OMIM:106100Angioedema, hereditary, 1.64
HP:0011276HP:0100665Angioedema1SERPING1 CL E G H7101228OMIM:106100Angioedema, hereditary, 1.64
HP:0011276HP:0001025Urticaria1SERPING1 CL E G H7101228ORPHA:100050Hereditary angioedema type 1HP:0040281 - Very frequent64
HP:0011276HP:0001009Telangiectasia1SETX CL E G H23064445OMIM:606002Spinocerebellar ataxia, autosomal recessive 1162
HP:0011276HP:0001025Urticaria1SF3B4 CL E G H1026210771OMIM:154400Acrofacial dysostosis 1, Nager type.49
HP:0011276HP:0001933Subcutaneous hemorrhage1SH2B3 CL E G H1001929605OMIM:254450Myelofibrosismyelofibrosis with myeloid metaplasia, included4
HP:0011276HP:0001933Subcutaneous hemorrhage1SIK3 CL E G H2338729165OMIM:618162Spondyloepimetaphyseal dysplasia, Krakow type
HP:0011276HP:0001009Telangiectasia1SKI CL E G H649710896ORPHA:16061p36 deletion syndromeHP:0040283 - Occasional150
HP:0011276HP:0001933Subcutaneous hemorrhage1SLC20A2 CL E G H657510947ORPHA:1980Bilateral striopallidodentate calcinosisHP:0040281 - Very frequent70
HP:0011276HP:0007394Prominent superficial blood vessels1SLC25A24 CL E G H2995720662OMIM:612289Fontaine progeroid syndrome
HP:0011276HP:0001025Urticaria1SLC27A4 CL E G H1099910998OMIM:608649ICHTHYOSIS PREMATURITY SYNDROME; IPS26
HP:0011276HP:0001009Telangiectasia1SLC29A3 CL E G H5531523096ORPHA:168569H syndrome68
HP:0011276HP:0001009Telangiectasia1SLC29A3 CL E G H5531523096OMIM:602782Histiocytosis-lymphadenopathy plus syndrome68
HP:0011276HP:0001933Subcutaneous hemorrhage1SLC2A10 CL E G H8103113444OMIM:208050Arterial tortuosity syndrome178
HP:0011276HP:0001009Telangiectasia1SLC2A10 CL E G H8103113444OMIM:208050Arterial tortuosity syndrome178
HP:0011276HP:0001009Telangiectasia1SLC2A10 CL E G H8103113444ORPHA:3342Arterial tortuosity syndrome178
HP:0011276HP:0001933Subcutaneous hemorrhage1SLC35A1 CL E G H1055911021OMIM:603585Congenital disorder of glycosylation, type IIf24
HP:0011276HP:0001933Subcutaneous hemorrhage1SLC35A1 CL E G H1055911021ORPHA:238459SLC35A1-CDGHP:0040281 - Very frequent24
HP:0011276HP:0001933Subcutaneous hemorrhage1SLC37A4 CL E G H25424061ORPHA:79259Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib110
HP:0011276HP:0001009Telangiectasia1SLC37A4 CL E G H25424061OMIM:232240GLYCOGEN STORAGE DISEASE Ic110
HP:0011276HP:0007394Prominent superficial blood vessels1SLC39A13 CL E G H9125220859OMIM:612350Ehlers-Danlos syndrome, spondylodysplastic type, 324
HP:0011276HP:0001933Subcutaneous hemorrhage1SLC39A13 CL E G H9125220859OMIM:612350Ehlers-Danlos syndrome, spondylodysplastic type, 324
HP:0011276HP:0001933Subcutaneous hemorrhage1SLC39A13 CL E G H9125220859ORPHA:157965SLC39A13-related spondylodysplastic Ehlers-Danlos syndrome24
HP:0011276HP:0010783Erythema1SLC39A4 CL E G H5563017129ORPHA:37Acrodermatitis enteropathicaHP:0040281 - Very frequent55
HP:0011276HP:0010783Erythema1SLC39A4 CL E G H5563017129OMIM:201100Acrodermatitis enteropathica, Zinc-Deficiency type55
HP:0011276HP:0001933Subcutaneous hemorrhage1SLC51A CL E G H20093129955OMIM:619484CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 6; PFIC6
HP:0011276HP:0001933Subcutaneous hemorrhage1SLFN14 CL E G H34261832689OMIM:616913Bleeding disorder, platelet-type, 206
HP:0011276HP:0010783Erythema1SLURP1 CL E G H5715218746ORPHA:87503Mal de Meleda15
HP:0011276HP:0010783Erythema1SLURP1 CL E G H5715218746OMIM:248300Meleda disease15
HP:0011276HP:0001933Subcutaneous hemorrhage1SMAD2 CL E G H40876768ORPHA:91387Familial thoracic aortic aneurysm and aortic dissection7
HP:0011276HP:0000965Cutis marmorata1SMAD2 CL E G H40876768ORPHA:91387Familial thoracic aortic aneurysm and aortic dissectionHP:0040281 - Very frequent7
HP:0011276HP:0001933Subcutaneous hemorrhage1SMAD3 CL E G H40886769ORPHA:284984Aneurysm-osteoarthritis syndrome260
HP:0011276HP:0000965Cutis marmorata1SMAD3 CL E G H40886769ORPHA:91387Familial thoracic aortic aneurysm and aortic dissectionHP:0040281 - Very frequent260
HP:0011276HP:0001933Subcutaneous hemorrhage1SMAD3 CL E G H40886769ORPHA:91387Familial thoracic aortic aneurysm and aortic dissection260
HP:0011276HP:0001933Subcutaneous hemorrhage1SMAD3 CL E G H40886769OMIM:613795LOEYS-DIETZ SYNDROME 3; LDS3260
HP:0011276HP:0001933Subcutaneous hemorrhage1SMAD4 CL E G H40896770ORPHA:91387Familial thoracic aortic aneurysm and aortic dissection504
HP:0011276HP:0000965Cutis marmorata1SMAD4 CL E G H40896770ORPHA:91387Familial thoracic aortic aneurysm and aortic dissectionHP:0040281 - Very frequent504
HP:0011276HP:0001009Telangiectasia1SMAD4 CL E G H40896770ORPHA:774Hereditary hemorrhagic telangiectasia504
HP:0011276HP:0001933Subcutaneous hemorrhage1SMAD4 CL E G H40896770ORPHA:774Hereditary hemorrhagic telangiectasia504
HP:0011276HP:0001009Telangiectasia1SMAD4 CL E G H40896770OMIM:175050Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome504
HP:0011276HP:0000965Cutis marmorata1SMC1A CL E G H824311111ORPHA:199Cornelia de Lange syndromeHP:0040282 - Frequent135
HP:0011276HP:0000965Cutis marmorata1SMC1A CL E G H824311111OMIM:300590Cornelia de Lange syndrome 2.135
HP:0011276HP:0000965Cutis marmorata1SMC3 CL E G H91262468ORPHA:199Cornelia de Lange syndromeHP:0040282 - Frequent91
HP:0011276HP:0000965Cutis marmorata1SMC3 CL E G H91262468OMIM:610759Cornelia de Lange syndrome 391
HP:0011276HP:0001933Subcutaneous hemorrhage1SNX10 CL E G H2988714974ORPHA:667Autosomal recessive malignant osteopetrosis2
HP:0011276HP:0001933Subcutaneous hemorrhage1SOS1 CL E G H665411187OMIM:610733Noonan syndrome 4315
HP:0011276HP:0001009Telangiectasia1SOX18 CL E G H5434511194OMIM:607823Hypotrichosis-Lymphedema-Telangiectasia syndrome7
HP:0011276HP:0001009Telangiectasia1SOX18 CL E G H5434511194ORPHA:69735Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome7
HP:0011276HP:0000965Cutis marmorata1SOX18 CL E G H5434511194ORPHA:69735Hypotrichosis-lymphedema-telangiectasia-renal defect syndromeHP:0040282 - Frequent7
HP:0011276HP:0001009Telangiectasia1SOX18 CL E G H5434511194OMIM:137940Hypotrichosis-Lymphedema-Telangiectasia-Renal defect syndrome7
HP:0011276HP:0001009Telangiectasia1SPEN CL E G H2301317575ORPHA:16061p36 deletion syndromeHP:0040283 - Occasional4
HP:0011276HP:0001025Urticaria1SPIB CL E G H668911242ORPHA:186Primary biliary cholangitis
HP:0011276HP:0001025Urticaria1SPINK5 CL E G H1100515464OMIM:256500Netherton syndrome.100
HP:0011276HP:0100665Angioedema1SPINK5 CL E G H1100515464OMIM:256500Netherton syndrome.100
HP:0011276HP:0001025Urticaria1SPINK5 CL E G H1100515464ORPHA:634Netherton syndromeHP:0040281 - Very frequent100
HP:0011276HP:0001933Subcutaneous hemorrhage1SPRED2 CL E G H20073417722OMIM:619745NOONAN SYNDROME 14; NS14
HP:0011276HP:0010783Erythema1SREBF1 CL E G H672011289OMIM:619016IFAP SYNDROME 2; IFAP21
HP:0011276HP:0001025Urticaria1SRSF2 CL E G H642710783ORPHA:98850Aggressive systemic mastocytosisHP:0040283 - Occasional1
HP:0011276HP:0001025Urticaria1SRSF2 CL E G H642710783ORPHA:98849Systemic mastocytosis with associated hematologic neoplasmHP:0040283 - Occasional1
HP:0011276HP:0000965Cutis marmorata1STAG1 CL E G H1027411354ORPHA:502434STAG1-related intellectual disability-facial dysmorphism-gastroesophageal reflux syndromeHP:0040283 - Occasional9
HP:0011276HP:0001933Subcutaneous hemorrhage1STAT3 CL E G H677411364ORPHA:520Acute promyelocytic leukemia110
HP:0011276HP:0010783Erythema1STAT3 CL E G H677411364OMIM:147060Hyper-IgE recurrent infection syndrome.110
HP:0011276HP:0001933Subcutaneous hemorrhage1STAT5B CL E G H677711367ORPHA:520Acute promyelocytic leukemia12
HP:0011276HP:0001933Subcutaneous hemorrhage1STIM1 CL E G H678611386ORPHA:3204Stormorken-Sjaastad-Langslet syndrome31
HP:0011276HP:0001009Telangiectasia1STING1 CL E G H34006127962OMIM:615934STING-associated vasculopathy, infantile-onset
HP:0011276HP:0000965Cutis marmorata1STING1 CL E G H34006127962OMIM:615934STING-associated vasculopathy, infantile-onset
HP:0011276HP:0033832Livedo1STING1 CL E G H34006127962OMIM:615934STING-associated vasculopathy, infantile-onset
HP:0011276HP:0010783Erythema1STING1 CL E G H34006127962OMIM:615934STING-associated vasculopathy, infantile-onset
HP:0011276HP:0001009Telangiectasia1STN1 CL E G H7999126200OMIM:617341Cerebroretinal microangiopathy with calcifications and cysts 22
HP:0011276HP:0001933Subcutaneous hemorrhage1STX11 CL E G H867611429ORPHA:540Familial hemophagocytic lymphohistiocytosis85
HP:0011276HP:0001009Telangiectasia1STXBP1 CL E G H681211444ORPHA:4958189q33.3q34.11 microdeletion syndromeHP:0040283 - Occasional237
HP:0011276HP:0001933Subcutaneous hemorrhage1STXBP2 CL E G H681311445ORPHA:540Familial hemophagocytic lymphohistiocytosis70
HP:0011276HP:0010783Erythema1SULT2B1 CL E G H682011459OMIM:617571Ichthyosis, congenital, autosomal recessive 14.4
HP:0011276HP:0001025Urticaria1SUPT16H CL E G H1119811465OMIM:619480NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND THIN CORPUS CALLOSUM; NEDDFAC
HP:0011276HP:0200029Vasculitis in the skin1SYK CL E G H685011491OMIM:619381IMMUNODEFICIENCY 82 WITH SYSTEMIC INFLAMMATION; IMD821
HP:0011276HP:0001009Telangiectasia1TALDO1 CL E G H688811559OMIM:606003Transaldolase deficiency34
HP:0011276HP:0001009Telangiectasia1TALDO1 CL E G H688811559ORPHA:101028Transaldolase deficiencyHP:0040282 - Frequent34
HP:0011276HP:0001933Subcutaneous hemorrhage1TBL1XR1 CL E G H7971829529ORPHA:520Acute promyelocytic leukemia22
HP:0011276HP:0001933Subcutaneous hemorrhage1TBX1 CL E G H689911592ORPHA:56722q11.2 deletion syndrome32
HP:0011276HP:0001933Subcutaneous hemorrhage1TBXA2R CL E G H691511608OMIM:614009BLEEDING DISORDER, PLATELET-TYPE, 13, SUSCEPTIBILITY TO; BDPLT1310
HP:0011276HP:0007394Prominent superficial blood vessels1TCF4 CL E G H692511634ORPHA:171Primary sclerosing cholangitis241
HP:0011276HP:0001009Telangiectasia1TCF4 CL E G H692511634ORPHA:171Primary sclerosing cholangitis241
HP:0011276HP:0001933Subcutaneous hemorrhage1TCIRG1 CL E G H1031211647ORPHA:667Autosomal recessive malignant osteopetrosis82
HP:0011276HP:0001009Telangiectasia1TERC CL E G H701211727ORPHA:1775Dyskeratosis congenita48
HP:0011276HP:0001933Subcutaneous hemorrhage1TERC CL E G H701211727ORPHA:88Idiopathic aplastic anemia48
HP:0011276HP:0001009Telangiectasia1TERT CL E G H701511730ORPHA:1775Dyskeratosis congenita238
HP:0011276HP:0001933Subcutaneous hemorrhage1TERT CL E G H701511730ORPHA:88Idiopathic aplastic anemia238
HP:0011276HP:0001025Urticaria1TET2 CL E G H5479025941ORPHA:98850Aggressive systemic mastocytosisHP:0040283 - Occasional3
HP:0011276HP:0001933Subcutaneous hemorrhage1TET2 CL E G H5479025941ORPHA:729Polycythemia vera3
HP:0011276HP:0001933Subcutaneous hemorrhage1TET2 CL E G H5479025941ORPHA:824Primary myelofibrosis3
HP:0011276HP:0001025Urticaria1TET2 CL E G H5479025941ORPHA:98849Systemic mastocytosis with associated hematologic neoplasmHP:0040283 - Occasional3
HP:0011276HP:0001933Subcutaneous hemorrhage1TFR2 CL E G H703611762OMIM:604250Hemochromatosis, type 367
HP:0011276HP:0001933Subcutaneous hemorrhage1TGFB2 CL E G H704211768ORPHA:91387Familial thoracic aortic aneurysm and aortic dissection162
HP:0011276HP:0000965Cutis marmorata1TGFB2 CL E G H704211768ORPHA:91387Familial thoracic aortic aneurysm and aortic dissectionHP:0040281 - Very frequent162
HP:0011276HP:0001933Subcutaneous hemorrhage1TGFB2 CL E G H704211768OMIM:614816LOEYS-DIETZ SYNDROME 4; LDS4162
HP:0011276HP:0001933Subcutaneous hemorrhage1TGFB3 CL E G H704311769ORPHA:91387Familial thoracic aortic aneurysm and aortic dissection85
HP:0011276HP:0000965Cutis marmorata1TGFB3 CL E G H704311769ORPHA:91387Familial thoracic aortic aneurysm and aortic dissectionHP:0040281 - Very frequent85
HP:0011276HP:0001933Subcutaneous hemorrhage1TGFB3 CL E G H704311769OMIM:615582LOEYS-DIETZ SYNDROME 5; LDS585
HP:0011276HP:0000965Cutis marmorata1TGFBR1 CL E G H704611772ORPHA:91387Familial thoracic aortic aneurysm and aortic dissectionHP:0040281 - Very frequent239
HP:0011276HP:0001933Subcutaneous hemorrhage1TGFBR1 CL E G H704611772ORPHA:91387Familial thoracic aortic aneurysm and aortic dissection239
HP:0011276HP:0001933Subcutaneous hemorrhage1TGFBR1 CL E G H704611772ORPHA:60030Loeys-Dietz syndrome239
HP:0011276HP:0001933Subcutaneous hemorrhage1TGFBR2 CL E G H704811773ORPHA:91387Familial thoracic aortic aneurysm and aortic dissection253
HP:0011276HP:0000965Cutis marmorata1TGFBR2 CL E G H704811773ORPHA:91387Familial thoracic aortic aneurysm and aortic dissectionHP:0040281 - Very frequent253
HP:0011276HP:0001933Subcutaneous hemorrhage1TGFBR2 CL E G H704811773ORPHA:60030Loeys-Dietz syndrome253
HP:0011276HP:0010783Erythema1TGM1 CL E G H705111777ORPHA:281127Acral self-healing collodion babyHP:0040281 - Very frequent98
HP:0011276HP:0010783Erythema1TGM5 CL E G H933311781ORPHA:263534Acral peeling skin syndromeHP:0040282 - Frequent44
HP:0011276HP:0010783Erythema1TGM5 CL E G H933311781OMIM:609796Peeling skin syndrome, Acral type.44
HP:0011276HP:0001009Telangiectasia1TINF2 CL E G H2627711824ORPHA:1775Dyskeratosis congenita60
HP:0011276HP:0001009Telangiectasia1TMC6 CL E G H1132218021ORPHA:302Epidermodysplasia verruciformis10
HP:0011276HP:0001009Telangiectasia1TMC8 CL E G H14713820474ORPHA:302Epidermodysplasia verruciformis4
HP:0011276HP:0001933Subcutaneous hemorrhage1TNFRSF13B CL E G H2349518153ORPHA:1572Common variable immunodeficiency32
HP:0011276HP:0001933Subcutaneous hemorrhage1TNFRSF13C CL E G H11565017755ORPHA:1572Common variable immunodeficiency12
HP:0011276HP:0001933Subcutaneous hemorrhage1TNFRSF1A CL E G H713211916ORPHA:32960Tumor necrosis factor receptor 1 associated periodic syndrome131
HP:0011276HP:0010783Erythema1TNFRSF1A CL E G H713211916ORPHA:32960Tumor necrosis factor receptor 1 associated periodic syndromeHP:0040282 - Frequent131
HP:0011276HP:0010783Erythema1TNFRSF1B CL E G H713311917ORPHA:2584Classic mycosis fungoidesHP:0040281 - Very frequent
HP:0011276HP:0001933Subcutaneous hemorrhage1TNFSF11 CL E G H860011926ORPHA:667Autosomal recessive malignant osteopetrosis44
HP:0011276HP:0001933Subcutaneous hemorrhage1TNFSF12 CL E G H874211927ORPHA:1572Common variable immunodeficiency1
HP:0011276HP:0001025Urticaria1TNFSF15 CL E G H996611931ORPHA:186Primary biliary cholangitis
HP:0011276HP:0001025Urticaria1TNPO3 CL E G H2353417103ORPHA:186Primary biliary cholangitis71
HP:0011276HP:0001933Subcutaneous hemorrhage1TNXB CL E G H714811976ORPHA:230839Classical-like Ehlers-Danlos syndrome type 1134
HP:0011276HP:0001933Subcutaneous hemorrhage1TNXB CL E G H714811976OMIM:606408Ehlers-Danlos syndrome, classic-like134
HP:0011276HP:0001933Subcutaneous hemorrhage1TP53 CL E G H715711998ORPHA:96253Cushing disease911
HP:0011276HP:0010783Erythema1TRAF3IP2 CL E G H107581343ORPHA:1334Chronic mucocutaneous candidiasisHP:0040281 - Very frequent4
HP:0011276HP:0000965Cutis marmorata1TREX1 CL E G H1127712269ORPHA:51Aicardi-Goutières syndromeHP:0040283 - Occasional56
HP:0011276HP:0010783Erythema1TREX1 CL E G H1127712269OMIM:225750Aicardi-Goutieres syndrome 156
HP:0011276HP:0001933Subcutaneous hemorrhage1TREX1 CL E G H1127712269OMIM:225750Aicardi-Goutieres syndrome 156
HP:0011276HP:0001009Telangiectasia1TREX1 CL E G H1127712269ORPHA:247691Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestationsHP:0040283 - Occasional56
HP:0011276HP:0200029Vasculitis in the skin1TREX1 CL E G H1127712269ORPHA:247691Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations56
HP:0011276HP:0001009Telangiectasia1TREX1 CL E G H1127712269OMIM:192315Vasculopathy, retinal, with cerebral leukodystrophy.56
HP:0011276HP:0200029Vasculitis in the skin1TREX1 CL E G H1127712269OMIM:192315Vasculopathy, retinal, with cerebral leukodystrophy.56
HP:0011276HP:0010783Erythema1TRNF CL E G H45587481ORPHA:550MELASHP:0040283 - Occasional
HP:0011276HP:0010783Erythema1TRNH CL E G H45647487ORPHA:550MELASHP:0040283 - Occasional
HP:0011276HP:0010783Erythema1TRNL1 CL E G H45677490ORPHA:550MELASHP:0040283 - Occasional
HP:0011276HP:0010783Erythema1TRNQ CL E G H45727495ORPHA:550MELASHP:0040283 - Occasional
HP:0011276HP:0010783Erythema1TRNS1 CL E G H45747497ORPHA:550MELASHP:0040283 - Occasional
HP:0011276HP:0010783Erythema1TRNS2 CL E G H45757498ORPHA:550MELASHP:0040283 - Occasional
HP:0011276HP:0010783Erythema1TRNW CL E G H45787501ORPHA:550MELASHP:0040283 - Occasional
HP:0011276HP:0010783Erythema1TRPM4 CL E G H5479517993ORPHA:316Progressive symmetric erythrokeratodermiaHP:0040281 - Very frequent124
HP:0011276HP:0010783Erythema1TRPV3 CL E G H16251418084ORPHA:659Mutilating palmoplantar keratoderma with periorificial keratotic plaquesHP:0040281 - Very frequent151
HP:0011276HP:0001009Telangiectasia1TSPAN12 CL E G H2355421641ORPHA:891Familial exudative vitreoretinopathy39
HP:0011276HP:0001009Telangiectasia1TYMS CL E G H729812441ORPHA:1775Dyskeratosis congenita1
HP:0011276HP:0001009Telangiectasia1UBE4B CL E G H1027712500ORPHA:16061p36 deletion syndromeHP:0040283 - Occasional
HP:0011276HP:0001933Subcutaneous hemorrhage1UFD1 CL E G H735312520ORPHA:56722q11.2 deletion syndrome
HP:0011276HP:0001933Subcutaneous hemorrhage1UNC13D CL E G H20129423147ORPHA:540Familial hemophagocytic lymphohistiocytosis116
HP:0011276HP:0001009Telangiectasia1USB1 CL E G H7965025792ORPHA:1775Dyskeratosis congenita8
HP:0011276HP:0001009Telangiectasia1USB1 CL E G H7965025792OMIM:604173Poikiloderma with neutropenia8
HP:0011276HP:0001009Telangiectasia1USF3 CL E G H20571730494ORPHA:201Cowden syndrome1
HP:0011276HP:0001933Subcutaneous hemorrhage1USP18 CL E G H1127412616OMIM:617397Pseudo-Torch syndrome 22
HP:0011276HP:0001933Subcutaneous hemorrhage1USP48 CL E G H8419618533ORPHA:96253Cushing disease1
HP:0011276HP:0001933Subcutaneous hemorrhage1USP8 CL E G H910112631ORPHA:96253Cushing disease7
HP:0011276HP:0010783Erythema1USP8 CL E G H910112631OMIM:219090Pituitary adenoma 4, ACTH-secreting, somatic7
HP:0011276HP:0001933Subcutaneous hemorrhage1USP8 CL E G H910112631OMIM:219090Pituitary adenoma 4, ACTH-secreting, somatic7
HP:0011276HP:0001009Telangiectasia1UVSSA CL E G H5765429304OMIM:614640Uv-Sensitive syndrome 3.3
HP:0011276HP:0001009Telangiectasia1VPS53 CL E G H5527525608OMIM:615851Pontocerebellar hypoplasia, type 2E26
HP:0011276HP:0001933Subcutaneous hemorrhage1VWF CL E G H745012726OMIM:193400Von willebrand disease, type 1533
HP:0011276HP:0001933Subcutaneous hemorrhage1VWF CL E G H745012726OMIM:613554Von willebrand disease, type 2533
HP:0011276HP:0001933Subcutaneous hemorrhage1VWF CL E G H745012726OMIM:277480Von willebrand disease, type 3533
HP:0011276HP:0001933Subcutaneous hemorrhage1WAS CL E G H745412731OMIM:313900Thrombocytopenia 165
HP:0011276HP:0001933Subcutaneous hemorrhage1WAS CL E G H745412731OMIM:301000Wiskott-Aldrich syndrome65
HP:0011276HP:0001025Urticaria1WAS CL E G H745412731ORPHA:906Wiskott-Aldrich syndromeHP:0040283 - Occasional65
HP:0011276HP:0001933Subcutaneous hemorrhage1WAS CL E G H745412731ORPHA:906Wiskott-Aldrich syndrome65
HP:0011276HP:0001933Subcutaneous hemorrhage1WIPF1 CL E G H745612736ORPHA:906Wiskott-Aldrich syndrome6
HP:0011276HP:0001025Urticaria1WIPF1 CL E G H745612736ORPHA:906Wiskott-Aldrich syndromeHP:0040283 - Occasional6
HP:0011276HP:0010783Erythema1WNT10A CL E G H8032613829OMIM:257980Odontoonychodermal dysplasia.71
HP:0011276HP:0001009Telangiectasia1WNT10A CL E G H8032613829ORPHA:50944Schöpf-Schulz-Passarge syndrome71
HP:0011276HP:0001009Telangiectasia1WRAP53 CL E G H5513525522ORPHA:1775Dyskeratosis congenita40
HP:0011276HP:0001009Telangiectasia1WRN CL E G H748612791ORPHA:902Werner syndrome310
HP:0011276HP:0010783Erythema1XPA CL E G H750712814ORPHA:910Xeroderma pigmentosumHP:0040282 - Frequent34
HP:0011276HP:0001009Telangiectasia1XPA CL E G H750712814ORPHA:910Xeroderma pigmentosumHP:0040281 - Very frequent34
HP:0011276HP:0001009Telangiectasia1XPA CL E G H750712814OMIM:278700Xeroderma pigmentosum, complementation group A.34
HP:0011276HP:0010783Erythema1XPC CL E G H750812816ORPHA:910Xeroderma pigmentosumHP:0040282 - Frequent86
HP:0011276HP:0001009Telangiectasia1XPC CL E G H750812816ORPHA:910Xeroderma pigmentosumHP:0040281 - Very frequent86
HP:0011276HP:0001009Telangiectasia1XPC CL E G H750812816OMIM:278720Xeroderma pigmentosum, complementation group C.86
HP:0011276HP:0100665Angioedema1XPNPEP2 CL E G H751212823OMIM:300909Acquired angioedema.4
HP:0011276HP:0100665Angioedema1XPNPEP2 CL E G H751212823ORPHA:100057Renin-angiotensin-aldosterone system-blocker-induced angioedema4
HP:0011276HP:0010783Erythema1XPNPEP2 CL E G H751212823ORPHA:100057Renin-angiotensin-aldosterone system-blocker-induced angioedema4
HP:0011276HP:0001933Subcutaneous hemorrhage1XPR1 CL E G H921312827ORPHA:1980Bilateral striopallidodentate calcinosisHP:0040281 - Very frequent4
HP:0011276HP:0001009Telangiectasia1XRCC4 CL E G H751812831ORPHA:99812LIG4 syndrome9
HP:0011276HP:0010783Erythema1XRCC4 CL E G H751812831ORPHA:99812LIG4 syndromeHP:0040282 - Frequent9
HP:0011276HP:0001933Subcutaneous hemorrhage1ZBTB16 CL E G H770412930ORPHA:520Acute promyelocytic leukemia1
HP:0011276HP:0007394Prominent superficial blood vessels1ZMPSTE24 CL E G H1026912877ORPHA:740Hutchinson-Gilford progeria syndromeHP:0040281 - Very frequent83
HP:0011276HP:0007394Prominent superficial blood vessels1ZMPSTE24 CL E G H1026912877OMIM:608612Mandibuloacral dysplasia with type B lipodystrophy83
HP:0011276HP:0007394Prominent superficial blood vessels1ZMPSTE24 CL E G H1026912877OMIM:275210Restrictive dermopathy, lethal.83
HP:0011276HP:0001009Telangiectasia1ZNF408 CL E G H7979720041ORPHA:891Familial exudative vitreoretinopathy14
HP:0011276HP:0001933Subcutaneous hemorrhage1ZNF469 CL E G H8462723216ORPHA:90354Brittle cornea syndrome397
HP:0011276HP:0034411Angiokeratoma of Mibelli2 CL E G H
HP:0011276HP:0034410Angiokeratoma circumscriptum naeviforme2 CL E G H
HP:0011276HP:0031181Necrolytic migratory erythema2 CL E G H
HP:0011276HP:0034409Fordyce angiokeratoma2 CL E G H
HP:0011276HP:0034408Solitary angiokeratoma2 CL E G H
HP:0011276HP:0410133Chronic idiopathic urticaria2 CL E G H
HP:0011276HP:0025536V-sign2 CL E G H
HP:0011276HP:0033622Migratory erythematous plaque2 CL E G H
HP:0011276HP:0025535Shawl sign2 CL E G H
HP:0011276HP:0040323Erythema of the eyelids2 CL E G H
HP:0011276HP:0033167Neutrophilic urticarial dermatosis2 CL E G H
HP:0011276HP:0100585Telangiectasia of the skin2ABCC6 CL E G H36857ORPHA:758Pseudoxanthoma elasticumHP:0040283 - Occasional415
HP:0011276HP:0000978Bruising susceptibility2ABCC6 CL E G H36857ORPHA:758Pseudoxanthoma elasticumHP:0040282 - Frequent415
HP:0011276HP:0000979Purpura2ACP5 CL E G H54124OMIM:607944Spondyloenchondrodysplasia with immune dysregulation.16
HP:0011276HP:0033505Livedo reticularis2ACTA2 CL E G H59130OMIM:611788AORTIC ANEURYSM, FAMILIAL THORACIC 6; AAT694
HP:0011276HP:0000978Bruising susceptibility2ACTA2 CL E G H59130ORPHA:91387Familial thoracic aortic aneurysm and aortic dissectionHP:0040283 - Occasional94
HP:0011276HP:0100579Mucosal telangiectasiae2ACVRL1 CL E G H94175ORPHA:774Hereditary hemorrhagic telangiectasiaHP:0040281 - Very frequent178
HP:0011276HP:0007420Spontaneous hematomas2ACVRL1 CL E G H94175ORPHA:774Hereditary hemorrhagic telangiectasiaHP:0040282 - Frequent178
HP:0011276HP:0100585Telangiectasia of the skin2ACVRL1 CL E G H94175ORPHA:774Hereditary hemorrhagic telangiectasiaHP:0040281 - Very frequent178
HP:0011276HP:0007763Retinal telangiectasia2ACVRL1 CL E G H94175ORPHA:774Hereditary hemorrhagic telangiectasiaHP:0040283 - Occasional178
HP:0011276HP:0001232Nail bed telangiectasia2ACVRL1 CL E G H94175OMIM:600376Telangiectasia, hereditary hemorrhagic, type 2.178
HP:0011276HP:0100579Mucosal telangiectasiae2ACVRL1 CL E G H94175OMIM:600376Telangiectasia, hereditary hemorrhagic, type 2178
HP:0011276HP:0100585Telangiectasia of the skin2ACVRL1 CL E G H94175OMIM:600376Telangiectasia, hereditary hemorrhagic, type 2178
HP:0011276HP:0033260Livedo racemosa2ADA2 CL E G H518161839OMIM:182410Sneddon syndrome22
HP:0011276HP:0033505Livedo reticularis2ADA2 CL E G H518161839OMIM:182410Sneddon syndrome22
HP:0011276HP:0000979Purpura2ADA2 CL E G H518161839OMIM:615688Vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome22
HP:0011276HP:0033260Livedo racemosa2ADA2 CL E G H518161839OMIM:615688Vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome22
HP:0011276HP:0033195Perianal erythema2ADAM17 CL E G H6868195OMIM:614328INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 1; NISBD12
HP:0011276HP:0033194Perioral erythema2ADAM17 CL E G H6868195OMIM:614328INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 1; NISBD12
HP:0011276HP:0000978Bruising susceptibility2ADAMTS2 CL E G H9509218OMIM:225410Ehlers-Danlos syndrome, type VII, autosomal recessive.165
HP:0011276HP:0001041Facial erythema2ADGRE2 CL E G H308173337OMIM:125630Dermodistortive urticaria.2
HP:0011276HP:0000978Bruising susceptibility2AEBP1 CL E G H165303ORPHA:536532Classical-like Ehlers-Danlos syndrome type 2HP:0040281 - Very frequent
HP:0011276HP:0001015Prominent superficial veins2AEBP1 CL E G H165303ORPHA:536532Classical-like Ehlers-Danlos syndrome type 2
HP:0011276HP:0000978Bruising susceptibility2AEBP1 CL E G H165303OMIM:618000Ehlers-Danlos syndrome, classic-like, 2.
HP:0011276HP:0001015Prominent superficial veins2AEBP1 CL E G H165303OMIM:618000Ehlers-Danlos syndrome, classic-like, 2
HP:0011276HP:0001071Angiokeratoma corporis diffusum2AGA CL E G H175318OMIM:208400ASPARTYLGLUCOSAMINURIA.76
HP:0011276HP:0001015Prominent superficial veins2AGPAT2 CL E G H10555325ORPHA:528Congenital generalized lipodystrophyHP:0040283 - Occasional85
HP:0011276HP:0001041Facial erythema2AIP CL E G H9049358OMIM:219090Pituitary adenoma 4, ACTH-secreting, somatic.95
HP:0011276HP:0000978Bruising susceptibility2AIP CL E G H9049358OMIM:219090Pituitary adenoma 4, ACTH-secreting, somatic.95
HP:0011276HP:0000979Purpura2AIP CL E G H9049358OMIM:219090Pituitary adenoma 4, ACTH-secreting, somatic.95
HP:0011276HP:0100579Mucosal telangiectasiae2AKT1 CL E G H207391ORPHA:201Cowden syndromeHP:0040282 - Frequent54
HP:0011276HP:0001041Facial erythema2ANAPC1 CL E G H6468219988ORPHA:221008Rothmund-Thomson syndrome type 1HP:0040282 - Frequent2
HP:0011276HP:0000978Bruising susceptibility2ANKRD26 CL E G H2285229186OMIM:188000THROMBOCYTOPENIA 2; THC2106
HP:0011276HP:0001015Prominent superficial veins2ANTXR1 CL E G H8416821014OMIM:230740Gapo syndrome8
HP:0011276HP:0100585Telangiectasia of the skin2ANTXR2 CL E G H11842921732ORPHA:2176Infantile systemic hyalinosisHP:0040281 - Very frequent49
HP:0011276HP:0000979Purpura2APOE CL E G H348613ORPHA:158029Sea-blue histiocytosis39
HP:0011276HP:0100585Telangiectasia of the skin2ARL6IP6 CL E G H15118824048ORPHA:1556Cutis marmorata telangiectatica congenitaHP:0040282 - Frequent1
HP:0011276HP:0000979Purpura2ARL6IP6 CL E G H15118824048ORPHA:1556Cutis marmorata telangiectatica congenitaHP:0040283 - Occasional1
HP:0011276HP:0000978Bruising susceptibility2ARMC5 CL E G H7979825781ORPHA:189427Cushing syndrome due to macronodular adrenal hyperplasiaHP:0040282 - Frequent7
HP:0011276HP:0100585Telangiectasia of the skin2ARPC4 CL E G H10093707OMIM:620141
HP:0011276HP:0000979Purpura2ARVCF CL E G H421728ORPHA:56722q11.2 deletion syndromeHP:0040283 - Occasional1
HP:0011276HP:0100585Telangiectasia of the skin2ARX CL E G H17030218060ORPHA:94083Partington syndrome166
HP:0011276HP:0100579Mucosal telangiectasiae2ATM CL E G H472795OMIM:208900ATAXIA-TELANGIECTASIA3267
HP:0011276HP:0100579Mucosal telangiectasiae2ATM CL E G H472795ORPHA:100Ataxia-telangiectasiaHP:0040281 - Very frequent3267
HP:0011276HP:0100585Telangiectasia of the skin2ATM CL E G H472795ORPHA:100Ataxia-telangiectasiaHP:0040281 - Very frequent3267
HP:0011276HP:0007763Retinal telangiectasia2ATP6 CL E G H45087414ORPHA:104Leber hereditary optic neuropathyHP:0040282 - Frequent
HP:0011276HP:0001015Prominent superficial veins2ATP6V0A2 CL E G H2354518481ORPHA:357074Autosomal recessive cutis laxa type 2, classic type140
HP:0011276HP:0001015Prominent superficial veins2ATP6V0A2 CL E G H2354518481ORPHA:2834Wrinkly skin syndrome140
HP:0011276HP:0001015Prominent superficial veins2ATP6V1A CL E G H523851ORPHA:357074Autosomal recessive cutis laxa type 2, classic type3
HP:0011276HP:0001015Prominent superficial veins2ATP6V1E1 CL E G H529857ORPHA:357074Autosomal recessive cutis laxa type 2, classic type2
HP:0011276HP:0007420Spontaneous hematomas2ATP7A CL E G H538869ORPHA:565Menkes diseaseHP:0040283 - Occasional192
HP:0011276HP:0000978Bruising susceptibility2ATP7A CL E G H538869OMIM:304150Occipital horn syndrome.192
HP:0011276HP:0000978Bruising susceptibility2ATP7A CL E G H538869ORPHA:198Occipital horn syndromeHP:0040282 - Frequent192
HP:0011276HP:0000978Bruising susceptibility2ATP7B CL E G H540870ORPHA:905Wilson diseaseHP:0040281 - Very frequent315
HP:0011276HP:0100585Telangiectasia of the skin2ATR CL E G H545882OMIM:614564Cutaneous telangiectasia and cancer syndrome, familial168
HP:0011276HP:0000978Bruising susceptibility2ATRX CL E G H546886ORPHA:231401Alpha-thalassemia-myelodysplastic syndromeHP:0040282 - Frequent169
HP:0011276HP:0000978Bruising susceptibility2ATRX CL E G H546886ORPHA:96253Cushing diseaseHP:0040282 - Frequent169
HP:0011276HP:0000979Purpura2ATRX CL E G H546886ORPHA:96253Cushing disease169
HP:0011276HP:0100585Telangiectasia of the skin2ATRX CL E G H546886ORPHA:100075Neuroendocrine tumor of stomach169
HP:0011276HP:0000978Bruising susceptibility2B3GALT6 CL E G H12679217978ORPHA:536467B3GALT6-related spondylodysplastic Ehlers-Danlos syndromeHP:0040282 - Frequent38
HP:0011276HP:0001015Prominent superficial veins2BANF1 CL E G H881517397OMIM:614008Nestor-Guillermo progeria syndrome22
HP:0011276HP:0000979Purpura2BCOR CL E G H5488020893ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent101
HP:0011276HP:0000978Bruising susceptibility2BCOR CL E G H5488020893ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent101
HP:0011276HP:0001041Facial erythema2BLM CL E G H6411058OMIM:210900Bloom syndrome314
HP:0011276HP:0100585Telangiectasia of the skin2BLM CL E G H6411058OMIM:210900Bloom syndrome314
HP:0011276HP:0000978Bruising susceptibility2BLOC1S3 CL E G H38855220914OMIM:614077Hermansky-Pudlak syndrome 8.42
HP:0011276HP:0000978Bruising susceptibility2BLOC1S5 CL E G H6391518561OMIM:619172HERMANSKY-PUDLAK SYNDROME 11; HPS11
HP:0011276HP:0000979Purpura2BRAF CL E G H6731097ORPHA:96253Cushing disease276
HP:0011276HP:0000978Bruising susceptibility2BRAF CL E G H6731097ORPHA:96253Cushing diseaseHP:0040282 - Frequent276
HP:0011276HP:0000978Bruising susceptibility2BRAF CL E G H6731097OMIM:163950Noonan syndrome 1276
HP:0011276HP:0001015Prominent superficial veins2BSCL2 CL E G H2658015832ORPHA:528Congenital generalized lipodystrophyHP:0040283 - Occasional105
HP:0011276HP:0000978Bruising susceptibility2C1R CL E G H7151246OMIM:130080Ehlers-Danlos syndrome, periodontal type, 1.15
HP:0011276HP:0001015Prominent superficial veins2C1R CL E G H7151246OMIM:130080Ehlers-Danlos syndrome, periodontal type, 115
HP:0011276HP:0000978Bruising susceptibility2C1S CL E G H7161247OMIM:617174Ehlers-Danlos syndrome, periodontal type, 2.7
HP:0011276HP:0000979Purpura2C2 CL E G H7171248OMIM:217000Complement component 2 deficiency.23
HP:0011276HP:0000979Purpura2C4A CL E G H7201323OMIM:614380Complement component 4A deficiency.1
HP:0011276HP:0000979Purpura2CALR CL E G H8111455OMIM:254450Myelofibrosismyelofibrosis with myeloid metaplasia, included1
HP:0011276HP:0000979Purpura2CALR CL E G H8111455ORPHA:824Primary myelofibrosisHP:0040283 - Occasional1
HP:0011276HP:0410134Physical urticaria2CARMIL2 CL E G H14620627089OMIM:618131IMMUNODEFICIENCY 58; IMD583
HP:0011276HP:0000978Bruising susceptibility2CASP10 CL E G H8431500ORPHA:3261Autoimmune lymphoproliferative syndromeHP:0040282 - Frequent87
HP:0011276HP:0000979Purpura2CASP10 CL E G H8431500OMIM:603909Autoimmune lymphoproliferative syndrome, type IIA87
HP:0011276HP:0001015Prominent superficial veins2CAV1 CL E G H8571527ORPHA:528Congenital generalized lipodystrophyHP:0040283 - Occasional11
HP:0011276HP:0100585Telangiectasia of the skin2CAV1 CL E G H8571527ORPHA:220393Diffuse cutaneous systemic sclerosisHP:0040282 - Frequent11
HP:0011276HP:0100585Telangiectasia of the skin2CAV1 CL E G H8571527ORPHA:220402Limited cutaneous systemic sclerosisHP:0040282 - Frequent11
HP:0011276HP:0100579Mucosal telangiectasiae2CAV1 CL E G H8571527ORPHA:220402Limited cutaneous systemic sclerosisHP:0040282 - Frequent11
HP:0011276HP:0001015Prominent superficial veins2CAVIN1 CL E G H2841199688ORPHA:528Congenital generalized lipodystrophyHP:0040283 - Occasional48
HP:0011276HP:0100585Telangiectasia of the skin2CCN2 CL E G H14902500ORPHA:220393Diffuse cutaneous systemic sclerosisHP:0040282 - Frequent
HP:0011276HP:0100579Mucosal telangiectasiae2CCN2 CL E G H14902500ORPHA:220402Limited cutaneous systemic sclerosisHP:0040282 - Frequent
HP:0011276HP:0100585Telangiectasia of the skin2CCN2 CL E G H14902500ORPHA:220402Limited cutaneous systemic sclerosisHP:0040282 - Frequent
HP:0011276HP:0100585Telangiectasia of the skin2CCR6 CL E G H12351607ORPHA:220393Diffuse cutaneous systemic sclerosisHP:0040282 - Frequent
HP:0011276HP:0100585Telangiectasia of the skin2CCR6 CL E G H12351607ORPHA:220402Limited cutaneous systemic sclerosisHP:0040282 - Frequent
HP:0011276HP:0100579Mucosal telangiectasiae2CCR6 CL E G H12351607ORPHA:220402Limited cutaneous systemic sclerosisHP:0040282 - Frequent
HP:0011276HP:0007420Spontaneous hematomas2CD109 CL E G H13522821685ORPHA:853Fetal and neonatal alloimmune thrombocytopeniaHP:0040282 - Frequent
HP:0011276HP:0000979Purpura2CD109 CL E G H13522821685ORPHA:853Fetal and neonatal alloimmune thrombocytopeniaHP:0040282 - Frequent
HP:0011276HP:0000979Purpura2CD19 CL E G H9301633ORPHA:1572Common variable immunodeficiencyHP:0040282 - Frequent38
HP:0011276HP:0000979Purpura2CD81 CL E G H9751701ORPHA:1572Common variable immunodeficiencyHP:0040282 - Frequent1
HP:0011276HP:0000979Purpura2CD81 CL E G H9751701OMIM:613496Immunodeficiency, common variable, 61
HP:0011276HP:0000978Bruising susceptibility2CDH23 CL E G H6407213733ORPHA:96253Cushing diseaseHP:0040282 - Frequent636
HP:0011276HP:0000979Purpura2CDH23 CL E G H6407213733ORPHA:96253Cushing disease636
HP:0011276HP:0000979Purpura2CFH CL E G H30754883OMIM:235400Hemolytic uremic syndrome, atypical, susceptibility to, 1.86
HP:0011276HP:0000979Purpura2CFHR1 CL E G H30784888OMIM:235400Hemolytic uremic syndrome, atypical, susceptibility to, 1.
HP:0011276HP:0000979Purpura2CFHR3 CL E G H1087816980OMIM:235400Hemolytic uremic syndrome, atypical, susceptibility to, 1.
HP:0011276HP:0000978Bruising susceptibility2CHST14 CL E G H11318924464OMIM:601776Ehlers-Danlos syndrome, musculocontractural type 1.27
HP:0011276HP:0000979Purpura2CHST14 CL E G H11318924464OMIM:601776Ehlers-Danlos syndrome, musculocontractural type 127
HP:0011276HP:0000978Bruising susceptibility2CHST14 CL E G H11318924464ORPHA:2953Musculocontractural Ehlers-Danlos syndromeHP:0040281 - Very frequent27
HP:0011276HP:0100585Telangiectasia of the skin2CIB1 CL E G H1051916920ORPHA:302Epidermodysplasia verruciformisHP:0040283 - Occasional
HP:0011276HP:0000978Bruising susceptibility2CLCN7 CL E G H11862025ORPHA:667Autosomal recessive malignant osteopetrosisHP:0040283 - Occasional102
HP:0011276HP:0000979Purpura2CLCN7 CL E G H11862025OMIM:611490Osteopetrosis, autosomal recessive 4102
HP:0011276HP:0001015Prominent superficial veins2COG4 CL E G H2583918620OMIM:618150Saul-Wilson syndrome.67
HP:0011276HP:0007420Spontaneous hematomas2COG8 CL E G H8434218623ORPHA:95428COG8-CDGHP:0040283 - Occasional39
HP:0011276HP:0000978Bruising susceptibility2COL1A1 CL E G H12772197ORPHA:287Classical Ehlers-Danlos syndromeHP:0040283 - Occasional373
HP:0011276HP:0000979Purpura2COL1A1 CL E G H12772197ORPHA:287Classical Ehlers-Danlos syndrome373
HP:0011276HP:0000978Bruising susceptibility2COL1A1 CL E G H12772197OMIM:619115COMBINED OSTEOGENESIS IMPERFECTA AND EHLERS-DANLOS SYNDROME 1; OIEDS1373
HP:0011276HP:0000978Bruising susceptibility2COL1A1 CL E G H12772197OMIM:130060Ehlers-Danlos syndrome, arthrochalasia type, 1.373
HP:0011276HP:0000978Bruising susceptibility2COL1A1 CL E G H12772197OMIM:166200Osteogenesis imperfecta, type I.373
HP:0011276HP:0000978Bruising susceptibility2COL1A2 CL E G H12782198ORPHA:230851Cardiac-valvular Ehlers-Danlos syndromeHP:0040282 - Frequent243
HP:0011276HP:0000978Bruising susceptibility2COL1A2 CL E G H12782198OMIM:619120COMBINED OSTEOGENESIS IMPERFECTA AND EHLERS-DANLOS SYNDROME 2; OIEDS2243
HP:0011276HP:0000978Bruising susceptibility2COL1A2 CL E G H12782198OMIM:617821Ehlers-Danlos syndrome, arthrochalasia type, 2.243
HP:0011276HP:0000978Bruising susceptibility2COL1A2 CL E G H12782198OMIM:225320Ehlers-Danlos syndrome, autosomal recessive, cardiac valvular form.243
HP:0011276HP:0100585Telangiectasia of the skin2COL3A1 CL E G H12812201ORPHA:2500AcrogeriaHP:0040282 - Frequent749
HP:0011276HP:0000978Bruising susceptibility2COL3A1 CL E G H12812201OMIM:130050Ehlers-Danlos syndrome, Vascular type749
HP:0011276HP:0000979Purpura2COL3A1 CL E G H12812201OMIM:130050Ehlers-Danlos syndrome, Vascular type749
HP:0011276HP:0000978Bruising susceptibility2COL3A1 CL E G H12812201OMIM:618343Polymicrogyria with or without vascular-type ehlers-danlos syndrome.749
HP:0011276HP:0000978Bruising susceptibility2COL3A1 CL E G H12812201ORPHA:286Vascular Ehlers-Danlos syndromeHP:0040281 - Very frequent749
HP:0011276HP:0100585Telangiectasia of the skin2COL3A1 CL E G H12812201ORPHA:286Vascular Ehlers-Danlos syndromeHP:0040282 - Frequent749
HP:0011276HP:0000979Purpura2COL5A1 CL E G H12892209ORPHA:287Classical Ehlers-Danlos syndrome660
HP:0011276HP:0000978Bruising susceptibility2COL5A1 CL E G H12892209ORPHA:287Classical Ehlers-Danlos syndromeHP:0040283 - Occasional660
HP:0011276HP:0000978Bruising susceptibility2COL5A1 CL E G H12892209OMIM:130000Ehlers-danlos syndrome, type I660
HP:0011276HP:0000978Bruising susceptibility2COL5A2 CL E G H12902210ORPHA:287Classical Ehlers-Danlos syndromeHP:0040283 - Occasional325
HP:0011276HP:0000979Purpura2COL5A2 CL E G H12902210ORPHA:287Classical Ehlers-Danlos syndrome325
HP:0011276HP:0000978Bruising susceptibility2COL5A2 CL E G H12902210OMIM:130010Ehlers-Danlos syndrome, classic type, 2325
HP:0011276HP:0000979Purpura2COMT CL E G H13122228ORPHA:56722q11.2 deletion syndromeHP:0040283 - Occasional6
HP:0011276HP:0007763Retinal telangiectasia2COX1 CL E G H45127419ORPHA:104Leber hereditary optic neuropathyHP:0040282 - Frequent
HP:0011276HP:0007763Retinal telangiectasia2COX3 CL E G H45147422ORPHA:104Leber hereditary optic neuropathyHP:0040282 - Frequent
HP:0011276HP:0000979Purpura2CR2 CL E G H13802336ORPHA:1572Common variable immunodeficiencyHP:0040282 - Frequent10
HP:0011276HP:0000978Bruising susceptibility2CREB3L1 CL E G H9099318856OMIM:616229Osteogenesis imperfecta, type XVI4
HP:0011276HP:0007763Retinal telangiectasia2CTC1 CL E G H8016926169OMIM:612199Cerebroretinal microangiopathy with calcifications and cysts.160
HP:0011276HP:0100585Telangiectasia of the skin2CTC1 CL E G H8016926169ORPHA:1775Dyskeratosis congenitaHP:0040282 - Frequent160
HP:0011276HP:0000979Purpura2CTLA4 CL E G H14932505ORPHA:900Granulomatosis with polyangiitisHP:0040283 - Occasional10
HP:0011276HP:0007763Retinal telangiectasia2CTNNB1 CL E G H14992514ORPHA:891Familial exudative vitreoretinopathy88
HP:0011276HP:0100579Mucosal telangiectasiae2CTSA CL E G H54769251OMIM:256540Galactosialidosis51
HP:0011276HP:0100585Telangiectasia of the skin2CYLD CL E G H15402584ORPHA:211Familial cylindromatosisHP:0040281 - Very frequent126
HP:0011276HP:0100585Telangiectasia of the skin2CYLD CL E G H15402584ORPHA:867Familial multiple trichoepitheliomaHP:0040282 - Frequent126
HP:0011276HP:0007763Retinal telangiectasia2CYTB CL E G H45197427ORPHA:104Leber hereditary optic neuropathyHP:0040282 - Frequent
HP:0011276HP:0100585Telangiectasia of the skin2DAXX CL E G H16162681ORPHA:100075Neuroendocrine tumor of stomach
HP:0011276HP:0100585Telangiectasia of the skin2DDB2 CL E G H16432718ORPHA:910Xeroderma pigmentosumHP:0040281 - Very frequent30
HP:0011276HP:0100579Mucosal telangiectasiae2DDB2 CL E G H16432718ORPHA:910Xeroderma pigmentosum30
HP:0011276HP:0100585Telangiectasia of the skin2DKC1 CL E G H17362890ORPHA:1775Dyskeratosis congenitaHP:0040282 - Frequent65
HP:0011276HP:0007763Retinal telangiectasia2DNAJC30 CL E G H8427716410ORPHA:104Leber hereditary optic neuropathyHP:0040282 - Frequent
HP:0011276HP:0007763Retinal telangiectasia2DNAJC30 CL E G H8427716410OMIM:619382LEBER HEREDITARY OPTIC NEUROPATHY, AUTOSOMAL RECESSIVE; LHONAR
HP:0011276HP:0000978Bruising susceptibility2DSE CL E G H2994021144ORPHA:2953Musculocontractural Ehlers-Danlos syndromeHP:0040281 - Very frequent13
HP:0011276HP:0025493Palmoplantar erythema2DSP CL E G H18323052OMIM:607655Skin fragility-woolly hair syndrome747
HP:0011276HP:0000978Bruising susceptibility2DTNBP1 CL E G H8406217328OMIM:614076Hermansky-Pudlak syndrome 7.46
HP:0011276HP:0100585Telangiectasia of the skin2ELMO2 CL E G H6391617233ORPHA:3019Ramon syndromeHP:0040283 - Occasional3
HP:0011276HP:0000978Bruising susceptibility2ELN CL E G H20063327ORPHA:91387Familial thoracic aortic aneurysm and aortic dissectionHP:0040283 - Occasional172
HP:0011276HP:0000978Bruising susceptibility2EMILIN1 CL E G H1111719880OMIM:6200802
HP:0011276HP:0100579Mucosal telangiectasiae2ENG CL E G H20223349ORPHA:774Hereditary hemorrhagic telangiectasiaHP:0040281 - Very frequent186
HP:0011276HP:0007420Spontaneous hematomas2ENG CL E G H20223349ORPHA:774Hereditary hemorrhagic telangiectasiaHP:0040282 - Frequent186
HP:0011276HP:0007763Retinal telangiectasia2ENG CL E G H20223349ORPHA:774Hereditary hemorrhagic telangiectasiaHP:0040283 - Occasional186
HP:0011276HP:0100585Telangiectasia of the skin2ENG CL E G H20223349ORPHA:774Hereditary hemorrhagic telangiectasiaHP:0040281 - Very frequent186
HP:0011276HP:0100585Telangiectasia of the skin2ENG CL E G H20223349OMIM:187300Telangiectasia, hereditary hemorrhagic, type 1186
HP:0011276HP:0001232Nail bed telangiectasia2ENG CL E G H20223349OMIM:187300Telangiectasia, hereditary hemorrhagic, type 1.186
HP:0011276HP:0100579Mucosal telangiectasiae2ENG CL E G H20223349OMIM:187300Telangiectasia, hereditary hemorrhagic, type 1186
HP:0011276HP:0000978Bruising susceptibility2ENPP1 CL E G H51673356ORPHA:758Pseudoxanthoma elasticumHP:0040282 - Frequent151
HP:0011276HP:0100585Telangiectasia of the skin2ENPP1 CL E G H51673356ORPHA:758Pseudoxanthoma elasticumHP:0040283 - Occasional151
HP:0011276HP:0100579Mucosal telangiectasiae2ERCC2 CL E G H20683434ORPHA:910Xeroderma pigmentosum106
HP:0011276HP:0100585Telangiectasia of the skin2ERCC2 CL E G H20683434ORPHA:910Xeroderma pigmentosumHP:0040281 - Very frequent106
HP:0011276HP:0100579Mucosal telangiectasiae2ERCC3 CL E G H20713435ORPHA:910Xeroderma pigmentosum54
HP:0011276HP:0100585Telangiectasia of the skin2ERCC3 CL E G H20713435ORPHA:910Xeroderma pigmentosumHP:0040281 - Very frequent54
HP:0011276HP:0100579Mucosal telangiectasiae2ERCC4 CL E G H20723436ORPHA:910Xeroderma pigmentosum158
HP:0011276HP:0100585Telangiectasia of the skin2ERCC4 CL E G H20723436ORPHA:910Xeroderma pigmentosumHP:0040281 - Very frequent158
HP:0011276HP:0100579Mucosal telangiectasiae2ERCC5 CL E G H20733437ORPHA:910Xeroderma pigmentosum83
HP:0011276HP:0100585Telangiectasia of the skin2ERCC5 CL E G H20733437ORPHA:910Xeroderma pigmentosumHP:0040281 - Very frequent83
HP:0011276HP:0000979Purpura2ETHE1 CL E G H2347423287OMIM:602473Encephalopathy, ethylmalonic42
HP:0011276HP:0000979Purpura2ETHE1 CL E G H2347423287ORPHA:51188Ethylmalonic encephalopathy42
HP:0011276HP:0000978Bruising susceptibility2ETV6 CL E G H21203495OMIM:616216Thrombocytopenia 5.13
HP:0011276HP:0000979Purpura2ETV6 CL E G H21203495OMIM:616216Thrombocytopenia 513
HP:0011276HP:0000978Bruising susceptibility2F10 CL E G H21593528ORPHA:328Congenital factor X deficiencyHP:0040283 - Occasional33
HP:0011276HP:0007420Spontaneous hematomas2F10 CL E G H21593528ORPHA:328Congenital factor X deficiencyHP:0040283 - Occasional33
HP:0011276HP:0007420Spontaneous hematomas2F13A1 CL E G H21623531ORPHA:331Congenital factor XIII deficiencyHP:0040282 - Frequent60
HP:0011276HP:0000979Purpura2F13A1 CL E G H21623531ORPHA:331Congenital factor XIII deficiency60
HP:0011276HP:0000978Bruising susceptibility2F13A1 CL E G H21623531ORPHA:331Congenital factor XIII deficiencyHP:0040282 - Frequent60
HP:0011276HP:0000979Purpura2F13A1 CL E G H21623531OMIM:613225Factor XIII, A subunit, deficiency of60
HP:0011276HP:0000978Bruising susceptibility2F13A1 CL E G H21623531OMIM:613225Factor XIII, A subunit, deficiency of.60
HP:0011276HP:0007420Spontaneous hematomas2F13A1 CL E G H21623531OMIM:613225Factor XIII, A subunit, deficiency of.60
HP:0011276HP:0000978Bruising susceptibility2F13B CL E G H21653534ORPHA:331Congenital factor XIII deficiencyHP:0040282 - Frequent32
HP:0011276HP:0000979Purpura2F13B CL E G H21653534ORPHA:331Congenital factor XIII deficiency32
HP:0011276HP:0007420Spontaneous hematomas2F13B CL E G H21653534ORPHA:331Congenital factor XIII deficiencyHP:0040282 - Frequent32
HP:0011276HP:0000979Purpura2F13B CL E G H21653534OMIM:613235Factor XIIIB deficiency32
HP:0011276HP:0000978Bruising susceptibility2F13B CL E G H21653534OMIM:613235Factor XIIIB deficiency.32
HP:0011276HP:0000978Bruising susceptibility2F2 CL E G H21473535OMIM:613679Congenital prothrombin deficiency.44
HP:0011276HP:0000979Purpura2F2 CL E G H21473535OMIM:613679Congenital prothrombin deficiency44
HP:0011276HP:0007420Spontaneous hematomas2F5 CL E G H21533542ORPHA:326Congenital factor V deficiencyHP:0040283 - Occasional159
HP:0011276HP:0000978Bruising susceptibility2F5 CL E G H21533542ORPHA:326Congenital factor V deficiencyHP:0040283 - Occasional159
HP:0011276HP:0000978Bruising susceptibility2F5 CL E G H21533542OMIM:227400Factor V deficiency.159
HP:0011276HP:0000978Bruising susceptibility2F7 CL E G H21553544ORPHA:327Congenital factor VII deficiencyHP:0040282 - Frequent70
HP:0011276HP:0007420Spontaneous hematomas2F8 CL E G H21573546ORPHA:177926Bleeding disorder in hemophilia A carriers without FVIII deficiencyHP:0040284 - Very rare303
HP:0011276HP:0000978Bruising susceptibility2F8 CL E G H21573546ORPHA:177926Bleeding disorder in hemophilia A carriers without FVIII deficiencyHP:0040281 - Very frequent303
HP:0011276HP:0000978Bruising susceptibility2F8 CL E G H21573546OMIM:306700Hemophilia A.303
HP:0011276HP:0007420Spontaneous hematomas2F8 CL E G H21573546ORPHA:169805Moderate hemophilia AHP:0040284 - Very rare303
HP:0011276HP:0000978Bruising susceptibility2F8 CL E G H21573546ORPHA:169802Severe hemophilia AHP:0040282 - Frequent303
HP:0011276HP:0000978Bruising susceptibility2FANCA CL E G H21753582OMIM:227650Fanconi anemia.340
HP:0011276HP:0000978Bruising susceptibility2FANCC CL E G H21763584OMIM:227645Fanconi anemia, complementation group C.410
HP:0011276HP:0000978Bruising susceptibility2FANCD2 CL E G H21773585OMIM:227646Fanconi anemia, complementation group D2.147
HP:0011276HP:0000978Bruising susceptibility2FANCE CL E G H21783586OMIM:600901Fanconi anemia, complementation group E.73
HP:0011276HP:0000978Bruising susceptibility2FAS CL E G H35511920ORPHA:3261Autoimmune lymphoproliferative syndromeHP:0040282 - Frequent59
HP:0011276HP:0000978Bruising susceptibility2FASLG CL E G H35611936ORPHA:3261Autoimmune lymphoproliferative syndromeHP:0040282 - Frequent37
HP:0011276HP:0000978Bruising susceptibility2FBN1 CL E G H22003603ORPHA:91387Familial thoracic aortic aneurysm and aortic dissectionHP:0040283 - Occasional1361
HP:0011276HP:0000978Bruising susceptibility2FBN1 CL E G H22003603OMIM:616914Marfan lipodystrophy syndrome1361
HP:0011276HP:0000978Bruising susceptibility2FCGR2C CL E G H910315626ORPHA:3002Immune thrombocytopeniaHP:0040283 - Occasional
HP:0011276HP:0000979Purpura2FCGR2C CL E G H910315626ORPHA:3002Immune thrombocytopeniaHP:0040282 - Frequent
HP:0011276HP:0100585Telangiectasia of the skin2FERMT1 CL E G H5561215889OMIM:173650Kindler syndrome136
HP:0011276HP:0000979Purpura2FERMT3 CL E G H8370623151OMIM:612840Leukocyte adhesion deficiency, type III23
HP:0011276HP:0000978Bruising susceptibility2FGA CL E G H22433661OMIM:202400Afibrinogenemia, congenitalhypofibrinogenemia, congenital, included47
HP:0011276HP:0000978Bruising susceptibility2FGB CL E G H22443662OMIM:202400Afibrinogenemia, congenitalhypofibrinogenemia, congenital, included62
HP:0011276HP:0000978Bruising susceptibility2FGG CL E G H22663694OMIM:202400Afibrinogenemia, congenitalhypofibrinogenemia, congenital, included34
HP:0011276HP:0000979Purpura2FIP1L1 CL E G H8160819124ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent4
HP:0011276HP:0000978Bruising susceptibility2FIP1L1 CL E G H8160819124ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent4
HP:0011276HP:0000978Bruising susceptibility2FKBP14 CL E G H5503318625OMIM:614557Ehlers-Danlos syndrome, kyphoscoliotic type, 2HP:0040283 - Occasional13
HP:0011276HP:0000978Bruising susceptibility2FKBP14 CL E G H5503318625ORPHA:300179Kyphoscoliotic Ehlers-Danlos syndrome due to FKBP22 deficiencyHP:0040282 - Frequent13
HP:0011276HP:0000978Bruising susceptibility2FLNA CL E G H23163754ORPHA:75497X-linked Ehlers-Danlos syndromeHP:0040281 - Very frequent493
HP:0011276HP:0001015Prominent superficial veins2FLT4 CL E G H23243767OMIM:153100Lymphatic malformation 190
HP:0011276HP:0001015Prominent superficial veins2FOS CL E G H23533796ORPHA:528Congenital generalized lipodystrophyHP:0040283 - Occasional
HP:0011276HP:0000978Bruising susceptibility2FOXE3 CL E G H23013808ORPHA:91387Familial thoracic aortic aneurysm and aortic dissectionHP:0040283 - Occasional23
HP:0011276HP:0007763Retinal telangiectasia2FRG1 CL E G H24833954OMIM:158900Facioscapulohumeral muscular dystrophy 1.1
HP:0011276HP:0000979Purpura2FYB1 CL E G H25334036OMIM:273900THROMBOCYTOPENIA 3; THC34
HP:0011276HP:0007763Retinal telangiectasia2FZD4 CL E G H83224042ORPHA:891Familial exudative vitreoretinopathy109
HP:0011276HP:0001015Prominent superficial veins2G6PC3 CL E G H9257924861OMIM:612541Neutropenia, severe congenital, 4, autosomal recessive37
HP:0011276HP:0000979Purpura2GATA1 CL E G H26234170OMIM:314050Thrombocytopenia with beta-thalassemia, X-linked29
HP:0011276HP:0000978Bruising susceptibility2GATA1 CL E G H26234170OMIM:314050Thrombocytopenia with beta-thalassemia, X-linked.29
HP:0011276HP:0000978Bruising susceptibility2GATA1 CL E G H26234170OMIM:300367Thrombocytopenia, X-linked, with or without dyserythropoietic anemia.29
HP:0011276HP:0000979Purpura2GATA1 CL E G H26234170OMIM:300367Thrombocytopenia, X-linked, with or without dyserythropoietic anemia29
HP:0011276HP:0000978Bruising susceptibility2GATA2 CL E G H26244171ORPHA:3226Deafness-lymphedema-leukemia syndromeHP:0040282 - Frequent137
HP:0011276HP:0000978Bruising susceptibility2GBA1 CL E G H26294177ORPHA:77259Gaucher disease type 1HP:0040282 - Frequent
HP:0011276HP:0000979Purpura2GBA1 CL E G H26294177OMIM:608013Gaucher disease, perinatal lethal.
HP:0011276HP:0000979Purpura2GBA1 CL E G H26294177ORPHA:2072Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome
HP:0011276HP:0007420Spontaneous hematomas2GDF2 CL E G H26584217ORPHA:774Hereditary hemorrhagic telangiectasiaHP:0040282 - Frequent8
HP:0011276HP:0100579Mucosal telangiectasiae2GDF2 CL E G H26584217ORPHA:774Hereditary hemorrhagic telangiectasiaHP:0040281 - Very frequent8
HP:0011276HP:0100585Telangiectasia of the skin2GDF2 CL E G H26584217ORPHA:774Hereditary hemorrhagic telangiectasiaHP:0040281 - Very frequent8
HP:0011276HP:0007763Retinal telangiectasia2GDF2 CL E G H26584217ORPHA:774Hereditary hemorrhagic telangiectasiaHP:0040283 - Occasional8
HP:0011276HP:0000978Bruising susceptibility2GFI1B CL E G H83284238OMIM:187900Bleeding disorder, platelet-type, 17.3
HP:0011276HP:0000979Purpura2GFI1B CL E G H83284238OMIM:187900Bleeding disorder, platelet-type, 173
HP:0011276HP:0000978Bruising susceptibility2GGCX CL E G H26774247OMIM:277450VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 1.129
HP:0011276HP:0000979Purpura2GGCX CL E G H26774247OMIM:277450VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 1129
HP:0011276HP:0000979Purpura2GIMAP5 CL E G H5534018005OMIM:619463PORTAL HYPERTENSION, NONCIRRHOTIC, 2; NCPH2
HP:0011276HP:0001041Facial erythema2GJA1 CL E G H26974274ORPHA:1010Autosomal dominant palmoplantar keratoderma and congenital alopecia68
HP:0011276HP:0025493Palmoplantar erythema2GJA1 CL E G H26974274OMIM:104100Palmoplantar keratoderma with congenital alopecia68
HP:0011276HP:0025493Palmoplantar erythema2GJA5 CL E G H27024279OMIM:612474Chromosome 1q21.1 deletion syndrome, 1.35-mb39
HP:0011276HP:0025493Palmoplantar erythema2GJA8 CL E G H27034281OMIM:612474Chromosome 1q21.1 deletion syndrome, 1.35-mb34
HP:0011276HP:0100585Telangiectasia of the skin2GLA CL E G H27174296ORPHA:324Fabry diseaseHP:0040281 - Very frequent291
HP:0011276HP:0001071Angiokeratoma corporis diffusum2GLA CL E G H27174296OMIM:301500Fabry disease291
HP:0011276HP:0100579Mucosal telangiectasiae2GLA CL E G H27174296ORPHA:324Fabry diseaseHP:0040281 - Very frequent291
HP:0011276HP:0001071Angiokeratoma corporis diffusum2GLB1 CL E G H27204298OMIM:230500GM1-gangliosidosis, type I.120
HP:0011276HP:0100585Telangiectasia of the skin2GNA11 CL E G H27674379ORPHA:1556Cutis marmorata telangiectatica congenitaHP:0040282 - Frequent16
HP:0011276HP:0000979Purpura2GNA11 CL E G H27674379ORPHA:1556Cutis marmorata telangiectatica congenitaHP:0040283 - Occasional16
HP:0011276HP:0000979Purpura2GNA14 CL E G H96304382ORPHA:1063Tufted angiomaHP:0040283 - Occasional
HP:0011276HP:0100579Mucosal telangiectasiae2GNAQ CL E G H27764390ORPHA:3205Sturge-Weber syndrome7
HP:0011276HP:0000978Bruising susceptibility2GNAS CL E G H27784392OMIM:219080ACTH-independent macronodular adrenal hyperplasia.101
HP:0011276HP:0000978Bruising susceptibility2GNAS CL E G H27784392ORPHA:189427Cushing syndrome due to macronodular adrenal hyperplasiaHP:0040282 - Frequent101
HP:0011276HP:0001041Facial erythema2GNB2 CL E G H27834398OMIM:619503NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND DYSMORPHIC FACIES; NEDHYDF
HP:0011276HP:0100585Telangiectasia of the skin2GNPTAB CL E G H7915829670ORPHA:576Mucolipidosis type II240
HP:0011276HP:0007420Spontaneous hematomas2GP1BA CL E G H28114439ORPHA:274Bernard-Soulier syndromeHP:0040282 - Frequent23
HP:0011276HP:0000978Bruising susceptibility2GP1BA CL E G H28114439ORPHA:274Bernard-Soulier syndromeHP:0040283 - Occasional23
HP:0011276HP:0000979Purpura2GP1BA CL E G H28114439ORPHA:274Bernard-Soulier syndrome23
HP:0011276HP:0000979Purpura2GP1BA CL E G H28114439OMIM:153670Bernard-Soulier syndrome, type A2, autosomal dominant23
HP:0011276HP:0000978Bruising susceptibility2GP1BA CL E G H28114439OMIM:153670Bernard-Soulier syndrome, type A2, autosomal dominant.23
HP:0011276HP:0000979Purpura2GP1BA CL E G H28114439OMIM:231200BERNARD-SOULIER SYNDROME; BSS23
HP:0011276HP:0000979Purpura2GP1BA CL E G H28114439ORPHA:853Fetal and neonatal alloimmune thrombocytopeniaHP:0040282 - Frequent23
HP:0011276HP:0007420Spontaneous hematomas2GP1BA CL E G H28114439ORPHA:853Fetal and neonatal alloimmune thrombocytopeniaHP:0040282 - Frequent23
HP:0011276HP:0000979Purpura2GP1BB CL E G H28124440ORPHA:56722q11.2 deletion syndromeHP:0040283 - Occasional8
HP:0011276HP:0007420Spontaneous hematomas2GP1BB CL E G H28124440ORPHA:274Bernard-Soulier syndromeHP:0040282 - Frequent8
HP:0011276HP:0000978Bruising susceptibility2GP1BB CL E G H28124440ORPHA:274Bernard-Soulier syndromeHP:0040283 - Occasional8
HP:0011276HP:0000979Purpura2GP1BB CL E G H28124440ORPHA:274Bernard-Soulier syndrome8
HP:0011276HP:0000979Purpura2GP1BB CL E G H28124440OMIM:231200BERNARD-SOULIER SYNDROME; BSS8
HP:0011276HP:0000979Purpura2GP1BB CL E G H28124440ORPHA:853Fetal and neonatal alloimmune thrombocytopeniaHP:0040282 - Frequent8
HP:0011276HP:0007420Spontaneous hematomas2GP1BB CL E G H28124440ORPHA:853Fetal and neonatal alloimmune thrombocytopeniaHP:0040282 - Frequent8
HP:0011276HP:0000978Bruising susceptibility2GP6 CL E G H5120614388OMIM:614201Bleeding disorder, platelet-type, 11.24
HP:0011276HP:0000979Purpura2GP6 CL E G H5120614388OMIM:614201Bleeding disorder, platelet-type, 1124
HP:0011276HP:0000978Bruising susceptibility2GP9 CL E G H28154444ORPHA:274Bernard-Soulier syndromeHP:0040283 - Occasional21
HP:0011276HP:0007420Spontaneous hematomas2GP9 CL E G H28154444ORPHA:274Bernard-Soulier syndromeHP:0040282 - Frequent21
HP:0011276HP:0000979Purpura2GP9 CL E G H28154444ORPHA:274Bernard-Soulier syndrome21
HP:0011276HP:0000979Purpura2GP9 CL E G H28154444OMIM:231200BERNARD-SOULIER SYNDROME; BSS21
HP:0011276HP:0100585Telangiectasia of the skin2GPR35 CL E G H28594492ORPHA:171Primary sclerosing cholangitis2
HP:0011276HP:0001015Prominent superficial veins2GPR35 CL E G H28594492ORPHA:171Primary sclerosing cholangitis2
HP:0011276HP:0000978Bruising susceptibility2GSN CL E G H29344620ORPHA:85448AGel amyloidosisHP:0040282 - Frequent53
HP:0011276HP:0000978Bruising susceptibility2HBA1 CL E G H30394823ORPHA:98791Alpha-thalassemia-intellectual disability syndrome linked to chromosome 16HP:0040282 - Frequent200
HP:0011276HP:0000978Bruising susceptibility2HBA2 CL E G H30404824ORPHA:98791Alpha-thalassemia-intellectual disability syndrome linked to chromosome 16HP:0040282 - Frequent88
HP:0011276HP:0000978Bruising susceptibility2HEY2 CL E G H234934881ORPHA:91387Familial thoracic aortic aneurysm and aortic dissectionHP:0040283 - Occasional
HP:0011276HP:0000979Purpura2HIRA CL E G H72904916ORPHA:56722q11.2 deletion syndromeHP:0040283 - Occasional3
HP:0011276HP:0000979Purpura2HLA-DPA1 CL E G H31134938ORPHA:900Granulomatosis with polyangiitisHP:0040283 - Occasional
HP:0011276HP:0000979Purpura2HLA-DPB1 CL E G H31154940ORPHA:900Granulomatosis with polyangiitisHP:0040283 - Occasional1
HP:0011276HP:0100585Telangiectasia of the skin2HLA-DRB1 CL E G H31234948ORPHA:220393Diffuse cutaneous systemic sclerosisHP:0040282 - Frequent2
HP:0011276HP:0100585Telangiectasia of the skin2HLA-DRB1 CL E G H31234948ORPHA:220402Limited cutaneous systemic sclerosisHP:0040282 - Frequent2
HP:0011276HP:0100579Mucosal telangiectasiae2HLA-DRB1 CL E G H31234948ORPHA:220402Limited cutaneous systemic sclerosisHP:0040282 - Frequent2
HP:0011276HP:0000979Purpura2HOXA11 CL E G H32075101OMIM:605432Radioulnar synostosis with amegakaryocytic thrombocytopenia.3
HP:0011276HP:0000979Purpura2HPS1 CL E G H32575163OMIM:203300Hermansky-Pudlak syndrome 1121
HP:0011276HP:0000978Bruising susceptibility2HPS1 CL E G H32575163OMIM:203300Hermansky-Pudlak syndrome 1.121
HP:0011276HP:0000978Bruising susceptibility2HPS3 CL E G H8434315597OMIM:614072Hermansky-Pudlak syndrome 3.67
HP:0011276HP:0000978Bruising susceptibility2HPS4 CL E G H8978115844OMIM:614073Hermansky-Pudlak syndrome 4.123
HP:0011276HP:0000978Bruising susceptibility2HPS5 CL E G H1123417022OMIM:614074Hermansky-Pudlak syndrome 5.105
HP:0011276HP:0000979Purpura2HPS6 CL E G H7980318817OMIM:614075Hermansky-Pudlak syndrome 645
HP:0011276HP:0000978Bruising susceptibility2HPS6 CL E G H7980318817OMIM:614075Hermansky-Pudlak syndrome 6.45
HP:0011276HP:0100585Telangiectasia of the skin2IARS2 CL E G H5569929685OMIM:616007Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia25
HP:0011276HP:0000979Purpura2ICOS CL E G H298515351ORPHA:1572Common variable immunodeficiencyHP:0040282 - Frequent32
HP:0011276HP:0000979Purpura2IFNG CL E G H34585438ORPHA:88Idiopathic aplastic anemia23
HP:0011276HP:0100585Telangiectasia of the skin2IKBKG CL E G H85175961ORPHA:464Incontinentia pigmentiHP:0040281 - Very frequent52
HP:0011276HP:0410134Physical urticaria2IL12A CL E G H35925969ORPHA:186Primary biliary cholangitis
HP:0011276HP:0410134Physical urticaria2IL12RB1 CL E G H35945971ORPHA:186Primary biliary cholangitis46
HP:0011276HP:0100585Telangiectasia of the skin2IL7 CL E G H35746023ORPHA:302Epidermodysplasia verruciformisHP:0040283 - Occasional
HP:0011276HP:0000978Bruising susceptibility2IPO8 CL E G H105269853ORPHA:60030Loeys-Dietz syndromeHP:0040283 - Occasional
HP:0011276HP:0000978Bruising susceptibility2IPO8 CL E G H105269853OMIM:619472VISS syndrome
HP:0011276HP:0000979Purpura2IRF2BP2 CL E G H35994821729ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent4
HP:0011276HP:0000978Bruising susceptibility2IRF2BP2 CL E G H35994821729ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent4
HP:0011276HP:0000979Purpura2IRF2BP2 CL E G H35994821729ORPHA:1572Common variable immunodeficiencyHP:0040282 - Frequent4
HP:0011276HP:0100585Telangiectasia of the skin2IRF5 CL E G H36636120ORPHA:220393Diffuse cutaneous systemic sclerosisHP:0040282 - Frequent4
HP:0011276HP:0100579Mucosal telangiectasiae2IRF5 CL E G H36636120ORPHA:220402Limited cutaneous systemic sclerosisHP:0040282 - Frequent4
HP:0011276HP:0100585Telangiectasia of the skin2IRF5 CL E G H36636120ORPHA:220402Limited cutaneous systemic sclerosisHP:0040282 - Frequent4
HP:0011276HP:0410134Physical urticaria2IRF5 CL E G H36636120ORPHA:186Primary biliary cholangitis4
HP:0011276HP:0007420Spontaneous hematomas2ITGA2 CL E G H36736137ORPHA:853Fetal and neonatal alloimmune thrombocytopeniaHP:0040282 - Frequent119
HP:0011276HP:0000979Purpura2ITGA2 CL E G H36736137ORPHA:853Fetal and neonatal alloimmune thrombocytopeniaHP:0040282 - Frequent119
HP:0011276HP:0000979Purpura2ITGA2B CL E G H36746138OMIM:187800Bleeding disorder, platelet-type, 1669
HP:0011276HP:0000979Purpura2ITGA2B CL E G H36746138ORPHA:853Fetal and neonatal alloimmune thrombocytopeniaHP:0040282 - Frequent69
HP:0011276HP:0007420Spontaneous hematomas2ITGA2B CL E G H36746138ORPHA:853Fetal and neonatal alloimmune thrombocytopeniaHP:0040282 - Frequent69
HP:0011276HP:0000979Purpura2ITGA2B CL E G H36746138ORPHA:849Glanzmann thrombastheniaHP:0040283 - Occasional69
HP:0011276HP:0000978Bruising susceptibility2ITGA2B CL E G H36746138OMIM:273800Glanzmann thrombasthenia.69
HP:0011276HP:0007420Spontaneous hematomas2ITGA2B CL E G H36746138ORPHA:849Glanzmann thrombastheniaHP:0040283 - Occasional69
HP:0011276HP:0000978Bruising susceptibility2ITGA2B CL E G H36746138ORPHA:849Glanzmann thrombastheniaHP:0040282 - Frequent69
HP:0011276HP:0000979Purpura2ITGA2B CL E G H36746138OMIM:273800Glanzmann thrombasthenia.69
HP:0011276HP:0000979Purpura2ITGB3 CL E G H36906156ORPHA:853Fetal and neonatal alloimmune thrombocytopeniaHP:0040282 - Frequent80
HP:0011276HP:0007420Spontaneous hematomas2ITGB3 CL E G H36906156ORPHA:853Fetal and neonatal alloimmune thrombocytopeniaHP:0040282 - Frequent80
HP:0011276HP:0000978Bruising susceptibility2ITGB3 CL E G H36906156ORPHA:849Glanzmann thrombastheniaHP:0040282 - Frequent80
HP:0011276HP:0000979Purpura2ITGB3 CL E G H36906156ORPHA:849Glanzmann thrombastheniaHP:0040283 - Occasional80
HP:0011276HP:0007420Spontaneous hematomas2ITGB3 CL E G H36906156ORPHA:849Glanzmann thrombastheniaHP:0040283 - Occasional80
HP:0011276HP:0000978Bruising susceptibility2ITGB3 CL E G H36906156OMIM:619267GLANZMANN THROMBASTHENIA 2; GT280
HP:0011276HP:0000979Purpura2JAK2 CL E G H37176192OMIM:254450Myelofibrosismyelofibrosis with myeloid metaplasia, included57
HP:0011276HP:0000978Bruising susceptibility2JAK2 CL E G H37176192ORPHA:729Polycythemia veraHP:0040281 - Very frequent57
HP:0011276HP:0000979Purpura2JAK2 CL E G H37176192ORPHA:824Primary myelofibrosisHP:0040283 - Occasional57
HP:0011276HP:0000979Purpura2JMJD1C CL E G H22103712313ORPHA:56722q11.2 deletion syndromeHP:0040283 - Occasional2
HP:0011276HP:0001041Facial erythema2KCNQ2 CL E G H37856296ORPHA:439218KCNQ2-related epileptic encephalopathyHP:0040282 - Frequent528
HP:0011276HP:0100585Telangiectasia of the skin2KIAA0319L CL E G H7993230071ORPHA:220402Limited cutaneous systemic sclerosisHP:0040282 - Frequent
HP:0011276HP:0100579Mucosal telangiectasiae2KIAA0319L CL E G H7993230071ORPHA:220402Limited cutaneous systemic sclerosisHP:0040282 - Frequent
HP:0011276HP:0100585Telangiectasia of the skin2KIT CL E G H38156342ORPHA:79455Cutaneous mastocytoma327
HP:0011276HP:0007583Telangiectasia macularis eruptiva perstans2KIT CL E G H38156342ORPHA:79455Cutaneous mastocytoma327
HP:0011276HP:0025081Darier's sign2KIT CL E G H38156342ORPHA:79455Cutaneous mastocytoma327
HP:0011276HP:0410134Physical urticaria2KIT CL E G H38156342ORPHA:79455Cutaneous mastocytoma327
HP:0011276HP:0007583Telangiectasia macularis eruptiva perstans2KIT CL E G H38156342OMIM:154800Mastocytosis, cutaneous.327
HP:0011276HP:0100579Mucosal telangiectasiae2KLLN CL E G H10014474837212ORPHA:201Cowden syndromeHP:0040282 - Frequent1
HP:0011276HP:0000978Bruising susceptibility2KRAS CL E G H38456407OMIM:609942Noonan syndrome 3196
HP:0011276HP:0031180Erythema migrans2KRT5 CL E G H38526442ORPHA:158681Epidermolysis bullosa simplex with circinate migratory erythemaHP:0040282 - Frequent173
HP:0011276HP:0031180Erythema migrans2KRT5 CL E G H38526442OMIM:609352EPIDERMOLYSIS BULLOSA SIMPLEX WITH MIGRATORY CIRCINATE ERYTHEMA173
HP:0011276HP:0100585Telangiectasia of the skin2LBR CL E G H39306518OMIM:613471Reynolds syndrome70
HP:0011276HP:0100585Telangiectasia of the skin2LBR CL E G H39306518ORPHA:779Reynolds syndromeHP:0040282 - Frequent70
HP:0011276HP:0100579Mucosal telangiectasiae2LBR CL E G H39306518OMIM:613471Reynolds syndrome70
HP:0011276HP:0100579Mucosal telangiectasiae2LBR CL E G H39306518ORPHA:779Reynolds syndromeHP:0040282 - Frequent70
HP:0011276HP:0000979Purpura2LCP2 CL E G H39376529OMIM:619374IMMUNODEFICIENCY 81; IMD81
HP:0011276HP:0001015Prominent superficial veins2LEMD2 CL E G H22149621244OMIM:619322MARBACH-RUSTAD PROGEROID SYNDROME; MARUPS1
HP:0011276HP:0100579Mucosal telangiectasiae2LIG1 CL E G H39786598OMIM:619774IMMUNODEFICIENCY 96; IMD969
HP:0011276HP:0100585Telangiectasia of the skin2LIG4 CL E G H39816601ORPHA:99812LIG4 syndromeHP:0040283 - Occasional88
HP:0011276HP:0000978Bruising susceptibility2LMAN1 CL E G H39986631ORPHA:35909Combined deficiency of factor V and factor VIIIHP:0040282 - Frequent56
HP:0011276HP:0100585Telangiectasia of the skin2LMNA CL E G H40006636ORPHA:79474Atypical Werner syndromeHP:0040281 - Very frequent645
HP:0011276HP:0001015Prominent superficial veins2LMNA CL E G H40006636ORPHA:79474Atypical Werner syndromeHP:0040281 - Very frequent645
HP:0011276HP:0001015Prominent superficial veins2LMNA CL E G H40006636OMIM:151660Lipodystrophy, familial partial, type 2.645
HP:0011276HP:0000978Bruising susceptibility2LOX CL E G H40156664ORPHA:91387Familial thoracic aortic aneurysm and aortic dissectionHP:0040283 - Occasional6
HP:0011276HP:0007763Retinal telangiectasia2LRP5 CL E G H40416697ORPHA:891Familial exudative vitreoretinopathy125
HP:0011276HP:0000978Bruising susceptibility2LYST CL E G H11301968ORPHA:352723Attenuated Chédiak-Higashi syndromeHP:0040281 - Very frequent239
HP:0011276HP:0000978Bruising susceptibility2LYST CL E G H11301968ORPHA:167Chédiak-Higashi syndromeHP:0040282 - Frequent239
HP:0011276HP:0000978Bruising susceptibility2LYST CL E G H11301968OMIM:214500Chediak-Higashi syndrome239
HP:0011276HP:0000978Bruising susceptibility2MAP2K1 CL E G H56046840OMIM:163950Noonan syndrome 1134
HP:0011276HP:0000978Bruising susceptibility2MAPK1 CL E G H55946871OMIM:619087NOONAN SYNDROME 13; NS132
HP:0011276HP:0100579Mucosal telangiectasiae2MASP1 CL E G H56486901OMIM:2579203mc syndrome 121
HP:0011276HP:0000978Bruising susceptibility2MAT2A CL E G H41446904ORPHA:91387Familial thoracic aortic aneurysm and aortic dissectionHP:0040283 - Occasional13
HP:0011276HP:0001041Facial erythema2MBTPS2 CL E G H5136015455OMIM:308800Keratosis follicularis spinulosa decalvans, X-linked.22
HP:0011276HP:0000978Bruising susceptibility2MCFD2 CL E G H9041118451ORPHA:35909Combined deficiency of factor V and factor VIIIHP:0040282 - Frequent77
HP:0011276HP:0000978Bruising susceptibility2MFAP5 CL E G H807629673ORPHA:91387Familial thoracic aortic aneurysm and aortic dissectionHP:0040283 - Occasional11
HP:0011276HP:0410134Physical urticaria2MMEL1 CL E G H7925814668ORPHA:186Primary biliary cholangitis
HP:0011276HP:0000979Purpura2MPL CL E G H43527217OMIM:254450Myelofibrosismyelofibrosis with myeloid metaplasia, included97
HP:0011276HP:0000978Bruising susceptibility2MPL CL E G H43527217ORPHA:729Polycythemia veraHP:0040281 - Very frequent97
HP:0011276HP:0000979Purpura2MPL CL E G H43527217ORPHA:824Primary myelofibrosisHP:0040283 - Occasional97
HP:0011276HP:0000979Purpura2MS4A1 CL E G H9317315ORPHA:1572Common variable immunodeficiencyHP:0040282 - Frequent1
HP:0011276HP:0001015Prominent superficial veins2MST1 CL E G H44857380ORPHA:171Primary sclerosing cholangitis1
HP:0011276HP:0100585Telangiectasia of the skin2MST1 CL E G H44857380ORPHA:171Primary sclerosing cholangitis1
HP:0011276HP:0000978Bruising susceptibility2MTAP CL E G H45077413OMIM:112250Diaphyseal medullary stenosis with malignant fibrous histiocytomaHP:0040283 - Occasional85
HP:0011276HP:0000979Purpura2MVK CL E G H45987530ORPHA:343Hyperimmunoglobulinemia D with periodic feverHP:0040283 - Occasional150
HP:0011276HP:0000979Purpura2MYD88 CL E G H46157562ORPHA:33226Waldenström macroglobulinemiaHP:0040283 - Occasional9
HP:0011276HP:0033505Livedo reticularis2MYH11 CL E G H46297569OMIM:132900Aortic aneurysm, familial thoracic 4418
HP:0011276HP:0000978Bruising susceptibility2MYH11 CL E G H46297569ORPHA:91387Familial thoracic aortic aneurysm and aortic dissectionHP:0040283 - Occasional418
HP:0011276HP:0000978Bruising susceptibility2MYH9 CL E G H46277579OMIM:155100Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss.297
HP:0011276HP:0000978Bruising susceptibility2MYH9 CL E G H46277579ORPHA:182050MYH9-related diseaseHP:0040282 - Frequent297
HP:0011276HP:0000978Bruising susceptibility2MYLK CL E G H46387590ORPHA:91387Familial thoracic aortic aneurysm and aortic dissectionHP:0040283 - Occasional326
HP:0011276HP:0000979Purpura2NABP1 CL E G H6485926232ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent
HP:0011276HP:0000978Bruising susceptibility2NABP1 CL E G H6485926232ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent
HP:0011276HP:0100585Telangiectasia of the skin2NAGA CL E G H46687631ORPHA:79279Alpha-N-acetylgalactosaminidase deficiency type 1HP:0040282 - Frequent47
HP:0011276HP:0100585Telangiectasia of the skin2NAGA CL E G H46687631ORPHA:79280Alpha-N-acetylgalactosaminidase deficiency type 2HP:0040281 - Very frequent47
HP:0011276HP:0100579Mucosal telangiectasiae2NAGA CL E G H46687631ORPHA:79280Alpha-N-acetylgalactosaminidase deficiency type 247
HP:0011276HP:0001071Angiokeratoma corporis diffusum2NAGA CL E G H46687631ORPHA:79280Alpha-N-acetylgalactosaminidase deficiency type 2HP:0040281 - Very frequent47
HP:0011276HP:0100579Mucosal telangiectasiae2NAGA CL E G H46687631OMIM:609242Kanzaki disease47
HP:0011276HP:0001071Angiokeratoma corporis diffusum2NAGA CL E G H46687631OMIM:609242Kanzaki disease.47
HP:0011276HP:0000978Bruising susceptibility2NBEAL2 CL E G H2321831928OMIM:139090Gray platelet syndrome.127
HP:0011276HP:0000978Bruising susceptibility2NBEAL2 CL E G H2321831928ORPHA:721Gray platelet syndromeHP:0040281 - Very frequent127
HP:0011276HP:0007763Retinal telangiectasia2ND1 CL E G H45357455ORPHA:104Leber hereditary optic neuropathyHP:0040282 - Frequent
HP:0011276HP:0007763Retinal telangiectasia2ND2 CL E G H45367456ORPHA:104Leber hereditary optic neuropathyHP:0040282 - Frequent
HP:0011276HP:0007763Retinal telangiectasia2ND4 CL E G H45387459ORPHA:104Leber hereditary optic neuropathyHP:0040282 - Frequent
HP:0011276HP:0007763Retinal telangiectasia2ND4L CL E G H45397460ORPHA:104Leber hereditary optic neuropathyHP:0040282 - Frequent
HP:0011276HP:0007763Retinal telangiectasia2ND5 CL E G H45407461ORPHA:104Leber hereditary optic neuropathyHP:0040282 - Frequent
HP:0011276HP:0007763Retinal telangiectasia2ND6 CL E G H45417462ORPHA:104Leber hereditary optic neuropathyHP:0040282 - Frequent
HP:0011276HP:0007763Retinal telangiectasia2NDP CL E G H46937678ORPHA:891Familial exudative vitreoretinopathy39
HP:0011276HP:0007763Retinal telangiectasia2NDUFS2 CL E G H47207708ORPHA:104Leber hereditary optic neuropathyHP:0040282 - Frequent65
HP:0011276HP:0000979Purpura2NEU1 CL E G H47587758ORPHA:93400Congenital sialidosis type 243
HP:0011276HP:0100585Telangiectasia of the skin2NF1 CL E G H47637765ORPHA:9768517q11 microdeletion syndromeHP:0040282 - Frequent1952
HP:0011276HP:0000978Bruising susceptibility2NFIX CL E G H47847788ORPHA:561Marshall-Smith syndromeHP:0040282 - Frequent40
HP:0011276HP:0000979Purpura2NFKB1 CL E G H47907794ORPHA:1572Common variable immunodeficiencyHP:0040282 - Frequent7
HP:0011276HP:0000979Purpura2NFKB2 CL E G H47917795ORPHA:1572Common variable immunodeficiencyHP:0040282 - Frequent11
HP:0011276HP:0100585Telangiectasia of the skin2NHP2 CL E G H5565114377ORPHA:1775Dyskeratosis congenitaHP:0040282 - Frequent27
HP:0011276HP:0000979Purpura2NLRP3 CL E G H11454816400ORPHA:1451CINCA syndromeHP:0040283 - Occasional217
HP:0011276HP:0100585Telangiectasia of the skin2NOP10 CL E G H5550514378ORPHA:1775Dyskeratosis congenitaHP:0040282 - Frequent17
HP:0011276HP:0000978Bruising susceptibility2NPM1 CL E G H48697910ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent12
HP:0011276HP:0000979Purpura2NPM1 CL E G H48697910ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent12
HP:0011276HP:0100585Telangiectasia of the skin2NPM1 CL E G H48697910ORPHA:1775Dyskeratosis congenitaHP:0040282 - Frequent12
HP:0011276HP:0000979Purpura2NR3C1 CL E G H29087978ORPHA:96253Cushing disease79
HP:0011276HP:0000978Bruising susceptibility2NR3C1 CL E G H29087978ORPHA:96253Cushing diseaseHP:0040282 - Frequent79
HP:0011276HP:0000978Bruising susceptibility2NTRK1 CL E G H49148031ORPHA:642Hereditary sensory and autonomic neuropathy type 4HP:0040283 - Occasional97
HP:0011276HP:0000978Bruising susceptibility2NUMA1 CL E G H49268059ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent
HP:0011276HP:0000979Purpura2NUMA1 CL E G H49268059ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent
HP:0011276HP:0000979Purpura2OCLN CL E G H1005066588104OMIM:251290Band-Like calcification with simplified gyration and polymicrogyria23
HP:0011276HP:0000979Purpura2ORAI1 CL E G H8487625896ORPHA:3204Stormorken-Sjaastad-Langslet syndromeHP:0040281 - Very frequent19
HP:0011276HP:0000979Purpura2P2RY12 CL E G H6480518124OMIM:609821Bleeding disorder, platelet-type, 85
HP:0011276HP:0000978Bruising susceptibility2P2RY12 CL E G H6480518124OMIM:609821Bleeding disorder, platelet-type, 85
HP:0011276HP:0100585Telangiectasia of the skin2PARN CL E G H50738609ORPHA:1775Dyskeratosis congenitaHP:0040282 - Frequent26
HP:0011276HP:0100579Mucosal telangiectasiae2PCNA CL E G H51118729OMIM:615919Ataxia-Telangiectasia-Like disorder 21
HP:0011276HP:0100585Telangiectasia of the skin2PCNA CL E G H51118729ORPHA:438134PCNA-related progressive neurodegenerative photosensitivity syndromeHP:0040281 - Very frequent1
HP:0011276HP:0007763Retinal telangiectasia2PCNA CL E G H51118729ORPHA:438134PCNA-related progressive neurodegenerative photosensitivity syndromeHP:0040282 - Frequent1
HP:0011276HP:0000978Bruising susceptibility2PDE11A CL E G H509408773ORPHA:1359Carney complex13
HP:0011276HP:0000978Bruising susceptibility2PDE11A CL E G H509408773OMIM:610475Pigmented nodular adrenocortical disease, primary, 2.13
HP:0011276HP:0000978Bruising susceptibility2PDE11A CL E G H509408773ORPHA:189439Primary pigmented nodular adrenocortical disease13
HP:0011276HP:0000978Bruising susceptibility2PDE8B CL E G H86228794ORPHA:189439Primary pigmented nodular adrenocortical disease75
HP:0011276HP:0007489Diffuse telangiectasia2PEPD CL E G H51848840OMIM:170100Prolidase deficiency.66
HP:0011276HP:0000979Purpura2PEPD CL E G H51848840OMIM:170100Prolidase deficiency66
HP:0011276HP:0100579Mucosal telangiectasiae2PEX6 CL E G H51908859ORPHA:95433Autosomal recessive spinocerebellar ataxia-blindness-deafness syndrome98
HP:0011276HP:0100579Mucosal telangiectasiae2PIK3CA CL E G H52908975ORPHA:201Cowden syndromeHP:0040282 - Frequent162
HP:0011276HP:0100585Telangiectasia of the skin2PIK3CA CL E G H52908975ORPHA:276280Hemihyperplasia-multiple lipomatosis syndromeHP:0040283 - Occasional162
HP:0011276HP:0100585Telangiectasia of the skin2PIK3CA CL E G H52908975ORPHA:60040Megalencephaly-capillary malformation-polymicrogyria syndromeHP:0040281 - Very frequent162
HP:0011276HP:0000978Bruising susceptibility2PLAU CL E G H53289052OMIM:601709Quebec platelet disorder.50
HP:0011276HP:0410134Physical urticaria2PLCG2 CL E G H53369066OMIM:614468FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 3; FCAS321
HP:0011276HP:0000978Bruising susceptibility2PLEC CL E G H53399069OMIM:131950Epidermolysis bullosa simplex, Ogna type.759
HP:0011276HP:0000978Bruising susceptibility2PLOD1 CL E G H53519081OMIM:225400Ehlers-Danlos syndrome, kyphoscoliotic type, 1105
HP:0011276HP:0000978Bruising susceptibility2PLOD1 CL E G H53519081ORPHA:1900Kyphoscoliotic Ehlers-Danlos syndrome due to lysyl hydroxylase 1 deficiencyHP:0040281 - Very frequent105
HP:0011276HP:0000978Bruising susceptibility2PLOD3 CL E G H89859083OMIM:612394Bone fragility with contractures, arterial rupture, and deafness.5
HP:0011276HP:0000979Purpura2PML CL E G H53719113ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent3
HP:0011276HP:0000978Bruising susceptibility2PML CL E G H53719113ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent3
HP:0011276HP:0100585Telangiectasia of the skin2POLE CL E G H54269177OMIM:615139Facial dysmorphism, immunodeficiency, livedo, and short stature1129
HP:0011276HP:0001015Prominent superficial veins2POLR3A CL E G H1112830074OMIM:264090Wiedemann-Rautenstrauch syndrome138
HP:0011276HP:0001015Prominent superficial veins2POLR3A CL E G H1112830074ORPHA:3455Wiedemann-Rautenstrauch syndrome138
HP:0011276HP:0100585Telangiectasia of the skin2PORCN CL E G H6484017652ORPHA:2092Focal dermal hypoplasiaHP:0040281 - Very frequent20
HP:0011276HP:0410134Physical urticaria2POU2AF1 CL E G H54509211ORPHA:186Primary biliary cholangitis
HP:0011276HP:0001015Prominent superficial veins2PPARG CL E G H54689236ORPHA:528Congenital generalized lipodystrophyHP:0040283 - Occasional42
HP:0011276HP:0001015Prominent superficial veins2PPARG CL E G H54689236OMIM:604367Lipodystrophy, familial partial, type 3.42
HP:0011276HP:0001015Prominent superficial veins2PPARG CL E G H54689236ORPHA:79083PPARG-related familial partial lipodystrophy42
HP:0011276HP:0001015Prominent superficial veins2PPP1R15B CL E G H8491914951OMIM:616817Microcephaly, short stature, and impaired glucose metabolism 2HP:0040283 - Occasional2
HP:0011276HP:0000978Bruising susceptibility2PRDM5 CL E G H111079349ORPHA:90354Brittle cornea syndromeHP:0040282 - Frequent58
HP:0011276HP:0000979Purpura2PRF1 CL E G H55519360ORPHA:540Familial hemophagocytic lymphohistiocytosisHP:0040282 - Frequent58
HP:0011276HP:0000978Bruising susceptibility2PRF1 CL E G H55519360ORPHA:540Familial hemophagocytic lymphohistiocytosisHP:0040283 - Occasional58
HP:0011276HP:0000979Purpura2PRF1 CL E G H55519360ORPHA:88Idiopathic aplastic anemia58
HP:0011276HP:0000978Bruising susceptibility2PRKACA CL E G H55669380OMIM:615830Pigmented nodular adrenocortical disease, primary, 4.2
HP:0011276HP:0000978Bruising susceptibility2PRKACA CL E G H55669380ORPHA:189439Primary pigmented nodular adrenocortical disease2
HP:0011276HP:0007420Spontaneous hematomas2PRKACG CL E G H55689382OMIM:616176Bleeding disorder, platelet-type, 19.2
HP:0011276HP:0000979Purpura2PRKAR1A CL E G H55739388ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent134
HP:0011276HP:0000978Bruising susceptibility2PRKAR1A CL E G H55739388ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent134
HP:0011276HP:0000978Bruising susceptibility2PRKAR1A CL E G H55739388ORPHA:1359Carney complex134
HP:0011276HP:0000978Bruising susceptibility2PRKAR1A CL E G H55739388OMIM:610489Pigmented nodular adrenocortical disease, primary, 1.134
HP:0011276HP:0000978Bruising susceptibility2PRKAR1A CL E G H55739388ORPHA:189439Primary pigmented nodular adrenocortical disease134
HP:0011276HP:0000978Bruising susceptibility2PRKCD CL E G H55809399ORPHA:3261Autoimmune lymphoproliferative syndromeHP:0040282 - Frequent10
HP:0011276HP:0000979Purpura2PRKCD CL E G H55809399ORPHA:1572Common variable immunodeficiencyHP:0040282 - Frequent10
HP:0011276HP:0000978Bruising susceptibility2PRKG1 CL E G H55929414ORPHA:91387Familial thoracic aortic aneurysm and aortic dissectionHP:0040283 - Occasional41
HP:0011276HP:0000979Purpura2PROC CL E G H56249451ORPHA:745Severe hereditary thrombophilia due to congenital protein C deficiencyHP:0040282 - Frequent65
HP:0011276HP:0000979Purpura2PROC CL E G H56249451OMIM:612304Thrombophilia due to protein C deficiency, autosomal recessive.65
HP:0011276HP:0000979Purpura2PROS1 CL E G H56279456ORPHA:743Severe hereditary thrombophilia due to congenital protein S deficiencyHP:0040281 - Very frequent75
HP:0011276HP:0000979Purpura2PROS1 CL E G H56279456OMIM:614514Thrombophilia due to protein S deficiency, autosomal recessive.75
HP:0011276HP:0000979Purpura2PROS1 CL E G H56279456OMIM:612336Thrombophilia, hereditary, due to protein S deficiency, autosomal.75
HP:0011276HP:0000979Purpura2PRTN3 CL E G H56579495ORPHA:900Granulomatosis with polyangiitisHP:0040283 - Occasional
HP:0011276HP:0001015Prominent superficial veins2PTDSS1 CL E G H97919587OMIM:151050Lenz-Majewski hyperostotic dwarfism6
HP:0011276HP:0100579Mucosal telangiectasiae2PTEN CL E G H57289588ORPHA:201Cowden syndromeHP:0040282 - Frequent948
HP:0011276HP:0000978Bruising susceptibility2PTPN11 CL E G H57819644OMIM:163950Noonan syndrome 1291
HP:0011276HP:0000979Purpura2PTPN22 CL E G H261919652ORPHA:900Granulomatosis with polyangiitisHP:0040283 - Occasional3
HP:0011276HP:0000978Bruising susceptibility2PYCR1 CL E G H58319721OMIM:612940Cutis laxa, autosomal recessive, type IIB53
HP:0011276HP:0001015Prominent superficial veins2PYCR1 CL E G H58319721OMIM:612940Cutis laxa, autosomal recessive, type IIB.53
HP:0011276HP:0001015Prominent superficial veins2PYCR1 CL E G H58319721OMIM:614438Cutis laxa, autosomal recessive, type IIIB53
HP:0011276HP:0000979Purpura2RAB27A CL E G H58739766ORPHA:79477Griscelli syndrome type 267
HP:0011276HP:0000978Bruising susceptibility2RARA CL E G H59149864ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent2
HP:0011276HP:0000979Purpura2RARA CL E G H59149864ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent2
HP:0011276HP:0000978Bruising susceptibility2RASGRP1 CL E G H101259878ORPHA:3261Autoimmune lymphoproliferative syndromeHP:0040282 - Frequent
HP:0011276HP:0001041Facial erythema2RECQL4 CL E G H94019949ORPHA:221016Rothmund-Thomson syndrome type 2HP:0040282 - Frequent445
HP:0011276HP:0001041Facial erythema2RHOH CL E G H399686OMIM:618307Epidermodysplasia verruciformis, susceptibility to, 4.
HP:0011276HP:0000978Bruising susceptibility2RIN2 CL E G H5445318750OMIM:613075Macs syndrome.43
HP:0011276HP:0000978Bruising susceptibility2RIN2 CL E G H5445318750ORPHA:217335RIN2 syndromeHP:0040282 - Frequent43
HP:0011276HP:0100579Mucosal telangiectasiae2RNF168 CL E G H16591826661ORPHA:420741RIDDLE syndrome7
HP:0011276HP:0000979Purpura2RREB1 CL E G H623910449ORPHA:56722q11.2 deletion syndromeHP:0040283 - Occasional
HP:0011276HP:0100585Telangiectasia of the skin2RTEL1 CL E G H5175015888ORPHA:1775Dyskeratosis congenitaHP:0040282 - Frequent77
HP:0011276HP:0000978Bruising susceptibility2RUNX1 CL E G H86110471OMIM:601399Platelet disorder, familial, with associated myeloid malignancy.181
HP:0011276HP:0000979Purpura2SAMD9 CL E G H548091348OMIM:617053Mirage syndrome8
HP:0011276HP:0000979Purpura2SBDS CL E G H5111919440ORPHA:88Idiopathic aplastic anemia26
HP:0011276HP:0000978Bruising susceptibility2SCARB2 CL E G H9501665ORPHA:77259Gaucher disease type 1HP:0040282 - Frequent77
HP:0011276HP:0100579Mucosal telangiectasiae2SDHB CL E G H639010681ORPHA:201Cowden syndromeHP:0040282 - Frequent237
HP:0011276HP:0100579Mucosal telangiectasiae2SDHC CL E G H639110682ORPHA:201Cowden syndromeHP:0040282 - Frequent147
HP:0011276HP:0100585Telangiectasia of the skin2SDHD CL E G H639210683ORPHA:100093Carcinoid syndrome129
HP:0011276HP:0100579Mucosal telangiectasiae2SDHD CL E G H639210683ORPHA:201Cowden syndromeHP:0040282 - Frequent129
HP:0011276HP:0100579Mucosal telangiectasiae2SEC23B CL E G H1048310702ORPHA:201Cowden syndromeHP:0040282 - Frequent60
HP:0011276HP:0000979Purpura2SEC24C CL E G H963210705ORPHA:56722q11.2 deletion syndromeHP:0040283 - Occasional
HP:0011276HP:0001015Prominent superficial veins2SEMA4D CL E G H1050710732ORPHA:171Primary sclerosing cholangitis
HP:0011276HP:0100585Telangiectasia of the skin2SEMA4D CL E G H1050710732ORPHA:171Primary sclerosing cholangitis
HP:0011276HP:0000978Bruising susceptibility2SERPINF2 CL E G H53459075ORPHA:79Congenital alpha2-antiplasmin deficiencyHP:0040283 - Occasional8
HP:0011276HP:0000978Bruising susceptibility2SERPINF2 CL E G H53459075OMIM:262850Plasmin inhibitor deficiency.8
HP:0011276HP:0410134Physical urticaria2SERPING1 CL E G H7101228ORPHA:100050Hereditary angioedema type 164
HP:0011276HP:0100579Mucosal telangiectasiae2SETX CL E G H23064445OMIM:606002Spinocerebellar ataxia, autosomal recessive 1162
HP:0011276HP:0000979Purpura2SH2B3 CL E G H1001929605OMIM:254450Myelofibrosismyelofibrosis with myeloid metaplasia, included4
HP:0011276HP:0000978Bruising susceptibility2SIK3 CL E G H2338729165OMIM:618162Spondyloepimetaphyseal dysplasia, Krakow type.
HP:0011276HP:0001015Prominent superficial veins2SLC25A24 CL E G H2995720662OMIM:612289Fontaine progeroid syndrome
HP:0011276HP:0410134Physical urticaria2SLC27A4 CL E G H1099910998OMIM:608649ICHTHYOSIS PREMATURITY SYNDROME; IPS26
HP:0011276HP:0100585Telangiectasia of the skin2SLC29A3 CL E G H5531523096ORPHA:168569H syndrome68
HP:0011276HP:0100585Telangiectasia of the skin2SLC29A3 CL E G H5531523096OMIM:602782Histiocytosis-lymphadenopathy plus syndrome68
HP:0011276HP:0000978Bruising susceptibility2SLC2A10 CL E G H8103113444OMIM:208050Arterial tortuosity syndrome.178
HP:0011276HP:0100585Telangiectasia of the skin2SLC2A10 CL E G H8103113444OMIM:208050Arterial tortuosity syndrome178
HP:0011276HP:0100585Telangiectasia of the skin2SLC2A10 CL E G H8103113444ORPHA:3342Arterial tortuosity syndromeHP:0040281 - Very frequent178
HP:0011276HP:0000978Bruising susceptibility2SLC37A4 CL E G H25424061ORPHA:79259Glycogen storage disease due to glucose-6-phosphatase deficiency type IbHP:0040283 - Occasional110
HP:0011276HP:0100585Telangiectasia of the skin2SLC37A4 CL E G H25424061OMIM:232240GLYCOGEN STORAGE DISEASE Ic110
HP:0011276HP:0001015Prominent superficial veins2SLC39A13 CL E G H9125220859OMIM:612350Ehlers-Danlos syndrome, spondylodysplastic type, 3.24
HP:0011276HP:0000978Bruising susceptibility2SLC39A13 CL E G H9125220859OMIM:612350Ehlers-Danlos syndrome, spondylodysplastic type, 3.24
HP:0011276HP:0000978Bruising susceptibility2SLC39A13 CL E G H9125220859ORPHA:157965SLC39A13-related spondylodysplastic Ehlers-Danlos syndromeHP:0040281 - Very frequent24
HP:0011276HP:0033195Perianal erythema2SLC39A4 CL E G H5563017129OMIM:201100Acrodermatitis enteropathica, Zinc-Deficiency type55
HP:0011276HP:0033194Perioral erythema2SLC39A4 CL E G H5563017129OMIM:201100Acrodermatitis enteropathica, Zinc-Deficiency type55
HP:0011276HP:0000978Bruising susceptibility2SLC51A CL E G H20093129955OMIM:619484CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 6; PFIC6
HP:0011276HP:0000978Bruising susceptibility2SLFN14 CL E G H34261832689OMIM:616913Bleeding disorder, platelet-type, 20.6
HP:0011276HP:0033194Perioral erythema2SLURP1 CL E G H5715218746OMIM:248300Meleda disease15
HP:0011276HP:0000978Bruising susceptibility2SMAD2 CL E G H40876768ORPHA:91387Familial thoracic aortic aneurysm and aortic dissectionHP:0040283 - Occasional7
HP:0011276HP:0000978Bruising susceptibility2SMAD3 CL E G H40886769ORPHA:284984Aneurysm-osteoarthritis syndromeHP:0040282 - Frequent260
HP:0011276HP:0000978Bruising susceptibility2SMAD3 CL E G H40886769ORPHA:91387Familial thoracic aortic aneurysm and aortic dissectionHP:0040283 - Occasional260
HP:0011276HP:0000978Bruising susceptibility2SMAD3 CL E G H40886769OMIM:613795LOEYS-DIETZ SYNDROME 3; LDS3260
HP:0011276HP:0000978Bruising susceptibility2SMAD4 CL E G H40896770ORPHA:91387Familial thoracic aortic aneurysm and aortic dissectionHP:0040283 - Occasional504
HP:0011276HP:0007420Spontaneous hematomas2SMAD4 CL E G H40896770ORPHA:774Hereditary hemorrhagic telangiectasiaHP:0040282 - Frequent504
HP:0011276HP:0007763Retinal telangiectasia2SMAD4 CL E G H40896770ORPHA:774Hereditary hemorrhagic telangiectasiaHP:0040283 - Occasional504
HP:0011276HP:0100579Mucosal telangiectasiae2SMAD4 CL E G H40896770ORPHA:774Hereditary hemorrhagic telangiectasiaHP:0040281 - Very frequent504
HP:0011276HP:0100585Telangiectasia of the skin2SMAD4 CL E G H40896770ORPHA:774Hereditary hemorrhagic telangiectasiaHP:0040281 - Very frequent504
HP:0011276HP:0000978Bruising susceptibility2SNX10 CL E G H2988714974ORPHA:667Autosomal recessive malignant osteopetrosisHP:0040283 - Occasional2
HP:0011276HP:0000978Bruising susceptibility2SOS1 CL E G H665411187OMIM:610733Noonan syndrome 4315
HP:0011276HP:0100585Telangiectasia of the skin2SOX18 CL E G H5434511194OMIM:607823Hypotrichosis-Lymphedema-Telangiectasia syndrome7
HP:0011276HP:0100585Telangiectasia of the skin2SOX18 CL E G H5434511194OMIM:137940Hypotrichosis-Lymphedema-Telangiectasia-Renal defect syndrome7
HP:0011276HP:0100585Telangiectasia of the skin2SOX18 CL E G H5434511194ORPHA:69735Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome7
HP:0011276HP:0410134Physical urticaria2SPIB CL E G H668911242ORPHA:186Primary biliary cholangitis
HP:0011276HP:0000978Bruising susceptibility2SPRED2 CL E G H20073417722OMIM:619745NOONAN SYNDROME 14; NS14
HP:0011276HP:0033194Perioral erythema2SREBF1 CL E G H672011289OMIM:619016IFAP SYNDROME 2; IFAP21
HP:0011276HP:0000978Bruising susceptibility2STAT3 CL E G H677411364ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent110
HP:0011276HP:0000979Purpura2STAT3 CL E G H677411364ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent110
HP:0011276HP:0000978Bruising susceptibility2STAT5B CL E G H677711367ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent12
HP:0011276HP:0000979Purpura2STAT5B CL E G H677711367ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent12
HP:0011276HP:0000979Purpura2STIM1 CL E G H678611386ORPHA:3204Stormorken-Sjaastad-Langslet syndromeHP:0040281 - Very frequent31
HP:0011276HP:0033505Livedo reticularis2STING1 CL E G H34006127962OMIM:615934STING-associated vasculopathy, infantile-onset
HP:0011276HP:0007763Retinal telangiectasia2STN1 CL E G H7999126200OMIM:617341Cerebroretinal microangiopathy with calcifications and cysts 2.2
HP:0011276HP:0000979Purpura2STX11 CL E G H867611429ORPHA:540Familial hemophagocytic lymphohistiocytosisHP:0040282 - Frequent85
HP:0011276HP:0000978Bruising susceptibility2STX11 CL E G H867611429ORPHA:540Familial hemophagocytic lymphohistiocytosisHP:0040283 - Occasional85
HP:0011276HP:0000979Purpura2STXBP2 CL E G H681311445ORPHA:540Familial hemophagocytic lymphohistiocytosisHP:0040282 - Frequent70
HP:0011276HP:0000978Bruising susceptibility2STXBP2 CL E G H681311445ORPHA:540Familial hemophagocytic lymphohistiocytosisHP:0040283 - Occasional70
HP:0011276HP:0410134Physical urticaria2SUPT16H CL E G H1119811465OMIM:619480NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND THIN CORPUS CALLOSUM; NEDDFAC
HP:0011276HP:0000978Bruising susceptibility2TBL1XR1 CL E G H7971829529ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent22
HP:0011276HP:0000979Purpura2TBL1XR1 CL E G H7971829529ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent22
HP:0011276HP:0000979Purpura2TBX1 CL E G H689911592ORPHA:56722q11.2 deletion syndromeHP:0040283 - Occasional32
HP:0011276HP:0000978Bruising susceptibility2TBXA2R CL E G H691511608OMIM:614009BLEEDING DISORDER, PLATELET-TYPE, 13, SUSCEPTIBILITY TO; BDPLT1310
HP:0011276HP:0000979Purpura2TBXA2R CL E G H691511608OMIM:614009BLEEDING DISORDER, PLATELET-TYPE, 13, SUSCEPTIBILITY TO; BDPLT1310
HP:0011276HP:0001015Prominent superficial veins2TCF4 CL E G H692511634ORPHA:171Primary sclerosing cholangitis241
HP:0011276HP:0100585Telangiectasia of the skin2TCF4 CL E G H692511634ORPHA:171Primary sclerosing cholangitis241
HP:0011276HP:0000978Bruising susceptibility2TCIRG1 CL E G H1031211647ORPHA:667Autosomal recessive malignant osteopetrosisHP:0040283 - Occasional82
HP:0011276HP:0100585Telangiectasia of the skin2TERC CL E G H701211727ORPHA:1775Dyskeratosis congenitaHP:0040282 - Frequent48
HP:0011276HP:0000979Purpura2TERC CL E G H701211727ORPHA:88Idiopathic aplastic anemia48
HP:0011276HP:0100585Telangiectasia of the skin2TERT CL E G H701511730ORPHA:1775Dyskeratosis congenitaHP:0040282 - Frequent238
HP:0011276HP:0000979Purpura2TERT CL E G H701511730ORPHA:88Idiopathic aplastic anemia238
HP:0011276HP:0000978Bruising susceptibility2TET2 CL E G H5479025941ORPHA:729Polycythemia veraHP:0040281 - Very frequent3
HP:0011276HP:0000979Purpura2TET2 CL E G H5479025941ORPHA:824Primary myelofibrosisHP:0040283 - Occasional3
HP:0011276HP:0000979Purpura2TFR2 CL E G H703611762OMIM:604250Hemochromatosis, type 3.67
HP:0011276HP:0000978Bruising susceptibility2TGFB2 CL E G H704211768ORPHA:91387Familial thoracic aortic aneurysm and aortic dissectionHP:0040283 - Occasional162
HP:0011276HP:0000978Bruising susceptibility2TGFB2 CL E G H704211768OMIM:614816LOEYS-DIETZ SYNDROME 4; LDS4162
HP:0011276HP:0000978Bruising susceptibility2TGFB3 CL E G H704311769ORPHA:91387Familial thoracic aortic aneurysm and aortic dissectionHP:0040283 - Occasional85
HP:0011276HP:0000978Bruising susceptibility2TGFB3 CL E G H704311769OMIM:615582LOEYS-DIETZ SYNDROME 5; LDS585
HP:0011276HP:0000978Bruising susceptibility2TGFBR1 CL E G H704611772ORPHA:91387Familial thoracic aortic aneurysm and aortic dissectionHP:0040283 - Occasional239
HP:0011276HP:0000978Bruising susceptibility2TGFBR1 CL E G H704611772ORPHA:60030Loeys-Dietz syndromeHP:0040283 - Occasional239
HP:0011276HP:0000978Bruising susceptibility2TGFBR2 CL E G H704811773ORPHA:91387Familial thoracic aortic aneurysm and aortic dissectionHP:0040283 - Occasional253
HP:0011276HP:0000978Bruising susceptibility2TGFBR2 CL E G H704811773ORPHA:60030Loeys-Dietz syndromeHP:0040283 - Occasional253
HP:0011276HP:0100585Telangiectasia of the skin2TINF2 CL E G H2627711824ORPHA:1775Dyskeratosis congenitaHP:0040282 - Frequent60
HP:0011276HP:0100585Telangiectasia of the skin2TMC6 CL E G H1132218021ORPHA:302Epidermodysplasia verruciformisHP:0040283 - Occasional10
HP:0011276HP:0100585Telangiectasia of the skin2TMC8 CL E G H14713820474ORPHA:302Epidermodysplasia verruciformisHP:0040283 - Occasional4
HP:0011276HP:0000979Purpura2TNFRSF13B CL E G H2349518153ORPHA:1572Common variable immunodeficiencyHP:0040282 - Frequent32
HP:0011276HP:0000979Purpura2TNFRSF13C CL E G H11565017755ORPHA:1572Common variable immunodeficiencyHP:0040282 - Frequent12
HP:0011276HP:0000978Bruising susceptibility2TNFRSF1A CL E G H713211916ORPHA:32960Tumor necrosis factor receptor 1 associated periodic syndromeHP:0040283 - Occasional131
HP:0011276HP:0000978Bruising susceptibility2TNFSF11 CL E G H860011926ORPHA:667Autosomal recessive malignant osteopetrosisHP:0040283 - Occasional44
HP:0011276HP:0000979Purpura2TNFSF12 CL E G H874211927ORPHA:1572Common variable immunodeficiencyHP:0040282 - Frequent1
HP:0011276HP:0410134Physical urticaria2TNFSF15 CL E G H996611931ORPHA:186Primary biliary cholangitis
HP:0011276HP:0410134Physical urticaria2TNPO3 CL E G H2353417103ORPHA:186Primary biliary cholangitis71
HP:0011276HP:0000978Bruising susceptibility2TNXB CL E G H714811976ORPHA:230839Classical-like Ehlers-Danlos syndrome type 1HP:0040282 - Frequent134
HP:0011276HP:0000978Bruising susceptibility2TNXB CL E G H714811976OMIM:606408Ehlers-Danlos syndrome, classic-like.134
HP:0011276HP:0000978Bruising susceptibility2TP53 CL E G H715711998ORPHA:96253Cushing diseaseHP:0040282 - Frequent911
HP:0011276HP:0000979Purpura2TP53 CL E G H715711998ORPHA:96253Cushing disease911
HP:0011276HP:0000979Purpura2TREX1 CL E G H1127712269OMIM:225750Aicardi-Goutieres syndrome 1.56
HP:0011276HP:0200030Punctate vasculitis skin lesions2TREX1 CL E G H1127712269ORPHA:247691Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestationsHP:0040284 - Very rare56
HP:0011276HP:0200030Punctate vasculitis skin lesions2TREX1 CL E G H1127712269OMIM:192315Vasculopathy, retinal, with cerebral leukodystrophy.56
HP:0011276HP:0007763Retinal telangiectasia2TSPAN12 CL E G H2355421641ORPHA:891Familial exudative vitreoretinopathy39
HP:0011276HP:0100585Telangiectasia of the skin2TYMS CL E G H729812441ORPHA:1775Dyskeratosis congenitaHP:0040282 - Frequent1
HP:0011276HP:0000979Purpura2UFD1 CL E G H735312520ORPHA:56722q11.2 deletion syndromeHP:0040283 - Occasional
HP:0011276HP:0000978Bruising susceptibility2UNC13D CL E G H20129423147ORPHA:540Familial hemophagocytic lymphohistiocytosisHP:0040283 - Occasional116
HP:0011276HP:0000979Purpura2UNC13D CL E G H20129423147ORPHA:540Familial hemophagocytic lymphohistiocytosisHP:0040282 - Frequent116
HP:0011276HP:0100585Telangiectasia of the skin2USB1 CL E G H7965025792ORPHA:1775Dyskeratosis congenitaHP:0040282 - Frequent8
HP:0011276HP:0100579Mucosal telangiectasiae2USF3 CL E G H20571730494ORPHA:201Cowden syndromeHP:0040282 - Frequent1
HP:0011276HP:0000979Purpura2USP18 CL E G H1127412616OMIM:617397Pseudo-Torch syndrome 22
HP:0011276HP:0000978Bruising susceptibility2USP48 CL E G H8419618533ORPHA:96253Cushing diseaseHP:0040282 - Frequent1
HP:0011276HP:0000979Purpura2USP48 CL E G H8419618533ORPHA:96253Cushing disease1
HP:0011276HP:0000978Bruising susceptibility2USP8 CL E G H910112631ORPHA:96253Cushing diseaseHP:0040282 - Frequent7
HP:0011276HP:0000979Purpura2USP8 CL E G H910112631ORPHA:96253Cushing disease7
HP:0011276HP:0000979Purpura2USP8 CL E G H910112631OMIM:219090Pituitary adenoma 4, ACTH-secreting, somatic.7
HP:0011276HP:0001041Facial erythema2USP8 CL E G H910112631OMIM:219090Pituitary adenoma 4, ACTH-secreting, somatic.7
HP:0011276HP:0000978Bruising susceptibility2USP8 CL E G H910112631OMIM:219090Pituitary adenoma 4, ACTH-secreting, somatic.7
HP:0011276HP:0100585Telangiectasia of the skin2VPS53 CL E G H5527525608OMIM:615851Pontocerebellar hypoplasia, type 2E26
HP:0011276HP:0000978Bruising susceptibility2VWF CL E G H745012726OMIM:193400Von willebrand disease, type 1533
HP:0011276HP:0000978Bruising susceptibility2VWF CL E G H745012726OMIM:613554Von willebrand disease, type 2.533
HP:0011276HP:0000978Bruising susceptibility2VWF CL E G H745012726OMIM:277480Von willebrand disease, type 3.533
HP:0011276HP:0000978Bruising susceptibility2WAS CL E G H745412731OMIM:313900Thrombocytopenia 1.65
HP:0011276HP:0000979Purpura2WAS CL E G H745412731OMIM:313900Thrombocytopenia 165
HP:0011276HP:0000979Purpura2WAS CL E G H745412731OMIM:301000Wiskott-Aldrich syndrome.65
HP:0011276HP:0000978Bruising susceptibility2WAS CL E G H745412731ORPHA:906Wiskott-Aldrich syndromeHP:0040281 - Very frequent65
HP:0011276HP:0000979Purpura2WAS CL E G H745412731ORPHA:906Wiskott-Aldrich syndromeHP:0040282 - Frequent65
HP:0011276HP:0007420Spontaneous hematomas2WAS CL E G H745412731ORPHA:906Wiskott-Aldrich syndromeHP:0040281 - Very frequent65
HP:0011276HP:0007420Spontaneous hematomas2WIPF1 CL E G H745612736ORPHA:906Wiskott-Aldrich syndromeHP:0040281 - Very frequent6
HP:0011276HP:0000979Purpura2WIPF1 CL E G H745612736ORPHA:906Wiskott-Aldrich syndromeHP:0040282 - Frequent6
HP:0011276HP:0000978Bruising susceptibility2WIPF1 CL E G H745612736ORPHA:906Wiskott-Aldrich syndromeHP:0040281 - Very frequent6
HP:0011276HP:0025493Palmoplantar erythema2WNT10A CL E G H8032613829OMIM:257980Odontoonychodermal dysplasia71
HP:0011276HP:0100585Telangiectasia of the skin2WNT10A CL E G H8032613829ORPHA:50944Schöpf-Schulz-Passarge syndrome71
HP:0011276HP:0100585Telangiectasia of the skin2WRAP53 CL E G H5513525522ORPHA:1775Dyskeratosis congenitaHP:0040282 - Frequent40
HP:0011276HP:0100585Telangiectasia of the skin2WRN CL E G H748612791ORPHA:902Werner syndromeHP:0040282 - Frequent310
HP:0011276HP:0100579Mucosal telangiectasiae2XPA CL E G H750712814ORPHA:910Xeroderma pigmentosum34
HP:0011276HP:0100585Telangiectasia of the skin2XPA CL E G H750712814ORPHA:910Xeroderma pigmentosumHP:0040281 - Very frequent34
HP:0011276HP:0100585Telangiectasia of the skin2XPC CL E G H750812816ORPHA:910Xeroderma pigmentosumHP:0040281 - Very frequent86
HP:0011276HP:0100579Mucosal telangiectasiae2XPC CL E G H750812816ORPHA:910Xeroderma pigmentosum86
HP:0011276HP:0100585Telangiectasia of the skin2XRCC4 CL E G H751812831ORPHA:99812LIG4 syndromeHP:0040283 - Occasional9
HP:0011276HP:0000978Bruising susceptibility2ZBTB16 CL E G H770412930ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent1
HP:0011276HP:0000979Purpura2ZBTB16 CL E G H770412930ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent1
HP:0011276HP:0001015Prominent superficial veins2ZMPSTE24 CL E G H1026912877OMIM:608612Mandibuloacral dysplasia with type B lipodystrophy83
HP:0011276HP:0007763Retinal telangiectasia2ZNF408 CL E G H7979720041ORPHA:891Familial exudative vitreoretinopathy14
HP:0011276HP:0000978Bruising susceptibility2ZNF469 CL E G H8462723216ORPHA:90354Brittle cornea syndromeHP:0040282 - Frequent397
HP:0011276HP:0410138Vibratory urticaria3 CL E G H
HP:0011276HP:0031363Palpable purpura3 CL E G H
HP:0011276HP:0009893Telangiectasia of the ear3 CL E G H
HP:0011276HP:0410137Solar urticaria3 CL E G H
HP:0011276HP:0007586Telangiectases producing 'marbled' skin3 CL E G H
HP:0011276HP:0410136Aquagenic urticaria3 CL E G H
HP:0011276HP:0025555Periungual teleangiectasia3 CL E G H
HP:0011276HP:0100885Lateral venous anomaly3 CL E G H
HP:0011276HP:0033370Bronchial telangiectasia3 CL E G H
HP:0011276HP:0000524Conjunctival telangiectasia3ACVRL1 CL E G H94175ORPHA:774Hereditary hemorrhagic telangiectasiaHP:0040283 - Occasional178
HP:0011276HP:0000228Oral cavity telangiectasia3ACVRL1 CL E G H94175OMIM:600376Telangiectasia, hereditary hemorrhagic, type 2178
HP:0011276HP:0000524Conjunctival telangiectasia3ACVRL1 CL E G H94175OMIM:600376Telangiectasia, hereditary hemorrhagic, type 2.178
HP:0011276HP:0007380Facial telangiectasia3ACVRL1 CL E G H94175OMIM:600376Telangiectasia, hereditary hemorrhagic, type 2178
HP:0011276HP:0100869Palmar telangiectasia3ACVRL1 CL E G H94175OMIM:600376Telangiectasia, hereditary hemorrhagic, type 2178
HP:0011276HP:0006107Fingerpad telangiectases3ACVRL1 CL E G H94175OMIM:600376Telangiectasia, hereditary hemorrhagic, type 2.178
HP:0011276HP:0000434Nasal mucosa telangiectasia3ACVRL1 CL E G H94175OMIM:600376Telangiectasia, hereditary hemorrhagic, type 2.178
HP:0011276HP:0002604Gastrointestinal telangiectasia3ACVRL1 CL E G H94175OMIM:600376Telangiectasia, hereditary hemorrhagic, type 2.178
HP:0011276HP:0007457Prominent veins on trunk3AEBP1 CL E G H165303ORPHA:536532Classical-like Ehlers-Danlos syndrome type 2HP:0040282 - Frequent
HP:0011276HP:0031365Macular purpura3AIP CL E G H9049358OMIM:219090Pituitary adenoma 4, ACTH-secreting, somatic95
HP:0011276HP:0001043Prominent scalp veins3ANTXR1 CL E G H8416821014OMIM:230740Gapo syndrome.8
HP:0011276HP:0031365Macular purpura3APOE CL E G H348613ORPHA:158029Sea-blue histiocytosis39
HP:0011276HP:0007380Facial telangiectasia3ARPC4 CL E G H10093707OMIM:620141
HP:0011276HP:0007380Facial telangiectasia3ARX CL E G H17030218060ORPHA:94083Partington syndromeHP:0040283 - Occasional166
HP:0011276HP:0000524Conjunctival telangiectasia3ATM CL E G H472795OMIM:208900ATAXIA-TELANGIECTASIA.3267
HP:0011276HP:0007457Prominent veins on trunk3ATP6V0A2 CL E G H2354518481ORPHA:357074Autosomal recessive cutis laxa type 2, classic typeHP:0040281 - Very frequent140
HP:0011276HP:0007457Prominent veins on trunk3ATP6V0A2 CL E G H2354518481ORPHA:2834Wrinkly skin syndromeHP:0040281 - Very frequent140
HP:0011276HP:0007457Prominent veins on trunk3ATP6V1A CL E G H523851ORPHA:357074Autosomal recessive cutis laxa type 2, classic typeHP:0040281 - Very frequent3
HP:0011276HP:0007457Prominent veins on trunk3ATP6V1E1 CL E G H529857ORPHA:357074Autosomal recessive cutis laxa type 2, classic typeHP:0040281 - Very frequent2
HP:0011276HP:0007380Facial telangiectasia3ATR CL E G H545882OMIM:614564Cutaneous telangiectasia and cancer syndrome, familial168
HP:0011276HP:0031365Macular purpura3ATRX CL E G H546886ORPHA:96253Cushing disease169
HP:0011276HP:0007380Facial telangiectasia3ATRX CL E G H546886ORPHA:100075Neuroendocrine tumor of stomachHP:0040284 - Very rare169
HP:0011276HP:0031365Macular purpura3BCOR CL E G H5488020893ORPHA:520Acute promyelocytic leukemia101
HP:0011276HP:0007380Facial telangiectasia3BLM CL E G H6411058OMIM:210900Bloom syndrome314
HP:0011276HP:0031365Macular purpura3BRAF CL E G H6731097ORPHA:96253Cushing disease276
HP:0011276HP:0031365Macular purpura3CALR CL E G H8111455ORPHA:824Primary myelofibrosis1
HP:0011276HP:0410135Cold urticaria3CARMIL2 CL E G H14620627089OMIM:618131IMMUNODEFICIENCY 58; IMD583
HP:0011276HP:0031365Macular purpura3CASP10 CL E G H8431500OMIM:603909Autoimmune lymphoproliferative syndrome, type IIA87
HP:0011276HP:0031365Macular purpura3CD109 CL E G H13522821685ORPHA:853Fetal and neonatal alloimmune thrombocytopenia
HP:0011276HP:0031365Macular purpura3CDH23 CL E G H6407213733ORPHA:96253Cushing disease636
HP:0011276HP:0031365Macular purpura3CHST14 CL E G H11318924464OMIM:601776Ehlers-Danlos syndrome, musculocontractural type 127
HP:0011276HP:0031365Macular purpura3CLCN7 CL E G H11862025OMIM:611490Osteopetrosis, autosomal recessive 4102
HP:0011276HP:0031365Macular purpura3COL1A1 CL E G H12772197ORPHA:287Classical Ehlers-Danlos syndrome373
HP:0011276HP:0031365Macular purpura3COL3A1 CL E G H12812201OMIM:130050Ehlers-Danlos syndrome, Vascular type749
HP:0011276HP:0031365Macular purpura3COL5A1 CL E G H12892209ORPHA:287Classical Ehlers-Danlos syndrome660
HP:0011276HP:0031365Macular purpura3COL5A2 CL E G H12902210ORPHA:287Classical Ehlers-Danlos syndrome325
HP:0011276HP:0030503Macular telangiectasia3CTNNB1 CL E G H14992514ORPHA:891Familial exudative vitreoretinopathyHP:0040283 - Occasional88
HP:0011276HP:0000524Conjunctival telangiectasia3CTSA CL E G H54769251OMIM:256540Galactosialidosis.51
HP:0011276HP:0007380Facial telangiectasia3DAXX CL E G H16162681ORPHA:100075Neuroendocrine tumor of stomachHP:0040284 - Very rare
HP:0011276HP:0000524Conjunctival telangiectasia3DDB2 CL E G H16432718ORPHA:910Xeroderma pigmentosumHP:0040281 - Very frequent30
HP:0011276HP:0000524Conjunctival telangiectasia3ENG CL E G H20223349ORPHA:774Hereditary hemorrhagic telangiectasiaHP:0040283 - Occasional186
HP:0011276HP:0002604Gastrointestinal telangiectasia3ENG CL E G H20223349OMIM:187300Telangiectasia, hereditary hemorrhagic, type 1.186
HP:0011276HP:0000524Conjunctival telangiectasia3ENG CL E G H20223349OMIM:187300Telangiectasia, hereditary hemorrhagic, type 1.186
HP:0011276HP:0000228Oral cavity telangiectasia3ENG CL E G H20223349OMIM:187300Telangiectasia, hereditary hemorrhagic, type 1186
HP:0011276HP:0006107Fingerpad telangiectases3ENG CL E G H20223349OMIM:187300Telangiectasia, hereditary hemorrhagic, type 1.186
HP:0011276HP:0000434Nasal mucosa telangiectasia3ENG CL E G H20223349OMIM:187300Telangiectasia, hereditary hemorrhagic, type 1.186
HP:0011276HP:0000524Conjunctival telangiectasia3ERCC2 CL E G H20683434ORPHA:910Xeroderma pigmentosumHP:0040281 - Very frequent106
HP:0011276HP:0000524Conjunctival telangiectasia3ERCC3 CL E G H20713435ORPHA:910Xeroderma pigmentosumHP:0040281 - Very frequent54
HP:0011276HP:0000524Conjunctival telangiectasia3ERCC4 CL E G H20723436ORPHA:910Xeroderma pigmentosumHP:0040281 - Very frequent158
HP:0011276HP:0000524Conjunctival telangiectasia3ERCC5 CL E G H20733437ORPHA:910Xeroderma pigmentosumHP:0040281 - Very frequent83
HP:0011276HP:0031365Macular purpura3ETHE1 CL E G H2347423287OMIM:602473Encephalopathy, ethylmalonic42
HP:0011276HP:0031365Macular purpura3ETHE1 CL E G H2347423287ORPHA:51188Ethylmalonic encephalopathy42
HP:0011276HP:0031365Macular purpura3ETV6 CL E G H21203495OMIM:616216Thrombocytopenia 513
HP:0011276HP:0031365Macular purpura3F13A1 CL E G H21623531ORPHA:331Congenital factor XIII deficiency60
HP:0011276HP:0031365Macular purpura3F13A1 CL E G H21623531OMIM:613225Factor XIII, A subunit, deficiency of60
HP:0011276HP:0031365Macular purpura3F13B CL E G H21653534ORPHA:331Congenital factor XIII deficiency32
HP:0011276HP:0031365Macular purpura3F13B CL E G H21653534OMIM:613235Factor XIIIB deficiency32
HP:0011276HP:0031365Macular purpura3F2 CL E G H21473535OMIM:613679Congenital prothrombin deficiency44
HP:0011276HP:0031365Macular purpura3FCGR2C CL E G H910315626ORPHA:3002Immune thrombocytopenia
HP:0011276HP:0031365Macular purpura3FERMT3 CL E G H8370623151OMIM:612840Leukocyte adhesion deficiency, type III23
HP:0011276HP:0031365Macular purpura3FIP1L1 CL E G H8160819124ORPHA:520Acute promyelocytic leukemia4
HP:0011276HP:0031365Macular purpura3FYB1 CL E G H25334036OMIM:273900THROMBOCYTOPENIA 3; THC34
HP:0011276HP:0030503Macular telangiectasia3FZD4 CL E G H83224042ORPHA:891Familial exudative vitreoretinopathyHP:0040283 - Occasional109
HP:0011276HP:0031365Macular purpura3GATA1 CL E G H26234170OMIM:314050Thrombocytopenia with beta-thalassemia, X-linked29
HP:0011276HP:0031365Macular purpura3GATA1 CL E G H26234170OMIM:300367Thrombocytopenia, X-linked, with or without dyserythropoietic anemia29
HP:0011276HP:0031365Macular purpura3GBA1 CL E G H26294177OMIM:608013Gaucher disease, perinatal lethal
HP:0011276HP:0031365Macular purpura3GBA1 CL E G H26294177ORPHA:2072Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome
HP:0011276HP:0000524Conjunctival telangiectasia3GDF2 CL E G H26584217ORPHA:774Hereditary hemorrhagic telangiectasiaHP:0040283 - Occasional8
HP:0011276HP:0031365Macular purpura3GFI1B CL E G H83284238OMIM:187900Bleeding disorder, platelet-type, 173
HP:0011276HP:0031365Macular purpura3GGCX CL E G H26774247OMIM:277450VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 1129
HP:0011276HP:0031365Macular purpura3GIMAP5 CL E G H5534018005OMIM:619463PORTAL HYPERTENSION, NONCIRRHOTIC, 2; NCPH2
HP:0011276HP:0000524Conjunctival telangiectasia3GLA CL E G H27174296ORPHA:324Fabry diseaseHP:0040281 - Very frequent291
HP:0011276HP:0031365Macular purpura3GNA14 CL E G H96304382ORPHA:1063Tufted angioma
HP:0011276HP:0000524Conjunctival telangiectasia3GNAQ CL E G H27764390ORPHA:3205Sturge-Weber syndromeHP:0040283 - Occasional7
HP:0011276HP:0007380Facial telangiectasia3GNPTAB CL E G H7915829670ORPHA:576Mucolipidosis type II240
HP:0011276HP:0031365Macular purpura3GP1BA CL E G H28114439ORPHA:274Bernard-Soulier syndrome23
HP:0011276HP:0031365Macular purpura3GP1BA CL E G H28114439OMIM:153670Bernard-Soulier syndrome, type A2, autosomal dominant23
HP:0011276HP:0031365Macular purpura3GP1BA CL E G H28114439ORPHA:853Fetal and neonatal alloimmune thrombocytopenia23
HP:0011276HP:0031365Macular purpura3GP1BB CL E G H28124440ORPHA:274Bernard-Soulier syndrome8
HP:0011276HP:0031365Macular purpura3GP1BB CL E G H28124440ORPHA:853Fetal and neonatal alloimmune thrombocytopenia8
HP:0011276HP:0031365Macular purpura3GP6 CL E G H5120614388OMIM:614201Bleeding disorder, platelet-type, 1124
HP:0011276HP:0031365Macular purpura3GP9 CL E G H28154444ORPHA:274Bernard-Soulier syndrome21
HP:0011276HP:0012522Spider hemangioma3GPR35 CL E G H28594492ORPHA:171Primary sclerosing cholangitisHP:0040282 - Frequent2
HP:0011276HP:0030168Dilated superficial abdominal veins3GPR35 CL E G H28594492ORPHA:171Primary sclerosing cholangitisHP:0040282 - Frequent2
HP:0011276HP:0100869Palmar telangiectasia3GPR35 CL E G H28594492ORPHA:171Primary sclerosing cholangitisHP:0040282 - Frequent2
HP:0011276HP:0031365Macular purpura3HOXA11 CL E G H32075101OMIM:605432Radioulnar synostosis with amegakaryocytic thrombocytopenia3
HP:0011276HP:0031365Macular purpura3HPS1 CL E G H32575163OMIM:203300Hermansky-Pudlak syndrome 1121
HP:0011276HP:0031365Macular purpura3HPS6 CL E G H7980318817OMIM:614075Hermansky-Pudlak syndrome 645
HP:0011276HP:0031365Macular purpura3IFNG CL E G H34585438ORPHA:88Idiopathic aplastic anemia23
HP:0011276HP:0011971Dermatographic urticaria3IL12A CL E G H35925969ORPHA:186Primary biliary cholangitisHP:0040281 - Very frequent
HP:0011276HP:0011971Dermatographic urticaria3IL12RB1 CL E G H35945971ORPHA:186Primary biliary cholangitisHP:0040281 - Very frequent46
HP:0011276HP:0031365Macular purpura3IRF2BP2 CL E G H35994821729ORPHA:520Acute promyelocytic leukemia4
HP:0011276HP:0011971Dermatographic urticaria3IRF5 CL E G H36636120ORPHA:186Primary biliary cholangitisHP:0040281 - Very frequent4
HP:0011276HP:0031365Macular purpura3ITGA2 CL E G H36736137ORPHA:853Fetal and neonatal alloimmune thrombocytopenia119
HP:0011276HP:0031365Macular purpura3ITGA2B CL E G H36746138OMIM:187800Bleeding disorder, platelet-type, 1669
HP:0011276HP:0031365Macular purpura3ITGA2B CL E G H36746138ORPHA:853Fetal and neonatal alloimmune thrombocytopenia69
HP:0011276HP:0031365Macular purpura3ITGA2B CL E G H36746138OMIM:273800Glanzmann thrombasthenia69
HP:0011276HP:0031365Macular purpura3ITGA2B CL E G H36746138ORPHA:849Glanzmann thrombasthenia69
HP:0011276HP:0031365Macular purpura3ITGB3 CL E G H36906156ORPHA:853Fetal and neonatal alloimmune thrombocytopenia80
HP:0011276HP:0031365Macular purpura3ITGB3 CL E G H36906156ORPHA:849Glanzmann thrombasthenia80
HP:0011276HP:0031365Macular purpura3JAK2 CL E G H37176192ORPHA:824Primary myelofibrosis57
HP:0011276HP:0011971Dermatographic urticaria3KIT CL E G H38156342ORPHA:79455Cutaneous mastocytoma327
HP:0011276HP:0100869Palmar telangiectasia3LBR CL E G H39306518OMIM:613471Reynolds syndrome.70
HP:0011276HP:0000228Oral cavity telangiectasia3LBR CL E G H39306518OMIM:613471Reynolds syndrome70
HP:0011276HP:0031365Macular purpura3LCP2 CL E G H39376529OMIM:619374IMMUNODEFICIENCY 81; IMD81
HP:0011276HP:0000524Conjunctival telangiectasia3LIG1 CL E G H39786598OMIM:619774IMMUNODEFICIENCY 96; IMD969
HP:0011276HP:0030503Macular telangiectasia3LRP5 CL E G H40416697ORPHA:891Familial exudative vitreoretinopathyHP:0040283 - Occasional125
HP:0011276HP:0000524Conjunctival telangiectasia3MASP1 CL E G H56486901OMIM:2579203mc syndrome 1.21
HP:0011276HP:0011971Dermatographic urticaria3MMEL1 CL E G H7925814668ORPHA:186Primary biliary cholangitisHP:0040281 - Very frequent
HP:0011276HP:0031365Macular purpura3MPL CL E G H43527217ORPHA:824Primary myelofibrosis97
HP:0011276HP:0030168Dilated superficial abdominal veins3MST1 CL E G H44857380ORPHA:171Primary sclerosing cholangitisHP:0040282 - Frequent1
HP:0011276HP:0100869Palmar telangiectasia3MST1 CL E G H44857380ORPHA:171Primary sclerosing cholangitisHP:0040282 - Frequent1
HP:0011276HP:0012522Spider hemangioma3MST1 CL E G H44857380ORPHA:171Primary sclerosing cholangitisHP:0040282 - Frequent1
HP:0011276HP:0031365Macular purpura3NABP1 CL E G H6485926232ORPHA:520Acute promyelocytic leukemia
HP:0011276HP:0000228Oral cavity telangiectasia3NAGA CL E G H46687631ORPHA:79280Alpha-N-acetylgalactosaminidase deficiency type 247
HP:0011276HP:0000228Oral cavity telangiectasia3NAGA CL E G H46687631OMIM:609242Kanzaki disease47
HP:0011276HP:0030503Macular telangiectasia3NDP CL E G H46937678ORPHA:891Familial exudative vitreoretinopathyHP:0040283 - Occasional39
HP:0011276HP:0031365Macular purpura3NEU1 CL E G H47587758ORPHA:93400Congenital sialidosis type 243
HP:0011276HP:0031365Macular purpura3NPM1 CL E G H48697910ORPHA:520Acute promyelocytic leukemia12
HP:0011276HP:0031365Macular purpura3NR3C1 CL E G H29087978ORPHA:96253Cushing disease79
HP:0011276HP:0031365Macular purpura3NUMA1 CL E G H49268059ORPHA:520Acute promyelocytic leukemia
HP:0011276HP:0031365Macular purpura3OCLN CL E G H1005066588104OMIM:251290Band-Like calcification with simplified gyration and polymicrogyria23
HP:0011276HP:0031365Macular purpura3P2RY12 CL E G H6480518124OMIM:609821Bleeding disorder, platelet-type, 85
HP:0011276HP:0000524Conjunctival telangiectasia3PCNA CL E G H51118729OMIM:615919Ataxia-Telangiectasia-Like disorder 2.1
HP:0011276HP:0031365Macular purpura3PEPD CL E G H51848840OMIM:170100Prolidase deficiency66
HP:0011276HP:0000524Conjunctival telangiectasia3PEX6 CL E G H51908859ORPHA:95433Autosomal recessive spinocerebellar ataxia-blindness-deafness syndromeHP:0040282 - Frequent98
HP:0011276HP:0011971Dermatographic urticaria3PLCG2 CL E G H53369066OMIM:614468FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 3; FCAS321
HP:0011276HP:0410135Cold urticaria3PLCG2 CL E G H53369066OMIM:614468FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 3; FCAS321
HP:0011276HP:0031365Macular purpura3PML CL E G H53719113ORPHA:520Acute promyelocytic leukemia3
HP:0011276HP:0007380Facial telangiectasia3POLE CL E G H54269177OMIM:615139Facial dysmorphism, immunodeficiency, livedo, and short stature1129
HP:0011276HP:0001043Prominent scalp veins3POLR3A CL E G H1112830074ORPHA:3455Wiedemann-Rautenstrauch syndromeHP:0040281 - Very frequent138
HP:0011276HP:0001043Prominent scalp veins3POLR3A CL E G H1112830074OMIM:264090Wiedemann-Rautenstrauch syndrome.138
HP:0011276HP:0011971Dermatographic urticaria3POU2AF1 CL E G H54509211ORPHA:186Primary biliary cholangitisHP:0040281 - Very frequent
HP:0011276HP:0007457Prominent veins on trunk3PPARG CL E G H54689236ORPHA:79083PPARG-related familial partial lipodystrophyHP:0040284 - Very rare42
HP:0011276HP:0031365Macular purpura3PRF1 CL E G H55519360ORPHA:540Familial hemophagocytic lymphohistiocytosis58
HP:0011276HP:0031365Macular purpura3PRF1 CL E G H55519360ORPHA:88Idiopathic aplastic anemia58
HP:0011276HP:0031365Macular purpura3PRKAR1A CL E G H55739388ORPHA:520Acute promyelocytic leukemia134
HP:0011276HP:0001043Prominent scalp veins3PTDSS1 CL E G H97919587OMIM:151050Lenz-Majewski hyperostotic dwarfism.6
HP:0011276HP:0031365Macular purpura3RAB27A CL E G H58739766ORPHA:79477Griscelli syndrome type 267
HP:0011276HP:0031365Macular purpura3RARA CL E G H59149864ORPHA:520Acute promyelocytic leukemia2
HP:0011276HP:0000524Conjunctival telangiectasia3RNF168 CL E G H16591826661ORPHA:420741RIDDLE syndromeHP:0040283 - Occasional7
HP:0011276HP:0031365Macular purpura3SAMD9 CL E G H548091348OMIM:617053Mirage syndrome8
HP:0011276HP:0031365Macular purpura3SBDS CL E G H5111919440ORPHA:88Idiopathic aplastic anemia26
HP:0011276HP:0007380Facial telangiectasia3SDHD CL E G H639210683ORPHA:100093Carcinoid syndromeHP:0040283 - Occasional129
HP:0011276HP:0012522Spider hemangioma3SEMA4D CL E G H1050710732ORPHA:171Primary sclerosing cholangitisHP:0040282 - Frequent
HP:0011276HP:0030168Dilated superficial abdominal veins3SEMA4D CL E G H1050710732ORPHA:171Primary sclerosing cholangitisHP:0040282 - Frequent
HP:0011276HP:0100869Palmar telangiectasia3SEMA4D CL E G H1050710732ORPHA:171Primary sclerosing cholangitisHP:0040282 - Frequent
HP:0011276HP:0011971Dermatographic urticaria3SERPING1 CL E G H7101228ORPHA:100050Hereditary angioedema type 1HP:0040281 - Very frequent64
HP:0011276HP:0000524Conjunctival telangiectasia3SETX CL E G H23064445OMIM:606002Spinocerebellar ataxia, autosomal recessive 1HP:0040283 - Occasional162
HP:0011276HP:0011971Dermatographic urticaria3SLC27A4 CL E G H1099910998OMIM:608649ICHTHYOSIS PREMATURITY SYNDROME; IPS26
HP:0011276HP:0007380Facial telangiectasia3SLC29A3 CL E G H5531523096ORPHA:168569H syndromeHP:0040283 - Occasional68
HP:0011276HP:0007380Facial telangiectasia3SLC29A3 CL E G H5531523096OMIM:602782Histiocytosis-lymphadenopathy plus syndrome68
HP:0011276HP:0007380Facial telangiectasia3SLC2A10 CL E G H8103113444OMIM:208050Arterial tortuosity syndrome178
HP:0011276HP:0012522Spider hemangioma3SLC37A4 CL E G H25424061OMIM:232240GLYCOGEN STORAGE DISEASE Ic.110
HP:0011276HP:0000524Conjunctival telangiectasia3SMAD4 CL E G H40896770ORPHA:774Hereditary hemorrhagic telangiectasiaHP:0040283 - Occasional504
HP:0011276HP:0100869Palmar telangiectasia3SOX18 CL E G H5434511194OMIM:607823Hypotrichosis-Lymphedema-Telangiectasia syndrome.7
HP:0011276HP:0007621Telangiectasia of extensor surfaces3SOX18 CL E G H5434511194OMIM:137940Hypotrichosis-Lymphedema-Telangiectasia-Renal defect syndrome.7
HP:0011276HP:0100869Palmar telangiectasia3SOX18 CL E G H5434511194ORPHA:69735Hypotrichosis-lymphedema-telangiectasia-renal defect syndromeHP:0040281 - Very frequent7
HP:0011276HP:0100870Plantar telangiectasia3SOX18 CL E G H5434511194ORPHA:69735Hypotrichosis-lymphedema-telangiectasia-renal defect syndromeHP:0040281 - Very frequent7
HP:0011276HP:0007380Facial telangiectasia3SOX18 CL E G H5434511194OMIM:137940Hypotrichosis-Lymphedema-Telangiectasia-Renal defect syndrome7
HP:0011276HP:0011971Dermatographic urticaria3SPIB CL E G H668911242ORPHA:186Primary biliary cholangitisHP:0040281 - Very frequent
HP:0011276HP:0031365Macular purpura3STAT3 CL E G H677411364ORPHA:520Acute promyelocytic leukemia110
HP:0011276HP:0031365Macular purpura3STAT5B CL E G H677711367ORPHA:520Acute promyelocytic leukemia12
HP:0011276HP:0031365Macular purpura3STX11 CL E G H867611429ORPHA:540Familial hemophagocytic lymphohistiocytosis85
HP:0011276HP:0031365Macular purpura3STXBP2 CL E G H681311445ORPHA:540Familial hemophagocytic lymphohistiocytosis70
HP:0011276HP:0011971Dermatographic urticaria3SUPT16H CL E G H1119811465OMIM:619480NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND THIN CORPUS CALLOSUM; NEDDFAC
HP:0011276HP:0031365Macular purpura3TBL1XR1 CL E G H7971829529ORPHA:520Acute promyelocytic leukemia22
HP:0011276HP:0031365Macular purpura3TBXA2R CL E G H691511608OMIM:614009BLEEDING DISORDER, PLATELET-TYPE, 13, SUSCEPTIBILITY TO; BDPLT1310
HP:0011276HP:0100869Palmar telangiectasia3TCF4 CL E G H692511634ORPHA:171Primary sclerosing cholangitisHP:0040282 - Frequent241
HP:0011276HP:0012522Spider hemangioma3TCF4 CL E G H692511634ORPHA:171Primary sclerosing cholangitisHP:0040282 - Frequent241
HP:0011276HP:0030168Dilated superficial abdominal veins3TCF4 CL E G H692511634ORPHA:171Primary sclerosing cholangitisHP:0040282 - Frequent241
HP:0011276HP:0031365Macular purpura3TERC CL E G H701211727ORPHA:88Idiopathic aplastic anemia48
HP:0011276HP:0031365Macular purpura3TERT CL E G H701511730ORPHA:88Idiopathic aplastic anemia238
HP:0011276HP:0031365Macular purpura3TET2 CL E G H5479025941ORPHA:824Primary myelofibrosis3
HP:0011276HP:0011971Dermatographic urticaria3TNFSF15 CL E G H996611931ORPHA:186Primary biliary cholangitisHP:0040281 - Very frequent
HP:0011276HP:0011971Dermatographic urticaria3TNPO3 CL E G H2353417103ORPHA:186Primary biliary cholangitisHP:0040281 - Very frequent71
HP:0011276HP:0031365Macular purpura3TP53 CL E G H715711998ORPHA:96253Cushing disease911
HP:0011276HP:0031365Macular purpura3TREX1 CL E G H1127712269OMIM:225750Aicardi-Goutieres syndrome 156
HP:0011276HP:0030503Macular telangiectasia3TSPAN12 CL E G H2355421641ORPHA:891Familial exudative vitreoretinopathyHP:0040283 - Occasional39
HP:0011276HP:0031365Macular purpura3UNC13D CL E G H20129423147ORPHA:540Familial hemophagocytic lymphohistiocytosis116
HP:0011276HP:0031365Macular purpura3USP18 CL E G H1127412616OMIM:617397Pseudo-Torch syndrome 22
HP:0011276HP:0031365Macular purpura3USP48 CL E G H8419618533ORPHA:96253Cushing disease1
HP:0011276HP:0031365Macular purpura3USP8 CL E G H910112631ORPHA:96253Cushing disease7
HP:0011276HP:0031365Macular purpura3USP8 CL E G H910112631OMIM:219090Pituitary adenoma 4, ACTH-secreting, somatic7
HP:0011276HP:0007380Facial telangiectasia3VPS53 CL E G H5527525608OMIM:615851Pontocerebellar hypoplasia, type 2E26
HP:0011276HP:0031365Macular purpura3WAS CL E G H745412731OMIM:313900Thrombocytopenia 165
HP:0011276HP:0031365Macular purpura3WAS CL E G H745412731ORPHA:906Wiskott-Aldrich syndrome65
HP:0011276HP:0031365Macular purpura3WAS CL E G H745412731OMIM:301000Wiskott-Aldrich syndrome65
HP:0011276HP:0031365Macular purpura3WIPF1 CL E G H745612736ORPHA:906Wiskott-Aldrich syndrome6
HP:0011276HP:0007380Facial telangiectasia3WNT10A CL E G H8032613829ORPHA:50944Schöpf-Schulz-Passarge syndromeHP:0040281 - Very frequent71
HP:0011276HP:0000524Conjunctival telangiectasia3XPA CL E G H750712814ORPHA:910Xeroderma pigmentosumHP:0040281 - Very frequent34
HP:0011276HP:0000524Conjunctival telangiectasia3XPC CL E G H750812816ORPHA:910Xeroderma pigmentosumHP:0040281 - Very frequent86
HP:0011276HP:0031365Macular purpura3ZBTB16 CL E G H770412930ORPHA:520Acute promyelocytic leukemia1
HP:0011276HP:0030503Macular telangiectasia3ZNF408 CL E G H7979720041ORPHA:891Familial exudative vitreoretinopathyHP:0040283 - Occasional14
HP:0011276HP:0025203Caput medusae4 CL E G H
HP:0011276HP:0000214Lip telangiectasia4ACVRL1 CL E G H94175OMIM:600376Telangiectasia, hereditary hemorrhagic, type 2.178
HP:0011276HP:0002707Palate telangiectasia4ACVRL1 CL E G H94175OMIM:600376Telangiectasia, hereditary hemorrhagic, type 2.178
HP:0011276HP:0000227Tongue telangiectasia4ACVRL1 CL E G H94175OMIM:600376Telangiectasia, hereditary hemorrhagic, type 2.178
HP:0011276HP:0031364Ecchymosis4AIP CL E G H9049358OMIM:219090Pituitary adenoma 4, ACTH-secreting, somatic.95
HP:0011276HP:0000967Petechiae4APOE CL E G H348613ORPHA:158029Sea-blue histiocytosisHP:0040281 - Very frequent39
HP:0011276HP:0031364Ecchymosis4ATRX CL E G H546886ORPHA:96253Cushing disease169
HP:0011276HP:0000967Petechiae4BCOR CL E G H5488020893ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent101
HP:0011276HP:0031364Ecchymosis4BCOR CL E G H5488020893ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent101
HP:0011276HP:0005598Facial telangiectasia in butterfly midface distribution4BLM CL E G H6411058OMIM:210900Bloom syndrome.314
HP:0011276HP:0031364Ecchymosis4BRAF CL E G H6731097ORPHA:96253Cushing disease276
HP:0011276HP:0031364Ecchymosis4CALR CL E G H8111455ORPHA:824Primary myelofibrosisHP:0040283 - Occasional1
HP:0011276HP:0000967Petechiae4CALR CL E G H8111455ORPHA:824Primary myelofibrosisHP:0040283 - Occasional1
HP:0011276HP:0000967Petechiae4CASP10 CL E G H8431500OMIM:603909Autoimmune lymphoproliferative syndrome, type IIA87
HP:0011276HP:0000967Petechiae4CD109 CL E G H13522821685ORPHA:853Fetal and neonatal alloimmune thrombocytopeniaHP:0040282 - Frequent
HP:0011276HP:0031364Ecchymosis4CD109 CL E G H13522821685ORPHA:853Fetal and neonatal alloimmune thrombocytopeniaHP:0040283 - Occasional
HP:0011276HP:0031364Ecchymosis4CDH23 CL E G H6407213733ORPHA:96253Cushing disease636
HP:0011276HP:0031364Ecchymosis4CHST14 CL E G H11318924464OMIM:601776Ehlers-Danlos syndrome, musculocontractural type 1.27
HP:0011276HP:0000967Petechiae4CLCN7 CL E G H11862025OMIM:611490Osteopetrosis, autosomal recessive 4.102
HP:0011276HP:0031364Ecchymosis4COL1A1 CL E G H12772197ORPHA:287Classical Ehlers-Danlos syndromeHP:0040283 - Occasional373
HP:0011276HP:0031364Ecchymosis4COL3A1 CL E G H12812201OMIM:130050Ehlers-Danlos syndrome, Vascular type749
HP:0011276HP:0031364Ecchymosis4COL5A1 CL E G H12892209ORPHA:287Classical Ehlers-Danlos syndromeHP:0040283 - Occasional660
HP:0011276HP:0031364Ecchymosis4COL5A2 CL E G H12902210ORPHA:287Classical Ehlers-Danlos syndromeHP:0040283 - Occasional325
HP:0011276HP:0000214Lip telangiectasia4ENG CL E G H20223349OMIM:187300Telangiectasia, hereditary hemorrhagic, type 1.186
HP:0011276HP:0002707Palate telangiectasia4ENG CL E G H20223349OMIM:187300Telangiectasia, hereditary hemorrhagic, type 1.186
HP:0011276HP:0000227Tongue telangiectasia4ENG CL E G H20223349OMIM:187300Telangiectasia, hereditary hemorrhagic, type 1.186
HP:0011276HP:0000967Petechiae4ETHE1 CL E G H2347423287OMIM:602473Encephalopathy, ethylmalonic.42
HP:0011276HP:0000967Petechiae4ETHE1 CL E G H2347423287ORPHA:51188Ethylmalonic encephalopathyHP:0040282 - Frequent42
HP:0011276HP:0000967Petechiae4ETV6 CL E G H21203495OMIM:616216Thrombocytopenia 5.13
HP:0011276HP:0031364Ecchymosis4F13A1 CL E G H21623531ORPHA:331Congenital factor XIII deficiencyHP:0040283 - Occasional60
HP:0011276HP:0031364Ecchymosis4F13A1 CL E G H21623531OMIM:613225Factor XIII, A subunit, deficiency of.60
HP:0011276HP:0031364Ecchymosis4F13B CL E G H21653534ORPHA:331Congenital factor XIII deficiencyHP:0040283 - Occasional32
HP:0011276HP:0031364Ecchymosis4F13B CL E G H21653534OMIM:613235Factor XIIIB deficiency.32
HP:0011276HP:0031364Ecchymosis4F2 CL E G H21473535OMIM:613679Congenital prothrombin deficiency.44
HP:0011276HP:0000967Petechiae4FCGR2C CL E G H910315626ORPHA:3002Immune thrombocytopeniaHP:0040282 - Frequent
HP:0011276HP:0000967Petechiae4FERMT3 CL E G H8370623151OMIM:612840Leukocyte adhesion deficiency, type III.23
HP:0011276HP:0031364Ecchymosis4FIP1L1 CL E G H8160819124ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent4
HP:0011276HP:0000967Petechiae4FIP1L1 CL E G H8160819124ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent4
HP:0011276HP:0000967Petechiae4FYB1 CL E G H25334036OMIM:273900THROMBOCYTOPENIA 3; THC34
HP:0011276HP:0000967Petechiae4GATA1 CL E G H26234170OMIM:314050Thrombocytopenia with beta-thalassemia, X-linked.29
HP:0011276HP:0000967Petechiae4GATA1 CL E G H26234170OMIM:300367Thrombocytopenia, X-linked, with or without dyserythropoietic anemia.29
HP:0011276HP:0000967Petechiae4GBA1 CL E G H26294177OMIM:608013Gaucher disease, perinatal lethal.
HP:0011276HP:0031364Ecchymosis4GBA1 CL E G H26294177ORPHA:2072Gaucher disease-ophthalmoplegia-cardiovascular calcification syndromeHP:0040284 - Very rare
HP:0011276HP:0031364Ecchymosis4GFI1B CL E G H83284238OMIM:187900Bleeding disorder, platelet-type, 17.3
HP:0011276HP:0000967Petechiae4GFI1B CL E G H83284238OMIM:187900Bleeding disorder, platelet-type, 17.3
HP:0011276HP:0031364Ecchymosis4GGCX CL E G H26774247OMIM:277450VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 1.129
HP:0011276HP:0031364Ecchymosis4GIMAP5 CL E G H5534018005OMIM:619463PORTAL HYPERTENSION, NONCIRRHOTIC, 2; NCPH2
HP:0011276HP:0000967Petechiae4GIMAP5 CL E G H5534018005OMIM:619463PORTAL HYPERTENSION, NONCIRRHOTIC, 2; NCPH2
HP:0011276HP:0000967Petechiae4GNA14 CL E G H96304382ORPHA:1063Tufted angiomaHP:0040283 - Occasional
HP:0011276HP:0007421Telangiectases of the cheeks4GNPTAB CL E G H7915829670ORPHA:576Mucolipidosis type IIHP:0040283 - Occasional240
HP:0011276HP:0000967Petechiae4GP1BA CL E G H28114439ORPHA:274Bernard-Soulier syndromeHP:0040282 - Frequent23
HP:0011276HP:0031364Ecchymosis4GP1BA CL E G H28114439OMIM:153670Bernard-Soulier syndrome, type A2, autosomal dominant.23
HP:0011276HP:0000967Petechiae4GP1BA CL E G H28114439OMIM:153670Bernard-Soulier syndrome, type A2, autosomal dominant.23
HP:0011276HP:0031364Ecchymosis4GP1BA CL E G H28114439ORPHA:853Fetal and neonatal alloimmune thrombocytopeniaHP:0040283 - Occasional23
HP:0011276HP:0000967Petechiae4GP1BA CL E G H28114439ORPHA:853Fetal and neonatal alloimmune thrombocytopeniaHP:0040282 - Frequent23
HP:0011276HP:0000967Petechiae4GP1BB CL E G H28124440ORPHA:274Bernard-Soulier syndromeHP:0040282 - Frequent8
HP:0011276HP:0031364Ecchymosis4GP1BB CL E G H28124440ORPHA:853Fetal and neonatal alloimmune thrombocytopeniaHP:0040283 - Occasional8
HP:0011276HP:0000967Petechiae4GP1BB CL E G H28124440ORPHA:853Fetal and neonatal alloimmune thrombocytopeniaHP:0040282 - Frequent8
HP:0011276HP:0031364Ecchymosis4GP6 CL E G H5120614388OMIM:614201Bleeding disorder, platelet-type, 11.24
HP:0011276HP:0000967Petechiae4GP9 CL E G H28154444ORPHA:274Bernard-Soulier syndromeHP:0040282 - Frequent21
HP:0011276HP:0000967Petechiae4HOXA11 CL E G H32075101OMIM:605432Radioulnar synostosis with amegakaryocytic thrombocytopenia.3
HP:0011276HP:0031364Ecchymosis4HPS1 CL E G H32575163OMIM:203300Hermansky-Pudlak syndrome 1121
HP:0011276HP:0031364Ecchymosis4HPS6 CL E G H7980318817OMIM:614075Hermansky-Pudlak syndrome 645
HP:0011276HP:0031364Ecchymosis4IFNG CL E G H34585438ORPHA:88Idiopathic aplastic anemiaHP:0040283 - Occasional23
HP:0011276HP:0000967Petechiae4IRF2BP2 CL E G H35994821729ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent4
HP:0011276HP:0031364Ecchymosis4IRF2BP2 CL E G H35994821729ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent4
HP:0011276HP:0031364Ecchymosis4ITGA2 CL E G H36736137ORPHA:853Fetal and neonatal alloimmune thrombocytopeniaHP:0040283 - Occasional119
HP:0011276HP:0000967Petechiae4ITGA2 CL E G H36736137ORPHA:853Fetal and neonatal alloimmune thrombocytopeniaHP:0040282 - Frequent119
HP:0011276HP:0000967Petechiae4ITGA2B CL E G H36746138OMIM:187800Bleeding disorder, platelet-type, 16.69
HP:0011276HP:0031364Ecchymosis4ITGA2B CL E G H36746138ORPHA:853Fetal and neonatal alloimmune thrombocytopeniaHP:0040283 - Occasional69
HP:0011276HP:0000967Petechiae4ITGA2B CL E G H36746138ORPHA:853Fetal and neonatal alloimmune thrombocytopeniaHP:0040282 - Frequent69
HP:0011276HP:0031364Ecchymosis4ITGA2B CL E G H36746138ORPHA:849Glanzmann thrombastheniaHP:0040283 - Occasional69
HP:0011276HP:0031364Ecchymosis4ITGA2B CL E G H36746138OMIM:273800Glanzmann thrombasthenia69
HP:0011276HP:0000967Petechiae4ITGB3 CL E G H36906156ORPHA:853Fetal and neonatal alloimmune thrombocytopeniaHP:0040282 - Frequent80
HP:0011276HP:0031364Ecchymosis4ITGB3 CL E G H36906156ORPHA:853Fetal and neonatal alloimmune thrombocytopeniaHP:0040283 - Occasional80
HP:0011276HP:0031364Ecchymosis4ITGB3 CL E G H36906156ORPHA:849Glanzmann thrombastheniaHP:0040283 - Occasional80
HP:0011276HP:0031364Ecchymosis4JAK2 CL E G H37176192ORPHA:824Primary myelofibrosisHP:0040283 - Occasional57
HP:0011276HP:0000967Petechiae4JAK2 CL E G H37176192ORPHA:824Primary myelofibrosisHP:0040283 - Occasional57
HP:0011276HP:0000214Lip telangiectasia4LBR CL E G H39306518OMIM:613471Reynolds syndrome.70
HP:0011276HP:0000967Petechiae4LCP2 CL E G H39376529OMIM:619374IMMUNODEFICIENCY 81; IMD81
HP:0011276HP:0000967Petechiae4MPL CL E G H43527217ORPHA:824Primary myelofibrosisHP:0040283 - Occasional97
HP:0011276HP:0031364Ecchymosis4MPL CL E G H43527217ORPHA:824Primary myelofibrosisHP:0040283 - Occasional97
HP:0011276HP:0000967Petechiae4NABP1 CL E G H6485926232ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent
HP:0011276HP:0031364Ecchymosis4NABP1 CL E G H6485926232ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent
HP:0011276HP:0000214Lip telangiectasia4NAGA CL E G H46687631ORPHA:79280Alpha-N-acetylgalactosaminidase deficiency type 2HP:0040281 - Very frequent47
HP:0011276HP:0007428Telangiectasia of the oral mucosa4NAGA CL E G H46687631ORPHA:79280Alpha-N-acetylgalactosaminidase deficiency type 2HP:0040281 - Very frequent47
HP:0011276HP:0000214Lip telangiectasia4NAGA CL E G H46687631OMIM:609242Kanzaki disease.47
HP:0011276HP:0007428Telangiectasia of the oral mucosa4NAGA CL E G H46687631OMIM:609242Kanzaki disease.47
HP:0011276HP:0000967Petechiae4NEU1 CL E G H47587758ORPHA:93400Congenital sialidosis type 2HP:0040283 - Occasional43
HP:0011276HP:0031364Ecchymosis4NPM1 CL E G H48697910ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent12
HP:0011276HP:0000967Petechiae4NPM1 CL E G H48697910ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent12
HP:0011276HP:0031364Ecchymosis4NR3C1 CL E G H29087978ORPHA:96253Cushing disease79
HP:0011276HP:0031364Ecchymosis4NUMA1 CL E G H49268059ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent
HP:0011276HP:0000967Petechiae4NUMA1 CL E G H49268059ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent
HP:0011276HP:0000967Petechiae4OCLN CL E G H1005066588104OMIM:251290Band-Like calcification with simplified gyration and polymicrogyria.23
HP:0011276HP:0031364Ecchymosis4P2RY12 CL E G H6480518124OMIM:609821Bleeding disorder, platelet-type, 8.5
HP:0011276HP:0000967Petechiae4PEPD CL E G H51848840OMIM:170100Prolidase deficiency66
HP:0011276HP:0000967Petechiae4PML CL E G H53719113ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent3
HP:0011276HP:0031364Ecchymosis4PML CL E G H53719113ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent3
HP:0011276HP:0007421Telangiectases of the cheeks4POLE CL E G H54269177OMIM:615139Facial dysmorphism, immunodeficiency, livedo, and short stature.1129
HP:0011276HP:0000967Petechiae4PRF1 CL E G H55519360ORPHA:540Familial hemophagocytic lymphohistiocytosisHP:0040282 - Frequent58
HP:0011276HP:0031364Ecchymosis4PRF1 CL E G H55519360ORPHA:540Familial hemophagocytic lymphohistiocytosisHP:0040282 - Frequent58
HP:0011276HP:0031364Ecchymosis4PRF1 CL E G H55519360ORPHA:88Idiopathic aplastic anemiaHP:0040283 - Occasional58
HP:0011276HP:0000967Petechiae4PRKAR1A CL E G H55739388ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent134
HP:0011276HP:0031364Ecchymosis4PRKAR1A CL E G H55739388ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent134
HP:0011276HP:0000967Petechiae4RAB27A CL E G H58739766ORPHA:79477Griscelli syndrome type 2HP:0040283 - Occasional67
HP:0011276HP:0031364Ecchymosis4RARA CL E G H59149864ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent2
HP:0011276HP:0000967Petechiae4RARA CL E G H59149864ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent2
HP:0011276HP:0000967Petechiae4SAMD9 CL E G H548091348OMIM:617053Mirage syndrome.8
HP:0011276HP:0031364Ecchymosis4SBDS CL E G H5111919440ORPHA:88Idiopathic aplastic anemiaHP:0040283 - Occasional26
HP:0011276HP:0007421Telangiectases of the cheeks4SLC2A10 CL E G H8103113444OMIM:208050Arterial tortuosity syndrome.178
HP:0011276HP:0005598Facial telangiectasia in butterfly midface distribution4SOX18 CL E G H5434511194OMIM:137940Hypotrichosis-Lymphedema-Telangiectasia-Renal defect syndrome.7
HP:0011276HP:0031364Ecchymosis4STAT3 CL E G H677411364ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent110
HP:0011276HP:0000967Petechiae4STAT3 CL E G H677411364ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent110
HP:0011276HP:0031364Ecchymosis4STAT5B CL E G H677711367ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent12
HP:0011276HP:0000967Petechiae4STAT5B CL E G H677711367ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent12
HP:0011276HP:0000967Petechiae4STX11 CL E G H867611429ORPHA:540Familial hemophagocytic lymphohistiocytosisHP:0040282 - Frequent85
HP:0011276HP:0031364Ecchymosis4STX11 CL E G H867611429ORPHA:540Familial hemophagocytic lymphohistiocytosisHP:0040282 - Frequent85
HP:0011276HP:0000967Petechiae4STXBP2 CL E G H681311445ORPHA:540Familial hemophagocytic lymphohistiocytosisHP:0040282 - Frequent70
HP:0011276HP:0031364Ecchymosis4STXBP2 CL E G H681311445ORPHA:540Familial hemophagocytic lymphohistiocytosisHP:0040282 - Frequent70
HP:0011276HP:0000967Petechiae4TBL1XR1 CL E G H7971829529ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent22
HP:0011276HP:0031364Ecchymosis4TBL1XR1 CL E G H7971829529ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent22
HP:0011276HP:0031364Ecchymosis4TBXA2R CL E G H691511608OMIM:614009BLEEDING DISORDER, PLATELET-TYPE, 13, SUSCEPTIBILITY TO; BDPLT1310
HP:0011276HP:0031364Ecchymosis4TERC CL E G H701211727ORPHA:88Idiopathic aplastic anemiaHP:0040283 - Occasional48
HP:0011276HP:0031364Ecchymosis4TERT CL E G H701511730ORPHA:88Idiopathic aplastic anemiaHP:0040283 - Occasional238
HP:0011276HP:0031364Ecchymosis4TET2 CL E G H5479025941ORPHA:824Primary myelofibrosisHP:0040283 - Occasional3
HP:0011276HP:0000967Petechiae4TET2 CL E G H5479025941ORPHA:824Primary myelofibrosisHP:0040283 - Occasional3
HP:0011276HP:0031364Ecchymosis4TP53 CL E G H715711998ORPHA:96253Cushing disease911
HP:0011276HP:0000967Petechiae4TREX1 CL E G H1127712269OMIM:225750Aicardi-Goutieres syndrome 156
HP:0011276HP:0000967Petechiae4UNC13D CL E G H20129423147ORPHA:540Familial hemophagocytic lymphohistiocytosisHP:0040282 - Frequent116
HP:0011276HP:0031364Ecchymosis4UNC13D CL E G H20129423147ORPHA:540Familial hemophagocytic lymphohistiocytosisHP:0040282 - Frequent116
HP:0011276HP:0000967Petechiae4USP18 CL E G H1127412616OMIM:617397Pseudo-Torch syndrome 2.2
HP:0011276HP:0031364Ecchymosis4USP48 CL E G H8419618533ORPHA:96253Cushing disease1
HP:0011276HP:0031364Ecchymosis4USP8 CL E G H910112631ORPHA:96253Cushing disease7
HP:0011276HP:0031364Ecchymosis4USP8 CL E G H910112631OMIM:219090Pituitary adenoma 4, ACTH-secreting, somatic.7
HP:0011276HP:0000967Petechiae4WAS CL E G H745412731OMIM:313900Thrombocytopenia 1.65
HP:0011276HP:0000967Petechiae4WAS CL E G H745412731ORPHA:906Wiskott-Aldrich syndromeHP:0040282 - Frequent65
HP:0011276HP:0000967Petechiae4WAS CL E G H745412731OMIM:301000Wiskott-Aldrich syndrome.65
HP:0011276HP:0000967Petechiae4WIPF1 CL E G H745612736ORPHA:906Wiskott-Aldrich syndromeHP:0040282 - Frequent6
HP:0011276HP:0000967Petechiae4ZBTB16 CL E G H770412930ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent1
HP:0011276HP:0031364Ecchymosis4ZBTB16 CL E G H770412930ORPHA:520Acute promyelocytic leukemiaHP:0040282 - Frequent1


Genes (554) :ABCC6 ABCC9 ABL1 ACP5 ACTA2 ACVRL1 ADA2 ADAM17 ADAMTS2 ADAR ADGRE2 AEBP1 AGA AGPAT2 AGXT AIP AKT1 AKT3 ALDH18A1 ALDH3A2 ALOX12B ALOXE3 ALPK1 ANAPC1 ANGPT1 ANKRD26 ANTXR1 ANTXR2 AP1S1 APOE AQP5 ARHGAP31 ARID1B ARL6IP6 ARMC5 ARPC1B ARPC4 ARVCF ARX ASXL1 ATM ATP2C1 ATP6 ATP6V0A2 ATP6V1A ATP6V1E1 ATP7A ATP7B ATR ATRX B3GALT6 BANF1 BCOR BLM BLOC1S3 BLOC1S5 BMP2 BMPR2 BRAF BRD4 BSCL2 C1R C1S C2 C4A CALR CARMIL2 CASP10 CASZ1 CAV1 CAVIN1 CBL CBS CCM2 CCN2 CCR6 CD109 CD19 CD28 CD81 CDH23 CDKN1B CFH CFHR1 CFHR3 CHST14 CIB1 CLCN7 CLEC7A COG4 COG8 COL1A1 COL1A2 COL3A1 COL5A1 COL5A2 COL7A1 COMT COX1 COX2 COX3 COX7B CPN1 CR2 CREB3L1 CSTA CTC1 CTLA4 CTNNB1 CTSA CTSB CYLD CYTB DAXX DDB2 DDR2 DDX11 DHCR7 DIAPH1 DKC1 DLL4 DNAJC30 DNASE1L3 DOCK6 DPM1 DSE DSG4 DSP DST DTNBP1 EGFR ELMO2 ELN ELOVL4 EMILIN1 ENG ENPP1 EOGT EPHB2 EPHB4 ERCC2 ERCC3 ERCC4 ERCC5 ERCC6 ETHE1 ETV6 F10 F12 F13A1 F13B F2 F5 F7 F8 FANCA FANCC FANCD2 FANCE FAS FASLG FBN1 FCGR2C FECH FERMT1 FERMT3 FGA FGB FGG FIP1L1 FKBP14 FLNA FLT4 FOS FOXE3 FOXP3 FRG1 FTO FUCA1 FYB1 FZD4 G6PC3 GABRD GATA1 GATA2 GBA1 GDF2 GFI1B GGCX GIMAP5 GJA1 GJA5 GJA8 GJB3 GJB4 GLA GLB1 GLUL GNA11 GNA14 GNAQ GNAS GNB2 GNPTAB GP1BA GP1BB GP6 GP9 GPR35 GSN GUCY1A1 H4C3 HBA1 HBA2 HCCS HDAC8 HEATR3 HEY2 HFE HIRA HLA-B HLA-DPA1 HLA-DPB1 HLA-DQB1 HLA-DRB1 HOXA11 HPGD HPS1 HPS3 HPS4 HPS5 HPS6 HS3ST6 HSPG2 IARS2 ICOS IFIH1 IFNG IKBKG IKZF1 IL12A IL12RB1 IL17F IL17RA IL17RC IL36RN IL7 IPO8 IRF2BP2 IRF5 ITGA2 ITGA2B ITGA3 ITGB3 JAK2 JAM2 JMJD1C KCNAB2 KCNQ2 KDSR KIAA0319L KIT KLLN KNG1 KRAS KRIT1 KRT1 KRT10 KRT14 KRT2 KRT5 KRT83 LARP7 LBR LCP2 LEMD2 LIG1 LIG4 LIPN LMAN1 LMNA LMX1B LORICRIN LOX LRP1 LRP5 LSM11 LUZP1 LYST MANBA MAP2K1 MAPK1 MASP1 MAT2A MBTPS2 MCFD2 MEFV MFAP5 MMEL1 MMP23B MPL MRE11 MS4A1 MST1 MTAP MVK MYD88 MYH11 MYH9 MYLK MYOF MYORG NABP1 NAGA NAXD NBEAL2 ND1 ND2 ND4 ND4L ND5 ND6 NDP NDUFB11 NDUFS2 NEU1 NF1 NFIA NFIX NFKB1 NFKB2 NHP2 NIPBL NLRC4 NLRP12 NLRP3 NOD2 NOP10 NOTCH1 NPM1 NR3C1 NSDHL NSUN2 NTRK1 NUMA1 OCLN ODC1 ORAI1 P2RY12 PARN PCNA PDCD10 PDE11A PDE8B PDGFB PDGFRB PDPN PDSS1 PEPD PERP PEX6 PGAP2 PGAP3 PGM3 PIGL PIGO PIGT PIGV PIGW PIGY PIK3CA PLAU PLCG2 PLEC PLG PLOD1 PLOD3 PML POLA1 POLD1 POLE POLH POLR3A PORCN POU2AF1 PPARG PPP1R15B PRDM16 PRDM5 PRF1 PRKACA PRKACG PRKAR1A PRKCD PRKCZ PRKG1 PROC PROS1 PRTN3 PSMB8 PSMG2 PTDSS1 PTEN PTPN11 PTPN22 PYCR1 RAB27A RAC2 RAD21 RARA RASA1 RASGRP1 RBPJ RECQL4 RERE RHOH RIN2 RNASEH2A RNASEH2B RNASEH2C RNF113A RNF168 RNF213 RNU7-1 RPS6KA3 RREB1 RTEL1 RUNX1 SAMD9 SAMHD1 SBDS SCARB2 SCN10A SCN11A SCN9A SDHB SDHC SDHD SEC23B SEC24C SEMA4D SERPINE1 SERPINF2 SERPING1 SETX SF3B4 SH2B3 SIK3 SKI SLC20A2 SLC25A24 SLC27A4 SLC29A3 SLC2A10 SLC35A1 SLC37A4 SLC39A13 SLC39A4 SLC51A SLFN14 SLURP1 SMAD2 SMAD3 SMAD4 SMC1A SMC3 SNX10 SOS1 SOX18 SPEN SPIB SPINK5 SPRED2 SREBF1 SRSF2 STAG1 STAT3 STAT5B STIM1 STING1 STN1 STX11 STXBP1 STXBP2 SULT2B1 SUPT16H SYK TALDO1 TBL1XR1 TBX1 TBXA2R TCF4 TCIRG1 TERC TERT TET2 TFR2 TGFB2 TGFB3 TGFBR1 TGFBR2 TGM1 TGM5 TINF2 TMC6 TMC8 TNFRSF13B TNFRSF13C TNFRSF1A TNFRSF1B TNFSF11 TNFSF12 TNFSF15 TNPO3 TNXB TP53 TRAF3IP2 TREX1 TRNF TRNH TRNL1 TRNQ TRNS1 TRNS2 TRNW TRPM4 TRPV3 TSPAN12 TYMS UBE4B UFD1 UNC13D USB1 USF3 USP18 USP48 USP8 UVSSA VPS53 VWF WAS WIPF1 WNT10A WRAP53 WRN XPA XPC XPNPEP2 XPR1 XRCC4 ZBTB16 ZMPSTE24 ZNF408 ZNF469

Diseases (501) :ORPHA:758 OMIM:619719 OMIM:617602 OMIM:607944 OMIM:611788 ORPHA:91387 ORPHA:2573 ORPHA:774 OMIM:600376 OMIM:182410 ORPHA:820 OMIM:615688 OMIM:614328 ORPHA:294023 OMIM:225410 ORPHA:51 OMIM:125630 ORPHA:536532 OMIM:618000 OMIM:208400 ORPHA:93 ORPHA:528 OMIM:259900 OMIM:219090 ORPHA:201 ORPHA:744 OMIM:615937 OMIM:219150 ORPHA:816 OMIM:242100 OMIM:606545 OMIM:614979 ORPHA:221008 OMIM:619361 OMIM:188000 OMIM:230740 ORPHA:2176 OMIM:609313 ORPHA:158029 ORPHA:2337 ORPHA:974 OMIM:100300 OMIM:135900 ORPHA:1556 ORPHA:189427 OMIM:617718 OMIM:620141 ORPHA:567 ORPHA:94083 ORPHA:98850 ORPHA:98849 ORPHA:100 OMIM:208900 OMIM:169600 ORPHA:2841 ORPHA:104 ORPHA:357074 ORPHA:2834 ORPHA:565 ORPHA:198 OMIM:304150 ORPHA:905 OMIM:614564 ORPHA:231401 ORPHA:96253 ORPHA:100075 ORPHA:536467 OMIM:614008 ORPHA:520 ORPHA:125 OMIM:210900 OMIM:614077 OMIM:619172 OMIM:235200 OMIM:178600 OMIM:163950 ORPHA:199 OMIM:130080 OMIM:617174 OMIM:217000 OMIM:614380 OMIM:254450 ORPHA:824 OMIM:618131 ORPHA:3261 OMIM:603909 ORPHA:1606 ORPHA:220393 ORPHA:220402 OMIM:606721 ORPHA:394 OMIM:236200 OMIM:603284 ORPHA:221061 ORPHA:853 ORPHA:1572 ORPHA:2584 OMIM:613496 ORPHA:276152 OMIM:235400 OMIM:601776 ORPHA:2953 ORPHA:302 ORPHA:667 OMIM:611490 ORPHA:1334 OMIM:618150 ORPHA:95428 ORPHA:287 OMIM:619115 ORPHA:31112 OMIM:130060 OMIM:166200 ORPHA:230851 OMIM:619120 OMIM:617821 OMIM:225320 ORPHA:2500 OMIM:130050 OMIM:618343 ORPHA:286 OMIM:130000 OMIM:130010 ORPHA:158673 ORPHA:550 ORPHA:2556 OMIM:212070 OMIM:616229 ORPHA:263534 OMIM:612199 ORPHA:1775 ORPHA:900 ORPHA:891 OMIM:256540 ORPHA:50943 OMIM:148370 ORPHA:211 ORPHA:867 ORPHA:910 OMIM:278740 OMIM:618175 OMIM:613398 ORPHA:818 OMIM:616589 OMIM:619382 ORPHA:36412 OMIM:614219 OMIM:608799 OMIM:607903 OMIM:615821 OMIM:607655 OMIM:614653 OMIM:614076 ORPHA:3019 OMIM:614457 ORPHA:1955 OMIM:620080 OMIM:187300 OMIM:615297 OMIM:618462 ORPHA:137667 OMIM:618196 OMIM:601675 OMIM:278730 ORPHA:220295 OMIM:278760 OMIM:278800 OMIM:600630 OMIM:602473 ORPHA:51188 OMIM:616216 ORPHA:328 OMIM:610618 ORPHA:331 OMIM:613225 OMIM:613235 OMIM:613679 ORPHA:326 OMIM:227400 ORPHA:327 ORPHA:177926 OMIM:306700 ORPHA:169805 ORPHA:169802 OMIM:227650 OMIM:227645 OMIM:227646 OMIM:600901 OMIM:601859 OMIM:616914 ORPHA:3002 ORPHA:79278 OMIM:177000 ORPHA:2908 OMIM:173650 OMIM:612840 OMIM:202400 OMIM:614557 ORPHA:300179 ORPHA:75497 OMIM:153100 ORPHA:37042 OMIM:158900 OMIM:612938 OMIM:230000 ORPHA:349 OMIM:273900 OMIM:612541 OMIM:314050 OMIM:300367 ORPHA:3226 ORPHA:77259 OMIM:608013 ORPHA:2072 OMIM:615506 OMIM:187900 OMIM:277450 OMIM:619463 ORPHA:1010 ORPHA:317 OMIM:617525 OMIM:104100 OMIM:612474 OMIM:617524 ORPHA:324 OMIM:301500 OMIM:230500 OMIM:610015 ORPHA:1063 ORPHA:3205 OMIM:219080 OMIM:619503 ORPHA:576 ORPHA:274 OMIM:153670 OMIM:231200 OMIM:614201 ORPHA:171 ORPHA:85448 OMIM:615750 ORPHA:401945 OMIM:619758 ORPHA:98791 OMIM:300882 OMIM:620072 ORPHA:36426 ORPHA:703 OMIM:605432 OMIM:259100 OMIM:203300 OMIM:614072 OMIM:614073 OMIM:614074 OMIM:614075 OMIM:619367 OMIM:616007 OMIM:615846 ORPHA:88 OMIM:308300 ORPHA:464 ORPHA:186 ORPHA:319552 OMIM:614204 ORPHA:60030 OMIM:619472 OMIM:187800 OMIM:273800 ORPHA:849 OMIM:614748 OMIM:619267 ORPHA:729 ORPHA:1980 ORPHA:439218 OMIM:617526 ORPHA:316 ORPHA:280785 ORPHA:79455 OMIM:606764 OMIM:154800 OMIM:619363 OMIM:609942 ORPHA:530838 OMIM:607602 ORPHA:79396 ORPHA:455 ORPHA:158681 OMIM:609352 ORPHA:319671 OMIM:613471 ORPHA:779 OMIM:619374 OMIM:619322 OMIM:619774 ORPHA:235 ORPHA:99812 OMIM:606593 OMIM:613943 ORPHA:35909 ORPHA:79474 ORPHA:740 OMIM:151660 ORPHA:495818 ORPHA:79100 OMIM:604093 ORPHA:352723 ORPHA:167 OMIM:214500 OMIM:248510 OMIM:619087 OMIM:257920 ORPHA:2273 OMIM:308800 ORPHA:659 ORPHA:342 OMIM:608068 OMIM:604391 OMIM:112250 ORPHA:343 ORPHA:33226 OMIM:132900 ORPHA:229 OMIM:155100 ORPHA:182050 OMIM:619366 ORPHA:79279 ORPHA:79280 OMIM:609242 OMIM:618321 OMIM:139090 ORPHA:721 ORPHA:93400 ORPHA:812 ORPHA:97685 ORPHA:401986 OMIM:613735 ORPHA:561 OMIM:614753 OMIM:122470 OMIM:616050 OMIM:616115 OMIM:611762 ORPHA:1451 OMIM:617772 OMIM:120100 ORPHA:47045 ORPHA:575 ORPHA:90340 OMIM:308050 ORPHA:642 OMIM:251290 ORPHA:544488 ORPHA:3204 OMIM:609821 OMIM:615919 ORPHA:438134 ORPHA:1359 OMIM:610475 ORPHA:189439 OMIM:614651 ORPHA:742 OMIM:170100 ORPHA:95433 ORPHA:247262 OMIM:615816 ORPHA:443811 ORPHA:3474 OMIM:615399 ORPHA:276280 OMIM:602501 ORPHA:60040 OMIM:601709 OMIM:614878 OMIM:614468 OMIM:131950 OMIM:619360 OMIM:225400 ORPHA:1900 OMIM:612394 OMIM:301220 OMIM:615381 OMIM:615139 ORPHA:90342 OMIM:278750 ORPHA:3455 OMIM:264090 ORPHA:2092 OMIM:305600 OMIM:604367 ORPHA:79083 OMIM:616817 ORPHA:90354 ORPHA:540 OMIM:615830 OMIM:616176 OMIM:610489 ORPHA:745 OMIM:612304 ORPHA:743 OMIM:614514 OMIM:612336 OMIM:256040 OMIM:619183 OMIM:151050 ORPHA:109 OMIM:612940 OMIM:614438 ORPHA:79477 OMIM:618987 OMIM:614701 ORPHA:90307 ORPHA:221016 OMIM:268400 OMIM:618307 OMIM:613075 ORPHA:217335 OMIM:300953 ORPHA:420741 OMIM:303600 OMIM:601399 OMIM:617053 ORPHA:90026 ORPHA:100093 ORPHA:465 ORPHA:79 OMIM:262850 OMIM:106100 ORPHA:100050 OMIM:606002 OMIM:154400 OMIM:618162 OMIM:612289 OMIM:608649 ORPHA:168569 OMIM:602782 OMIM:208050 ORPHA:3342 OMIM:603585 ORPHA:238459 ORPHA:79259 OMIM:232240 OMIM:612350 ORPHA:157965 ORPHA:37 OMIM:201100 OMIM:619484 OMIM:616913 ORPHA:87503 OMIM:248300 ORPHA:284984 OMIM:613795 OMIM:175050 OMIM:300590 OMIM:610759 OMIM:610733 OMIM:607823 ORPHA:69735 OMIM:137940 OMIM:256500 ORPHA:634 OMIM:619745 OMIM:619016 ORPHA:502434 OMIM:147060 OMIM:615934 OMIM:617341 OMIM:617571 OMIM:619480 OMIM:619381 ORPHA:101028 OMIM:606003 OMIM:614009 OMIM:604250 OMIM:614816 OMIM:615582 ORPHA:281127 OMIM:609796 ORPHA:32960 ORPHA:230839 OMIM:606408 OMIM:225750 ORPHA:247691 OMIM:192315 OMIM:604173 OMIM:617397 OMIM:614640 OMIM:615851 OMIM:193400 OMIM:613554 OMIM:277480 OMIM:313900 ORPHA:906 OMIM:301000 OMIM:257980 ORPHA:50944 ORPHA:902 OMIM:278700 OMIM:278720 OMIM:300909 ORPHA:100057 OMIM:608612 OMIM:275210
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.